"Protein","Cluster","Silo","0","3","5","7","9","11","13","15","Avg","StDev","CoeffcientVariance","Variance","Median","Slope","Kurtosis","Skewness","Max","Min","Range","X1st_quartile","X4th_quartile","Sum","Day0.Day15","Day3.Day15","Avg_Day0.7","Avg_Day9.15","X1sthalf.2ndhalf","Range_Day0.7","Range_Day9.15","Sum.TotalProteinIDs","High.Low","Variability","Tag","column1","column2","column3","column4","column5","column6","column7","column8","column9","column10","column11","column12","column13","clean","Entry","Entry.name","Status","Protein.names","Gene.names","Organism","Length","Gene.ontology..biological.process.","Gene.ontology.IDs","Pathway","Cross.reference..UniPathway.","Cross.reference..CDD.","Cross.reference..Pfam.","Gene.ontology..GO."
"CHOYP_AAEL_AAEL007173.1.1|m.41471",48,"3",9,10,10,0,8,15.5,15,7.5,13.6428571429,5.0050994404,"0.3668659276",25.0510204082,15,"#VALUE!","-1.6765233594","-0.4617527624",19.5,6,13.5,9.5,19.5,95.5,"0.8857142857","0.3428571429",12,15.75,-3.75,9.5,12,1.1311145327,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_AAEL_AAEL007173.1.1|m.41471","O43399","TPD54_HUMAN","35.71","182","84","3","50","231","55","203","3.00E-27","108","1","O43399","TPD54_HUMAN","reviewed","Tumor protein D54 (hD54) (Tumor protein D52-like 2)","TPD52L2","Homo sapiens (Human)","206","regulation of cell proliferation [GO:0042127]","GO:0003723; GO:0005737; GO:0042127; GO:0042803; GO:0046982; GO:0048471","","","","PF04201;","cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; regulation of cell proliferation [GO:0042127]"
"CHOYP_AAEL_AAEL007173.1.1|m.41471",37,"9",9,0,18.5,0,13.5,6,19.5,17.5,13.6428571429,5.0050994404,"0.3668659276",25.0510204082,15,"#VALUE!","-1.6765233594","-0.4617527624",19.5,6,13.5,9.5,19.5,95.5,"0.8857142857","0.3428571429",12,15.75,-3.75,9.5,12,1.1311145327,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_AAEL_AAEL007173.1.1|m.41471","O43399","TPD54_HUMAN","35.71","182","84","3","50","231","55","203","3.00E-27","108","1","O43399","TPD54_HUMAN","reviewed","Tumor protein D54 (hD54) (Tumor protein D52-like 2)","TPD52L2","Homo sapiens (Human)","206","regulation of cell proliferation [GO:0042127]","GO:0003723; GO:0005737; GO:0042127; GO:0042803; GO:0046982; GO:0048471","","","","PF04201;","cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; regulation of cell proliferation [GO:0042127]"
"CHOYP_AAEL_AAEL008069.2.2|m.60920",37,"3",10,7,12.5,24.5,28,41,30,37,40.7142857143,13.1796844284,"0.3237115474",173.7040816327,37,"#VALUE!","-2.0020304488","0.3400107729",59.5,25,34.5,29,59.5,285,"0.7192982456","1.0438596491",39.625,41.875,-2.25,31.5,32,3.3755774014,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_AAEL_AAEL008069.2.2|m.60920","P46531","NOTC1_HUMAN","32.8","625","331","23","1703","2308","306","860","6.00E-68","261","1","P46531","NOTC1_HUMAN","reviewed","Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]","NOTCH1 TAN1","Homo sapiens (Human)","2555","animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; humoral immune response [GO:0006959]; immune response [GO:0006955]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; in utero embryonic development [GO:0001701]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of auditory receptor cell differentiation [GO:0045608]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; transcription initiation from RNA polymerase II promoter [GO:0006367]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]","GO:0000122; GO:0000139; GO:0001047; GO:0001190; GO:0001669; GO:0001701; GO:0001708; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002193; GO:0002437; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003256; GO:0003270; GO:0003273; GO:0003344; GO:0003700; GO:0004857; GO:0004872; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006367; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009986; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016021; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031960; GO:0032495; GO:0032496; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0043065; GO:0043086; GO:0043235; GO:0043565; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0050679; GO:0050768; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061314; GO:0061384; GO:0061419; GO:0070986; GO:0071372; GO:0072017; GO:0072044; GO:0072144; GO:0072602; GO:0090051; GO:0090090; GO:0097150; GO:1901201; GO:1902263; GO:1903849; GO:2000737; GO:2000811; GO:2000974; GO:2001027","","","","PF12796;PF11936;PF00008;PF07645;PF12661;PF06816;PF07684;PF00066;","acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; core promoter binding [GO:0001047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; receptor activity [GO:0004872]; sequence-specific DNA binding [GO:0043565]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; transcriptional activator activity, RNA polymerase II transcription factor binding [GO:0001190]; animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of auditory receptor cell differentiation [GO:0045608]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; regulation of transcription, DNA-templated [GO:0006355]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; transcription initiation from RNA polymerase II promoter [GO:0006367]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]"
"CHOYP_AAEL_AAEL008069.2.2|m.60920",79,"9",10,10,27.5,21.5,44.5,59.5,48.5,57,40.7142857143,13.1796844284,"0.3237115474",173.7040816327,37,"#VALUE!","-2.0020304488","0.3400107729",59.5,25,34.5,29,59.5,285,"0.7192982456","1.0438596491",39.625,41.875,-2.25,31.5,32,3.3755774014,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_AAEL_AAEL008069.2.2|m.60920","P46531","NOTC1_HUMAN","32.8","625","331","23","1703","2308","306","860","6.00E-68","261","1","P46531","NOTC1_HUMAN","reviewed","Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]","NOTCH1 TAN1","Homo sapiens (Human)","2555","animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; humoral immune response [GO:0006959]; immune response [GO:0006955]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; in utero embryonic development [GO:0001701]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of auditory receptor cell differentiation [GO:0045608]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; transcription initiation from RNA polymerase II promoter [GO:0006367]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]","GO:0000122; GO:0000139; GO:0001047; GO:0001190; GO:0001669; GO:0001701; GO:0001708; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002193; GO:0002437; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003256; GO:0003270; GO:0003273; GO:0003344; GO:0003700; GO:0004857; GO:0004872; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006367; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009986; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016021; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031960; GO:0032495; GO:0032496; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0043065; GO:0043086; GO:0043235; GO:0043565; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0050679; GO:0050768; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061314; GO:0061384; GO:0061419; GO:0070986; GO:0071372; GO:0072017; GO:0072044; GO:0072144; GO:0072602; GO:0090051; GO:0090090; GO:0097150; GO:1901201; GO:1902263; GO:1903849; GO:2000737; GO:2000811; GO:2000974; GO:2001027","","","","PF12796;PF11936;PF00008;PF07645;PF12661;PF06816;PF07684;PF00066;","acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; core promoter binding [GO:0001047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; receptor activity [GO:0004872]; sequence-specific DNA binding [GO:0043565]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; transcriptional activator activity, RNA polymerase II transcription factor binding [GO:0001190]; animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of auditory receptor cell differentiation [GO:0045608]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; regulation of transcription, DNA-templated [GO:0006355]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; transcription initiation from RNA polymerase II promoter [GO:0006367]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]"
"CHOYP_ABCE1.2.2|m.42246",37,"3",9.5,15.5,25.5,6.5,20.5,3,16.5,9,12.8571428571,4.0418726717,"0.3143678745",16.3367346939,12.5,"#VALUE!","-2.0147883057","-0.0735243617",18,7,11,9.5,18,90,"0.3","1.25",9.75,13.5,-3.75,13.5,9,1.065971811,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ABCE1.2.2|m.42246","P61222","ABCE1_MOUSE","83.95","598","96","0","14","611","2","599","0","1063","1","P61222","ABCE1_MOUSE","reviewed","ATP-binding cassette sub-family E member 1 (RNase L inhibitor) (Ribonuclease 4 inhibitor) (RNS4I)","Abce1 Rli","Mus musculus (Mouse)","599","negative regulation of endoribonuclease activity [GO:0060702]; ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415]","GO:0000054; GO:0005506; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006413; GO:0006415; GO:0016020; GO:0016887; GO:0043024; GO:0060698; GO:0060702","","","cd03236;","PF00005;PF00037;PF04068;","cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; endoribonuclease inhibitor activity [GO:0060698]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]; negative regulation of endoribonuclease activity [GO:0060702]; ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415]"
"CHOYP_ABCE1.2.2|m.42246",48,"9",9.5,22,15,2,11,12.5,18,10,12.8571428571,4.0418726717,"0.3143678745",16.3367346939,12.5,"#VALUE!","-2.0147883057","-0.0735243617",18,7,11,9.5,18,90,"0.3","1.25",9.75,13.5,-3.75,13.5,9,1.065971811,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ABCE1.2.2|m.42246","P61222","ABCE1_MOUSE","83.95","598","96","0","14","611","2","599","0","1063","1","P61222","ABCE1_MOUSE","reviewed","ATP-binding cassette sub-family E member 1 (RNase L inhibitor) (Ribonuclease 4 inhibitor) (RNS4I)","Abce1 Rli","Mus musculus (Mouse)","599","negative regulation of endoribonuclease activity [GO:0060702]; ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415]","GO:0000054; GO:0005506; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006413; GO:0006415; GO:0016020; GO:0016887; GO:0043024; GO:0060698; GO:0060702","","","cd03236;","PF00005;PF00037;PF04068;","cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; endoribonuclease inhibitor activity [GO:0060698]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]; negative regulation of endoribonuclease activity [GO:0060702]; ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415]"
"CHOYP_ACT.23.27|m.58454",34,"3",79,47,39,65,32,77,67,54,61.5714285714,37.3787836799,"0.6070800134",1397.1734693878,67,"#VALUE!","1.1217908649","0.2432875424",130,0,130,43.25,130,431,"0.5923076923","0.6153846154",64.125,62.875,1.25,47.5,130,5.1048205614,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ACT.23.27|m.58454","P86700","ACT_CHIOP","45.43","350","33","8","20","369","1","192","1.00E-77","244","1","P86700","ACT_CHIOP","reviewed","Actin, muscle (Alpha-actin) (Fragments)","","Chionoecetes opilio (Crab-beetle)","192","","GO:0005524; GO:0005737; GO:0005856","","","","PF00022;","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]"
"CHOYP_ACT.23.27|m.58454",73,"9",79,0,31,69.5,37,80,0,130,61.5714285714,37.3787836799,"0.6070800134",1397.1734693878,67,"#VALUE!","1.1217908649","0.2432875424",130,0,130,43.25,130,431,"0.5923076923","0.6153846154",64.125,62.875,1.25,47.5,130,5.1048205614,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ACT.23.27|m.58454","P86700","ACT_CHIOP","45.43","350","33","8","20","369","1","192","1.00E-77","244","1","P86700","ACT_CHIOP","reviewed","Actin, muscle (Alpha-actin) (Fragments)","","Chionoecetes opilio (Crab-beetle)","192","","GO:0005524; GO:0005737; GO:0005856","","","","PF00022;","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]"
"CHOYP_ACT.5.27|m.15585",47,"3",0,189.5,0,0,0,0,0,0,0,0,"#DIV/0!",0,0,"#VALUE!","#DIV/0!","Err:502",0,0,0,0,0,0,"#DIV/0!","#DIV/0!",0,0,0,0,0,0,"low_abundance","low_variance","low_abundance-low_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_ACT.5.27|m.15585",48,"9",0,0,0,0,0,0,0,0,0,0,"#DIV/0!",0,0,"#VALUE!","#DIV/0!","Err:502",0,0,0,0,0,0,"#DIV/0!","#DIV/0!",0,0,0,0,0,0,"low_abundance","low_variance","low_abundance-low_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_ACT.6.27|m.15622",46,"3",0,0,0,86.5,0,0,83,79,36.2142857143,41.9556374067,"1.158538311",1760.2755102041,0,"#VALUE!","-2.7040570179","0.4004934455",91.5,0,91.5,0,91.5,253.5,"0","0",20.75,42.625,-21.875,83,91.5,3.0024872676,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ACT.6.27|m.15622","Q39596","ACT_OXYRB","98.82","85","1","0","3","87","1","85","2.00E-54","177","1","Q39596","ACT_OXYRB","reviewed","Actin (Fragment)","","Oxybasis rubra (Red goosefoot) (Chenopodium rubrum)","85","","GO:0005524; GO:0005737; GO:0005856","","","","PF00022;","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]"
"CHOYP_ACT.6.27|m.15622",80,"9",0,0,0,0,0,0,0,91.5,36.2142857143,41.9556374067,"1.158538311",1760.2755102041,0,"#VALUE!","-2.7040570179","0.4004934455",91.5,0,91.5,0,91.5,253.5,"0","0",20.75,42.625,-21.875,83,91.5,3.0024872676,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ACT.6.27|m.15622","Q39596","ACT_OXYRB","98.82","85","1","0","3","87","1","85","2.00E-54","177","1","Q39596","ACT_OXYRB","reviewed","Actin (Fragment)","","Oxybasis rubra (Red goosefoot) (Chenopodium rubrum)","85","","GO:0005524; GO:0005737; GO:0005856","","","","PF00022;","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]"
"CHOYP_ACT3.3.3|m.66907",28,"3",86.5,48,83,46.5,58,67,75,55,57.5,21.2317148221,"0.3692472143",450.7857142857,56,"#VALUE!","2.0826040736","-0.9913413433",87,14,73,53.25,87,402.5,"1.046875","0.8046875",51.875,65.5,-13.625,61,32,4.7672628213,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ACT3.3.3|m.66907","Q25379","ACT3_LYTPI","94.19","172","10","0","122","293","1","172","9.00E-119","345","1","Q25379","ACT3_LYTPI","reviewed","Actin, cytoskeletal 3 (LPC3) (Fragment)","","Lytechinus pictus (Painted sea urchin)","172","","GO:0005524; GO:0005737; GO:0005856","","","","PF00022;","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]"
"CHOYP_ACT3.3.3|m.66907",23,"9",86.5,65.5,57.5,46,84,51.5,87,64,57.5,21.2317148221,"0.3692472143",450.7857142857,56,"#VALUE!","2.0826040736","-0.9913413433",87,14,73,53.25,87,402.5,"1.046875","0.8046875",51.875,65.5,-13.625,61,32,4.7672628213,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ACT3.3.3|m.66907","Q25379","ACT3_LYTPI","94.19","172","10","0","122","293","1","172","9.00E-119","345","1","Q25379","ACT3_LYTPI","reviewed","Actin, cytoskeletal 3 (LPC3) (Fragment)","","Lytechinus pictus (Painted sea urchin)","172","","GO:0005524; GO:0005737; GO:0005856","","","","PF00022;","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]"
"CHOYP_ACT5.3.3|m.41147",48,"3",0,8.5,0,8,10,7,6,28,13.6428571429,11.9842583825,"0.878427316",143.6224489796,13,"#VALUE!","-1.0523133212","0.6220544544",33.5,0,33.5,3.5,33.5,95.5,"7","0",6.75,18.875,-12.125,14,32.5,1.1311145327,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ACT5.3.3|m.41147","Q9P7X7","ARP4_SCHPO","30.73","371","183","10","129","443","63","415","1.00E-40","155","1","Q9P7X7","ARP4_SCHPO","reviewed","Actin-related protein 4 (Actin-like protein arp4) (Actin-like protein 4) (Altered polarity protein 5)","alp5 arp4 SPBP23A10.08","Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)","433","chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; histone exchange [GO:0043486]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]","GO:0000812; GO:0005634; GO:0006281; GO:0006338; GO:0006351; GO:0006355; GO:0031011; GO:0035267; GO:0043189; GO:0043486; GO:0043981; GO:0043982; GO:0043983","","","","PF00022;","H4/H2A histone acetyltransferase complex [GO:0043189]; Ino80 complex [GO:0031011]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; histone exchange [GO:0043486]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
"CHOYP_ACT5.3.3|m.41147",37,"9",0,16.5,0,2,4,0,33.5,1,13.6428571429,11.9842583825,"0.878427316",143.6224489796,13,"#VALUE!","-1.0523133212","0.6220544544",33.5,0,33.5,3.5,33.5,95.5,"7","0",6.75,18.875,-12.125,14,32.5,1.1311145327,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ACT5.3.3|m.41147","Q9P7X7","ARP4_SCHPO","30.73","371","183","10","129","443","63","415","1.00E-40","155","1","Q9P7X7","ARP4_SCHPO","reviewed","Actin-related protein 4 (Actin-like protein arp4) (Actin-like protein 4) (Altered polarity protein 5)","alp5 arp4 SPBP23A10.08","Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)","433","chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; histone exchange [GO:0043486]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]","GO:0000812; GO:0005634; GO:0006281; GO:0006338; GO:0006351; GO:0006355; GO:0031011; GO:0035267; GO:0043189; GO:0043486; GO:0043981; GO:0043982; GO:0043983","","","","PF00022;","H4/H2A histone acetyltransferase complex [GO:0043189]; Ino80 complex [GO:0031011]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; histone exchange [GO:0043486]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
"CHOYP_ACTN.1.2|m.15252",17,"3",80,106.5,104,91,86.5,102,98,108,102.2857142857,20.056807079,"0.1960861027",402.2755102041,108,"#VALUE!","2.1816793499","-1.3412271791",126,60,66,95.75,126,716,"0.8908296943","1.0131004367",94,110.5,-16.5,56,32.5,8.4803979628,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ACTN.1.2|m.15252","P18091","ACTN_DROME","74.78","896","189","4","72","934","33","924","0","1405","1","P18091","ACTN_DROME","reviewed","Alpha-actinin, sarcomeric (F-actin cross-linking protein)","Actn fliA l(1)2Cb CG4376","Drosophila melanogaster (Fruit fly)","924","actin cytoskeleton reorganization [GO:0031532]; cytoskeletal anchoring at plasma membrane [GO:0007016]; flight behavior [GO:0007629]; sarcomere organization [GO:0045214]","GO:0003779; GO:0005509; GO:0005925; GO:0007016; GO:0007629; GO:0030018; GO:0031532; GO:0045214","","","cd00014;cd00051;","PF00307;PF13405;PF08726;PF00435;","focal adhesion [GO:0005925]; Z disc [GO:0030018]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; actin cytoskeleton reorganization [GO:0031532]; cytoskeletal anchoring at plasma membrane [GO:0007016]; flight behavior [GO:0007629]; sarcomere organization [GO:0045214]"
"CHOYP_ACTN.1.2|m.15252",64,"9",80,101,94.5,88,107,116,126,114.5,102.2857142857,20.056807079,"0.1960861027",402.2755102041,108,"#VALUE!","2.1816793499","-1.3412271791",126,60,66,95.75,126,716,"0.8908296943","1.0131004367",94,110.5,-16.5,56,32.5,8.4803979628,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ACTN.1.2|m.15252","P18091","ACTN_DROME","74.78","896","189","4","72","934","33","924","0","1405","1","P18091","ACTN_DROME","reviewed","Alpha-actinin, sarcomeric (F-actin cross-linking protein)","Actn fliA l(1)2Cb CG4376","Drosophila melanogaster (Fruit fly)","924","actin cytoskeleton reorganization [GO:0031532]; cytoskeletal anchoring at plasma membrane [GO:0007016]; flight behavior [GO:0007629]; sarcomere organization [GO:0045214]","GO:0003779; GO:0005509; GO:0005925; GO:0007016; GO:0007629; GO:0030018; GO:0031532; GO:0045214","","","cd00014;cd00051;","PF00307;PF13405;PF08726;PF00435;","focal adhesion [GO:0005925]; Z disc [GO:0030018]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; actin cytoskeleton reorganization [GO:0031532]; cytoskeletal anchoring at plasma membrane [GO:0007016]; flight behavior [GO:0007629]; sarcomere organization [GO:0045214]"
"CHOYP_AGAP_AGAP002739.1.5|m.19925",22,"3",51,45.5,80.5,89.5,81.5,77,64,22,44,27.0686956781,"0.615197629",732.7142857143,42.5,"#VALUE!","-2.1434196939","0.0638713276",80,8.5,71.5,19.25,80,308,"1.033557047","0.5704697987",48,48.25,-0.25,68.5,63.5,3.6479924198,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_AGAP_AGAP002739.1.5|m.19925","Q04721","NOTC2_HUMAN","32.95","792","426","27","1696","2469","562","1266","2.00E-90","335","1","Q04721","NOTC2_HUMAN","reviewed","Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)]","NOTCH2","Homo sapiens (Human)","2471","animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell cycle arrest [GO:0007050]; cell fate determination [GO:0001709]; cell growth [GO:0016049]; hemopoiesis [GO:0030097]; marginal zone B cell differentiation [GO:0002315]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; nervous system development [GO:0007399]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; positive regulation of Ras protein signal transduction [GO:0046579]; pulmonary valve morphogenesis [GO:0003184]; regulation of developmental process [GO:0050793]; regulation of transcription, DNA-templated [GO:0006355]; stem cell population maintenance [GO:0019827]; transcription initiation from RNA polymerase II promoter [GO:0006367]","GO:0000139; GO:0001709; GO:0002315; GO:0003184; GO:0004872; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005886; GO:0005887; GO:0006355; GO:0006367; GO:0006915; GO:0007050; GO:0007219; GO:0007275; GO:0007399; GO:0008285; GO:0009887; GO:0009986; GO:0016020; GO:0016049; GO:0019827; GO:0030097; GO:0038049; GO:0043066; GO:0043235; GO:0046579; GO:0046849; GO:0050793; GO:0060413; GO:0061314","","","","PF12796;PF11936;PF00008;PF07645;PF12661;PF06816;PF07684;PF00066;","cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; receptor activity [GO:0004872]; transcription factor activity, ligand-activated RNA polymerase II transcription factor binding [GO:0038049]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell cycle arrest [GO:0007050]; cell fate determination [GO:0001709]; cell growth [GO:0016049]; hemopoiesis [GO:0030097]; marginal zone B cell differentiation [GO:0002315]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; nervous system development [GO:0007399]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; positive regulation of Ras protein signal transduction [GO:0046579]; pulmonary valve morphogenesis [GO:0003184]; regulation of developmental process [GO:0050793]; regulation of transcription, DNA-templated [GO:0006355]; stem cell population maintenance [GO:0019827]; transcription initiation from RNA polymerase II promoter [GO:0006367]"
"CHOYP_AGAP_AGAP002739.1.5|m.19925",23,"9",51,69,77.5,61,80.5,42.5,80,74.5,44,27.0686956781,"0.615197629",732.7142857143,42.5,"#VALUE!","-2.1434196939","0.0638713276",80,8.5,71.5,19.25,80,308,"1.033557047","0.5704697987",48,48.25,-0.25,68.5,63.5,3.6479924198,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_AGAP_AGAP002739.1.5|m.19925","Q04721","NOTC2_HUMAN","32.95","792","426","27","1696","2469","562","1266","2.00E-90","335","1","Q04721","NOTC2_HUMAN","reviewed","Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)]","NOTCH2","Homo sapiens (Human)","2471","animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell cycle arrest [GO:0007050]; cell fate determination [GO:0001709]; cell growth [GO:0016049]; hemopoiesis [GO:0030097]; marginal zone B cell differentiation [GO:0002315]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; nervous system development [GO:0007399]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; positive regulation of Ras protein signal transduction [GO:0046579]; pulmonary valve morphogenesis [GO:0003184]; regulation of developmental process [GO:0050793]; regulation of transcription, DNA-templated [GO:0006355]; stem cell population maintenance [GO:0019827]; transcription initiation from RNA polymerase II promoter [GO:0006367]","GO:0000139; GO:0001709; GO:0002315; GO:0003184; GO:0004872; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005886; GO:0005887; GO:0006355; GO:0006367; GO:0006915; GO:0007050; GO:0007219; GO:0007275; GO:0007399; GO:0008285; GO:0009887; GO:0009986; GO:0016020; GO:0016049; GO:0019827; GO:0030097; GO:0038049; GO:0043066; GO:0043235; GO:0046579; GO:0046849; GO:0050793; GO:0060413; GO:0061314","","","","PF12796;PF11936;PF00008;PF07645;PF12661;PF06816;PF07684;PF00066;","cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; receptor activity [GO:0004872]; transcription factor activity, ligand-activated RNA polymerase II transcription factor binding [GO:0038049]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell cycle arrest [GO:0007050]; cell fate determination [GO:0001709]; cell growth [GO:0016049]; hemopoiesis [GO:0030097]; marginal zone B cell differentiation [GO:0002315]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; nervous system development [GO:0007399]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; positive regulation of Ras protein signal transduction [GO:0046579]; pulmonary valve morphogenesis [GO:0003184]; regulation of developmental process [GO:0050793]; regulation of transcription, DNA-templated [GO:0006355]; stem cell population maintenance [GO:0019827]; transcription initiation from RNA polymerase II promoter [GO:0006367]"
"CHOYP_ANK.2.3|m.19487",48,"3",21.5,4.5,28.5,0,0,0,3.5,0,6.2142857143,12.6487072825,"2.0354241604",159.9897959184,0,"#VALUE!","6.7137185877","2.5770208859",37,0,37,0,37,43.5,"#DIV/0!","#DIV/0!",1.625,9.25,-7.625,3.5,37,0.5152197086,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ANK.2.3|m.19487","G5E8K5","ANK3_MOUSE","53.57","1609","666","14","19","1615","16","1555","0","1675","1","G5E8K5","ANK3_MOUSE","reviewed","Ankyrin-3 (ANK-3) (Ankyrin-G)","Ank3","Mus musculus (Mouse)","1961","axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; protein targeting to plasma membrane [GO:0072661]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808]","GO:0000281; GO:0005200; GO:0005764; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008092; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043001; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045838; GO:0050808; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0072661; GO:0090314; GO:0099612; GO:1900827; GO:1902260; GO:2000651; GO:2001259","","","","PF00023;PF12796;PF13606;PF00531;PF00791;","axon [GO:0030424]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; costamere [GO:0043034]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; protein targeting to plasma membrane [GO:0072661]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808]"
"CHOYP_ANK.2.3|m.19487",37,"9",21.5,0,0,5,39.5,0,0,0,6.2142857143,12.6487072825,"2.0354241604",159.9897959184,0,"#VALUE!","6.7137185877","2.5770208859",37,0,37,0,37,43.5,"#DIV/0!","#DIV/0!",1.625,9.25,-7.625,3.5,37,0.5152197086,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ANK.2.3|m.19487","G5E8K5","ANK3_MOUSE","53.57","1609","666","14","19","1615","16","1555","0","1675","1","G5E8K5","ANK3_MOUSE","reviewed","Ankyrin-3 (ANK-3) (Ankyrin-G)","Ank3","Mus musculus (Mouse)","1961","axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; protein targeting to plasma membrane [GO:0072661]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808]","GO:0000281; GO:0005200; GO:0005764; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008092; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043001; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045184; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045838; GO:0050808; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0072661; GO:0090314; GO:0099612; GO:1900827; GO:1902260; GO:2000651; GO:2001259","","","","PF00023;PF12796;PF13606;PF00531;PF00791;","axon [GO:0030424]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; costamere [GO:0043034]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; protein targeting to plasma membrane [GO:0072661]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808]"
"CHOYP_ANK3.7.9|m.43272",37,"3",0,4.5,4.5,0,34,5.5,0,0,2.5714285714,6.29868791,"2.4494897428",39.6734693878,0,"#VALUE!","7","2.6457513111",18,0,18,0,18,18,"#DIV/0!","#DIV/0!",5.875,0,5.875,18,0,0.2131943622,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ANK3.7.9|m.43272","Q01484","ANK2_HUMAN","67.5","843","268","4","13","854","17","854","0","1210","1","Q01484","ANK2_HUMAN","reviewed","Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin)","ANK2","Homo sapiens (Human)","3957","atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; ER to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein targeting to plasma membrane [GO:0072661]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]","GO:0002027; GO:0003283; GO:0005200; GO:0005622; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006888; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043005; GO:0043034; GO:0043268; GO:0044325; GO:0045121; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0072661; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:1901018; GO:1901019; GO:1901021; GO:2001259","","","","PF00023;PF12796;PF00531;PF00791;","A band [GO:0031672]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intercalated disc [GO:0014704]; intracellular [GO:0005622]; M band [GO:0031430]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein binding, bridging [GO:0030674]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; ER to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein targeting to plasma membrane [GO:0072661]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]"
"CHOYP_ANK3.7.9|m.43272",48,"9",0,3.5,0,0,0,0,0,0,2.5714285714,6.29868791,"2.4494897428",39.6734693878,0,"#VALUE!","7","2.6457513111",18,0,18,0,18,18,"#DIV/0!","#DIV/0!",5.875,0,5.875,18,0,0.2131943622,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ANK3.7.9|m.43272","Q01484","ANK2_HUMAN","67.5","843","268","4","13","854","17","854","0","1210","1","Q01484","ANK2_HUMAN","reviewed","Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin)","ANK2","Homo sapiens (Human)","3957","atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; ER to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein targeting to plasma membrane [GO:0072661]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]","GO:0002027; GO:0003283; GO:0005200; GO:0005622; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006888; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0034613; GO:0036309; GO:0036371; GO:0042383; GO:0043005; GO:0043034; GO:0043268; GO:0044325; GO:0045121; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0072661; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:1901018; GO:1901019; GO:1901021; GO:2001259","","","","PF00023;PF12796;PF00531;PF00791;","A band [GO:0031672]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intercalated disc [GO:0014704]; intracellular [GO:0005622]; M band [GO:0031430]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein binding, bridging [GO:0030674]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; ER to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein targeting to plasma membrane [GO:0072661]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005]"
"CHOYP_APLP.1.2|m.5955",48,"9",12,15,9.5,15,7.5,4,1.5,5.5,3.3571428571,1.5518257845,"0.4622459783",2.4081632653,3,"#VALUE!","-1.7914248779","0.4209067364",5.5,1.5,4,2,5.5,23.5,"2.1818181818","0.7272727273",5.25,3.625,1.625,10,4,0.278337084,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_APLP.1.2|m.5955","Q9U943","APLP_LOCMI","30.04","1142","708","26","5","1089","9","1116","4.00E-130","467","1","Q9U943","APLP_LOCMI","reviewed","Apolipophorins [Cleaved into: Apolipophorin-2 (Apolipophorin II) (apoLp-2); Apolipophorin-1 (Apolipophorin I) (apoLp-1)]","","Locusta migratoria (Migratory locust)","3380","Wnt signaling pathway [GO:0016055]","GO:0005319; GO:0005576; GO:0008289; GO:0016055","","","","PF08742;PF06448;PF09172;PF01347;PF00094;","extracellular region [GO:0005576]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; Wnt signaling pathway [GO:0016055]"
"CHOYP_APLP.1.2|m.5955",37,"3",12,24.5,10,19.5,18.5,12,3,2,3.3571428571,1.5518257845,"0.4622459783",2.4081632653,3,"#VALUE!","-1.7914248779","0.4209067364",5.5,1.5,4,2,5.5,23.5,"2.1818181818","0.7272727273",5.25,3.625,1.625,10,4,0.278337084,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_APLP.1.2|m.5955","Q9U943","APLP_LOCMI","30.04","1142","708","26","5","1089","9","1116","4.00E-130","467","1","Q9U943","APLP_LOCMI","reviewed","Apolipophorins [Cleaved into: Apolipophorin-2 (Apolipophorin II) (apoLp-2); Apolipophorin-1 (Apolipophorin I) (apoLp-1)]","","Locusta migratoria (Migratory locust)","3380","Wnt signaling pathway [GO:0016055]","GO:0005319; GO:0005576; GO:0008289; GO:0016055","","","","PF08742;PF06448;PF09172;PF01347;PF00094;","extracellular region [GO:0005576]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; Wnt signaling pathway [GO:0016055]"
"CHOYP_APLP.2.2|m.55987",48,"9",26.5,15,9.5,15,7.5,4,1.5,5.5,3.3571428571,1.5518257845,"0.4622459783",2.4081632653,3,"#VALUE!","-1.7914248779","0.4209067364",5.5,1.5,4,2,5.5,23.5,"2.1818181818","0.7272727273",5.25,3.625,1.625,10,4,0.278337084,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_APLP.2.2|m.55987","Q9U943","APLP_LOCMI","30.04","1142","708","26","22","1106","9","1116","3.00E-130","468","1","Q9U943","APLP_LOCMI","reviewed","Apolipophorins [Cleaved into: Apolipophorin-2 (Apolipophorin II) (apoLp-2); Apolipophorin-1 (Apolipophorin I) (apoLp-1)]","","Locusta migratoria (Migratory locust)","3380","Wnt signaling pathway [GO:0016055]","GO:0005319; GO:0005576; GO:0008289; GO:0016055","","","","PF08742;PF06448;PF09172;PF01347;PF00094;","extracellular region [GO:0005576]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; Wnt signaling pathway [GO:0016055]"
"CHOYP_APLP.2.2|m.55987",37,"3",26.5,24.5,10,19.5,18.5,12,3,2,3.3571428571,1.5518257845,"0.4622459783",2.4081632653,3,"#VALUE!","-1.7914248779","0.4209067364",5.5,1.5,4,2,5.5,23.5,"2.1818181818","0.7272727273",5.25,3.625,1.625,10,4,0.278337084,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_APLP.2.2|m.55987","Q9U943","APLP_LOCMI","30.04","1142","708","26","22","1106","9","1116","3.00E-130","468","1","Q9U943","APLP_LOCMI","reviewed","Apolipophorins [Cleaved into: Apolipophorin-2 (Apolipophorin II) (apoLp-2); Apolipophorin-1 (Apolipophorin I) (apoLp-1)]","","Locusta migratoria (Migratory locust)","3380","Wnt signaling pathway [GO:0016055]","GO:0005319; GO:0005576; GO:0008289; GO:0016055","","","","PF08742;PF06448;PF09172;PF01347;PF00094;","extracellular region [GO:0005576]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; Wnt signaling pathway [GO:0016055]"
"CHOYP_ATPB.1.1|m.21960",18,"3",111,122,113,118.5,123.5,109.5,77.5,63.5,74.5714285714,16.2292253389,"0.21763329",263.387755102,77.5,"#VALUE!","1.2518785766","-0.5082964257",100.5,44,56.5,68.25,100.5,522,"1.3353658537","0.993902439",78.125,79.75,-1.625,65.5,37,6.1826365036,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ATPB.1.1|m.21960","Q25117","ATPB_HEMPU","81.47","491","87","3","5","494","6","493","0","791","1","Q25117","ATPB_HEMPU","reviewed","ATP synthase subunit beta, mitochondrial (EC 3.6.3.14)","","Hemicentrotus pulcherrimus (Sea urchin) (Strongylocentrotus pulcherrimus)","523","ATP synthesis coupled proton transport [GO:0015986]","GO:0005524; GO:0005743; GO:0015986; GO:0045261; GO:0046933","","","","PF00006;PF02874;","mitochondrial inner membrane [GO:0005743]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986]"
"CHOYP_ATPB.1.1|m.21960",66,"9",111,119,92.5,71,109,81.5,100.5,82,74.5714285714,16.2292253389,"0.21763329",263.387755102,77.5,"#VALUE!","1.2518785766","-0.5082964257",100.5,44,56.5,68.25,100.5,522,"1.3353658537","0.993902439",78.125,79.75,-1.625,65.5,37,6.1826365036,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ATPB.1.1|m.21960","Q25117","ATPB_HEMPU","81.47","491","87","3","5","494","6","493","0","791","1","Q25117","ATPB_HEMPU","reviewed","ATP synthase subunit beta, mitochondrial (EC 3.6.3.14)","","Hemicentrotus pulcherrimus (Sea urchin) (Strongylocentrotus pulcherrimus)","523","ATP synthesis coupled proton transport [GO:0015986]","GO:0005524; GO:0005743; GO:0015986; GO:0045261; GO:0046933","","","","PF00006;PF02874;","mitochondrial inner membrane [GO:0005743]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986]"
"CHOYP_BRAFLDRAFT_115608.1.1|m.25984",12,"3",135.5,135.5,145,146.5,141.5,147.5,124.5,121,120,31.1287648325,"0.2594063736",969,124.5,"#VALUE!","3.2462312218","-1.6333953995",150.5,51.5,99,115.5,150.5,840,"0.9866220736","0.889632107",114.125,132.75,-18.625,96,40.5,9.9490702357,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_BRAFLDRAFT_115608.1.1|m.25984","P33198","IDHP_PIG","75.97","412","96","3","62","471","6","416","0","675","1","P33198","IDHP_PIG","reviewed","Isocitrate dehydrogenase [NADP], mitochondrial (IDH) (EC 1.1.1.42) (ICD-M) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) (Fragment)","IDH2","Sus scrofa (Pig)","421","2-oxoglutarate metabolic process [GO:0006103]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]","GO:0000287; GO:0004450; GO:0005739; GO:0006097; GO:0006099; GO:0006102; GO:0006103; GO:0051287","","","","PF00180;","mitochondrion [GO:0005739]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; 2-oxoglutarate metabolic process [GO:0006103]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]"
"CHOYP_BRAFLDRAFT_115608.1.1|m.25984",61,"9",135.5,135.5,138.5,135.5,150,133,150.5,149.5,120,31.1287648325,"0.2594063736",969,124.5,"#VALUE!","3.2462312218","-1.6333953995",150.5,51.5,99,115.5,150.5,840,"0.9866220736","0.889632107",114.125,132.75,-18.625,96,40.5,9.9490702357,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_BRAFLDRAFT_115608.1.1|m.25984","P33198","IDHP_PIG","75.97","412","96","3","62","471","6","416","0","675","1","P33198","IDHP_PIG","reviewed","Isocitrate dehydrogenase [NADP], mitochondrial (IDH) (EC 1.1.1.42) (ICD-M) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) (Fragment)","IDH2","Sus scrofa (Pig)","421","2-oxoglutarate metabolic process [GO:0006103]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]","GO:0000287; GO:0004450; GO:0005739; GO:0006097; GO:0006099; GO:0006102; GO:0006103; GO:0051287","","","","PF00180;","mitochondrion [GO:0005739]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; 2-oxoglutarate metabolic process [GO:0006103]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099]"
"CHOYP_BRAFLDRAFT_118602.2.5|m.17419",28,"3",23.5,30.5,45,52.5,33,40,27,25.5,49.0714285714,29.8010409351,"0.607299233",888.1020408163,31.5,"#VALUE!","-2.2986845696","0.3157838272",88.5,12,76.5,26.25,88.5,343.5,"0.4651162791","0.8488372093",38,57.875,-19.875,61,63,4.0684590785,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_BRAFLDRAFT_118602.2.5|m.17419","Q2PC93","SSPO_CHICK","34.22","1166","669","38","225","1349","192","1300","7.00E-177","621","1","Q2PC93","SSPO_CHICK","reviewed","SCO-spondin","SSPO","Gallus gallus (Chicken)","5255","cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]","GO:0005615; GO:0007155; GO:0007399; GO:0030154","","","","PF00754;PF00057;PF01826;PF00090;PF00093;PF00094;","extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]"
"CHOYP_BRAFLDRAFT_118602.2.5|m.17419",71,"9",23.5,41.5,39,38.5,49.5,73,88.5,86,49.0714285714,29.8010409351,"0.607299233",888.1020408163,31.5,"#VALUE!","-2.2986845696","0.3157838272",88.5,12,76.5,26.25,88.5,343.5,"0.4651162791","0.8488372093",38,57.875,-19.875,61,63,4.0684590785,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_BRAFLDRAFT_118602.2.5|m.17419","Q2PC93","SSPO_CHICK","34.22","1166","669","38","225","1349","192","1300","7.00E-177","621","1","Q2PC93","SSPO_CHICK","reviewed","SCO-spondin","SSPO","Gallus gallus (Chicken)","5255","cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]","GO:0005615; GO:0007155; GO:0007399; GO:0030154","","","","PF00754;PF00057;PF01826;PF00090;PF00093;PF00094;","extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]"
"CHOYP_BRAFLDRAFT_123986.1.1|m.47284",48,"9",12,14.5,16.5,12,11.5,5,7,5,7.4285714286,2.2108267915,"0.2976112989",4.887755102,7,"#VALUE!","-0.2913664079","0.7018490828",11.5,5,6.5,5.5,11.5,52,"1.6","1",6.875,8.125,-1.25,3.5,6.5,0.6158948241,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_BRAFLDRAFT_123986.1.1|m.47284","Q7ZY18","MC6ZB_XENLA","73.33","810","203","6","10","807","16","824","0","1228","1","Q7ZY18","MC6ZB_XENLA","reviewed","Zygotic DNA replication licensing factor mcm6-B (EC 3.6.4.12) (Zygotic minichromosome maintenance protein 6-B) (zMCM6-B) (zMCM6b)","zmcm6-b zmcm6b","Xenopus laevis (African clawed frog)","825","cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; regulation of DNA-dependent DNA replication initiation [GO:0030174]","GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006270; GO:0007049; GO:0030174; GO:0042555; GO:0046872","","","","PF00493;PF14551;PF17207;","MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; regulation of DNA-dependent DNA replication initiation [GO:0030174]"
"CHOYP_BRAFLDRAFT_123986.1.1|m.47284",37,"3",12,13,19.5,17.5,14.5,8,8.5,9,7.4285714286,2.2108267915,"0.2976112989",4.887755102,7,"#VALUE!","-0.2913664079","0.7018490828",11.5,5,6.5,5.5,11.5,52,"1.6","1",6.875,8.125,-1.25,3.5,6.5,0.6158948241,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_BRAFLDRAFT_123986.1.1|m.47284","Q7ZY18","MC6ZB_XENLA","73.33","810","203","6","10","807","16","824","0","1228","1","Q7ZY18","MC6ZB_XENLA","reviewed","Zygotic DNA replication licensing factor mcm6-B (EC 3.6.4.12) (Zygotic minichromosome maintenance protein 6-B) (zMCM6-B) (zMCM6b)","zmcm6-b zmcm6b","Xenopus laevis (African clawed frog)","825","cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; regulation of DNA-dependent DNA replication initiation [GO:0030174]","GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006270; GO:0007049; GO:0030174; GO:0042555; GO:0046872","","","","PF00493;PF14551;PF17207;","MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; regulation of DNA-dependent DNA replication initiation [GO:0030174]"
"CHOYP_BRAFLDRAFT_125037.1.3|m.2939",37,"3",6,11.5,11,19.5,18.5,15.5,10,11,10.5714285714,6.3043554753,"0.5963579504",39.7448979592,9,"#VALUE!","4.5902258944","1.9152632853",25,3.5,21.5,7.75,25,74,"1.8235294118","1.0588235294",9.5,12.875,-3.375,12,18,0.8764657112,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_BRAFLDRAFT_125037.1.3|m.2939","A9CPT4","TDRD1_ORYLA","24.63","816","470","23","1725","2429","208","989","2.00E-47","191","1","A9CPT4","TDRD1_ORYLA","reviewed","Tudor domain-containing protein 1","tdrd1","Oryzias latipes (Japanese rice fish) (Japanese killifish)","1133","DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]","GO:0007275; GO:0007281; GO:0007283; GO:0031047; GO:0034587; GO:0043046; GO:0043186; GO:0046872; GO:0051321; GO:0071546","","","","PF00567;PF01753;","P granule [GO:0043186]; pi-body [GO:0071546]; metal ion binding [GO:0046872]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]"
"CHOYP_BRAFLDRAFT_125037.1.3|m.2939",48,"9",6,12.5,17,10.5,13,9,7,8.5,10.5714285714,6.3043554753,"0.5963579504",39.7448979592,9,"#VALUE!","4.5902258944","1.9152632853",25,3.5,21.5,7.75,25,74,"1.8235294118","1.0588235294",9.5,12.875,-3.375,12,18,0.8764657112,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_BRAFLDRAFT_125037.1.3|m.2939","A9CPT4","TDRD1_ORYLA","24.63","816","470","23","1725","2429","208","989","2.00E-47","191","1","A9CPT4","TDRD1_ORYLA","reviewed","Tudor domain-containing protein 1","tdrd1","Oryzias latipes (Japanese rice fish) (Japanese killifish)","1133","DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]","GO:0007275; GO:0007281; GO:0007283; GO:0031047; GO:0034587; GO:0043046; GO:0043186; GO:0046872; GO:0051321; GO:0071546","","","","PF00567;PF01753;","P granule [GO:0043186]; pi-body [GO:0071546]; metal ion binding [GO:0046872]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283]"
"CHOYP_BRAFLDRAFT_125880.1.3|m.7081",37,"3",11.5,17.5,19.5,18,16,12.5,9,5,7.7142857143,2.8139593719,"0.3647725112",7.9183673469,9,"#VALUE!","-1.7646282814","-0.2125420014",11.5,3.5,8,5.25,11.5,54,"1.1904761905","1.0952380952",9.125,7.5,1.625,9,5.5,0.6395830866,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_BRAFLDRAFT_125880.1.3|m.7081","P41996","CPG2_CAEEL","30.17","116","78","2","17","130","243","357","0.000003","48.9","1","P41996","CPG2_CAEEL","reviewed","Chondroitin proteoglycan-2 (Cytokinesis protein B0280.5)","cpg-2 B0280.5","Caenorhabditis elegans","524","chitin metabolic process [GO:0006030]; eggshell formation [GO:0030703]; embryo development [GO:0009790]; mitotic cytokinesis [GO:0000281]; regulation of cytokinesis [GO:0032465]","GO:0000281; GO:0005576; GO:0006030; GO:0008061; GO:0009790; GO:0030703; GO:0032465","","","","PF01607;","extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitin metabolic process [GO:0006030]; eggshell formation [GO:0030703]; embryo development [GO:0009790]; mitotic cytokinesis [GO:0000281]; regulation of cytokinesis [GO:0032465]"
"CHOYP_BRAFLDRAFT_125880.1.3|m.7081",48,"9",11.5,15.5,13.5,12,13,11.5,9,10.5,7.7142857143,2.8139593719,"0.3647725112",7.9183673469,9,"#VALUE!","-1.7646282814","-0.2125420014",11.5,3.5,8,5.25,11.5,54,"1.1904761905","1.0952380952",9.125,7.5,1.625,9,5.5,0.6395830866,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_BRAFLDRAFT_125880.1.3|m.7081","P41996","CPG2_CAEEL","30.17","116","78","2","17","130","243","357","0.000003","48.9","1","P41996","CPG2_CAEEL","reviewed","Chondroitin proteoglycan-2 (Cytokinesis protein B0280.5)","cpg-2 B0280.5","Caenorhabditis elegans","524","chitin metabolic process [GO:0006030]; eggshell formation [GO:0030703]; embryo development [GO:0009790]; mitotic cytokinesis [GO:0000281]; regulation of cytokinesis [GO:0032465]","GO:0000281; GO:0005576; GO:0006030; GO:0008061; GO:0009790; GO:0030703; GO:0032465","","","","PF01607;","extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitin metabolic process [GO:0006030]; eggshell formation [GO:0030703]; embryo development [GO:0009790]; mitotic cytokinesis [GO:0000281]; regulation of cytokinesis [GO:0032465]"
"CHOYP_BRAFLDRAFT_127065.6.7|m.30727",38,"3",93,157.5,90.5,31.5,21.5,18.5,14,20,11.8571428571,4.0241617203,"0.339387133",16.193877551,12,"#VALUE!","1.2235397958","1.0984858489",20,7.5,12.5,8.5,20,83,"2.0555555556","1.3888888889",13.125,12.25,0.875,11,12,0.9830628923,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_BRAFLDRAFT_127065.6.7|m.30727","Q62009","POSTN_MOUSE","34.22","263","163","7","46","302","110","368","3.00E-36","142","1","Q62009","POSTN_MOUSE","reviewed","Periostin (PN) (Osteoblast-specific factor 2) (OSF-2)","Postn Osf2","Mus musculus (Mouse)","838","bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neuron projection extension [GO:1990138]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of smooth muscle cell migration [GO:0014911]; regulation of Notch signaling pathway [GO:0008593]; regulation of systemic arterial blood pressure [GO:0003073]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to muscle activity [GO:0014850]; tissue development [GO:0009888]","GO:0001666; GO:0001953; GO:0003073; GO:0005578; GO:0005615; GO:0005802; GO:0007155; GO:0008201; GO:0008593; GO:0009612; GO:0009888; GO:0014850; GO:0014911; GO:0030198; GO:0031012; GO:0031594; GO:0032355; GO:0044344; GO:0046872; GO:0071307; GO:0071356; GO:0071560; GO:1900025; GO:1904209; GO:1990138; GO:1990523","","","","PF02469;","extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; proteinaceous extracellular matrix [GO:0005578]; trans-Golgi network [GO:0005802]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neuron projection extension [GO:1990138]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of smooth muscle cell migration [GO:0014911]; regulation of Notch signaling pathway [GO:0008593]; regulation of systemic arterial blood pressure [GO:0003073]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to muscle activity [GO:0014850]; tissue development [GO:0009888]"
"CHOYP_BRAFLDRAFT_127065.6.7|m.30727",74,"9",93,138.5,33,14,10,12.5,8,9,11.8571428571,4.0241617203,"0.339387133",16.193877551,12,"#VALUE!","1.2235397958","1.0984858489",20,7.5,12.5,8.5,20,83,"2.0555555556","1.3888888889",13.125,12.25,0.875,11,12,0.9830628923,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_BRAFLDRAFT_127065.6.7|m.30727","Q62009","POSTN_MOUSE","34.22","263","163","7","46","302","110","368","3.00E-36","142","1","Q62009","POSTN_MOUSE","reviewed","Periostin (PN) (Osteoblast-specific factor 2) (OSF-2)","Postn Osf2","Mus musculus (Mouse)","838","bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neuron projection extension [GO:1990138]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of smooth muscle cell migration [GO:0014911]; regulation of Notch signaling pathway [GO:0008593]; regulation of systemic arterial blood pressure [GO:0003073]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to muscle activity [GO:0014850]; tissue development [GO:0009888]","GO:0001666; GO:0001953; GO:0003073; GO:0005578; GO:0005615; GO:0005802; GO:0007155; GO:0008201; GO:0008593; GO:0009612; GO:0009888; GO:0014850; GO:0014911; GO:0030198; GO:0031012; GO:0031594; GO:0032355; GO:0044344; GO:0046872; GO:0071307; GO:0071356; GO:0071560; GO:1900025; GO:1904209; GO:1990138; GO:1990523","","","","PF02469;","extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; proteinaceous extracellular matrix [GO:0005578]; trans-Golgi network [GO:0005802]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neuron projection extension [GO:1990138]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of smooth muscle cell migration [GO:0014911]; regulation of Notch signaling pathway [GO:0008593]; regulation of systemic arterial blood pressure [GO:0003073]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to muscle activity [GO:0014850]; tissue development [GO:0009888]"
"CHOYP_BRAFLDRAFT_130809.1.1|m.5127",37,"9",9.5,10.5,12,12,20,16,11,15.5,11.3571428571,3.1477235052,"0.2771580445",9.9081632653,11,"#VALUE!","-1.0458783613","0.2997880853",16,7,9,9.5,16,79.5,"1.1612903226","1.0322580645",13,11.375,1.625,11,7.5,0.941608433,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_BRAFLDRAFT_130809.1.1|m.5127",48,"3",9.5,13,10.5,10,14,18,11,11,11.3571428571,3.1477235052,"0.2771580445",9.9081632653,11,"#VALUE!","-1.0458783613","0.2997880853",16,7,9,9.5,16,79.5,"1.1612903226","1.0322580645",13,11.375,1.625,11,7.5,0.941608433,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_BRAFLDRAFT_204923.1.2|m.1690",37,"3",13,11.5,14.5,14,16,13,10.5,14,10.5,2.6186146828,"0.2493918746",6.8571428571,11,"#VALUE!","0.65390625","-0.7656640615",14,5.5,8.5,9.5,14,73.5,"1.1818181818","0.7727272727",9.375,12.25,-2.875,7.5,3,0.8705436456,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_BRAFLDRAFT_204923.1.2|m.1690","P48147","PPCE_HUMAN","64.26","705","250","2","2","704","4","708","0","979","1","P48147","PPCE_HUMAN","reviewed","Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme)","PREP PEP","Homo sapiens (Human)","710","proteolysis [GO:0006508]","GO:0004252; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008236; GO:0016020; GO:0070008","","","","PF00326;PF02897;","cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; serine-type endopeptidase activity [GO:0004252]; serine-type exopeptidase activity [GO:0070008]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508]"
"CHOYP_BRAFLDRAFT_204923.1.2|m.1690",48,"9",13,12,11,9,7.5,8.5,11,11,10.5,2.6186146828,"0.2493918746",6.8571428571,11,"#VALUE!","0.65390625","-0.7656640615",14,5.5,8.5,9.5,14,73.5,"1.1818181818","0.7727272727",9.375,12.25,-2.875,7.5,3,0.8705436456,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_BRAFLDRAFT_204923.1.2|m.1690","P48147","PPCE_HUMAN","64.26","705","250","2","2","704","4","708","0","979","1","P48147","PPCE_HUMAN","reviewed","Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme)","PREP PEP","Homo sapiens (Human)","710","proteolysis [GO:0006508]","GO:0004252; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008236; GO:0016020; GO:0070008","","","","PF00326;PF02897;","cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; serine-type endopeptidase activity [GO:0004252]; serine-type exopeptidase activity [GO:0070008]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508]"
"CHOYP_BRAFLDRAFT_225253.1.1|m.9264",37,"3",12.5,13,15,14.5,14,7,12,13.5,9.9285714286,4.4193452281,"0.4451139079",19.5306122449,11,"#VALUE!","2.4743821307","-1.41443621",15,0.5,14.5,8.75,15,69.5,"0.7368421053","0.8421052632",6.875,12.25,-5.375,11.5,5.5,0.8231671207,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_BRAFLDRAFT_225253.1.1|m.9264","O75694","NU155_HUMAN","49.82","1377","638","13","13","1342","20","1390","0","1373","1","O75694","NU155_HUMAN","reviewed","Nuclear pore complex protein Nup155 (155 kDa nucleoporin) (Nucleoporin Nup155)","NUP155 KIAA0791","Homo sapiens (Human)","1391","atrial cardiac muscle cell action potential [GO:0086014]; gene silencing by RNA [GO:0031047]; intracellular transport of virus [GO:0075733]; mitotic nuclear envelope disassembly [GO:0007077]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; protein targeting to nuclear inner membrane [GO:0036228]; regulation of cellular response to heat [GO:1900034]; regulation of glucose transport [GO:0010827]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]","GO:0000972; GO:0005215; GO:0005635; GO:0006405; GO:0006406; GO:0006409; GO:0006606; GO:0006998; GO:0007077; GO:0010827; GO:0016020; GO:0016032; GO:0016925; GO:0017056; GO:0019083; GO:0031047; GO:0031965; GO:0036228; GO:0044611; GO:0075733; GO:0086014; GO:1900034","","","","PF03177;PF08801;","membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore inner ring [GO:0044611]; structural constituent of nuclear pore [GO:0017056]; transporter activity [GO:0005215]; atrial cardiac muscle cell action potential [GO:0086014]; gene silencing by RNA [GO:0031047]; intracellular transport of virus [GO:0075733]; mitotic nuclear envelope disassembly [GO:0007077]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; protein targeting to nuclear inner membrane [GO:0036228]; regulation of cellular response to heat [GO:1900034]; regulation of glucose transport [GO:0010827]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]"
"CHOYP_BRAFLDRAFT_225253.1.1|m.9264",48,"9",12.5,12.5,15,10.5,9,8,15,9.5,9.9285714286,4.4193452281,"0.4451139079",19.5306122449,11,"#VALUE!","2.4743821307","-1.41443621",15,0.5,14.5,8.75,15,69.5,"0.7368421053","0.8421052632",6.875,12.25,-5.375,11.5,5.5,0.8231671207,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_BRAFLDRAFT_225253.1.1|m.9264","O75694","NU155_HUMAN","49.82","1377","638","13","13","1342","20","1390","0","1373","1","O75694","NU155_HUMAN","reviewed","Nuclear pore complex protein Nup155 (155 kDa nucleoporin) (Nucleoporin Nup155)","NUP155 KIAA0791","Homo sapiens (Human)","1391","atrial cardiac muscle cell action potential [GO:0086014]; gene silencing by RNA [GO:0031047]; intracellular transport of virus [GO:0075733]; mitotic nuclear envelope disassembly [GO:0007077]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; protein targeting to nuclear inner membrane [GO:0036228]; regulation of cellular response to heat [GO:1900034]; regulation of glucose transport [GO:0010827]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]","GO:0000972; GO:0005215; GO:0005635; GO:0006405; GO:0006406; GO:0006409; GO:0006606; GO:0006998; GO:0007077; GO:0010827; GO:0016020; GO:0016032; GO:0016925; GO:0017056; GO:0019083; GO:0031047; GO:0031965; GO:0036228; GO:0044611; GO:0075733; GO:0086014; GO:1900034","","","","PF03177;PF08801;","membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore inner ring [GO:0044611]; structural constituent of nuclear pore [GO:0017056]; transporter activity [GO:0005215]; atrial cardiac muscle cell action potential [GO:0086014]; gene silencing by RNA [GO:0031047]; intracellular transport of virus [GO:0075733]; mitotic nuclear envelope disassembly [GO:0007077]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; protein import into nucleus [GO:0006606]; protein sumoylation [GO:0016925]; protein targeting to nuclear inner membrane [GO:0036228]; regulation of cellular response to heat [GO:1900034]; regulation of glucose transport [GO:0010827]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]; tRNA export from nucleus [GO:0006409]; viral process [GO:0016032]; viral transcription [GO:0019083]"
"CHOYP_BRAFLDRAFT_277494.3.3|m.62602",28,"3",41.5,44.5,54.5,53,54.5,50.5,42.5,44.5,40.6428571429,7.9897894023,"0.196585328",63.8367346939,42.5,"#VALUE!","5.0574415926","-2.1425633201",47,22,25,40.75,47,284.5,"1.0744680851","0.8617021277",38.875,44.875,-6,28.5,6,3.3696553358,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_BRAFLDRAFT_277494.3.3|m.62602","Q80XI3","IF4G3_MOUSE","44.26","1037","501","20","608","1613","589","1579","0","826","1","Q80XI3","IF4G3_MOUSE","reviewed","Eukaryotic translation initiation factor 4 gamma 3 (eIF-4-gamma 3) (eIF-4G 3) (eIF4G 3) (eIF-4-gamma II) (eIF4GII)","Eif4g3","Mus musculus (Mouse)","1579","positive regulation of meiosis I [GO:0060903]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283]","GO:0001934; GO:0003723; GO:0003743; GO:0007283; GO:0045727; GO:0060903","","","","PF02847;PF02854;PF02020;","RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; positive regulation of meiosis I [GO:0060903]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283]"
"CHOYP_BRAFLDRAFT_277494.3.3|m.62602",37,"9",41.5,43,44,34.5,50,40.5,41,47,40.6428571429,7.9897894023,"0.196585328",63.8367346939,42.5,"#VALUE!","5.0574415926","-2.1425633201",47,22,25,40.75,47,284.5,"1.0744680851","0.8617021277",38.875,44.875,-6,28.5,6,3.3696553358,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_BRAFLDRAFT_277494.3.3|m.62602","Q80XI3","IF4G3_MOUSE","44.26","1037","501","20","608","1613","589","1579","0","826","1","Q80XI3","IF4G3_MOUSE","reviewed","Eukaryotic translation initiation factor 4 gamma 3 (eIF-4-gamma 3) (eIF-4G 3) (eIF4G 3) (eIF-4-gamma II) (eIF4GII)","Eif4g3","Mus musculus (Mouse)","1579","positive regulation of meiosis I [GO:0060903]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283]","GO:0001934; GO:0003723; GO:0003743; GO:0007283; GO:0045727; GO:0060903","","","","PF02847;PF02854;PF02020;","RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; positive regulation of meiosis I [GO:0060903]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283]"
"CHOYP_BRAFLDRAFT_59014.1.1|m.59709",37,"9",20.5,19.5,13,10.5,9.5,9.5,16.5,12,11,2.4640269015,"0.2240024456",6.0714285714,10,"#VALUE!","3.4743529412","1.8194394227",16.5,9,7.5,9.25,16.5,77,"0.7083333333","0.7916666667",9,12.375,-3.375,1,6.5,0.9119981049,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_BRAFLDRAFT_59014.1.1|m.59709","Q99NB1","ACS2L_MOUSE","61.15","646","245","4","36","676","32","676","0","834","1","Q99NB1","ACS2L_MOUSE","reviewed","Acetyl-coenzyme A synthetase 2-like, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 2) (Acetyl-CoA synthetase 2) (AceCS2) (Acyl-CoA synthetase short-chain family member 1)","Acss1 Acas2 Acas2l","Mus musculus (Mouse)","682","acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; propionate biosynthetic process [GO:0019542]","GO:0003987; GO:0005524; GO:0005739; GO:0005759; GO:0006085; GO:0016208; GO:0019413; GO:0019427; GO:0019542","","","cd05966;","PF16177;PF00501;PF13193;","mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; propionate biosynthetic process [GO:0019542]"
"CHOYP_BRAFLDRAFT_59014.1.1|m.59709",48,"3",20.5,21,16,15,10,8.5,9,11,11,2.4640269015,"0.2240024456",6.0714285714,10,"#VALUE!","3.4743529412","1.8194394227",16.5,9,7.5,9.25,16.5,77,"0.7083333333","0.7916666667",9,12.375,-3.375,1,6.5,0.9119981049,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_BRAFLDRAFT_59014.1.1|m.59709","Q99NB1","ACS2L_MOUSE","61.15","646","245","4","36","676","32","676","0","834","1","Q99NB1","ACS2L_MOUSE","reviewed","Acetyl-coenzyme A synthetase 2-like, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 2) (Acetyl-CoA synthetase 2) (AceCS2) (Acyl-CoA synthetase short-chain family member 1)","Acss1 Acas2 Acas2l","Mus musculus (Mouse)","682","acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; propionate biosynthetic process [GO:0019542]","GO:0003987; GO:0005524; GO:0005739; GO:0005759; GO:0006085; GO:0016208; GO:0019413; GO:0019427; GO:0019542","","","cd05966;","PF16177;PF00501;PF13193;","mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; propionate biosynthetic process [GO:0019542]"
"CHOYP_BRAFLDRAFT_80496.6.10|m.29014",37,"9",19.5,21.5,39.5,38,33,20,14.5,11.5,15,6.8712652193,"0.458084348",47.2142857143,14.5,"#VALUE!","1.1436296264","0.909633954",28.5,5.5,23,11,28.5,105,"2.347826087","1.7391304348",16.75,16.25,0.5,21.5,18,1.2436337795,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_BRAFLDRAFT_80496.6.10|m.29014","Q6DFV8","VWDE_MOUSE","29.2","250","153","9","4630","4867","394","631","2.00E-20","103","1","Q6DFV8","VWDE_MOUSE","reviewed","von Willebrand factor D and EGF domain-containing protein","Vwde Gm467","Mus musculus (Mouse)","926","","GO:0005576","","","","PF00094;","extracellular region [GO:0005576]"
"CHOYP_BRAFLDRAFT_80496.6.10|m.29014",42,"3",19.5,21.5,54,85,58,27,14.5,10.5,15,6.8712652193,"0.458084348",47.2142857143,14.5,"#VALUE!","1.1436296264","0.909633954",28.5,5.5,23,11,28.5,105,"2.347826087","1.7391304348",16.75,16.25,0.5,21.5,18,1.2436337795,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_BRAFLDRAFT_80496.6.10|m.29014","Q6DFV8","VWDE_MOUSE","29.2","250","153","9","4630","4867","394","631","2.00E-20","103","1","Q6DFV8","VWDE_MOUSE","reviewed","von Willebrand factor D and EGF domain-containing protein","Vwde Gm467","Mus musculus (Mouse)","926","","GO:0005576","","","","PF00094;","extracellular region [GO:0005576]"
"CHOYP_BRAFLDRAFT_99083.1.1|m.11705",48,"3",25,18,13.5,13,13,14,9.5,8.5,11,4.166190449,"0.3787445863",17.3571428571,9.5,"#VALUE!","-1.1729004725","0.0806584362",16.5,4.5,12,8.5,16.5,77,"1.0769230769","1.2692307692",11.125,11.625,-0.5,12,8,0.9119981049,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_BRAFLDRAFT_99083.1.1|m.11705","Q9DAK2","PACRG_MOUSE","81.53","222","39","1","22","243","22","241","3.00E-134","385","1","Q9DAK2","PACRG_MOUSE","reviewed","Parkin coregulated gene protein homolog (Hypertension-related protein 1-like protein) (PARK2 coregulated gene protein)","Pacrg","Mus musculus (Mouse)","241","cellular response to unfolded protein [GO:0034620]; negative regulation of cell death [GO:0060548]; spermatid development [GO:0007286]","GO:0001664; GO:0003779; GO:0005634; GO:0005739; GO:0005829; GO:0005929; GO:0007286; GO:0030544; GO:0031072; GO:0031625; GO:0031982; GO:0034620; GO:0043005; GO:0043014; GO:0044297; GO:0048487; GO:0051087; GO:0051879; GO:0060548; GO:0097225","","","","PF10274;","cell body [GO:0044297]; cilium [GO:0005929]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; chaperone binding [GO:0051087]; G-protein coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; ubiquitin protein ligase binding [GO:0031625]; cellular response to unfolded protein [GO:0034620]; negative regulation of cell death [GO:0060548]; spermatid development [GO:0007286]"
"CHOYP_BRAFLDRAFT_99083.1.1|m.11705",37,"9",25,13,15.5,12.5,14,16.5,16.5,13,11,4.166190449,"0.3787445863",17.3571428571,9.5,"#VALUE!","-1.1729004725","0.0806584362",16.5,4.5,12,8.5,16.5,77,"1.0769230769","1.2692307692",11.125,11.625,-0.5,12,8,0.9119981049,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_BRAFLDRAFT_99083.1.1|m.11705","Q9DAK2","PACRG_MOUSE","81.53","222","39","1","22","243","22","241","3.00E-134","385","1","Q9DAK2","PACRG_MOUSE","reviewed","Parkin coregulated gene protein homolog (Hypertension-related protein 1-like protein) (PARK2 coregulated gene protein)","Pacrg","Mus musculus (Mouse)","241","cellular response to unfolded protein [GO:0034620]; negative regulation of cell death [GO:0060548]; spermatid development [GO:0007286]","GO:0001664; GO:0003779; GO:0005634; GO:0005739; GO:0005829; GO:0005929; GO:0007286; GO:0030544; GO:0031072; GO:0031625; GO:0031982; GO:0034620; GO:0043005; GO:0043014; GO:0044297; GO:0048487; GO:0051087; GO:0051879; GO:0060548; GO:0097225","","","","PF10274;","cell body [GO:0044297]; cilium [GO:0005929]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; chaperone binding [GO:0051087]; G-protein coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; ubiquitin protein ligase binding [GO:0031625]; cellular response to unfolded protein [GO:0034620]; negative regulation of cell death [GO:0060548]; spermatid development [GO:0007286]"
"CHOYP_CALM.22.50|m.31010",37,"3",4.5,5,2,0,32.5,7,5,3.5,3.6428571429,2.9965967091,"0.822595175",8.9795918367,3.5,"#VALUE!","-1.2070444215","0.2703726503",8.5,0,8.5,1,8.5,25.5,"#DIV/0!","#DIV/0!",5.125,3,2.125,8.5,6.5,0.3020253464,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_CALM.22.50|m.31010","P62154","CALM_LOCMI","97.99","149","3","0","1","149","1","149","1.00E-100","292","1","P62154","CALM_LOCMI","reviewed","Calmodulin (CaM)","","Locusta migratoria (Migratory locust)","149","","GO:0005509","","","cd00051;","PF13499;","calcium ion binding [GO:0005509]"
"CHOYP_CALM.22.50|m.31010",48,"9",4.5,0,6,4.5,6,8.5,2,0,3.6428571429,2.9965967091,"0.822595175",8.9795918367,3.5,"#VALUE!","-1.2070444215","0.2703726503",8.5,0,8.5,1,8.5,25.5,"#DIV/0!","#DIV/0!",5.125,3,2.125,8.5,6.5,0.3020253464,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_CALM.22.50|m.31010","P62154","CALM_LOCMI","97.99","149","3","0","1","149","1","149","1.00E-100","292","1","P62154","CALM_LOCMI","reviewed","Calmodulin (CaM)","","Locusta migratoria (Migratory locust)","149","","GO:0005509","","","cd00051;","PF13499;","calcium ion binding [GO:0005509]"
"CHOYP_CATA.1.3|m.11120",48,"3",7.5,8,15,14.5,15.5,20,0,12.5,9.2857142857,7.3962207669,"0.7965160826",54.7040816327,11,"#VALUE!","-1.7075198638","0.0074880699",20,0,20,2.25,20,65,"4.4444444444","4.4444444444",10,11.25,-1.25,20,12.5,0.7698685301,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_CATA.1.3|m.11120",37,"9",7.5,14.5,17.5,8.5,18,20,17,4.5,9.2857142857,7.3962207669,"0.7965160826",54.7040816327,11,"#VALUE!","-1.7075198638","0.0074880699",20,0,20,2.25,20,65,"4.4444444444","4.4444444444",10,11.25,-1.25,20,12.5,0.7698685301,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_CATA.3.3|m.21642",48,"9",0,6,10,9,18.5,1.5,7.5,17,13.0714285714,6.6139925884,"0.505988504",43.7448979592,13.5,"#VALUE!","0.5895081441","-0.2190294294",24,1.5,22.5,10,24,91.5,"1.1764705882","0.0882352941",14.75,13.125,1.625,22.5,9.5,1.0837380078,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_CATA.3.3|m.21642","Q9XZD5","CATA_TOXGO","59.96","472","184","4","24","491","16","486","0","584","1","Q9XZD5","CATA_TOXGO","reviewed","Peroxisomal catalase (EC 1.11.1.6)","","Toxoplasma gondii","502","hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]","GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872","","","","PF00199;PF06628;","peroxisome [GO:0005777]; catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]"
"CHOYP_CATA.3.3|m.21642",37,"3",0,0,15,14.5,15.5,20,24,12.5,13.0714285714,6.6139925884,"0.505988504",43.7448979592,13.5,"#VALUE!","0.5895081441","-0.2190294294",24,1.5,22.5,10,24,91.5,"1.1764705882","0.0882352941",14.75,13.125,1.625,22.5,9.5,1.0837380078,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_CATA.3.3|m.21642","Q9XZD5","CATA_TOXGO","59.96","472","184","4","24","491","16","486","0","584","1","Q9XZD5","CATA_TOXGO","reviewed","Peroxisomal catalase (EC 1.11.1.6)","","Toxoplasma gondii","502","hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]","GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872","","","","PF00199;PF06628;","peroxisome [GO:0005777]; catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]"
"CHOYP_CATB.1.2|m.5440",32,"3",76.5,82,67.5,45,40.5,58,41,44.5,43.2857142857,12.2266019776,"0.282462752",149.4897959184,44.5,"#VALUE!","2.4140733278","-1.2525695737",58.5,17.5,41,40.5,58.5,303,"0.9914529915","0.9230769231",42.625,47.625,-5,40.5,18.5,3.5887717636,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_CATB.1.2|m.5440","A1E295","CATB_PIG","59.76","328","121","6","14","338","11","330","3.00E-139","405","1","A1E295","CATB_PIG","reviewed","Cathepsin B (EC 3.4.22.1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain]","CTSB","Sus scrofa (Pig)","335","cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of catalytic activity [GO:0050790]; viral entry into host cell [GO:0046718]","GO:0004197; GO:0005615; GO:0005730; GO:0005739; GO:0005764; GO:0030574; GO:0030855; GO:0042470; GO:0046697; GO:0046718; GO:0048471; GO:0050790; GO:0051603; GO:0070062; GO:0097067","","","","PF00112;PF08127;","extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; cysteine-type endopeptidase activity [GO:0004197]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of catalytic activity [GO:0050790]; viral entry into host cell [GO:0046718]"
"CHOYP_CATB.1.2|m.5440",28,"9",76.5,72,44,41,54,54,47.5,58.5,43.2857142857,12.2266019776,"0.282462752",149.4897959184,44.5,"#VALUE!","2.4140733278","-1.2525695737",58.5,17.5,41,40.5,58.5,303,"0.9914529915","0.9230769231",42.625,47.625,-5,40.5,18.5,3.5887717636,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_CATB.1.2|m.5440","A1E295","CATB_PIG","59.76","328","121","6","14","338","11","330","3.00E-139","405","1","A1E295","CATB_PIG","reviewed","Cathepsin B (EC 3.4.22.1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain]","CTSB","Sus scrofa (Pig)","335","cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of catalytic activity [GO:0050790]; viral entry into host cell [GO:0046718]","GO:0004197; GO:0005615; GO:0005730; GO:0005739; GO:0005764; GO:0030574; GO:0030855; GO:0042470; GO:0046697; GO:0046718; GO:0048471; GO:0050790; GO:0051603; GO:0070062; GO:0097067","","","","PF00112;PF08127;","extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; cysteine-type endopeptidase activity [GO:0004197]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of catalytic activity [GO:0050790]; viral entry into host cell [GO:0046718]"
"CHOYP_CHER.1.1|m.63350",17,"3",104.5,118,116.5,96,90,96.5,87,99.5,96.6428571429,28.5566032966,"0.2954859173",815.4795918367,99.5,"#VALUE!","1.9006912458","-0.1385347977",147,44,103,87,147,676.5,"0.9460784314","1.0784313725",84.375,108.875,-24.5,66,60,8.0125547791,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_CHER.1.1|m.63350","Q9VEN1","FLNA_DROME","43.4","841","463","8","23","854","1372","2208","0","696","1","Q9VEN1","FLNA_DROME","reviewed","Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1)","cher cheerio sko CG3937","Drosophila melanogaster (Fruit fly)","2210","behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; mitotic nuclear division [GO:0007067]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; olfactory learning [GO:0008355]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sleep [GO:0030431]","GO:0003779; GO:0005829; GO:0005886; GO:0007067; GO:0007301; GO:0007303; GO:0007611; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0008355; GO:0015629; GO:0030431; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0048149; GO:0051495","","","cd00014;","PF00307;PF00630;","actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; mitotic nuclear division [GO:0007067]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; olfactory learning [GO:0008355]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sleep [GO:0030431]"
"CHOYP_CHER.1.1|m.63350",65,"9",104.5,119,93.5,72.5,96,110,147,102,96.6428571429,28.5566032966,"0.2954859173",815.4795918367,99.5,"#VALUE!","1.9006912458","-0.1385347977",147,44,103,87,147,676.5,"0.9460784314","1.0784313725",84.375,108.875,-24.5,66,60,8.0125547791,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_CHER.1.1|m.63350","Q9VEN1","FLNA_DROME","43.4","841","463","8","23","854","1372","2208","0","696","1","Q9VEN1","FLNA_DROME","reviewed","Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1)","cher cheerio sko CG3937","Drosophila melanogaster (Fruit fly)","2210","behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; mitotic nuclear division [GO:0007067]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; olfactory learning [GO:0008355]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sleep [GO:0030431]","GO:0003779; GO:0005829; GO:0005886; GO:0007067; GO:0007301; GO:0007303; GO:0007611; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0008355; GO:0015629; GO:0030431; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0048149; GO:0051495","","","cd00014;","PF00307;PF00630;","actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; mitotic nuclear division [GO:0007067]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; olfactory learning [GO:0008355]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sleep [GO:0030431]"
"CHOYP_CLH1.2.2|m.22327",12,"3",105,116.5,138,136,128,119.5,121.5,136,125.6428571429,22.2641837387,"0.1772021446",495.693877551,133,"#VALUE!","4.6298788664","-1.9772711581",149.5,74.5,75,125.75,149.5,879.5,"0.8984962406","1.015037594",112.625,137.125,-24.5,60.5,19.5,10.4169134194,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_CLH1.2.2|m.22327","P49951","CLH1_BOVIN","83.99","1680","262","2","872","2550","2","1675","0","2981","1","P49951","CLH1_BOVIN","reviewed","Clathrin heavy chain 1","CLTC","Bos taurus (Bovine)","1675","autophagy [GO:0006914]; cell division [GO:0051301]; intracellular protein transport [GO:0006886]; mitotic nuclear division [GO:0007067]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; vesicle-mediated transport [GO:0016192]","GO:0005198; GO:0005739; GO:0005819; GO:0006886; GO:0006914; GO:0007067; GO:0016192; GO:0030117; GO:0030130; GO:0030132; GO:0042470; GO:0042802; GO:0051301; GO:1900126","","","","PF00637;PF09268;PF01394;","clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; melanosome [GO:0042470]; membrane coat [GO:0030117]; mitochondrion [GO:0005739]; spindle [GO:0005819]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; autophagy [GO:0006914]; cell division [GO:0051301]; intracellular protein transport [GO:0006886]; mitotic nuclear division [GO:0007067]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; vesicle-mediated transport [GO:0016192]"
"CHOYP_CLH1.2.2|m.22327",61,"9",105,123,124,124,128,135,149.5,133,125.6428571429,22.2641837387,"0.1772021446",495.693877551,133,"#VALUE!","4.6298788664","-1.9772711581",149.5,74.5,75,125.75,149.5,879.5,"0.8984962406","1.015037594",112.625,137.125,-24.5,60.5,19.5,10.4169134194,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_CLH1.2.2|m.22327","P49951","CLH1_BOVIN","83.99","1680","262","2","872","2550","2","1675","0","2981","1","P49951","CLH1_BOVIN","reviewed","Clathrin heavy chain 1","CLTC","Bos taurus (Bovine)","1675","autophagy [GO:0006914]; cell division [GO:0051301]; intracellular protein transport [GO:0006886]; mitotic nuclear division [GO:0007067]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; vesicle-mediated transport [GO:0016192]","GO:0005198; GO:0005739; GO:0005819; GO:0006886; GO:0006914; GO:0007067; GO:0016192; GO:0030117; GO:0030130; GO:0030132; GO:0042470; GO:0042802; GO:0051301; GO:1900126","","","","PF00637;PF09268;PF01394;","clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; melanosome [GO:0042470]; membrane coat [GO:0030117]; mitochondrion [GO:0005739]; spindle [GO:0005819]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; autophagy [GO:0006914]; cell division [GO:0051301]; intracellular protein transport [GO:0006886]; mitotic nuclear division [GO:0007067]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; vesicle-mediated transport [GO:0016192]"
"CHOYP_CNDP2.3.4|m.30467",37,"9",31,37,44,38.5,46,47.5,48,23.5,40.8571428571,9.8114884764,"0.2401413263",96.2653061224,47.5,"#VALUE!","-0.9931708768","-0.8081263084",51,23.5,27.5,33.75,51,286,"2","2.0212765957",40.5,42.75,-2.25,16.5,27.5,3.3874215326,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_CNDP2.3.4|m.30467","Q9D1A2","CNDP2_MOUSE","69.98","473","141","1","1","472","1","473","0","713","1","Q9D1A2","CNDP2_MOUSE","reviewed","Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1)","Cndp2 Cn2","Mus musculus (Mouse)","475","proteolysis [GO:0006508]","GO:0004180; GO:0005654; GO:0005829; GO:0006508; GO:0008233; GO:0008237; GO:0016805; GO:0046872; GO:0070062; GO:0102008; GO:0103046","","","cd05676;","PF07687;PF01546;","cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; proteolysis [GO:0006508]"
"CHOYP_CNDP2.3.4|m.30467",28,"3",31,35,20,34.5,39.5,47,36.5,51,40.8571428571,9.8114884764,"0.2401413263",96.2653061224,47.5,"#VALUE!","-0.9931708768","-0.8081263084",51,23.5,27.5,33.75,51,286,"2","2.0212765957",40.5,42.75,-2.25,16.5,27.5,3.3874215326,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_CNDP2.3.4|m.30467","Q9D1A2","CNDP2_MOUSE","69.98","473","141","1","1","472","1","473","0","713","1","Q9D1A2","CNDP2_MOUSE","reviewed","Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1)","Cndp2 Cn2","Mus musculus (Mouse)","475","proteolysis [GO:0006508]","GO:0004180; GO:0005654; GO:0005829; GO:0006508; GO:0008233; GO:0008237; GO:0016805; GO:0046872; GO:0070062; GO:0102008; GO:0103046","","","cd05676;","PF07687;PF01546;","cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; proteolysis [GO:0006508]"
"CHOYP_CO6A5.1.6|m.5838",14,"3",88.5,110,157,157.5,157.5,166.5,104.5,110.5,121,36.3789578112,"0.3006525439",1323.4285714286,110.5,"#VALUE!","-1.2122170016","-0.2216114958",168.5,61,107.5,99,168.5,847,"0.9881305638","0.8961424332",120.75,132.625,-11.875,105.5,75,10.0319791543,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_CO6A5.1.6|m.5838","A8TX70","CO6A5_HUMAN","28.98","911","531","27","67","964","235","1042","7.00E-93","341","1","A8TX70","CO6A5_HUMAN","reviewed","Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain) (von Willebrand factor A domain-containing protein 4)","COL6A5 COL29A1 VWA4","Homo sapiens (Human)","2615","cell adhesion [GO:0007155]; collagen catabolic process [GO:0030574]","GO:0005576; GO:0005578; GO:0005581; GO:0007155; GO:0030574","","","","PF01391;PF00092;","collagen trimer [GO:0005581]; extracellular region [GO:0005576]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]; collagen catabolic process [GO:0030574]"
"CHOYP_CO6A5.1.6|m.5838",60,"9",88.5,134.5,147.5,127.5,168.5,151,158,168.5,121,36.3789578112,"0.3006525439",1323.4285714286,110.5,"#VALUE!","-1.2122170016","-0.2216114958",168.5,61,107.5,99,168.5,847,"0.9881305638","0.8961424332",120.75,132.625,-11.875,105.5,75,10.0319791543,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_CO6A5.1.6|m.5838","A8TX70","CO6A5_HUMAN","28.98","911","531","27","67","964","235","1042","7.00E-93","341","1","A8TX70","CO6A5_HUMAN","reviewed","Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain) (von Willebrand factor A domain-containing protein 4)","COL6A5 COL29A1 VWA4","Homo sapiens (Human)","2615","cell adhesion [GO:0007155]; collagen catabolic process [GO:0030574]","GO:0005576; GO:0005578; GO:0005581; GO:0007155; GO:0030574","","","","PF01391;PF00092;","collagen trimer [GO:0005581]; extracellular region [GO:0005576]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]; collagen catabolic process [GO:0030574]"
"CHOYP_contig_009176|m.10652",48,"3",17,1.5,5.5,0,0,22,0,0,7.5,9.5543557755,"1.2739141034",91.2857142857,1.5,"#VALUE!","0.6206264189","1.2722147203",26.5,0,26.5,0,26.5,52.5,"2.5882352941","3.1176470588",12.5,6.125,6.375,26.5,16,0.6218168897,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_contig_009176|m.10652","Q9NR12","PDLI7_HUMAN","33.4","497","260","11","19","501","13","452","7.00E-76","253","1","Q9NR12","PDLI7_HUMAN","reviewed","PDZ and LIM domain protein 7 (LIM mineralization protein) (LMP) (Protein enigma)","PDLIM7 ENIGMA","Homo sapiens (Human)","457","actin cytoskeleton organization [GO:0030036]; axon guidance [GO:0007411]; ossification [GO:0001503]; positive regulation of osteoblast differentiation [GO:0045669]; receptor-mediated endocytosis [GO:0006898]","GO:0001503; GO:0001725; GO:0001726; GO:0005634; GO:0005829; GO:0005913; GO:0005925; GO:0006898; GO:0007411; GO:0008270; GO:0015629; GO:0030036; GO:0045669","","","","PF00412;PF00595;","actin cytoskeleton [GO:0015629]; cell-cell adherens junction [GO:0005913]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; ruffle [GO:0001726]; stress fiber [GO:0001725]; zinc ion binding [GO:0008270]; actin cytoskeleton organization [GO:0030036]; axon guidance [GO:0007411]; ossification [GO:0001503]; positive regulation of osteoblast differentiation [GO:0045669]; receptor-mediated endocytosis [GO:0006898]"
"CHOYP_contig_009176|m.10652",37,"9",17,0,3,3,16.5,26.5,16,8.5,7.5,9.5543557755,"1.2739141034",91.2857142857,1.5,"#VALUE!","0.6206264189","1.2722147203",26.5,0,26.5,0,26.5,52.5,"2.5882352941","3.1176470588",12.5,6.125,6.375,26.5,16,0.6218168897,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_contig_009176|m.10652","Q9NR12","PDLI7_HUMAN","33.4","497","260","11","19","501","13","452","7.00E-76","253","1","Q9NR12","PDLI7_HUMAN","reviewed","PDZ and LIM domain protein 7 (LIM mineralization protein) (LMP) (Protein enigma)","PDLIM7 ENIGMA","Homo sapiens (Human)","457","actin cytoskeleton organization [GO:0030036]; axon guidance [GO:0007411]; ossification [GO:0001503]; positive regulation of osteoblast differentiation [GO:0045669]; receptor-mediated endocytosis [GO:0006898]","GO:0001503; GO:0001725; GO:0001726; GO:0005634; GO:0005829; GO:0005913; GO:0005925; GO:0006898; GO:0007411; GO:0008270; GO:0015629; GO:0030036; GO:0045669","","","","PF00412;PF00595;","actin cytoskeleton [GO:0015629]; cell-cell adherens junction [GO:0005913]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; ruffle [GO:0001726]; stress fiber [GO:0001725]; zinc ion binding [GO:0008270]; actin cytoskeleton organization [GO:0030036]; axon guidance [GO:0007411]; ossification [GO:0001503]; positive regulation of osteoblast differentiation [GO:0045669]; receptor-mediated endocytosis [GO:0006898]"
"CHOYP_contig_016567|m.19514",48,"3",0,0,5,14.5,7,11,13,8.5,12.7857142857,5.8178121984,"0.4550244177",33.8469387755,12.5,"#VALUE!","-0.6434001797","0.114724322",21,3.5,17.5,9.5,21,89.5,"0.5365853659","0.6097560976",10,15.125,-5.125,9.5,12.5,1.0600497454,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_contig_016567|m.19514",37,"9",0,0.5,4,9,17,12.5,21,20.5,12.7857142857,5.8178121984,"0.4550244177",33.8469387755,12.5,"#VALUE!","-0.6434001797","0.114724322",21,3.5,17.5,9.5,21,89.5,"0.5365853659","0.6097560976",10,15.125,-5.125,9.5,12.5,1.0600497454,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_contig_027060|m.30790",37,"9",11,13.5,11.5,12,17.5,15,13,14,12,1.9820624179,"0.1651718682",3.9285714286,11.5,"#VALUE!","-1.065322314","0.0178347031",15,9,6,10.75,15,84,"1.2142857143","1.0714285714",13.125,12.125,1,8,4,0.9949070236,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_contig_027060|m.30790",48,"3",11,12,14,13,10.5,17,11.5,10,12,1.9820624179,"0.1651718682",3.9285714286,11.5,"#VALUE!","-1.065322314","0.0178347031",15,9,6,10.75,15,84,"1.2142857143","1.0714285714",13.125,12.125,1,8,4,0.9949070236,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_contig_041958|m.48141",28,"9",15,21.5,38,43.5,35.5,33,53,60.5,31.4285714286,17.5609724988,"0.5587582159",308.387755102,24,"#VALUE!","-0.7649746768","0.6228376789",60.5,7.5,53,21,60.5,220,"0.5537190083","0.5454545455",23.875,39.5,-15.625,26,40,2.6057088713,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_contig_041958|m.48141",37,"3",15,16.5,37.5,41.5,30.5,33.5,21.5,24,31.4285714286,17.5609724988,"0.5587582159",308.387755102,24,"#VALUE!","-0.7649746768","0.6228376789",60.5,7.5,53,21,60.5,220,"0.5537190083","0.5454545455",23.875,39.5,-15.625,26,40,2.6057088713,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_contig_043813|m.50619",48,"3",15.5,14,14,14,14,14,7.5,8,9.9285714286,5.3547613754,"0.5393284839",28.6734693878,8,"#VALUE!","-0.1710914502","-0.6212095281",16,0,16,7.75,16,69.5,"0.9032258065","0.935483871",9,11.875,-2.875,14.5,8,0.8231671207,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_contig_043813|m.50619",37,"9",15.5,16.5,15.5,11.5,15,14.5,16,15.5,9.9285714286,5.3547613754,"0.5393284839",28.6734693878,8,"#VALUE!","-0.1710914502","-0.6212095281",16,0,16,7.75,16,69.5,"0.9032258065","0.935483871",9,11.875,-2.875,14.5,8,0.8231671207,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_contig_043818|m.50622",18,"3",153.5,139.5,116,98.5,108,124,92.5,91,100.5714285714,32.8475141171,"0.3266088051",1078.9591836735,92.5,"#VALUE!","-1.1638363263","-0.2737786397",142.5,46.5,96,81,142.5,704,"0.8701754386","0.8701754386",96.75,110.25,-13.5,77.5,71.5,8.338268388,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_contig_043818|m.50622","Q5TZA2","CROCC_HUMAN","44.01","2020","1051","21","76","2069","38","2003","0","1341","1","Q5TZA2","CROCC_HUMAN","reviewed","Rootletin (Ciliary rootlet coiled-coil protein)","CROCC KIAA0445","Homo sapiens (Human)","2017","cell cycle [GO:0007049]; centriole-centriole cohesion [GO:0010457]; centrosome organization [GO:0051297]; ciliary basal body organization [GO:0032053]; epithelial structure maintenance [GO:0010669]; establishment of organelle localization [GO:0051656]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]","GO:0001917; GO:0005198; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0007049; GO:0008104; GO:0010457; GO:0010669; GO:0015629; GO:0019894; GO:0032053; GO:0033365; GO:0035253; GO:0045494; GO:0045724; GO:0051297; GO:0051656; GO:0070062; GO:1903566","","","","","actin cytoskeleton [GO:0015629]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary rootlet [GO:0035253]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; kinesin binding [GO:0019894]; structural molecule activity [GO:0005198]; cell cycle [GO:0007049]; centriole-centriole cohesion [GO:0010457]; centrosome organization [GO:0051297]; ciliary basal body organization [GO:0032053]; epithelial structure maintenance [GO:0010669]; establishment of organelle localization [GO:0051656]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]"
"CHOYP_contig_043818|m.50622",64,"9",153.5,104.5,104,97.5,128,124,136.5,142.5,100.5714285714,32.8475141171,"0.3266088051",1078.9591836735,92.5,"#VALUE!","-1.1638363263","-0.2737786397",142.5,46.5,96,81,142.5,704,"0.8701754386","0.8701754386",96.75,110.25,-13.5,77.5,71.5,8.338268388,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_contig_043818|m.50622","Q5TZA2","CROCC_HUMAN","44.01","2020","1051","21","76","2069","38","2003","0","1341","1","Q5TZA2","CROCC_HUMAN","reviewed","Rootletin (Ciliary rootlet coiled-coil protein)","CROCC KIAA0445","Homo sapiens (Human)","2017","cell cycle [GO:0007049]; centriole-centriole cohesion [GO:0010457]; centrosome organization [GO:0051297]; ciliary basal body organization [GO:0032053]; epithelial structure maintenance [GO:0010669]; establishment of organelle localization [GO:0051656]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]","GO:0001917; GO:0005198; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0007049; GO:0008104; GO:0010457; GO:0010669; GO:0015629; GO:0019894; GO:0032053; GO:0033365; GO:0035253; GO:0045494; GO:0045724; GO:0051297; GO:0051656; GO:0070062; GO:1903566","","","","","actin cytoskeleton [GO:0015629]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary rootlet [GO:0035253]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; kinesin binding [GO:0019894]; structural molecule activity [GO:0005198]; cell cycle [GO:0007049]; centriole-centriole cohesion [GO:0010457]; centrosome organization [GO:0051297]; ciliary basal body organization [GO:0032053]; epithelial structure maintenance [GO:0010669]; establishment of organelle localization [GO:0051656]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]"
"CHOYP_contig_044503|m.51534",48,"3",10.5,13,8.5,9,7.5,7,3,3,6.2857142857,4.0165474056,"0.6389961782",16.1326530612,5.5,"#VALUE!","-1.073058269","0.6480721725",13,1.5,11.5,3,13,44,"0.5384615385","0.5384615385",4.625,8.125,-3.5,5.5,10,0.5211417743,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_contig_044503|m.51534",37,"9",10.5,12,15.5,7.5,28.5,7,11,13,6.2857142857,4.0165474056,"0.6389961782",16.1326530612,5.5,"#VALUE!","-1.073058269","0.6480721725",13,1.5,11.5,3,13,44,"0.5384615385","0.5384615385",4.625,8.125,-3.5,5.5,10,0.5211417743,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_COX1.6.15|m.25748",37,"3",16,16,15,15,16.5,15,10,9,9.4285714286,2.3364896048,"0.2478095035",5.4591836735,10,"#VALUE!","4.8907530789","-2.1148322532",11.5,4,7.5,9.5,11.5,66,"1.4285714286","1.0952380952",10.125,10.125,0,11,2,0.7817126614,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_COX1.6.15|m.25748","Q9BYJ9","YTHD1_HUMAN","43.99","557","223","20","19","510","11","543","6.00E-125","384","1","Q9BYJ9","YTHD1_HUMAN","reviewed","YTH domain-containing family protein 1 (Dermatomyositis associated with cancer putative autoantigen 1) (DACA-1)","YTHDF1 C20orf21","Homo sapiens (Human)","559","positive regulation of translational initiation [GO:0045948]","GO:0003723; GO:0005737; GO:0043022; GO:0045948; GO:1990247","","","","PF04146;","cytoplasm [GO:0005737]; N6-methyladenosine-containing RNA binding [GO:1990247]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; positive regulation of translational initiation [GO:0045948]"
"CHOYP_COX1.6.15|m.25748",48,"9",16,16,14.5,12.5,17.5,11.5,11,10.5,9.4285714286,2.3364896048,"0.2478095035",5.4591836735,10,"#VALUE!","4.8907530789","-2.1148322532",11.5,4,7.5,9.5,11.5,66,"1.4285714286","1.0952380952",10.125,10.125,0,11,2,0.7817126614,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_COX1.6.15|m.25748","Q9BYJ9","YTHD1_HUMAN","43.99","557","223","20","19","510","11","543","6.00E-125","384","1","Q9BYJ9","YTHD1_HUMAN","reviewed","YTH domain-containing family protein 1 (Dermatomyositis associated with cancer putative autoantigen 1) (DACA-1)","YTHDF1 C20orf21","Homo sapiens (Human)","559","positive regulation of translational initiation [GO:0045948]","GO:0003723; GO:0005737; GO:0043022; GO:0045948; GO:1990247","","","","PF04146;","cytoplasm [GO:0005737]; N6-methyladenosine-containing RNA binding [GO:1990247]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; positive regulation of translational initiation [GO:0045948]"
"CHOYP_CUL3B.1.1|m.61644",37,"3",0,6,7,7.5,32.5,16,0,5,2.7857142857,5.0839884712,"1.8250215025",25.8469387755,0,"#VALUE!","4.4308959866","2.128105927",14.5,0,14.5,0,14.5,19.5,"#DIV/0!","#DIV/0!",7.625,1.25,6.375,16,5,0.230960559,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_CUL3B.1.1|m.61644","A3RLT6","RSSA_PINFU","83.96","293","42","5","34","324","1","290","2.00E-164","468","1","A3RLT6","RSSA_PINFU","reviewed","40S ribosomal protein SA","","Pinctada fucata (Akoya pearl oyster) (Pinctada imbricata fucata)","301","translation [GO:0006412]","GO:0003735; GO:0006412; GO:0015935","","","cd01425;","PF16122;PF00318;","small ribosomal subunit [GO:0015935]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]"
"CHOYP_CUL3B.1.1|m.61644",48,"9",0,8,7,15.5,0,14.5,0,0,2.7857142857,5.0839884712,"1.8250215025",25.8469387755,0,"#VALUE!","4.4308959866","2.128105927",14.5,0,14.5,0,14.5,19.5,"#DIV/0!","#DIV/0!",7.625,1.25,6.375,16,5,0.230960559,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_CUL3B.1.1|m.61644","A3RLT6","RSSA_PINFU","83.96","293","42","5","34","324","1","290","2.00E-164","468","1","A3RLT6","RSSA_PINFU","reviewed","40S ribosomal protein SA","","Pinctada fucata (Akoya pearl oyster) (Pinctada imbricata fucata)","301","translation [GO:0006412]","GO:0003735; GO:0006412; GO:0015935","","","cd01425;","PF16122;PF00318;","small ribosomal subunit [GO:0015935]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]"
"CHOYP_DAB2.1.1|m.22396",37,"3",11,9,14.5,11,15.5,11.5,12,14.5,11.7142857143,1.8680995472,"0.1594719126",3.4897959184,12,"#VALUE!","-1.1953216374","-0.0965105328",14.5,9,5.5,10.25,14.5,82,"1.0454545455","1.1363636364",11.25,12.125,-0.875,3.5,5,0.9712187611,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_DAB2.1.1|m.22396","P98081","DAB_DROME","60.69","145","57","0","38","182","38","182","3.00E-52","202","1","P98081","DAB_DROME","reviewed","Protein disabled","Dab CG9695","Drosophila melanogaster (Fruit fly)","2224","cellularization [GO:0007349]; clathrin-dependent endocytosis [GO:0072583]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; motor neuron axon guidance [GO:0008045]; neurogenesis [GO:0022008]; sevenless signaling pathway [GO:0045500]; synaptic vesicle endocytosis [GO:0048488]","GO:0005118; GO:0005737; GO:0007349; GO:0007391; GO:0008045; GO:0017124; GO:0022008; GO:0030424; GO:0042051; GO:0042169; GO:0045202; GO:0045500; GO:0048488; GO:0072583","","","","PF00640;","axon [GO:0030424]; cytoplasm [GO:0005737]; synapse [GO:0045202]; sevenless binding [GO:0005118]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; cellularization [GO:0007349]; clathrin-dependent endocytosis [GO:0072583]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; motor neuron axon guidance [GO:0008045]; neurogenesis [GO:0022008]; sevenless signaling pathway [GO:0045500]; synaptic vesicle endocytosis [GO:0048488]"
"CHOYP_DAB2.1.1|m.22396",48,"9",11,15.5,14,12,13.5,12.5,9.5,11,11.7142857143,1.8680995472,"0.1594719126",3.4897959184,12,"#VALUE!","-1.1953216374","-0.0965105328",14.5,9,5.5,10.25,14.5,82,"1.0454545455","1.1363636364",11.25,12.125,-0.875,3.5,5,0.9712187611,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_DAB2.1.1|m.22396","P98081","DAB_DROME","60.69","145","57","0","38","182","38","182","3.00E-52","202","1","P98081","DAB_DROME","reviewed","Protein disabled","Dab CG9695","Drosophila melanogaster (Fruit fly)","2224","cellularization [GO:0007349]; clathrin-dependent endocytosis [GO:0072583]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; motor neuron axon guidance [GO:0008045]; neurogenesis [GO:0022008]; sevenless signaling pathway [GO:0045500]; synaptic vesicle endocytosis [GO:0048488]","GO:0005118; GO:0005737; GO:0007349; GO:0007391; GO:0008045; GO:0017124; GO:0022008; GO:0030424; GO:0042051; GO:0042169; GO:0045202; GO:0045500; GO:0048488; GO:0072583","","","","PF00640;","axon [GO:0030424]; cytoplasm [GO:0005737]; synapse [GO:0045202]; sevenless binding [GO:0005118]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; cellularization [GO:0007349]; clathrin-dependent endocytosis [GO:0072583]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; motor neuron axon guidance [GO:0008045]; neurogenesis [GO:0022008]; sevenless signaling pathway [GO:0045500]; synaptic vesicle endocytosis [GO:0048488]"
"CHOYP_DDB1.1.1|m.59135",37,"3",17.5,18.5,14.5,15.5,17,13.5,11.5,14,12.6428571429,2.2790080191,"0.1802605213",5.193877551,13,"#VALUE!","1.3575700264","-1.1435325798",15,8,7,11.75,15,88.5,"0.9","0.8666666667",11.5,14,-2.5,5.5,3,1.0482056141,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_DDB1.1.1|m.59135","Q805F9","DDB1_CHICK","75.55","1141","276","3","1","1139","1","1140","0","1812","1","Q805F9","DDB1_CHICK","reviewed","DNA damage-binding protein 1 (DDB p127 subunit) (Damage-specific DNA-binding protein 1) (UV-damaged DNA-binding factor)","DDB1 RCJMB04_6h2","Gallus gallus (Chicken)","1140","DNA repair [GO:0006281]; histone H2A monoubiquitination [GO:0035518]; interaction with symbiont [GO:0051702]; negative regulation of apoptotic process [GO:0043066]; nucleotide-excision repair [GO:0006289]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral release from host cell [GO:1902188]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of mitotic cell cycle phase transition [GO:1901990]; UV-damage excision repair [GO:0070914]; Wnt signaling pathway [GO:0016055]","GO:0000784; GO:0003684; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006289; GO:0016055; GO:0031461; GO:0031464; GO:0031465; GO:0035518; GO:0042787; GO:0043066; GO:0043161; GO:0045070; GO:0046726; GO:0051702; GO:0070062; GO:0070914; GO:0080008; GO:1901990; GO:1902188","PATHWAY: Protein modification; protein ubiquitination. {ECO:0000305|PubMed:25043012}.","","","PF03178;","Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; DNA repair [GO:0006281]; histone H2A monoubiquitination [GO:0035518]; interaction with symbiont [GO:0051702]; negative regulation of apoptotic process [GO:0043066]; nucleotide-excision repair [GO:0006289]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral release from host cell [GO:1902188]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of mitotic cell cycle phase transition [GO:1901990]; UV-damage excision repair [GO:0070914]; Wnt signaling pathway [GO:0016055]"
"CHOYP_DDB1.1.1|m.59135",48,"9",17.5,16.5,16,12.5,12,13,12,15,12.6428571429,2.2790080191,"0.1802605213",5.193877551,13,"#VALUE!","1.3575700264","-1.1435325798",15,8,7,11.75,15,88.5,"0.9","0.8666666667",11.5,14,-2.5,5.5,3,1.0482056141,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_DDB1.1.1|m.59135","Q805F9","DDB1_CHICK","75.55","1141","276","3","1","1139","1","1140","0","1812","1","Q805F9","DDB1_CHICK","reviewed","DNA damage-binding protein 1 (DDB p127 subunit) (Damage-specific DNA-binding protein 1) (UV-damaged DNA-binding factor)","DDB1 RCJMB04_6h2","Gallus gallus (Chicken)","1140","DNA repair [GO:0006281]; histone H2A monoubiquitination [GO:0035518]; interaction with symbiont [GO:0051702]; negative regulation of apoptotic process [GO:0043066]; nucleotide-excision repair [GO:0006289]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral release from host cell [GO:1902188]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of mitotic cell cycle phase transition [GO:1901990]; UV-damage excision repair [GO:0070914]; Wnt signaling pathway [GO:0016055]","GO:0000784; GO:0003684; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006289; GO:0016055; GO:0031461; GO:0031464; GO:0031465; GO:0035518; GO:0042787; GO:0043066; GO:0043161; GO:0045070; GO:0046726; GO:0051702; GO:0070062; GO:0070914; GO:0080008; GO:1901990; GO:1902188","PATHWAY: Protein modification; protein ubiquitination. {ECO:0000305|PubMed:25043012}.","","","PF03178;","Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; DNA repair [GO:0006281]; histone H2A monoubiquitination [GO:0035518]; interaction with symbiont [GO:0051702]; negative regulation of apoptotic process [GO:0043066]; nucleotide-excision repair [GO:0006289]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral release from host cell [GO:1902188]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of mitotic cell cycle phase transition [GO:1901990]; UV-damage excision repair [GO:0070914]; Wnt signaling pathway [GO:0016055]"
"CHOYP_DFA_06569.1.1|m.9782",45,"3",77,63,5.5,0,0.5,0,0,0,0.1428571429,0.3499271061,"2.4494897428",0.1224489796,0,"#VALUE!","7","2.6457513111",1,0,1,0,1,1,"#DIV/0!","#DIV/0!",0.25,0,0.25,1,0,0.0118441312,"low_abundance","low_variance","low_abundance-low_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_DFA_06569.1.1|m.9782",48,"9",77,18.5,0,0,0.5,1,0,0,0.1428571429,0.3499271061,"2.4494897428",0.1224489796,0,"#VALUE!","7","2.6457513111",1,0,1,0,1,1,"#DIV/0!","#DIV/0!",0.25,0,0.25,1,0,0.0118441312,"low_abundance","low_variance","low_abundance-low_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_DNAH5.2.2|m.61452",35,"3",133,112.5,61,60.5,41.5,24.5,31.5,19,25.9285714286,9.0649583224,"0.3496127177",82.1734693878,24.5,"#VALUE!","-0.5933611499","-0.2516489403",39,10.5,28.5,20.75,39,181.5,"1","1.5918367347",26.375,25.125,1.25,28.5,15.5,2.1497098188,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_DNAH5.2.2|m.61452","Q8TE73","DYH5_HUMAN","62.56","4631","1627","21","57","4592","6","4624","0","5986","1","Q8TE73","DYH5_HUMAN","reviewed","Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5)","DNAH5 DNAHC5 HL1 KIAA1603","Homo sapiens (Human)","4624","cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158]","GO:0003341; GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0016887; GO:0021670; GO:0030317; GO:0036157; GO:0036158; GO:0060271","","","","PF07728;PF12780;PF08385;PF08393;PF03028;PF12777;","axoneme [GO:0005930]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158]"
"CHOYP_DNAH5.2.2|m.61452",37,"9",133,57,45,40.5,15,39,34.5,24.5,25.9285714286,9.0649583224,"0.3496127177",82.1734693878,24.5,"#VALUE!","-0.5933611499","-0.2516489403",39,10.5,28.5,20.75,39,181.5,"1","1.5918367347",26.375,25.125,1.25,28.5,15.5,2.1497098188,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_DNAH5.2.2|m.61452","Q8TE73","DYH5_HUMAN","62.56","4631","1627","21","57","4592","6","4624","0","5986","1","Q8TE73","DYH5_HUMAN","reviewed","Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5)","DNAH5 DNAHC5 HL1 KIAA1603","Homo sapiens (Human)","4624","cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158]","GO:0003341; GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0016887; GO:0021670; GO:0030317; GO:0036157; GO:0036158; GO:0060271","","","","PF07728;PF12780;PF08385;PF08393;PF03028;PF12777;","axoneme [GO:0005930]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158]"
"CHOYP_DNAH7.2.2|m.46648",45,"3",68.5,57.5,30,27,20,9,16.5,11,12.9285714286,4.0833159794,"0.3158365951",16.6734693878,11.5,"#VALUE!","-1.832639639","0.0187324824",18.5,7,11.5,10,18.5,90.5,"1","1.8888888889",12.375,12.5,-0.125,10,9.5,1.0718938766,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_DNAH7.2.2|m.46648","Q8WXX0","DYH7_HUMAN","68.68","4007","1224","11","23","4019","38","4023","0","5799","1","Q8WXX0","DYH7_HUMAN","reviewed","Dynein heavy chain 7, axonemal (Axonemal beta dynein heavy chain 7) (Ciliary dynein heavy chain 7) (Dynein heavy chain-like protein 2) (hDHC2)","DNAH7 KIAA0944","Homo sapiens (Human)","4024","cilium-dependent cell motility [GO:0060285]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]","GO:0003341; GO:0003777; GO:0005509; GO:0005524; GO:0005829; GO:0005858; GO:0005874; GO:0005929; GO:0036156; GO:0036159; GO:0060285","","","","PF12780;PF08393;PF03028;PF12777;","axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; cytosol [GO:0005829]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; microtubule motor activity [GO:0003777]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159]"
"CHOYP_DNAH7.2.2|m.46648",37,"9",68.5,26.5,25.5,24,6,17,18.5,9,12.9285714286,4.0833159794,"0.3158365951",16.6734693878,11.5,"#VALUE!","-1.832639639","0.0187324824",18.5,7,11.5,10,18.5,90.5,"1","1.8888888889",12.375,12.5,-0.125,10,9.5,1.0718938766,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_DNAH7.2.2|m.46648","Q8WXX0","DYH7_HUMAN","68.68","4007","1224","11","23","4019","38","4023","0","5799","1","Q8WXX0","DYH7_HUMAN","reviewed","Dynein heavy chain 7, axonemal (Axonemal beta dynein heavy chain 7) (Ciliary dynein heavy chain 7) (Dynein heavy chain-like protein 2) (hDHC2)","DNAH7 KIAA0944","Homo sapiens (Human)","4024","cilium-dependent cell motility [GO:0060285]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]","GO:0003341; GO:0003777; GO:0005509; GO:0005524; GO:0005829; GO:0005858; GO:0005874; GO:0005929; GO:0036156; GO:0036159; GO:0060285","","","","PF12780;PF08393;PF03028;PF12777;","axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; cytosol [GO:0005829]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; microtubule motor activity [GO:0003777]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159]"
"CHOYP_DYHC.1.3|m.10664",25,"3",169.5,149,83,83.5,60,44,60,48.5,47.3571428571,12.310606013,"0.2599524648",151.5510204082,48.5,"#VALUE!","0.7512748462","-0.7872364591",63,23.5,39.5,42,63,331.5,"1.023255814","1.4651162791",47.625,46.25,1.375,39.5,11.5,3.9263295037,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_DYHC.1.3|m.10664","P23098","DYHC_TRIGR","73.97","4464","1149","6","9","4463","6","4465","0","7031","1","P23098","DYHC_TRIGR","reviewed","Dynein beta chain, ciliary","","Tripneustes gratilla (Hawaian sea urchin) (Echinus gratilla)","4466","cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]","GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0016887; GO:0030030; GO:0030286; GO:0031514","","","","PF07728;PF12780;PF08385;PF08393;PF03028;PF12777;","cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]"
"CHOYP_DYHC.1.3|m.10664",32,"9",169.5,78.5,79.5,70,36.5,63,52.5,43,47.3571428571,12.310606013,"0.2599524648",151.5510204082,48.5,"#VALUE!","0.7512748462","-0.7872364591",63,23.5,39.5,42,63,331.5,"1.023255814","1.4651162791",47.625,46.25,1.375,39.5,11.5,3.9263295037,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_DYHC.1.3|m.10664","P23098","DYHC_TRIGR","73.97","4464","1149","6","9","4463","6","4465","0","7031","1","P23098","DYHC_TRIGR","reviewed","Dynein beta chain, ciliary","","Tripneustes gratilla (Hawaian sea urchin) (Echinus gratilla)","4466","cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]","GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0016887; GO:0030030; GO:0030286; GO:0031514","","","","PF07728;PF12780;PF08385;PF08393;PF03028;PF12777;","cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]"
"CHOYP_ECHM.1.1|m.38462",48,"3",15,15.5,13,16.5,12.5,14.5,10,14,12.1428571429,2.3711703818,"0.195272855",5.6224489796,12,"#VALUE!","-0.7879400924","-0.5331642628",15,8,7,10.75,15,85,"1","1.0344827586",11.875,13,-1.125,7,3,1.0067511548,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ECHM.1.1|m.38462","Q8BH95","ECHM_MOUSE","68.56","264","83","0","37","300","26","289","7.00E-131","380","1","Q8BH95","ECHM_MOUSE","reviewed","Enoyl-CoA hydratase, mitochondrial (EC 4.2.1.17) (Enoyl-CoA hydratase 1) (Short-chain enoyl-CoA hydratase) (SCEH)","Echs1","Mus musculus (Mouse)","290","fatty acid beta-oxidation [GO:0006635]","GO:0004300; GO:0005739; GO:0005759; GO:0006635; GO:0070062","PATHWAY: Lipid metabolism; fatty acid beta-oxidation. {ECO:0000250|UniProtKB:P30084}.","","","PF00378;","extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635]"
"CHOYP_ECHM.1.1|m.38462",37,"9",15,11.5,15,14,14,15,11.5,14.5,12.1428571429,2.3711703818,"0.195272855",5.6224489796,12,"#VALUE!","-0.7879400924","-0.5331642628",15,8,7,10.75,15,85,"1","1.0344827586",11.875,13,-1.125,7,3,1.0067511548,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ECHM.1.1|m.38462","Q8BH95","ECHM_MOUSE","68.56","264","83","0","37","300","26","289","7.00E-131","380","1","Q8BH95","ECHM_MOUSE","reviewed","Enoyl-CoA hydratase, mitochondrial (EC 4.2.1.17) (Enoyl-CoA hydratase 1) (Short-chain enoyl-CoA hydratase) (SCEH)","Echs1","Mus musculus (Mouse)","290","fatty acid beta-oxidation [GO:0006635]","GO:0004300; GO:0005739; GO:0005759; GO:0006635; GO:0070062","PATHWAY: Lipid metabolism; fatty acid beta-oxidation. {ECO:0000250|UniProtKB:P30084}.","","","PF00378;","extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635]"
"CHOYP_EF1A.2.4|m.50858",49,"9",268.5,349,319.5,281.5,356.5,325,341,349,286.3571428571,61.6683029752,"0.2153545128",3802.9795918367,294.5,"#VALUE!","2.0096192064","-1.3964052516",349,156.5,192.5,269.25,349,2004.5,"1.0257879656","0.9312320917",283.5,307.125,-23.625,201.5,98.5,23.7415610565,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_EF1A.2.4|m.50858","Q92005","EF1A_DANRE","84.53","459","71","0","1","459","1","459","0","813","1","Q92005","EF1A_DANRE","reviewed","Elongation factor 1-alpha (EF-1-alpha)","eef1a ef1a","Danio rerio (Zebrafish) (Brachydanio rerio)","462","","GO:0003746; GO:0003924; GO:0005525; GO:0005622; GO:0005737","","","","PF03144;PF03143;","cytoplasm [GO:0005737]; intracellular [GO:0005622]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]"
"CHOYP_EF1A.2.4|m.50858",1,"3",268.5,295.5,332,294.5,298,358,294.5,288,286.3571428571,61.6683029752,"0.2153545128",3802.9795918367,294.5,"#VALUE!","2.0096192064","-1.3964052516",349,156.5,192.5,269.25,349,2004.5,"1.0257879656","0.9312320917",283.5,307.125,-23.625,201.5,98.5,23.7415610565,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_EF1A.2.4|m.50858","Q92005","EF1A_DANRE","84.53","459","71","0","1","459","1","459","0","813","1","Q92005","EF1A_DANRE","reviewed","Elongation factor 1-alpha (EF-1-alpha)","eef1a ef1a","Danio rerio (Zebrafish) (Brachydanio rerio)","462","","GO:0003746; GO:0003924; GO:0005525; GO:0005622; GO:0005737","","","","PF03144;PF03143;","cytoplasm [GO:0005737]; intracellular [GO:0005622]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]"
"CHOYP_EF1A.3.4|m.63413",37,"9",0.5,14,3.5,10.5,15.5,21.5,24.5,15.5,14.4285714286,6.8370240572,"0.4738531525",46.7448979592,15.5,"#VALUE!","-1.3802932502","-0.0320130949",24.5,5.5,19,8.5,24.5,101,"0.8387096774","1.3870967742",11.375,17.125,-5.75,16,13,1.1962572545,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_EF1A.3.4|m.63413","Q5RKI1","IF4A2_RAT","84.16","322","50","1","1","321","38","359","0","570","1","Q5RKI1","IF4A2_RAT","reviewed","Eukaryotic initiation factor 4A-II (eIF-4A-II) (eIF4A-II) (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A-2)","Eif4a2","Rattus norvegicus (Rat)","407","negative regulation of RNA-directed 5'-3' RNA polymerase activity [GO:1900260]; regulation of gene expression [GO:0010468]; RNA secondary structure unwinding [GO:0010501]; translational initiation [GO:0006413]","GO:0003743; GO:0004004; GO:0005524; GO:0006413; GO:0010468; GO:0010501; GO:0048471; GO:1900260","","","","PF00270;PF00271;","perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; translation initiation factor activity [GO:0003743]; negative regulation of RNA-directed 5'-3' RNA polymerase activity [GO:1900260]; regulation of gene expression [GO:0010468]; RNA secondary structure unwinding [GO:0010501]; translational initiation [GO:0006413]"
"CHOYP_EF1A.3.4|m.63413",48,"3",0.5,15,19.5,5.5,8.5,13,5.5,17,14.4285714286,6.8370240572,"0.4738531525",46.7448979592,15.5,"#VALUE!","-1.3802932502","-0.0320130949",24.5,5.5,19,8.5,24.5,101,"0.8387096774","1.3870967742",11.375,17.125,-5.75,16,13,1.1962572545,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_EF1A.3.4|m.63413","Q5RKI1","IF4A2_RAT","84.16","322","50","1","1","321","38","359","0","570","1","Q5RKI1","IF4A2_RAT","reviewed","Eukaryotic initiation factor 4A-II (eIF-4A-II) (eIF4A-II) (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A-2)","Eif4a2","Rattus norvegicus (Rat)","407","negative regulation of RNA-directed 5'-3' RNA polymerase activity [GO:1900260]; regulation of gene expression [GO:0010468]; RNA secondary structure unwinding [GO:0010501]; translational initiation [GO:0006413]","GO:0003743; GO:0004004; GO:0005524; GO:0006413; GO:0010468; GO:0010501; GO:0048471; GO:1900260","","","","PF00270;PF00271;","perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; translation initiation factor activity [GO:0003743]; negative regulation of RNA-directed 5'-3' RNA polymerase activity [GO:1900260]; regulation of gene expression [GO:0010468]; RNA secondary structure unwinding [GO:0010501]; translational initiation [GO:0006413]"
"CHOYP_EF1G.3.3|m.63510",28,"3",49.5,48,69,72.5,61.5,77.5,54.5,51.5,57.5,12.2270192606,"0.2126438132",149.5,56.5,"#VALUE!","0.9942237783","-1.0402146495",70,33,37,53,70,402.5,"1.1071428571","0.9928571429",58.625,61.375,-2.75,44.5,18.5,4.7672628213,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_EF1G.3.3|m.63510","P12261","EF1G_ARTSA","61.12","427","151","5","1","414","1","425","0","531","1","P12261","EF1G_ARTSA","reviewed","Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma)","","Artemia salina (Brine shrimp)","430","","GO:0003746","","","","PF00647;PF00043;PF02798;","translation elongation factor activity [GO:0003746]"
"CHOYP_EF1G.3.3|m.63510",23,"9",49.5,60.5,53.5,53.5,77,69.5,67.5,70,57.5,12.2270192606,"0.2126438132",149.5,56.5,"#VALUE!","0.9942237783","-1.0402146495",70,33,37,53,70,402.5,"1.1071428571","0.9928571429",58.625,61.375,-2.75,44.5,18.5,4.7672628213,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_EF1G.3.3|m.63510","P12261","EF1G_ARTSA","61.12","427","151","5","1","414","1","425","0","531","1","P12261","EF1G_ARTSA","reviewed","Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma)","","Artemia salina (Brine shrimp)","430","","GO:0003746","","","","PF00647;PF00043;PF02798;","translation elongation factor activity [GO:0003746]"
"CHOYP_EF2.4.5|m.30186",13,"3",66.5,109,155,131,203.5,173,113.5,151,128.5714285714,30.9970373831,"0.2410880685",960.8163265306,140,"#VALUE!","2.4584322407","-1.5249612229",160.5,62,98.5,119,160.5,900,"1.0778816199","0.9252336449",124.25,144,-19.75,111,36,10.6597181097,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_EF2.4.5|m.30186","P29691","EF2_CAEEL","77","852","186","2","1","842","1","852","0","1375","1","P29691","EF2_CAEEL","reviewed","Elongation factor 2 (EF-2)","eef-2 F25H5.4","Caenorhabditis elegans","852","","GO:0003746; GO:0003924; GO:0005525; GO:0005737","","","","PF00679;PF14492;PF03764;PF03144;","cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]"
"CHOYP_EF2.4.5|m.30186",60,"9",66.5,145,159,118.5,160,148.5,140,160.5,128.5714285714,30.9970373831,"0.2410880685",960.8163265306,140,"#VALUE!","2.4584322407","-1.5249612229",160.5,62,98.5,119,160.5,900,"1.0778816199","0.9252336449",124.25,144,-19.75,111,36,10.6597181097,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_EF2.4.5|m.30186","P29691","EF2_CAEEL","77","852","186","2","1","842","1","852","0","1375","1","P29691","EF2_CAEEL","reviewed","Elongation factor 2 (EF-2)","eef-2 F25H5.4","Caenorhabditis elegans","852","","GO:0003746; GO:0003924; GO:0005525; GO:0005737","","","","PF00679;PF14492;PF03764;PF03144;","cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]"
"CHOYP_EF2.5.5|m.39855",41,"3",65,42,61.5,54,35,7,39.5,43,28.0714285714,12.8547616843,"0.4579304417",165.2448979592,26.5,"#VALUE!","-1.7466703255","-0.2523770252",43,8.5,34.5,18.5,43,196.5,"0.5","0.6071428571",19.5,31.375,-11.875,32.5,29,2.3273717873,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_EF2.5.5|m.39855","A7GZW3","LEPA_CAMC5","42.57","148","69","3","18","165","3","134","8.00E-24","110","1","A7GZW3","LEPA_CAMC5","reviewed","Elongation factor 4 (EF-4) (EC 3.6.5.n1) (Ribosomal back-translocase LepA)","lepA Ccur92_14510 CCV52592_1454","Campylobacter curvus (strain 525.92)","596","translation [GO:0006412]","GO:0003924; GO:0005525; GO:0005886; GO:0006412","","","","PF00679;PF03144;PF06421;","plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation [GO:0006412]"
"CHOYP_EF2.5.5|m.39855",37,"9",65,46,48,34.5,7.5,8.5,26.5,14,28.0714285714,12.8547616843,"0.4579304417",165.2448979592,26.5,"#VALUE!","-1.7466703255","-0.2523770252",43,8.5,34.5,18.5,43,196.5,"0.5","0.6071428571",19.5,31.375,-11.875,32.5,29,2.3273717873,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_EF2.5.5|m.39855","A7GZW3","LEPA_CAMC5","42.57","148","69","3","18","165","3","134","8.00E-24","110","1","A7GZW3","LEPA_CAMC5","reviewed","Elongation factor 4 (EF-4) (EC 3.6.5.n1) (Ribosomal back-translocase LepA)","lepA Ccur92_14510 CCV52592_1454","Campylobacter curvus (strain 525.92)","596","translation [GO:0006412]","GO:0003924; GO:0005525; GO:0005886; GO:0006412","","","","PF00679;PF03144;PF06421;","plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation [GO:0006412]"
"CHOYP_EF2.5.5|m.39856",37,"9",51,52,43.5,39.5,43,38.5,42.5,43,36.5714285714,7.1435713929,"0.1953320303",51.0306122449,38,"#VALUE!","4.9185647214","-2.0654897104",43,20,23,37,43,256,"0.976744186","0.8953488372",34.375,40.125,-5.75,22,6,3.0320975956,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_EF2.5.5|m.39856","Q7QC84","MMSA_ANOGA","73.94","518","132","1","11","525","4","521","0","808","1","Q7QC84","MMSA_ANOGA","reviewed","Probable methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27)","AGAP002499","Anopheles gambiae (African malaria mosquito)","521","","GO:0004491; GO:0005739; GO:0018478","","","cd07085;","PF00171;","mitochondrion [GO:0005739]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]"
"CHOYP_EF2.5.5|m.39856",28,"3",51,52,49.5,46.5,48,42,37,37,36.5714285714,7.1435713929,"0.1953320303",51.0306122449,38,"#VALUE!","4.9185647214","-2.0654897104",43,20,23,37,43,256,"0.976744186","0.8953488372",34.375,40.125,-5.75,22,6,3.0320975956,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_EF2.5.5|m.39856","Q7QC84","MMSA_ANOGA","73.94","518","132","1","11","525","4","521","0","808","1","Q7QC84","MMSA_ANOGA","reviewed","Probable methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27)","AGAP002499","Anopheles gambiae (African malaria mosquito)","521","","GO:0004491; GO:0005739; GO:0018478","","","cd07085;","PF00171;","mitochondrion [GO:0005739]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]"
"CHOYP_EIF2A.1.1|m.12752",37,"3",12,13,17,13,15.5,20.5,11.5,13,10.8571428571,2.2314999074,"0.2055328862",4.9795918367,11.5,"#VALUE!","2.7631987369","-1.6795268225",13,6,7,10.5,13,76,"1.64","0.92",12.375,11.75,0.625,14.5,3.5,0.9001539737,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_EIF2A.1.1|m.12752","Q5ZKC1","EIF2A_CHICK","52.34","577","260","7","5","569","1","574","0","591","1","Q5ZKC1","EIF2A_CHICK","reviewed","Eukaryotic translation initiation factor 2A (eIF-2A)","EIF2A RCJMB04_11n11","Gallus gallus (Chicken)","586","regulation of translation [GO:0006417]; ribosome assembly [GO:0042255]","GO:0000049; GO:0003729; GO:0003743; GO:0005737; GO:0005850; GO:0006417; GO:0022627; GO:0042255; GO:0043022","","","","PF08662;","cytoplasm [GO:0005737]; cytosolic small ribosomal subunit [GO:0022627]; eukaryotic translation initiation factor 2 complex [GO:0005850]; mRNA binding [GO:0003729]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; tRNA binding [GO:0000049]; regulation of translation [GO:0006417]; ribosome assembly [GO:0042255]"
"CHOYP_EIF2A.1.1|m.12752",48,"9",12,11,12.5,9,15,11.5,9.5,12.5,10.8571428571,2.2314999074,"0.2055328862",4.9795918367,11.5,"#VALUE!","2.7631987369","-1.6795268225",13,6,7,10.5,13,76,"1.64","0.92",12.375,11.75,0.625,14.5,3.5,0.9001539737,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_EIF2A.1.1|m.12752","Q5ZKC1","EIF2A_CHICK","52.34","577","260","7","5","569","1","574","0","591","1","Q5ZKC1","EIF2A_CHICK","reviewed","Eukaryotic translation initiation factor 2A (eIF-2A)","EIF2A RCJMB04_11n11","Gallus gallus (Chicken)","586","regulation of translation [GO:0006417]; ribosome assembly [GO:0042255]","GO:0000049; GO:0003729; GO:0003743; GO:0005737; GO:0005850; GO:0006417; GO:0022627; GO:0042255; GO:0043022","","","","PF08662;","cytoplasm [GO:0005737]; cytosolic small ribosomal subunit [GO:0022627]; eukaryotic translation initiation factor 2 complex [GO:0005850]; mRNA binding [GO:0003729]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; tRNA binding [GO:0000049]; regulation of translation [GO:0006417]; ribosome assembly [GO:0042255]"
"CHOYP_EIF3E.1.1|m.27167",37,"3",17,16.5,15.5,14,20.5,13,14.5,12.5,11.2142857143,2.2177392423,"0.1977601872",4.9183673469,10,"#VALUE!","-2.0211428867","0.5207005754",14.5,9,5.5,9.25,14.5,78.5,"1.4444444444","1",11.5,11.375,0.125,5.5,5,0.9297643018,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_EIF3E.1.1|m.27167","Q641X8","EIF3E_RAT","77.32","441","96","3","22","459","1","440","0","717","1","Q641X8","EIF3E_RAT","reviewed","Eukaryotic translation initiation factor 3 subunit E (eIF3e) (Eukaryotic translation initiation factor 3 subunit 6) (eIF-3 p48)","Eif3e Eif3s6 Int6","Rattus norvegicus (Rat)","445","nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; translational initiation [GO:0006413]","GO:0000184; GO:0003743; GO:0005634; GO:0005852; GO:0006413; GO:0016605","","","","PF09440;PF01399;","eukaryotic translation initiation factor 3 complex [GO:0005852]; nucleus [GO:0005634]; PML body [GO:0016605]; translation initiation factor activity [GO:0003743]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; translational initiation [GO:0006413]"
"CHOYP_EIF3E.1.1|m.27167",48,"9",17,13.5,14.5,14.5,8,9,14,9,11.2142857143,2.2177392423,"0.1977601872",4.9183673469,10,"#VALUE!","-2.0211428867","0.5207005754",14.5,9,5.5,9.25,14.5,78.5,"1.4444444444","1",11.5,11.375,0.125,5.5,5,0.9297643018,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_EIF3E.1.1|m.27167","Q641X8","EIF3E_RAT","77.32","441","96","3","22","459","1","440","0","717","1","Q641X8","EIF3E_RAT","reviewed","Eukaryotic translation initiation factor 3 subunit E (eIF3e) (Eukaryotic translation initiation factor 3 subunit 6) (eIF-3 p48)","Eif3e Eif3s6 Int6","Rattus norvegicus (Rat)","445","nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; translational initiation [GO:0006413]","GO:0000184; GO:0003743; GO:0005634; GO:0005852; GO:0006413; GO:0016605","","","","PF09440;PF01399;","eukaryotic translation initiation factor 3 complex [GO:0005852]; nucleus [GO:0005634]; PML body [GO:0016605]; translation initiation factor activity [GO:0003743]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; translational initiation [GO:0006413]"
"CHOYP_EIF5A.1.3|m.22684",28,"3",29,52.5,56.5,38.5,37.5,48,26,42,35.1428571429,10.8124078385,"0.3076701417",116.9081632653,39.5,"#VALUE!","0.0931478411","-0.7735797499",49.5,15,34.5,29,49.5,246,"0.9696969697","0.6464646465",30.25,43.25,-13,33,10,2.9136562833,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_EIF5A.1.3|m.22684","P10160","IF5A1_RABIT","64.56","158","51","2","1","158","1","153","3.00E-69","213","1","P10160","IF5A1_RABIT","reviewed","Eukaryotic translation initiation factor 5A-1 (eIF-5A-1) (eIF-5A1) (Eukaryotic initiation factor 5A isoform 1) (eIF-5A) (eIF-4D)","EIF5A","Oryctolagus cuniculus (Rabbit)","154","mRNA transport [GO:0051028]; positive regulation of translation [GO:0045727]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; protein transport [GO:0015031]; translational frameshifting [GO:0006452]","GO:0003746; GO:0005643; GO:0005789; GO:0006452; GO:0015031; GO:0043022; GO:0045727; GO:0045901; GO:0045905; GO:0051028","","","","PF01287;","endoplasmic reticulum membrane [GO:0005789]; nuclear pore [GO:0005643]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; mRNA transport [GO:0051028]; positive regulation of translation [GO:0045727]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; protein transport [GO:0015031]; translational frameshifting [GO:0006452]"
"CHOYP_EIF5A.1.3|m.22684",37,"9",29,44,37.5,23,41.5,32,42,49.5,35.1428571429,10.8124078385,"0.3076701417",116.9081632653,39.5,"#VALUE!","0.0931478411","-0.7735797499",49.5,15,34.5,29,49.5,246,"0.9696969697","0.6464646465",30.25,43.25,-13,33,10,2.9136562833,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_EIF5A.1.3|m.22684","P10160","IF5A1_RABIT","64.56","158","51","2","1","158","1","153","3.00E-69","213","1","P10160","IF5A1_RABIT","reviewed","Eukaryotic translation initiation factor 5A-1 (eIF-5A-1) (eIF-5A1) (Eukaryotic initiation factor 5A isoform 1) (eIF-5A) (eIF-4D)","EIF5A","Oryctolagus cuniculus (Rabbit)","154","mRNA transport [GO:0051028]; positive regulation of translation [GO:0045727]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; protein transport [GO:0015031]; translational frameshifting [GO:0006452]","GO:0003746; GO:0005643; GO:0005789; GO:0006452; GO:0015031; GO:0043022; GO:0045727; GO:0045901; GO:0045905; GO:0051028","","","","PF01287;","endoplasmic reticulum membrane [GO:0005789]; nuclear pore [GO:0005643]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; mRNA transport [GO:0051028]; positive regulation of translation [GO:0045727]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; protein transport [GO:0015031]; translational frameshifting [GO:0006452]"
"CHOYP_ENPL.3.4|m.39476",41,"9",26.5,58,55.5,56.5,31,11,43.5,38.5,33.5714285714,13.9166615748,"0.4145388554",193.6734693878,38.5,"#VALUE!","-0.9724457757","-0.4594007205",53,11,42,23.5,53,235,"1.3636363636","0.2857142857",30.75,41.125,-10.375,41.5,23.5,2.7833708397,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ENPL.3.4|m.39476","Q66HD0","ENPL_RAT","68.34","758","228","7","6","758","5","755","0","1028","1","Q66HD0","ENPL_RAT","reviewed","Endoplasmin (94 kDa glucose-regulated protein) (GRP-94) (Heat shock protein 90 kDa beta member 1)","Hsp90b1 Grp94 Tra1","Rattus norvegicus (Rat)","804","cellular response to manganese ion [GO:0071287]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; protein folding [GO:0006457]","GO:0005524; GO:0005788; GO:0005790; GO:0006457; GO:0030433; GO:0042470; GO:0071287","","","","PF02518;PF00183;","endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; smooth endoplasmic reticulum [GO:0005790]; ATP binding [GO:0005524]; cellular response to manganese ion [GO:0071287]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; protein folding [GO:0006457]"
"CHOYP_ENPL.3.4|m.39476",28,"3",26.5,32.5,58.5,51,48,52.5,42,29.5,33.5714285714,13.9166615748,"0.4145388554",193.6734693878,38.5,"#VALUE!","-0.9724457757","-0.4594007205",53,11,42,23.5,53,235,"1.3636363636","0.2857142857",30.75,41.125,-10.375,41.5,23.5,2.7833708397,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ENPL.3.4|m.39476","Q66HD0","ENPL_RAT","68.34","758","228","7","6","758","5","755","0","1028","1","Q66HD0","ENPL_RAT","reviewed","Endoplasmin (94 kDa glucose-regulated protein) (GRP-94) (Heat shock protein 90 kDa beta member 1)","Hsp90b1 Grp94 Tra1","Rattus norvegicus (Rat)","804","cellular response to manganese ion [GO:0071287]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; protein folding [GO:0006457]","GO:0005524; GO:0005788; GO:0005790; GO:0006457; GO:0030433; GO:0042470; GO:0071287","","","","PF02518;PF00183;","endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; smooth endoplasmic reticulum [GO:0005790]; ATP binding [GO:0005524]; cellular response to manganese ion [GO:0071287]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; protein folding [GO:0006457]"
"CHOYP_ENPL.4.4|m.47194",44,"3",29,53,12,31.5,9,52.5,7.5,48.5,37.2857142857,22.424248901,"0.6014166372",502.8469387755,40,"#VALUE!","-1.444100976","-0.3367438042",65,5,60,19.75,65,261,"0.8076923077","0.9692307692",38.75,39.625,-0.875,55.5,60,3.0913182518,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ENPL.4.4|m.47194","Q04619","HS90B_CHICK","46.49","727","365","9","65","780","4","717","0","622","1","Q04619","HS90B_CHICK","reviewed","Heat shock cognate protein HSP 90-beta","HSP90AB1 HSPCB","Gallus gallus (Chicken)","725","protein folding [GO:0006457]; response to stress [GO:0006950]","GO:0005524; GO:0005829; GO:0006457; GO:0006950; GO:0042470","","","","PF02518;PF00183;","cytosol [GO:0005829]; melanosome [GO:0042470]; ATP binding [GO:0005524]; protein folding [GO:0006457]; response to stress [GO:0006950]"
"CHOYP_ENPL.4.4|m.47194",79,"9",29,11,9.5,10.5,29.5,63,40,65,37.2857142857,22.424248901,"0.6014166372",502.8469387755,40,"#VALUE!","-1.444100976","-0.3367438042",65,5,60,19.75,65,261,"0.8076923077","0.9692307692",38.75,39.625,-0.875,55.5,60,3.0913182518,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ENPL.4.4|m.47194","Q04619","HS90B_CHICK","46.49","727","365","9","65","780","4","717","0","622","1","Q04619","HS90B_CHICK","reviewed","Heat shock cognate protein HSP 90-beta","HSP90AB1 HSPCB","Gallus gallus (Chicken)","725","protein folding [GO:0006457]; response to stress [GO:0006950]","GO:0005524; GO:0005829; GO:0006457; GO:0006950; GO:0042470","","","","PF02518;PF00183;","cytosol [GO:0005829]; melanosome [GO:0042470]; ATP binding [GO:0005524]; protein folding [GO:0006457]; response to stress [GO:0006950]"
"CHOYP_EPN4.2.3|m.66030",48,"3",0,6,15.5,5.5,0,12.5,6,0,7.1428571429,5.6106676819,"0.7854934755",31.4795918367,7,"#VALUE!","-1.1455525954","0.1842931294",15.5,0,15.5,3,15.5,50,"0.8928571429","1.1071428571",10.375,5.25,5.125,9.5,14,0.5922065616,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_EPN4.2.3|m.66030",37,"9",0,12.5,15.5,11.5,21,15.5,7,14,7.1428571429,5.6106676819,"0.7854934755",31.4795918367,7,"#VALUE!","-1.1455525954","0.1842931294",15.5,0,15.5,3,15.5,50,"0.8928571429","1.1071428571",10.375,5.25,5.125,9.5,14,0.5922065616,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_EPS-8.1.1|m.17522",37,"3",18.5,2.5,4,12.5,17.5,20.5,14.5,15.5,10.5,4.0355562548,"0.3843386909",16.2857142857,9.5,"#VALUE!","-1.9019390582","-0.1014259034",15.5,4.5,11,7.5,15.5,73.5,"2.1578947368","1.5263157895",13.5,10,3.5,16,9,0.8705436456,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_EPS-8.1.1|m.17522","Q08509","EPS8_MOUSE","31.52","606","330","24","36","594","17","584","2.00E-64","236","1","Q08509","EPS8_MOUSE","reviewed","Epidermal growth factor receptor kinase substrate 8","Eps8","Mus musculus (Mouse)","821","actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin polymerization-dependent cell motility [GO:0070358]; adult locomotory behavior [GO:0008344]; barbed-end actin filament capping [GO:0051016]; behavioral response to ethanol [GO:0048149]; dendritic cell migration [GO:0036336]; exit from mitosis [GO:0010458]; Rac protein signal transduction [GO:0016601]; regulation of actin filament length [GO:0030832]; regulation of cell shape [GO:0008360]","GO:0003779; GO:0005903; GO:0005938; GO:0008344; GO:0008360; GO:0010458; GO:0014069; GO:0016601; GO:0017146; GO:0030054; GO:0030426; GO:0030832; GO:0031532; GO:0031982; GO:0032420; GO:0032587; GO:0035591; GO:0036336; GO:0045202; GO:0048149; GO:0048365; GO:0051016; GO:0051017; GO:0051764; GO:0070062; GO:0070358","","","cd01210;","PF08416;PF00018;","brush border [GO:0005903]; cell cortex [GO:0005938]; cell junction [GO:0030054]; extracellular exosome [GO:0070062]; growth cone [GO:0030426]; NMDA selective glutamate receptor complex [GO:0017146]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; stereocilium [GO:0032420]; synapse [GO:0045202]; vesicle [GO:0031982]; actin binding [GO:0003779]; Rac GTPase binding [GO:0048365]; signaling adaptor activity [GO:0035591]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin polymerization-dependent cell motility [GO:0070358]; adult locomotory behavior [GO:0008344]; barbed-end actin filament capping [GO:0051016]; behavioral response to ethanol [GO:0048149]; dendritic cell migration [GO:0036336]; exit from mitosis [GO:0010458]; Rac protein signal transduction [GO:0016601]; regulation of actin filament length [GO:0030832]; regulation of cell shape [GO:0008360]"
"CHOYP_EPS-8.1.1|m.17522",48,"9",18.5,25,17.5,2.5,18,14.5,6.5,9.5,10.5,4.0355562548,"0.3843386909",16.2857142857,9.5,"#VALUE!","-1.9019390582","-0.1014259034",15.5,4.5,11,7.5,15.5,73.5,"2.1578947368","1.5263157895",13.5,10,3.5,16,9,0.8705436456,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_EPS-8.1.1|m.17522","Q08509","EPS8_MOUSE","31.52","606","330","24","36","594","17","584","2.00E-64","236","1","Q08509","EPS8_MOUSE","reviewed","Epidermal growth factor receptor kinase substrate 8","Eps8","Mus musculus (Mouse)","821","actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin polymerization-dependent cell motility [GO:0070358]; adult locomotory behavior [GO:0008344]; barbed-end actin filament capping [GO:0051016]; behavioral response to ethanol [GO:0048149]; dendritic cell migration [GO:0036336]; exit from mitosis [GO:0010458]; Rac protein signal transduction [GO:0016601]; regulation of actin filament length [GO:0030832]; regulation of cell shape [GO:0008360]","GO:0003779; GO:0005903; GO:0005938; GO:0008344; GO:0008360; GO:0010458; GO:0014069; GO:0016601; GO:0017146; GO:0030054; GO:0030426; GO:0030832; GO:0031532; GO:0031982; GO:0032420; GO:0032587; GO:0035591; GO:0036336; GO:0045202; GO:0048149; GO:0048365; GO:0051016; GO:0051017; GO:0051764; GO:0070062; GO:0070358","","","cd01210;","PF08416;PF00018;","brush border [GO:0005903]; cell cortex [GO:0005938]; cell junction [GO:0030054]; extracellular exosome [GO:0070062]; growth cone [GO:0030426]; NMDA selective glutamate receptor complex [GO:0017146]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; stereocilium [GO:0032420]; synapse [GO:0045202]; vesicle [GO:0031982]; actin binding [GO:0003779]; Rac GTPase binding [GO:0048365]; signaling adaptor activity [GO:0035591]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin polymerization-dependent cell motility [GO:0070358]; adult locomotory behavior [GO:0008344]; barbed-end actin filament capping [GO:0051016]; behavioral response to ethanol [GO:0048149]; dendritic cell migration [GO:0036336]; exit from mitosis [GO:0010458]; Rac protein signal transduction [GO:0016601]; regulation of actin filament length [GO:0030832]; regulation of cell shape [GO:0008360]"
"CHOYP_F10A1.2.4|m.11805",48,"9",7,5.5,17.5,15,15.5,12.5,2,7.5,12.1428571429,5.0406510755,"0.4151124415",25.4081632653,15,"#VALUE!","0.8795308463","-1.362261517",16.5,2,14.5,10,16.5,85,"2","1.6666666667",14.75,10.25,4.5,4,14,1.0067511548,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_F10A1.2.4|m.11805","Q5ZLF0","F10A1_CHICK","52.26","398","141","5","11","404","9","361","6.00E-127","378","1","Q5ZLF0","F10A1_CHICK","reviewed","Hsc70-interacting protein (Hip) (Protein FAM10A1) (Protein ST13 homolog)","ST13 FAM10A1 RCJMB04_6h13","Gallus gallus (Chicken)","361","","GO:0005737","","","","PF13181;","cytoplasm [GO:0005737]"
"CHOYP_F10A1.2.4|m.11805",37,"3",7,4.5,15.5,19.5,19.5,15,16.5,15.5,12.1428571429,5.0406510755,"0.4151124415",25.4081632653,15,"#VALUE!","0.8795308463","-1.362261517",16.5,2,14.5,10,16.5,85,"2","1.6666666667",14.75,10.25,4.5,4,14,1.0067511548,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_F10A1.2.4|m.11805","Q5ZLF0","F10A1_CHICK","52.26","398","141","5","11","404","9","361","6.00E-127","378","1","Q5ZLF0","F10A1_CHICK","reviewed","Hsc70-interacting protein (Hip) (Protein FAM10A1) (Protein ST13 homolog)","ST13 FAM10A1 RCJMB04_6h13","Gallus gallus (Chicken)","361","","GO:0005737","","","","PF13181;","cytoplasm [GO:0005737]"
"CHOYP_FASN.3.4|m.60278",48,"9",3.5,20,7,7,9.5,3.5,4,2.5,7.3571428571,4.2318037839,"0.5751966308",17.9081632653,7.5,"#VALUE!","-0.4697920958","0.7519187156",15,2.5,12.5,3.75,15,51.5,"3.2","1.4",6.625,8.25,-1.625,4.5,12.5,0.6099727585,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_FASN.3.4|m.60278","P12276","FAS_CHICK","49.96","2520","1166","32","64","2521","3","2489","0","2447","1","P12276","FAS_CHICK","reviewed","Fatty acid synthase (EC 2.3.1.85) [Includes: [Acyl-carrier-protein] S-acetyltransferase (EC 2.3.1.38); [Acyl-carrier-protein] S-malonyltransferase (EC 2.3.1.39); 3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41); 3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100); 3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59); Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.39); Oleoyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14)]","FASN FAS","Gallus gallus (Chicken)","2512","fatty acid biosynthetic process [GO:0006633]; lactate metabolic process [GO:0006089]; positive regulation of appetite [GO:0032100]","GO:0003697; GO:0004312; GO:0004313; GO:0004314; GO:0004315; GO:0004316; GO:0004317; GO:0004319; GO:0004320; GO:0005623; GO:0006089; GO:0006633; GO:0016295; GO:0016296; GO:0031177; GO:0032100; GO:0047117; GO:0047451; GO:0102132","","","","PF00698;PF00107;PF16197;PF00109;PF02801;PF08659;PF00550;PF14765;PF00975;","cell [GO:0005623]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [GO:0004317]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; [acyl-carrier-protein] S-acetyltransferase activity [GO:0004313]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity [GO:0047117]; enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity [GO:0004319]; fatty acid synthase activity [GO:0004312]; myristoyl-[acyl-carrier-protein] hydrolase activity [GO:0016295]; oleoyl-[acyl-carrier-protein] hydrolase activity [GO:0004320]; palmitoyl-[acyl-carrier-protein] hydrolase activity [GO:0016296]; phosphopantetheine binding [GO:0031177]; single-stranded DNA binding [GO:0003697]; fatty acid biosynthetic process [GO:0006633]; lactate metabolic process [GO:0006089]; positive regulation of appetite [GO:0032100]"
"CHOYP_FASN.3.4|m.60278",37,"3",3.5,30.5,25.5,23.5,27.5,8,7.5,11.5,7.3571428571,4.2318037839,"0.5751966308",17.9081632653,7.5,"#VALUE!","-0.4697920958","0.7519187156",15,2.5,12.5,3.75,15,51.5,"3.2","1.4",6.625,8.25,-1.625,4.5,12.5,0.6099727585,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_FASN.3.4|m.60278","P12276","FAS_CHICK","49.96","2520","1166","32","64","2521","3","2489","0","2447","1","P12276","FAS_CHICK","reviewed","Fatty acid synthase (EC 2.3.1.85) [Includes: [Acyl-carrier-protein] S-acetyltransferase (EC 2.3.1.38); [Acyl-carrier-protein] S-malonyltransferase (EC 2.3.1.39); 3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41); 3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100); 3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59); Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.39); Oleoyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14)]","FASN FAS","Gallus gallus (Chicken)","2512","fatty acid biosynthetic process [GO:0006633]; lactate metabolic process [GO:0006089]; positive regulation of appetite [GO:0032100]","GO:0003697; GO:0004312; GO:0004313; GO:0004314; GO:0004315; GO:0004316; GO:0004317; GO:0004319; GO:0004320; GO:0005623; GO:0006089; GO:0006633; GO:0016295; GO:0016296; GO:0031177; GO:0032100; GO:0047117; GO:0047451; GO:0102132","","","","PF00698;PF00107;PF16197;PF00109;PF02801;PF08659;PF00550;PF14765;PF00975;","cell [GO:0005623]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [GO:0004317]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; [acyl-carrier-protein] S-acetyltransferase activity [GO:0004313]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity [GO:0047117]; enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity [GO:0004319]; fatty acid synthase activity [GO:0004312]; myristoyl-[acyl-carrier-protein] hydrolase activity [GO:0016295]; oleoyl-[acyl-carrier-protein] hydrolase activity [GO:0004320]; palmitoyl-[acyl-carrier-protein] hydrolase activity [GO:0016296]; phosphopantetheine binding [GO:0031177]; single-stranded DNA binding [GO:0003697]; fatty acid biosynthetic process [GO:0006633]; lactate metabolic process [GO:0006089]; positive regulation of appetite [GO:0032100]"
"CHOYP_FLNA.2.6|m.11845",30,"3",2,1,155.5,76.5,4.5,102.5,1.5,3.5,58.5,70.3618200041,"1.2027661539",4950.7857142857,3.5,"#VALUE!","-0.4055242928","0.977525335",190.5,1.5,189,2.25,190.5,409.5,"1.1202185792","1.2896174863",56.125,71.875,-15.75,116.5,188.5,4.8501717399,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_FLNA.2.6|m.11845","Q9VEN1","FLNA_DROME","51.02","2250","1031","24","21","2242","4","2210","0","2251","1","Q9VEN1","FLNA_DROME","reviewed","Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1)","cher cheerio sko CG3937","Drosophila melanogaster (Fruit fly)","2210","behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; mitotic nuclear division [GO:0007067]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; olfactory learning [GO:0008355]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sleep [GO:0030431]","GO:0003779; GO:0005829; GO:0005886; GO:0007067; GO:0007301; GO:0007303; GO:0007611; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0008355; GO:0015629; GO:0030431; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0048149; GO:0051495","","","cd00014;","PF00307;PF00630;","actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; mitotic nuclear division [GO:0007067]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; olfactory learning [GO:0008355]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sleep [GO:0030431]"
"CHOYP_FLNA.2.6|m.11845",70,"9",2,154.5,3,155.5,86.5,118,190.5,91.5,58.5,70.3618200041,"1.2027661539",4950.7857142857,3.5,"#VALUE!","-0.4055242928","0.977525335",190.5,1.5,189,2.25,190.5,409.5,"1.1202185792","1.2896174863",56.125,71.875,-15.75,116.5,188.5,4.8501717399,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_FLNA.2.6|m.11845","Q9VEN1","FLNA_DROME","51.02","2250","1031","24","21","2242","4","2210","0","2251","1","Q9VEN1","FLNA_DROME","reviewed","Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1)","cher cheerio sko CG3937","Drosophila melanogaster (Fruit fly)","2210","behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; mitotic nuclear division [GO:0007067]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; olfactory learning [GO:0008355]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sleep [GO:0030431]","GO:0003779; GO:0005829; GO:0005886; GO:0007067; GO:0007301; GO:0007303; GO:0007611; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0008355; GO:0015629; GO:0030431; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0048149; GO:0051495","","","cd00014;","PF00307;PF00630;","actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; mitotic nuclear division [GO:0007067]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; olfactory learning [GO:0008355]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sleep [GO:0030431]"
"CHOYP_FLNC.2.5|m.37450",5,"3",209.5,222,91,171.5,245,80.5,254.5,257.5,195.7857142857,61.7991314912,"0.3156467862",3819.1326530612,223.5,"#VALUE!","-0.5239838356","-0.9221614872",257.5,83.5,174,157.5,257.5,1370.5,"0.3601789709","0.3736017897",150.875,211.875,-61,174,127.5,16.2323818548,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_FLNC.2.5|m.37450","P21333","FLNA_HUMAN","43.8","2413","1251","41","559","2905","273","2646","0","1793","1","P21333","FLNA_HUMAN","reviewed","Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin)","FLNA FLN FLN1","Homo sapiens (Human)","2647","actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; cell junction assembly [GO:0034329]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; establishment of protein localization [GO:0045184]; formation of radial glial scaffolds [GO:0021943]; mitotic spindle assembly [GO:0090307]; mRNA transcription from RNA polymerase II promoter [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase I promoter [GO:0016479]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription factor import into nucleus [GO:0042993]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; wound healing, spreading of cells [GO:0044319]","GO:0001664; GO:0001948; GO:0002576; GO:0003723; GO:0004871; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0008134; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0017048; GO:0017160; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030168; GO:0030334; GO:0030863; GO:0031012; GO:0031267; GO:0031523; GO:0031532; GO:0034329; GO:0034394; GO:0034988; GO:0042177; GO:0042789; GO:0042803; GO:0042993; GO:0043025; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0048365; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051220; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090307; GO:0097440; GO:1900026; GO:1901381; GO:1905000; GO:1905031; GO:2000179; GO:2001046; GO:2001224","","","cd00014;","PF00307;PF00630;","actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; Myb complex [GO:0031523]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; Fc-gamma receptor I complex binding [GO:0034988]; G-protein coupled receptor binding [GO:0001664]; glycoprotein binding [GO:0001948]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; Rac GTPase binding [GO:0048365]; Ral GTPase binding [GO:0017160]; Rho GTPase binding [GO:0017048]; RNA binding [GO:0003723]; signal transducer activity [GO:0004871]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; cell junction assembly [GO:0034329]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; establishment of protein localization [GO:0045184]; formation of radial glial scaffolds [GO:0021943]; mitotic spindle assembly [GO:0090307]; mRNA transcription from RNA polymerase II promoter [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase I promoter [GO:0016479]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription factor import into nucleus [GO:0042993]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; wound healing, spreading of cells [GO:0044319]"
"CHOYP_FLNC.2.5|m.37450",53,"9",209.5,91,268,88.5,191.5,83.5,130,223.5,195.7857142857,61.7991314912,"0.3156467862",3819.1326530612,223.5,"#VALUE!","-0.5239838356","-0.9221614872",257.5,83.5,174,157.5,257.5,1370.5,"0.3601789709","0.3736017897",150.875,211.875,-61,174,127.5,16.2323818548,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_FLNC.2.5|m.37450","P21333","FLNA_HUMAN","43.8","2413","1251","41","559","2905","273","2646","0","1793","1","P21333","FLNA_HUMAN","reviewed","Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin)","FLNA FLN FLN1","Homo sapiens (Human)","2647","actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; cell junction assembly [GO:0034329]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; establishment of protein localization [GO:0045184]; formation of radial glial scaffolds [GO:0021943]; mitotic spindle assembly [GO:0090307]; mRNA transcription from RNA polymerase II promoter [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase I promoter [GO:0016479]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription factor import into nucleus [GO:0042993]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; wound healing, spreading of cells [GO:0044319]","GO:0001664; GO:0001948; GO:0002576; GO:0003723; GO:0004871; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0008134; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0017048; GO:0017160; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030168; GO:0030334; GO:0030863; GO:0031012; GO:0031267; GO:0031523; GO:0031532; GO:0034329; GO:0034394; GO:0034988; GO:0042177; GO:0042789; GO:0042803; GO:0042993; GO:0043025; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0048365; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051220; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090307; GO:0097440; GO:1900026; GO:1901381; GO:1905000; GO:1905031; GO:2000179; GO:2001046; GO:2001224","","","cd00014;","PF00307;PF00630;","actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; Myb complex [GO:0031523]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; Fc-gamma receptor I complex binding [GO:0034988]; G-protein coupled receptor binding [GO:0001664]; glycoprotein binding [GO:0001948]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; Rac GTPase binding [GO:0048365]; Ral GTPase binding [GO:0017160]; Rho GTPase binding [GO:0017048]; RNA binding [GO:0003723]; signal transducer activity [GO:0004871]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; cell junction assembly [GO:0034329]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; establishment of protein localization [GO:0045184]; formation of radial glial scaffolds [GO:0021943]; mitotic spindle assembly [GO:0090307]; mRNA transcription from RNA polymerase II promoter [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription from RNA polymerase I promoter [GO:0016479]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription factor import into nucleus [GO:0042993]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; wound healing, spreading of cells [GO:0044319]"
"CHOYP_FLNC.3.5|m.38669",37,"3",0,26,19,9.5,0,40.5,0,0,14.5714285714,13.5815751544,"0.9320688831",184.4591836735,14.5,"#VALUE!","-2.4666914546","0.052730244",32,0,32,0,32,102,"2.7931034483","2.2068965517",18.125,17.5,0.625,40.5,29,1.2081013858,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_FLNC.3.5|m.38669","Q14315","FLNC_HUMAN","39.94","2401","1282","54","595","2924","277","2588","0","1412","1","Q14315","FLNC_HUMAN","reviewed","Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin)","FLNC ABPL FLN2","Homo sapiens (Human)","2725","cell junction assembly [GO:0034329]; muscle fiber development [GO:0048747]","GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0034329; GO:0042383; GO:0043034; GO:0048747","","","cd00014;","PF00307;PF00630;","costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; cell junction assembly [GO:0034329]; muscle fiber development [GO:0048747]"
"CHOYP_FLNC.3.5|m.38669",45,"9",0,54,0,20,11,32,26.5,14.5,14.5714285714,13.5815751544,"0.9320688831",184.4591836735,14.5,"#VALUE!","-2.4666914546","0.052730244",32,0,32,0,32,102,"2.7931034483","2.2068965517",18.125,17.5,0.625,40.5,29,1.2081013858,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_FLNC.3.5|m.38669","Q14315","FLNC_HUMAN","39.94","2401","1282","54","595","2924","277","2588","0","1412","1","Q14315","FLNC_HUMAN","reviewed","Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin)","FLNC ABPL FLN2","Homo sapiens (Human)","2725","cell junction assembly [GO:0034329]; muscle fiber development [GO:0048747]","GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0034329; GO:0042383; GO:0043034; GO:0048747","","","cd00014;","PF00307;PF00630;","costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; cell junction assembly [GO:0034329]; muscle fiber development [GO:0048747]"
"CHOYP_GCN1L.1.1|m.1352",37,"9",32,42.5,44,37,41,42.5,36,34.5,33.2142857143,8.8715320905,"0.2670998909",78.7040816327,36,"#VALUE!","2.7489850366","-1.578387338",42.5,14,28.5,31.5,42.5,232.5,"1.2173913043","1.231884058",31.75,36.875,-5.125,28.5,6,2.7537605117,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_GCN1L.1.1|m.1352","E9PVA8","GCN1_MOUSE","51.12","2682","1286","16","6","2674","1","2670","0","2597","1","E9PVA8","GCN1_MOUSE","reviewed","eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)","Gcn1 Gcn1l1","Mus musculus (Mouse)","2671","cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]","GO:0003723; GO:0005829; GO:0005844; GO:0005913; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0098641; GO:1990253","","","","","cell-cell adherens junction [GO:0005913]; cytosol [GO:0005829]; membrane [GO:0016020]; polysome [GO:0005844]; cadherin binding involved in cell-cell adhesion [GO:0098641]; protein kinase regulator activity [GO:0019887]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]"
"CHOYP_GCN1L.1.1|m.1352",28,"3",32,37,52,54.5,53.5,42,28.5,40.5,33.2142857143,8.8715320905,"0.2670998909",78.7040816327,36,"#VALUE!","2.7489850366","-1.578387338",42.5,14,28.5,31.5,42.5,232.5,"1.2173913043","1.231884058",31.75,36.875,-5.125,28.5,6,2.7537605117,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_GCN1L.1.1|m.1352","E9PVA8","GCN1_MOUSE","51.12","2682","1286","16","6","2674","1","2670","0","2597","1","E9PVA8","GCN1_MOUSE","reviewed","eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1)","Gcn1 Gcn1l1","Mus musculus (Mouse)","2671","cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]","GO:0003723; GO:0005829; GO:0005844; GO:0005913; GO:0006417; GO:0016020; GO:0019887; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0098641; GO:1990253","","","","","cell-cell adherens junction [GO:0005913]; cytosol [GO:0005829]; membrane [GO:0016020]; polysome [GO:0005844]; cadherin binding involved in cell-cell adhesion [GO:0098641]; protein kinase regulator activity [GO:0019887]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]"
"CHOYP_GST7.1.1|m.59335",37,"3",23,37,29,15.5,15.5,10,8.5,9,8.4285714286,2.0775770817,"0.2464921961",4.3163265306,9,"#VALUE!","5.6887983502","-2.3001830453",10,3.5,6.5,8.75,10,59,"1","0.9",7.75,9.5,-1.75,6.5,1,0.6988037427,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_GST7.1.1|m.59335","P46088","GST_NOTSL","40.2","204","112","2","1","200","1","198","3.00E-41","144","1","P46088","GST_NOTSL","reviewed","Glutathione S-transferase (EC 2.5.1.18) (GST class-sigma)","","Nototodarus sloanii (Wellington flying squid) (Ommastrephes sloanei)","203","","GO:0004364; GO:0005737","","","","PF14497;PF02798;","cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]"
"CHOYP_GST7.1.1|m.59335",48,"9",23,18.5,18,12,11,9,10,10,8.4285714286,2.0775770817,"0.2464921961",4.3163265306,9,"#VALUE!","5.6887983502","-2.3001830453",10,3.5,6.5,8.75,10,59,"1","0.9",7.75,9.5,-1.75,6.5,1,0.6988037427,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_GST7.1.1|m.59335","P46088","GST_NOTSL","40.2","204","112","2","1","200","1","198","3.00E-41","144","1","P46088","GST_NOTSL","reviewed","Glutathione S-transferase (EC 2.5.1.18) (GST class-sigma)","","Nototodarus sloanii (Wellington flying squid) (Ommastrephes sloanei)","203","","GO:0004364; GO:0005737","","","","PF14497;PF02798;","cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]"
"CHOYP_HMCN1.23.44|m.42684",26,"3",0.5,2,112.5,113.5,104.5,81,42,29,52.9285714286,23.2416322445,"0.4391131598",540.1734693878,54,"#VALUE!","-0.2919686582","0.4182301041",94,21,73,35.5,94,370.5,"1.5","1.3240740741",53.875,59,-5.125,60,65,4.3882506218,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_HMCN1.23.44|m.42684","A2AAJ9","OBSCN_MOUSE","21.8","1697","1028","71","4110","5740","3547","5010","1.00E-49","202","1","A2AAJ9","OBSCN_MOUSE","reviewed","Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK)","Obscn Gm878","Mus musculus (Mouse)","8891","cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]","GO:0004674; GO:0005089; GO:0005524; GO:0005576; GO:0005829; GO:0005863; GO:0005886; GO:0007275; GO:0014704; GO:0016604; GO:0030018; GO:0030154; GO:0030506; GO:0031430; GO:0031432; GO:0035023; GO:0042383; GO:0046777; GO:0046872","","","cd00063;","PF00041;PF07679;PF00612;PF00069;PF00621;","cytosol [GO:0005829]; extracellular region [GO:0005576]; intercalated disc [GO:0014704]; M band [GO:0031430]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; titin binding [GO:0031432]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]"
"CHOYP_HMCN1.23.44|m.42684",21,"9",0.5,86,106.5,98,93.5,71.5,94,54,52.9285714286,23.2416322445,"0.4391131598",540.1734693878,54,"#VALUE!","-0.2919686582","0.4182301041",94,21,73,35.5,94,370.5,"1.5","1.3240740741",53.875,59,-5.125,60,65,4.3882506218,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_HMCN1.23.44|m.42684","A2AAJ9","OBSCN_MOUSE","21.8","1697","1028","71","4110","5740","3547","5010","1.00E-49","202","1","A2AAJ9","OBSCN_MOUSE","reviewed","Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK)","Obscn Gm878","Mus musculus (Mouse)","8891","cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]","GO:0004674; GO:0005089; GO:0005524; GO:0005576; GO:0005829; GO:0005863; GO:0005886; GO:0007275; GO:0014704; GO:0016604; GO:0030018; GO:0030154; GO:0030506; GO:0031430; GO:0031432; GO:0035023; GO:0042383; GO:0046777; GO:0046872","","","cd00063;","PF00041;PF07679;PF00612;PF00069;PF00621;","cytosol [GO:0005829]; extracellular region [GO:0005576]; intercalated disc [GO:0014704]; M band [GO:0031430]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; titin binding [GO:0031432]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]"
"CHOYP_HMCN1.28.44|m.47379",48,"3",0.5,0,0,6.5,8,9.5,9.5,10,14,10.177004892,"0.7269289209",103.5714285714,10,"#VALUE!","-0.5589711296","0.526481838",32,0.5,31.5,7,32,98,"0.4418604651","0.9302325581",9.875,17,-7.125,19.5,27.5,1.1607248608,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_HMCN1.28.44|m.47379","D3YXG0","HMCN1_MOUSE","35.92","3730","2205","61","461","4051","1951","5634","0","2284","1","D3YXG0","HMCN1_MOUSE","reviewed","Hemicentin-1 (Fibulin-6) (FIBL-6)","Hmcn1","Mus musculus (Mouse)","5634","cell cycle [GO:0007049]; cell division [GO:0051301]","GO:0005509; GO:0005576; GO:0005604; GO:0005938; GO:0007049; GO:0030054; GO:0032154; GO:0051301; GO:0070062","","","cd00255;","PF12662;PF07645;PF07474;PF07679;PF00090;","basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell cycle [GO:0007049]; cell division [GO:0051301]"
"CHOYP_HMCN1.28.44|m.47379",37,"9",0.5,0.5,2.5,6,19,20,32,21.5,14,10.177004892,"0.7269289209",103.5714285714,10,"#VALUE!","-0.5589711296","0.526481838",32,0.5,31.5,7,32,98,"0.4418604651","0.9302325581",9.875,17,-7.125,19.5,27.5,1.1607248608,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_HMCN1.28.44|m.47379","D3YXG0","HMCN1_MOUSE","35.92","3730","2205","61","461","4051","1951","5634","0","2284","1","D3YXG0","HMCN1_MOUSE","reviewed","Hemicentin-1 (Fibulin-6) (FIBL-6)","Hmcn1","Mus musculus (Mouse)","5634","cell cycle [GO:0007049]; cell division [GO:0051301]","GO:0005509; GO:0005576; GO:0005604; GO:0005938; GO:0007049; GO:0030054; GO:0032154; GO:0051301; GO:0070062","","","cd00255;","PF12662;PF07645;PF07474;PF07679;PF00090;","basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell cycle [GO:0007049]; cell division [GO:0051301]"
"CHOYP_HN1L.2.2|m.9837",48,"9",19,14,9.5,3,14.5,11.5,8,17,10.2857142857,4.1391609127,"0.4024184221",17.1326530612,11.5,"#VALUE!","1.323675037","-0.4476931216",17,2.5,14.5,8.5,17,72,"1.1176470588","0.6764705882",11.25,11.5,-0.25,16.5,9,0.8527774488,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_HN1L.2.2|m.9837",37,"3",19,22,15.5,12.5,9.5,19,12,12,10.2857142857,4.1391609127,"0.4024184221",17.1326530612,11.5,"#VALUE!","1.323675037","-0.4476931216",17,2.5,14.5,8.5,17,72,"1.1176470588","0.6764705882",11.25,11.5,-0.25,16.5,9,0.8527774488,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_HSP7D.2.3|m.34782",20,"3",68.5,78.5,105.5,69,98,113.5,72,93.5,89.5714285714,26.5039465679,"0.2958973301",702.4591836735,93.5,"#VALUE!","-0.9527858627","-0.0520850437",125,47,78,71.5,125,627,"0.908","0.76",81.875,103.25,-21.375,66.5,54,7.4262702831,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_HSP7D.2.3|m.34782","Q9U639","HSP7D_MANSE","89.2","611","62","1","8","618","6","612","0","1136","1","Q9U639","HSP7D_MANSE","reviewed","Heat shock 70 kDa protein cognate 4 (Hsc 70-4)","","Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)","652","","GO:0005524; GO:0005634","","","","PF00012;","nucleus [GO:0005634]; ATP binding [GO:0005524]"
"CHOYP_HSP7D.2.3|m.34782",64,"9",68.5,86,99,98,113.5,95,123.5,125,89.5714285714,26.5039465679,"0.2958973301",702.4591836735,93.5,"#VALUE!","-0.9527858627","-0.0520850437",125,47,78,71.5,125,627,"0.908","0.76",81.875,103.25,-21.375,66.5,54,7.4262702831,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_HSP7D.2.3|m.34782","Q9U639","HSP7D_MANSE","89.2","611","62","1","8","618","6","612","0","1136","1","Q9U639","HSP7D_MANSE","reviewed","Heat shock 70 kDa protein cognate 4 (Hsc 70-4)","","Manduca sexta (Tobacco hawkmoth) (Tobacco hornworm)","652","","GO:0005524; GO:0005634","","","","PF00012;","nucleus [GO:0005634]; ATP binding [GO:0005524]"
"CHOYP_HSP7D.3.3|m.41778",48,"3",10.5,12.5,12.5,8.5,11,11.5,6.5,10,9.6428571429,4.1893937996,"0.4344556533",17.5510204082,10,"#VALUE!","-1.0352977285","-0.4153225446",15,2.5,12.5,6.75,15,67.5,"0.8846153846","1.0384615385",8.5,11.25,-2.75,11,8,0.7994788582,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_HSP7D.3.3|m.41778","O18373","SPS1_DROME","83.5","309","51","0","1","309","90","398","0","563","1","O18373","SPS1_DROME","reviewed","Selenide, water dikinase (EC 2.7.9.3) (Protein patufet) (Selenium donor protein) (Selenophosphate synthase) (dSelD)","SelD PTF1 ptuf CG8553","Drosophila melanogaster (Fruit fly)","398","cell cycle [GO:0007049]; cell proliferation [GO:0008283]; glutamine metabolic process [GO:0006541]; imaginal disc development [GO:0007444]; mitochondrion organization [GO:0007005]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; neurogenesis [GO:0022008]; positive regulation of cell proliferation [GO:0008284]; regulation of glucose metabolic process [GO:0010906]; selenocysteine biosynthetic process [GO:0016260]","GO:0005524; GO:0006541; GO:0007005; GO:0007049; GO:0007444; GO:0008283; GO:0008284; GO:0010906; GO:0016260; GO:0016301; GO:0022008; GO:2000378","","","","PF00586;PF02769;","ATP binding [GO:0005524]; kinase activity [GO:0016301]; cell cycle [GO:0007049]; cell proliferation [GO:0008283]; glutamine metabolic process [GO:0006541]; imaginal disc development [GO:0007444]; mitochondrion organization [GO:0007005]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; neurogenesis [GO:0022008]; positive regulation of cell proliferation [GO:0008284]; regulation of glucose metabolic process [GO:0010906]; selenocysteine biosynthetic process [GO:0016260]"
"CHOYP_HSP7D.3.3|m.41778",37,"9",10.5,13.5,12.5,10.5,16.5,13.5,15,13,9.6428571429,4.1893937996,"0.4344556533",17.5510204082,10,"#VALUE!","-1.0352977285","-0.4153225446",15,2.5,12.5,6.75,15,67.5,"0.8846153846","1.0384615385",8.5,11.25,-2.75,11,8,0.7994788582,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_HSP7D.3.3|m.41778","O18373","SPS1_DROME","83.5","309","51","0","1","309","90","398","0","563","1","O18373","SPS1_DROME","reviewed","Selenide, water dikinase (EC 2.7.9.3) (Protein patufet) (Selenium donor protein) (Selenophosphate synthase) (dSelD)","SelD PTF1 ptuf CG8553","Drosophila melanogaster (Fruit fly)","398","cell cycle [GO:0007049]; cell proliferation [GO:0008283]; glutamine metabolic process [GO:0006541]; imaginal disc development [GO:0007444]; mitochondrion organization [GO:0007005]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; neurogenesis [GO:0022008]; positive regulation of cell proliferation [GO:0008284]; regulation of glucose metabolic process [GO:0010906]; selenocysteine biosynthetic process [GO:0016260]","GO:0005524; GO:0006541; GO:0007005; GO:0007049; GO:0007444; GO:0008283; GO:0008284; GO:0010906; GO:0016260; GO:0016301; GO:0022008; GO:2000378","","","","PF00586;PF02769;","ATP binding [GO:0005524]; kinase activity [GO:0016301]; cell cycle [GO:0007049]; cell proliferation [GO:0008283]; glutamine metabolic process [GO:0006541]; imaginal disc development [GO:0007444]; mitochondrion organization [GO:0007005]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; neurogenesis [GO:0022008]; positive regulation of cell proliferation [GO:0008284]; regulation of glucose metabolic process [GO:0010906]; selenocysteine biosynthetic process [GO:0016260]"
"CHOYP_HSP90AA1.1.1|m.14867",17,"3",90.5,94.5,114.5,101.5,109,111.5,93.5,114,107.2142857143,18.5219120096,"0.1727560081",343.0612244898,114,"#VALUE!","1.5034871166","-1.3524819793",126.5,69,57.5,100.5,126.5,750.5,"0.8814229249","0.9328063241",98,117.5,-19.5,49,19,8.8890204903,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_HSP90AA1.1.1|m.14867","Q90474","H90A1_DANRE","78.49","688","144","3","1","685","1","687","0","1094","1","Q90474","H90A1_DANRE","reviewed","Heat shock protein HSP 90-alpha 1","hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652","Danio rerio (Zebrafish) (Brachydanio rerio)","725","leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]","GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0016887; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688","","","","PF02518;PF00183;","A band [GO:0031672]; melanosome [GO:0042470]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; nitric-oxide synthase regulator activity [GO:0030235]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]"
"CHOYP_HSP90AA1.1.1|m.14867",64,"9",90.5,111,118,80.5,123.5,118,122,126.5,107.2142857143,18.5219120096,"0.1727560081",343.0612244898,114,"#VALUE!","1.5034871166","-1.3524819793",126.5,69,57.5,100.5,126.5,750.5,"0.8814229249","0.9328063241",98,117.5,-19.5,49,19,8.8890204903,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_HSP90AA1.1.1|m.14867","Q90474","H90A1_DANRE","78.49","688","144","3","1","685","1","687","0","1094","1","Q90474","H90A1_DANRE","reviewed","Heat shock protein HSP 90-alpha 1","hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652","Danio rerio (Zebrafish) (Brachydanio rerio)","725","leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]","GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0016887; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688","","","","PF02518;PF00183;","A band [GO:0031672]; melanosome [GO:0042470]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; nitric-oxide synthase regulator activity [GO:0030235]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]"
"CHOYP_IDE.1.3|m.8450",48,"9",13,10,12.5,8,10,6,7.5,5.5,8.9285714286,3.4061768622,"0.3814918086",11.6020408163,7.5,"#VALUE!","-1.705865317","0.5167187083",14.5,5.5,9,5.75,14.5,62.5,"2.5454545455","1.0909090909",9.25,9.875,-0.625,8.5,9,0.7402582021,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_IDE.1.3|m.8450","P35559","IDE_RAT","58.66","987","401","4","35","1018","36","1018","0","1215","1","P35559","IDE_RAT","reviewed","Insulin-degrading enzyme (EC 3.4.24.56) (Insulin protease) (Insulinase) (Insulysin)","Ide","Rattus norvegicus (Rat)","1019","beta-amyloid metabolic process [GO:0050435]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; negative regulation of proteolysis [GO:0045861]; peptide catabolic process [GO:0043171]; positive regulation of protein oligomerization [GO:0032461]; protein heterooligomerization [GO:0051291]; protein homotetramerization [GO:0051289]; proteolysis involved in cellular protein catabolic process [GO:0051603]; ubiquitin homeostasis [GO:0010992]","GO:0001540; GO:0004222; GO:0005524; GO:0005615; GO:0005634; GO:0005739; GO:0005782; GO:0005829; GO:0005886; GO:0008233; GO:0008270; GO:0008340; GO:0009986; GO:0010815; GO:0010992; GO:0016887; GO:0017046; GO:0031597; GO:0031626; GO:0032461; GO:0042447; GO:0042803; GO:0043171; GO:0043559; GO:0044257; GO:0045861; GO:0050435; GO:0051289; GO:0051291; GO:0051603; GO:1901143","","","","PF00675;PF05193;PF16187;","cell surface [GO:0009986]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; beta-amyloid binding [GO:0001540]; beta-endorphin binding [GO:0031626]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; beta-amyloid metabolic process [GO:0050435]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; negative regulation of proteolysis [GO:0045861]; peptide catabolic process [GO:0043171]; positive regulation of protein oligomerization [GO:0032461]; protein heterooligomerization [GO:0051291]; protein homotetramerization [GO:0051289]; proteolysis involved in cellular protein catabolic process [GO:0051603]; ubiquitin homeostasis [GO:0010992]"
"CHOYP_IDE.1.3|m.8450",37,"3",13,12.5,17.5,14.5,15.5,14,11.5,12,8.9285714286,3.4061768622,"0.3814918086",11.6020408163,7.5,"#VALUE!","-1.705865317","0.5167187083",14.5,5.5,9,5.75,14.5,62.5,"2.5454545455","1.0909090909",9.25,9.875,-0.625,8.5,9,0.7402582021,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_IDE.1.3|m.8450","P35559","IDE_RAT","58.66","987","401","4","35","1018","36","1018","0","1215","1","P35559","IDE_RAT","reviewed","Insulin-degrading enzyme (EC 3.4.24.56) (Insulin protease) (Insulinase) (Insulysin)","Ide","Rattus norvegicus (Rat)","1019","beta-amyloid metabolic process [GO:0050435]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; negative regulation of proteolysis [GO:0045861]; peptide catabolic process [GO:0043171]; positive regulation of protein oligomerization [GO:0032461]; protein heterooligomerization [GO:0051291]; protein homotetramerization [GO:0051289]; proteolysis involved in cellular protein catabolic process [GO:0051603]; ubiquitin homeostasis [GO:0010992]","GO:0001540; GO:0004222; GO:0005524; GO:0005615; GO:0005634; GO:0005739; GO:0005782; GO:0005829; GO:0005886; GO:0008233; GO:0008270; GO:0008340; GO:0009986; GO:0010815; GO:0010992; GO:0016887; GO:0017046; GO:0031597; GO:0031626; GO:0032461; GO:0042447; GO:0042803; GO:0043171; GO:0043559; GO:0044257; GO:0045861; GO:0050435; GO:0051289; GO:0051291; GO:0051603; GO:1901143","","","","PF00675;PF05193;PF16187;","cell surface [GO:0009986]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; beta-amyloid binding [GO:0001540]; beta-endorphin binding [GO:0031626]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; beta-amyloid metabolic process [GO:0050435]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; negative regulation of proteolysis [GO:0045861]; peptide catabolic process [GO:0043171]; positive regulation of protein oligomerization [GO:0032461]; protein heterooligomerization [GO:0051291]; protein homotetramerization [GO:0051289]; proteolysis involved in cellular protein catabolic process [GO:0051603]; ubiquitin homeostasis [GO:0010992]"
"CHOYP_ISCW_ISCW018425.1.1|m.35608",37,"9",6,12,13.5,13,16.5,16.5,17.5,16.5,12,4.5197977199,"0.37664981",20.4285714286,11,"#VALUE!","-1.980478263","-0.1203236105",17.5,5.5,12,8.5,17.5,84,"0.7878787879","1",10.5,13.75,-3.25,11,7.5,0.9949070236,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ISCW_ISCW018425.1.1|m.35608","P81623","ERP29_BOVIN","41.26","223","122","8","101","318","33","251","4.00E-44","157","1","P81623","ERP29_BOVIN","reviewed","Endoplasmic reticulum resident protein 29 (ERp29)","ERP29","Bos taurus (Bovine)","258","activation of MAPK activity [GO:0000187]; intracellular protein transport [GO:0006886]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]","GO:0000187; GO:0005783; GO:0005788; GO:0006457; GO:0006886; GO:0009306; GO:0009986; GO:0010628; GO:0010629; GO:0016020; GO:0042470; GO:0050709; GO:0070062; GO:1902235","","","cd00238;","PF07749;PF07912;","cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; membrane [GO:0016020]; activation of MAPK activity [GO:0000187]; intracellular protein transport [GO:0006886]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]"
"CHOYP_ISCW_ISCW018425.1.1|m.35608",48,"3",6,8.5,13.5,12,15,13,7,11,12,4.5197977199,"0.37664981",20.4285714286,11,"#VALUE!","-1.980478263","-0.1203236105",17.5,5.5,12,8.5,17.5,84,"0.7878787879","1",10.5,13.75,-3.25,11,7.5,0.9949070236,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ISCW_ISCW018425.1.1|m.35608","P81623","ERP29_BOVIN","41.26","223","122","8","101","318","33","251","4.00E-44","157","1","P81623","ERP29_BOVIN","reviewed","Endoplasmic reticulum resident protein 29 (ERp29)","ERP29","Bos taurus (Bovine)","258","activation of MAPK activity [GO:0000187]; intracellular protein transport [GO:0006886]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]","GO:0000187; GO:0005783; GO:0005788; GO:0006457; GO:0006886; GO:0009306; GO:0009986; GO:0010628; GO:0010629; GO:0016020; GO:0042470; GO:0050709; GO:0070062; GO:1902235","","","cd00238;","PF07749;PF07912;","cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; membrane [GO:0016020]; activation of MAPK activity [GO:0000187]; intracellular protein transport [GO:0006886]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; protein folding [GO:0006457]; protein secretion [GO:0009306]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]"
"CHOYP_KARG.2.11|m.2196",12,"3",176,158.5,130.5,129,131.5,124,133.5,138.5,140.3571428571,17.8379897284,"0.1270900032",318.193877551,138.5,"#VALUE!","1.7832838905","-0.6144274571",168.5,105.5,63,135.75,168.5,982.5,"0.821192053","0.9768211921",127.625,149,-21.375,42,30.5,11.6368589364,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_KARG.2.11|m.2196","Q9NH48","KARG_ERISI","59.02","327","126","3","86","408","32","354","2.00E-131","389","1","Q9NH48","KARG_ERISI","reviewed","Arginine kinase (AK) (EC 2.7.3.3)","","Eriocheir sinensis (Chinese mitten crab)","357","","GO:0004054; GO:0005524","","","","PF00217;PF02807;","arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]"
"CHOYP_KARG.2.11|m.2196",61,"9",176,125.5,126,127,134.5,147.5,168.5,151,140.3571428571,17.8379897284,"0.1270900032",318.193877551,138.5,"#VALUE!","1.7832838905","-0.6144274571",168.5,105.5,63,135.75,168.5,982.5,"0.821192053","0.9768211921",127.625,149,-21.375,42,30.5,11.6368589364,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_KARG.2.11|m.2196","Q9NH48","KARG_ERISI","59.02","327","126","3","86","408","32","354","2.00E-131","389","1","Q9NH48","KARG_ERISI","reviewed","Arginine kinase (AK) (EC 2.7.3.3)","","Eriocheir sinensis (Chinese mitten crab)","357","","GO:0004054; GO:0005524","","","","PF00217;PF02807;","arginine kinase activity [GO:0004054]; ATP binding [GO:0005524]"
"CHOYP_KCY.1.1|m.29973",48,"3",7,11.5,8.5,13,7,12.5,7.5,7.5,10.0714285714,4.938396005,"0.490337192",24.387755102,7.5,"#VALUE!","-1.9520540607","0.310626124",17.5,4,13.5,6.25,17.5,70.5,"0.8333333333","1.1666666667",10.375,10.375,0,13.5,10,0.8350112519,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_KCY.1.1|m.29973","Q7ZWE9","KCY_DANRE","63.35","191","65","1","3","188","2","192","4.00E-79","241","1","Q7ZWE9","KCY_DANRE","reviewed","UMP-CMP kinase (EC 2.7.4.14) (Deoxycytidylate kinase) (CK) (dCMP kinase) (Nucleoside-diphosphate kinase) (EC 2.7.4.6) (Uridine monophosphate/cytidine monophosphate kinase) (UMP/CMP kinase) (UMP/CMPK)","cmpk cmpk1","Danio rerio (Zebrafish) (Brachydanio rerio)","196","'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; pyrimidine nucleotide biosynthetic process [GO:0006221]","GO:0004127; GO:0004550; GO:0005524; GO:0005634; GO:0005737; GO:0006165; GO:0006207; GO:0006221; GO:0009041; GO:0009142","","","cd01428;","","cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; uridylate kinase activity [GO:0009041]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; pyrimidine nucleotide biosynthetic process [GO:0006221]"
"CHOYP_KCY.1.1|m.29973",37,"9",7,15,8.5,15,15.5,17.5,14,15,10.0714285714,4.938396005,"0.490337192",24.387755102,7.5,"#VALUE!","-1.9520540607","0.310626124",17.5,4,13.5,6.25,17.5,70.5,"0.8333333333","1.1666666667",10.375,10.375,0,13.5,10,0.8350112519,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_KCY.1.1|m.29973","Q7ZWE9","KCY_DANRE","63.35","191","65","1","3","188","2","192","4.00E-79","241","1","Q7ZWE9","KCY_DANRE","reviewed","UMP-CMP kinase (EC 2.7.4.14) (Deoxycytidylate kinase) (CK) (dCMP kinase) (Nucleoside-diphosphate kinase) (EC 2.7.4.6) (Uridine monophosphate/cytidine monophosphate kinase) (UMP/CMP kinase) (UMP/CMPK)","cmpk cmpk1","Danio rerio (Zebrafish) (Brachydanio rerio)","196","'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; pyrimidine nucleotide biosynthetic process [GO:0006221]","GO:0004127; GO:0004550; GO:0005524; GO:0005634; GO:0005737; GO:0006165; GO:0006207; GO:0006221; GO:0009041; GO:0009142","","","cd01428;","","cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; uridylate kinase activity [GO:0009041]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; pyrimidine nucleotide biosynthetic process [GO:0006221]"
"CHOYP_KS6A1.1.1|m.38387",37,"3",13.5,13.5,13.5,14.5,15,16.5,9.5,11.5,11.5714285714,3.0287735782,"0.2617458648",9.1734693878,11.5,"#VALUE!","-0.0883911304","-0.060896971",16.5,6.5,10,9.75,16.5,81,"1.2222222222","1",11.5,12.875,-1.375,10,6.5,0.9593746299,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_KS6A1.1.1|m.38387","Q07598","NLTP_CHICK","67.11","526","167","5","7","528","16","539","0","742","1","Q07598","NLTP_CHICK","reviewed","Non-specific lipid-transfer protein (NSL-TP) (EC 2.3.1.176) (Propanoyl-CoA C-acyltransferase) (SCP-chi) (SCPX) (Sterol carrier protein 2) (SCP-2) (Sterol carrier protein X) (SCP-X) (Fragment)","SCP2","Gallus gallus (Chicken)","547","lipid transport [GO:0006869]; metabolic process [GO:0008152]","GO:0005739; GO:0005777; GO:0006869; GO:0008152; GO:0008289; GO:0033814","","","","PF02036;PF02803;PF00108;","mitochondrion [GO:0005739]; peroxisome [GO:0005777]; lipid binding [GO:0008289]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; lipid transport [GO:0006869]; metabolic process [GO:0008152]"
"CHOYP_KS6A1.1.1|m.38387",48,"9",13.5,13,13,9.5,12.5,13.5,10,13.5,11.5714285714,3.0287735782,"0.2617458648",9.1734693878,11.5,"#VALUE!","-0.0883911304","-0.060896971",16.5,6.5,10,9.75,16.5,81,"1.2222222222","1",11.5,12.875,-1.375,10,6.5,0.9593746299,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_KS6A1.1.1|m.38387","Q07598","NLTP_CHICK","67.11","526","167","5","7","528","16","539","0","742","1","Q07598","NLTP_CHICK","reviewed","Non-specific lipid-transfer protein (NSL-TP) (EC 2.3.1.176) (Propanoyl-CoA C-acyltransferase) (SCP-chi) (SCPX) (Sterol carrier protein 2) (SCP-2) (Sterol carrier protein X) (SCP-X) (Fragment)","SCP2","Gallus gallus (Chicken)","547","lipid transport [GO:0006869]; metabolic process [GO:0008152]","GO:0005739; GO:0005777; GO:0006869; GO:0008152; GO:0008289; GO:0033814","","","","PF02036;PF02803;PF00108;","mitochondrion [GO:0005739]; peroxisome [GO:0005777]; lipid binding [GO:0008289]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; lipid transport [GO:0006869]; metabolic process [GO:0008152]"
"CHOYP_LDLR.6.7|m.57984",31,"3",27.5,31,59,73,123.5,69.5,37.5,39.5,42.5,11.3105513318,"0.2661306196",127.9285714286,40.5,"#VALUE!","1.9958592516","0.5533066",64.5,24,40.5,38.5,64.5,297.5,"1.4479166667","1.34375",48.875,42.875,6,45.5,8.5,3.5236290418,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_LDLR.6.7|m.57984",28,"9",27.5,43.5,53,43.5,70.5,64.5,43.5,48,42.5,11.3105513318,"0.2661306196",127.9285714286,40.5,"#VALUE!","1.9958592516","0.5533066",64.5,24,40.5,38.5,64.5,297.5,"1.4479166667","1.34375",48.875,42.875,6,45.5,8.5,3.5236290418,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_LOC100182585.2.2|m.24665",37,"3",18.5,20.5,20.5,17.5,17,2.5,12.5,14.5,11.5,5.7008771255,"0.4957284457",32.5,14.5,"#VALUE!","-1.0230735418","-0.9961340918",17,2.5,14.5,7.75,17,80.5,"0.1470588235","0.8529411765",8.125,12.625,-4.5,12,14.5,0.9534525643,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100182585.2.2|m.24665","Q2PFW9","NOVA1_MACFA","64.18","201","65","1","80","273","52","252","2.00E-78","261","1","Q2PFW9","NOVA1_MACFA","reviewed","RNA-binding protein Nova-1 (Neuro-oncological ventral antigen 1) (Ventral neuron-specific protein 1)","NOVA1 QflA-17531 QtsA-14227","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","483","mRNA splicing, via spliceosome [GO:0000398]","GO:0000398; GO:0003723; GO:0005634","","","","PF00013;","nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"
"CHOYP_LOC100182585.2.2|m.24665",48,"9",18.5,17.5,10,7.5,2.5,14.5,16.5,17,11.5,5.7008771255,"0.4957284457",32.5,14.5,"#VALUE!","-1.0230735418","-0.9961340918",17,2.5,14.5,7.75,17,80.5,"0.1470588235","0.8529411765",8.125,12.625,-4.5,12,14.5,0.9534525643,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100182585.2.2|m.24665","Q2PFW9","NOVA1_MACFA","64.18","201","65","1","80","273","52","252","2.00E-78","261","1","Q2PFW9","NOVA1_MACFA","reviewed","RNA-binding protein Nova-1 (Neuro-oncological ventral antigen 1) (Ventral neuron-specific protein 1)","NOVA1 QflA-17531 QtsA-14227","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","483","mRNA splicing, via spliceosome [GO:0000398]","GO:0000398; GO:0003723; GO:0005634","","","","PF00013;","nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]"
"CHOYP_LOC100197130.2.2|m.39076",22,"3",35.5,44,99,91,99.5,84.5,60.5,54.5,69.5,19.1740151544,"0.2758851101",367.6428571429,67.5,"#VALUE!","-0.9438474273","-0.3245273951",94.5,37,57.5,57.5,94.5,486.5,"1.0180722892","1.1385542169",69.125,73.625,-4.5,57.5,35,5.7621698448,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_LOC100197130.2.2|m.39076",21,"9",35.5,81,104.5,89.5,97,94.5,89.5,83,69.5,19.1740151544,"0.2758851101",367.6428571429,67.5,"#VALUE!","-0.9438474273","-0.3245273951",94.5,37,57.5,57.5,94.5,486.5,"1.0180722892","1.1385542169",69.125,73.625,-4.5,57.5,35,5.7621698448,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_LOC100211409.1.1|m.4742",48,"3",7,10.5,10.5,5.5,3.5,8,15,19,16.0714285714,4.5546567334,"0.2834008634",20.7448979592,15.5,"#VALUE!","1.333535813","0.3360985901",24.5,8.5,16,14.25,24.5,112.5,"0.3265306122","0.6734693878",12,18.125,-6.125,8.5,11,1.3324647637,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100211409.1.1|m.4742","P04792","HSPB1_HUMAN","38.67","75","43","2","161","233","95","168","3.00E-10","60.8","1","P04792","HSPB1_HUMAN","reviewed","Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)","HSPB1 HSP27 HSP28","Homo sapiens (Human)","205","anterograde axonal protein transport [GO:0099641]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chaperone-mediated protein folding [GO:0061077]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of protein phosphorylation [GO:0001932]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]","GO:0000502; GO:0001895; GO:0001932; GO:0003723; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044183; GO:0045766; GO:0048010; GO:0061077; GO:0070062; GO:0070527; GO:0099641; GO:1902176; GO:1904115; GO:2001028","","","","PF00011;","axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; spindle [GO:0005819]; Z disc [GO:0030018]; identical protein binding [GO:0042802]; protein binding involved in protein folding [GO:0044183]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein kinase C inhibitor activity [GO:0008426]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; anterograde axonal protein transport [GO:0099641]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chaperone-mediated protein folding [GO:0061077]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of protein phosphorylation [GO:0001932]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"
"CHOYP_LOC100211409.1.1|m.4742",37,"9",7,5.5,16,13,18,16.5,15.5,24.5,16.0714285714,4.5546567334,"0.2834008634",20.7448979592,15.5,"#VALUE!","1.333535813","0.3360985901",24.5,8.5,16,14.25,24.5,112.5,"0.3265306122","0.6734693878",12,18.125,-6.125,8.5,11,1.3324647637,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100211409.1.1|m.4742","P04792","HSPB1_HUMAN","38.67","75","43","2","161","233","95","168","3.00E-10","60.8","1","P04792","HSPB1_HUMAN","reviewed","Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)","HSPB1 HSP27 HSP28","Homo sapiens (Human)","205","anterograde axonal protein transport [GO:0099641]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chaperone-mediated protein folding [GO:0061077]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of protein phosphorylation [GO:0001932]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]","GO:0000502; GO:0001895; GO:0001932; GO:0003723; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044183; GO:0045766; GO:0048010; GO:0061077; GO:0070062; GO:0070527; GO:0099641; GO:1902176; GO:1904115; GO:2001028","","","","PF00011;","axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; spindle [GO:0005819]; Z disc [GO:0030018]; identical protein binding [GO:0042802]; protein binding involved in protein folding [GO:0044183]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein kinase C inhibitor activity [GO:0008426]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; anterograde axonal protein transport [GO:0099641]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chaperone-mediated protein folding [GO:0061077]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of protein phosphorylation [GO:0001932]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"
"CHOYP_LOC100367089.1.4|m.1384",48,"3",0,0,0,6.5,9,0,0,0,7,11.1835338141,"1.5976476877",125.0714285714,0,"#VALUE!","-0.297094815","1.3170066048",27.5,0,27.5,0,27.5,49,"0","0",0,12.25,-12.25,0,27.5,0.5803624304,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100367089.1.4|m.1384","Q15746","MYLK_HUMAN","29.58","409","252","9","1498","1900","433","811","6.00E-48","195","1","Q15746","MYLK_HUMAN","reviewed","Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]","MYLK MLCK MLCK1 MYLK1","Homo sapiens (Human)","1914","aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; muscle contraction [GO:0006936]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]","GO:0001725; GO:0004687; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006936; GO:0006939; GO:0014820; GO:0030027; GO:0030335; GO:0032060; GO:0032154; GO:0046872; GO:0051928; GO:0060414; GO:0070062; GO:0071476; GO:0090303","","","cd00063;","PF00041;PF07679;PF00069;","cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; muscle contraction [GO:0006936]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]"
"CHOYP_LOC100367089.1.4|m.1384",37,"9",0,0,0.5,0,9.5,0,27.5,21.5,7,11.1835338141,"1.5976476877",125.0714285714,0,"#VALUE!","-0.297094815","1.3170066048",27.5,0,27.5,0,27.5,49,"0","0",0,12.25,-12.25,0,27.5,0.5803624304,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100367089.1.4|m.1384","Q15746","MYLK_HUMAN","29.58","409","252","9","1498","1900","433","811","6.00E-48","195","1","Q15746","MYLK_HUMAN","reviewed","Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]","MYLK MLCK MLCK1 MYLK1","Homo sapiens (Human)","1914","aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; muscle contraction [GO:0006936]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]","GO:0001725; GO:0004687; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006936; GO:0006939; GO:0014820; GO:0030027; GO:0030335; GO:0032060; GO:0032154; GO:0046872; GO:0051928; GO:0060414; GO:0070062; GO:0071476; GO:0090303","","","cd00063;","PF00041;PF07679;PF00069;","cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; muscle contraction [GO:0006936]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]"
"CHOYP_LOC100367974.1.3|m.19352",37,"3",29.5,30.5,23.5,17,18,10,8.5,4.5,8.7857142857,3.4211228614,"0.389396098",11.7040816327,8.5,"#VALUE!","-1.2378135145","0.2386730246",13.5,4.5,9,6.25,13.5,61.5,"1.1111111111","1.5",9.125,8.75,0.375,9,9,0.7284140708,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100367974.1.3|m.19352","Q8BSN3","CC151_MOUSE","39.77","533","302","3","320","843","65","587","4.00E-99","327","1","Q8BSN3","CC151_MOUSE","reviewed","Coiled-coil domain-containing protein 151","Ccdc151","Mus musculus (Mouse)","593","cilium movement [GO:0003341]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; outer dynein arm assembly [GO:0036158]; regulation of cilium assembly [GO:1902017]","GO:0003341; GO:0005814; GO:0005929; GO:0005930; GO:0007368; GO:0007507; GO:0036064; GO:0036158; GO:0061371; GO:1902017","","","","","axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cilium movement [GO:0003341]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; outer dynein arm assembly [GO:0036158]; regulation of cilium assembly [GO:1902017]"
"CHOYP_LOC100367974.1.3|m.19352",48,"9",29.5,19,13,10,9,13.5,13.5,9,8.7857142857,3.4211228614,"0.389396098",11.7040816327,8.5,"#VALUE!","-1.2378135145","0.2386730246",13.5,4.5,9,6.25,13.5,61.5,"1.1111111111","1.5",9.125,8.75,0.375,9,9,0.7284140708,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100367974.1.3|m.19352","Q8BSN3","CC151_MOUSE","39.77","533","302","3","320","843","65","587","4.00E-99","327","1","Q8BSN3","CC151_MOUSE","reviewed","Coiled-coil domain-containing protein 151","Ccdc151","Mus musculus (Mouse)","593","cilium movement [GO:0003341]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; outer dynein arm assembly [GO:0036158]; regulation of cilium assembly [GO:1902017]","GO:0003341; GO:0005814; GO:0005929; GO:0005930; GO:0007368; GO:0007507; GO:0036064; GO:0036158; GO:0061371; GO:1902017","","","","","axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cilium movement [GO:0003341]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; outer dynein arm assembly [GO:0036158]; regulation of cilium assembly [GO:1902017]"
"CHOYP_LOC100368639.1.1|m.56563",37,"3",13,15.5,16.5,12,15.5,15.5,15,17.5,12.8571428571,2.849991049,"0.2216659705",8.1224489796,13,"#VALUE!","-0.7424850383","0.0970877605",17.5,8.5,9,10.75,17.5,90,"1.1923076923","0.8076923077",12.375,14,-1.625,7,6.5,1.065971811,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100368639.1.1|m.56563","Q5PPY6","EIF3H_XENLA","61.3","323","121","3","44","365","14","333","4.00E-140","409","1","Q5PPY6","EIF3H_XENLA","reviewed","Eukaryotic translation initiation factor 3 subunit H (eIF3h) (Eukaryotic translation initiation factor 3 subunit 3) (eIF-3-gamma) (eIF3 p40 subunit)","eif3h eif3s3","Xenopus laevis (African clawed frog)","334","translational initiation [GO:0006413]","GO:0003743; GO:0005852; GO:0006413","","","cd08065;","PF01398;","eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; translational initiation [GO:0006413]"
"CHOYP_LOC100368639.1.1|m.56563",48,"9",13,12.5,15,14,12,10.5,11,13,12.8571428571,2.849991049,"0.2216659705",8.1224489796,13,"#VALUE!","-0.7424850383","0.0970877605",17.5,8.5,9,10.75,17.5,90,"1.1923076923","0.8076923077",12.375,14,-1.625,7,6.5,1.065971811,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100368639.1.1|m.56563","Q5PPY6","EIF3H_XENLA","61.3","323","121","3","44","365","14","333","4.00E-140","409","1","Q5PPY6","EIF3H_XENLA","reviewed","Eukaryotic translation initiation factor 3 subunit H (eIF3h) (Eukaryotic translation initiation factor 3 subunit 3) (eIF-3-gamma) (eIF3 p40 subunit)","eif3h eif3s3","Xenopus laevis (African clawed frog)","334","translational initiation [GO:0006413]","GO:0003743; GO:0005852; GO:0006413","","","cd08065;","PF01398;","eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; translational initiation [GO:0006413]"
"CHOYP_LOC100369657.2.2|m.45309",37,"3",0,0.5,19.5,33,29,17,11.5,22,12.2857142857,8.3188990637,"0.6771196912",69.2040816327,11.5,"#VALUE!","-0.8085348479","0.6987812755",26.5,2.5,24,5.75,26.5,86,"6.8","3",12,13.75,-1.75,9.5,24,1.018595286,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100369657.2.2|m.45309","P19891","ASNS_CRIGR","57.96","559","224","4","1","550","1","557","0","694","1","P19891","ASNS_CRIGR","reviewed","Asparagine synthetase [glutamine-hydrolyzing] (EC 6.3.5.4) (Glutamine-dependent asparagine synthetase)","ASNS AS","Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)","561","glutamine metabolic process [GO:0006541]; L-asparagine biosynthetic process [GO:0070981]","GO:0004066; GO:0005524; GO:0006541; GO:0070981","PATHWAY: Amino-acid biosynthesis; L-asparagine biosynthesis; L-asparagine from L-aspartate (L-Gln route): step 1/1.","","cd01991;cd00712;","PF00733;PF13537;","asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]; ATP binding [GO:0005524]; glutamine metabolic process [GO:0006541]; L-asparagine biosynthetic process [GO:0070981]"
"CHOYP_LOC100369657.2.2|m.45309",48,"9",0,6.5,14.5,14,11.5,7.5,4,2.5,12.2857142857,8.3188990637,"0.6771196912",69.2040816327,11.5,"#VALUE!","-0.8085348479","0.6987812755",26.5,2.5,24,5.75,26.5,86,"6.8","3",12,13.75,-1.75,9.5,24,1.018595286,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100369657.2.2|m.45309","P19891","ASNS_CRIGR","57.96","559","224","4","1","550","1","557","0","694","1","P19891","ASNS_CRIGR","reviewed","Asparagine synthetase [glutamine-hydrolyzing] (EC 6.3.5.4) (Glutamine-dependent asparagine synthetase)","ASNS AS","Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)","561","glutamine metabolic process [GO:0006541]; L-asparagine biosynthetic process [GO:0070981]","GO:0004066; GO:0005524; GO:0006541; GO:0070981","PATHWAY: Amino-acid biosynthesis; L-asparagine biosynthesis; L-asparagine from L-aspartate (L-Gln route): step 1/1.","","cd01991;cd00712;","PF00733;PF13537;","asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]; ATP binding [GO:0005524]; glutamine metabolic process [GO:0006541]; L-asparagine biosynthetic process [GO:0070981]"
"CHOYP_LOC100370637.1.2|m.12891",37,"3",13,15.5,19.5,15.5,16.5,15,10.5,13,12.0714285714,2.2269224669,"0.1844787842",4.9591836735,13,"#VALUE!","1.4719097699","-1.2795544397",14.5,7.5,7,11.25,14.5,84.5,"1.0344827586","0.9655172414",11.75,13.125,-1.375,7.5,2.5,1.0008290892,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100370637.1.2|m.12891","Q64060","DDX4_RAT","55.56","531","215","6","250","777","201","713","0","570","1","Q64060","DDX4_RAT","reviewed","Probable ATP-dependent RNA helicase DDX4 (EC 3.6.4.13) (DEAD box protein 4) (Vasa homolog) (rVLG)","Ddx4","Rattus norvegicus (Rat)","713","cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; male meiosis [GO:0007140]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]","GO:0003676; GO:0004004; GO:0005524; GO:0005737; GO:0007140; GO:0007275; GO:0007283; GO:0010501; GO:0030154; GO:0031047; GO:0034587; GO:0043046; GO:0043186; GO:0048471; GO:0071546; GO:0071547","","","","PF00270;PF00271;","cytoplasm [GO:0005737]; P granule [GO:0043186]; perinuclear region of cytoplasm [GO:0048471]; pi-body [GO:0071546]; piP-body [GO:0071547]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; nucleic acid binding [GO:0003676]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; male meiosis [GO:0007140]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]"
"CHOYP_LOC100370637.1.2|m.12891",48,"9",13,17.5,15,11.5,12,14,12,14.5,12.0714285714,2.2269224669,"0.1844787842",4.9591836735,13,"#VALUE!","1.4719097699","-1.2795544397",14.5,7.5,7,11.25,14.5,84.5,"1.0344827586","0.9655172414",11.75,13.125,-1.375,7.5,2.5,1.0008290892,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100370637.1.2|m.12891","Q64060","DDX4_RAT","55.56","531","215","6","250","777","201","713","0","570","1","Q64060","DDX4_RAT","reviewed","Probable ATP-dependent RNA helicase DDX4 (EC 3.6.4.13) (DEAD box protein 4) (Vasa homolog) (rVLG)","Ddx4","Rattus norvegicus (Rat)","713","cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; male meiosis [GO:0007140]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]","GO:0003676; GO:0004004; GO:0005524; GO:0005737; GO:0007140; GO:0007275; GO:0007283; GO:0010501; GO:0030154; GO:0031047; GO:0034587; GO:0043046; GO:0043186; GO:0048471; GO:0071546; GO:0071547","","","","PF00270;PF00271;","cytoplasm [GO:0005737]; P granule [GO:0043186]; perinuclear region of cytoplasm [GO:0048471]; pi-body [GO:0071546]; piP-body [GO:0071547]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; nucleic acid binding [GO:0003676]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; male meiosis [GO:0007140]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]"
"CHOYP_LOC100371254.1.1|m.1838",48,"9",13,14,13.5,12,14,7.5,12.5,8.5,9.3571428571,1.7467170372,"0.1866720498",3.0510204082,8.5,"#VALUE!","-0.6158521717","0.753038826",12.5,7.5,5,8,12.5,65.5,"1.9411764706","0.8823529412",10,10.5,-0.5,9,4,0.7757905958,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100371254.1.1|m.1838","Q6PAM1","TXLNA_MOUSE","45.35","430","197","7","380","775","128","553","5.00E-94","311","1","Q6PAM1","TXLNA_MOUSE","reviewed","Alpha-taxilin","Txlna Txln","Mus musculus (Mouse)","554","B cell activation [GO:0042113]; exocytosis [GO:0006887]","GO:0005737; GO:0006887; GO:0016020; GO:0042113","","","","PF09728;","cytoplasm [GO:0005737]; membrane [GO:0016020]; B cell activation [GO:0042113]; exocytosis [GO:0006887]"
"CHOYP_LOC100371254.1.1|m.1838",37,"3",13,15,12,15,15.5,16.5,7.5,11,9.3571428571,1.7467170372,"0.1866720498",3.0510204082,8.5,"#VALUE!","-0.6158521717","0.753038826",12.5,7.5,5,8,12.5,65.5,"1.9411764706","0.8823529412",10,10.5,-0.5,9,4,0.7757905958,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100371254.1.1|m.1838","Q6PAM1","TXLNA_MOUSE","45.35","430","197","7","380","775","128","553","5.00E-94","311","1","Q6PAM1","TXLNA_MOUSE","reviewed","Alpha-taxilin","Txlna Txln","Mus musculus (Mouse)","554","B cell activation [GO:0042113]; exocytosis [GO:0006887]","GO:0005737; GO:0006887; GO:0016020; GO:0042113","","","","PF09728;","cytoplasm [GO:0005737]; membrane [GO:0016020]; B cell activation [GO:0042113]; exocytosis [GO:0006887]"
"CHOYP_LOC100372150.1.1|m.7059",37,"9",12,12.5,11,10.5,15.5,10.5,16.5,15,10.2857142857,4.1218680132,"0.400737168",16.9897959184,10,"#VALUE!","-0.7870588426","0.0466625908",16.5,4,12.5,8,16.5,72,"0.8333333333","0.7",9.25,11.875,-2.625,8.5,10.5,0.8527774488,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100372150.1.1|m.7059","P28289","TMOD1_HUMAN","44.94","336","178","5","55","385","12","345","6.00E-84","266","1","P28289","TMOD1_HUMAN","reviewed","Tropomodulin-1 (Erythrocyte tropomodulin) (E-Tmod)","TMOD1 D9S57E TMOD","Homo sapiens (Human)","359","adult locomotory behavior [GO:0008344]; lens fiber cell development [GO:0070307]; muscle filament sliding [GO:0030049]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694]","GO:0003779; GO:0005829; GO:0005884; GO:0008344; GO:0016020; GO:0030016; GO:0030017; GO:0030049; GO:0030239; GO:0030863; GO:0051694; GO:0070307","","","","PF03250;","actin filament [GO:0005884]; cortical cytoskeleton [GO:0030863]; cytosol [GO:0005829]; membrane [GO:0016020]; myofibril [GO:0030016]; sarcomere [GO:0030017]; actin binding [GO:0003779]; adult locomotory behavior [GO:0008344]; lens fiber cell development [GO:0070307]; muscle filament sliding [GO:0030049]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694]"
"CHOYP_LOC100372150.1.1|m.7059",48,"3",12,11,12,9,9,12.5,10,10,10.2857142857,4.1218680132,"0.400737168",16.9897959184,10,"#VALUE!","-0.7870588426","0.0466625908",16.5,4,12.5,8,16.5,72,"0.8333333333","0.7",9.25,11.875,-2.625,8.5,10.5,0.8527774488,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100372150.1.1|m.7059","P28289","TMOD1_HUMAN","44.94","336","178","5","55","385","12","345","6.00E-84","266","1","P28289","TMOD1_HUMAN","reviewed","Tropomodulin-1 (Erythrocyte tropomodulin) (E-Tmod)","TMOD1 D9S57E TMOD","Homo sapiens (Human)","359","adult locomotory behavior [GO:0008344]; lens fiber cell development [GO:0070307]; muscle filament sliding [GO:0030049]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694]","GO:0003779; GO:0005829; GO:0005884; GO:0008344; GO:0016020; GO:0030016; GO:0030017; GO:0030049; GO:0030239; GO:0030863; GO:0051694; GO:0070307","","","","PF03250;","actin filament [GO:0005884]; cortical cytoskeleton [GO:0030863]; cytosol [GO:0005829]; membrane [GO:0016020]; myofibril [GO:0030016]; sarcomere [GO:0030017]; actin binding [GO:0003779]; adult locomotory behavior [GO:0008344]; lens fiber cell development [GO:0070307]; muscle filament sliding [GO:0030049]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694]"
"CHOYP_LOC100372926.2.3|m.61794",37,"9",51,41.5,47,42.5,38.5,43.5,35,44,34.7857142857,7.4203250933,"0.2133153004",55.0612244898,35,"#VALUE!","0.8028052793","-0.6917070315",44,20.5,23.5,32,44,243.5,"1.1022727273","0.9886363636",37.25,35.75,1.5,28,13,2.8840459552,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100372926.2.3|m.61794","P48605","TCPG_DROME","69.6","556","154","4","164","716","1","544","0","805","1","P48605","TCPG_DROME","reviewed","T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma)","Cctgamma CCT-3 Cctg CG8977","Drosophila melanogaster (Fruit fly)","544","'de novo' protein folding [GO:0006458]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; terminal branching, open tracheal system [GO:0007430]; trachea morphogenesis [GO:0060439]","GO:0005524; GO:0005832; GO:0005875; GO:0006457; GO:0006458; GO:0007430; GO:0042623; GO:0044183; GO:0051082; GO:0060439; GO:0061077","","","cd03337;","PF00118;","chaperonin-containing T-complex [GO:0005832]; microtubule associated complex [GO:0005875]; ATP binding [GO:0005524]; ATPase activity, coupled [GO:0042623]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082]; 'de novo' protein folding [GO:0006458]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; terminal branching, open tracheal system [GO:0007430]; trachea morphogenesis [GO:0060439]"
"CHOYP_LOC100372926.2.3|m.61794",28,"3",51,44,50.5,58.5,62.5,48.5,36.5,33,34.7857142857,7.4203250933,"0.2133153004",55.0612244898,35,"#VALUE!","0.8028052793","-0.6917070315",44,20.5,23.5,32,44,243.5,"1.1022727273","0.9886363636",37.25,35.75,1.5,28,13,2.8840459552,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100372926.2.3|m.61794","P48605","TCPG_DROME","69.6","556","154","4","164","716","1","544","0","805","1","P48605","TCPG_DROME","reviewed","T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma)","Cctgamma CCT-3 Cctg CG8977","Drosophila melanogaster (Fruit fly)","544","'de novo' protein folding [GO:0006458]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; terminal branching, open tracheal system [GO:0007430]; trachea morphogenesis [GO:0060439]","GO:0005524; GO:0005832; GO:0005875; GO:0006457; GO:0006458; GO:0007430; GO:0042623; GO:0044183; GO:0051082; GO:0060439; GO:0061077","","","cd03337;","PF00118;","chaperonin-containing T-complex [GO:0005832]; microtubule associated complex [GO:0005875]; ATP binding [GO:0005524]; ATPase activity, coupled [GO:0042623]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082]; 'de novo' protein folding [GO:0006458]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; terminal branching, open tracheal system [GO:0007430]; trachea morphogenesis [GO:0060439]"
"CHOYP_LOC100373842.4.4|m.40731",48,"3",1.5,0,0.5,4,17,6,13,15,15.7142857143,6.1809450437,"0.3933328664",38.2040816327,15,"#VALUE!","0.557298344","0.2224108622",26.5,5.5,21,12.75,26.5,110,"0.2264150943","0.7924528302",11.375,17.625,-6.25,15.5,14,1.3028544356,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100373842.4.4|m.40731","Q9WTP0","E41L1_RAT","54.72","371","156","6","61","424","92","457","1.00E-130","420","1","Q9WTP0","E41L1_RAT","reviewed","Band 4.1-like protein 1 (Neuronal protein 4.1) (4.1N)","Epb41l1 Epb4.1l1","Rattus norvegicus (Rat)","879","actomyosin structure organization [GO:0031032]; cortical actin cytoskeleton organization [GO:0030866]","GO:0005102; GO:0005200; GO:0005737; GO:0005856; GO:0019898; GO:0030866; GO:0031032; GO:0043234; GO:0097060","","","","PF05902;PF08736;PF09380;PF00373;PF09379;PF04382;","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extrinsic component of membrane [GO:0019898]; protein complex [GO:0043234]; synaptic membrane [GO:0097060]; receptor binding [GO:0005102]; structural constituent of cytoskeleton [GO:0005200]; actomyosin structure organization [GO:0031032]; cortical actin cytoskeleton organization [GO:0030866]"
"CHOYP_LOC100373842.4.4|m.40731",37,"9",1.5,0,2.5,10.5,26.5,21,16.5,26.5,15.7142857143,6.1809450437,"0.3933328664",38.2040816327,15,"#VALUE!","0.557298344","0.2224108622",26.5,5.5,21,12.75,26.5,110,"0.2264150943","0.7924528302",11.375,17.625,-6.25,15.5,14,1.3028544356,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100373842.4.4|m.40731","Q9WTP0","E41L1_RAT","54.72","371","156","6","61","424","92","457","1.00E-130","420","1","Q9WTP0","E41L1_RAT","reviewed","Band 4.1-like protein 1 (Neuronal protein 4.1) (4.1N)","Epb41l1 Epb4.1l1","Rattus norvegicus (Rat)","879","actomyosin structure organization [GO:0031032]; cortical actin cytoskeleton organization [GO:0030866]","GO:0005102; GO:0005200; GO:0005737; GO:0005856; GO:0019898; GO:0030866; GO:0031032; GO:0043234; GO:0097060","","","","PF05902;PF08736;PF09380;PF00373;PF09379;PF04382;","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extrinsic component of membrane [GO:0019898]; protein complex [GO:0043234]; synaptic membrane [GO:0097060]; receptor binding [GO:0005102]; structural constituent of cytoskeleton [GO:0005200]; actomyosin structure organization [GO:0031032]; cortical actin cytoskeleton organization [GO:0030866]"
"CHOYP_LOC100373864.1.2|m.16543",37,"3",14.5,15,16,17.5,10,16,15,16,13.2857142857,3.5742845723,"0.2690321721",12.7755102041,15,"#VALUE!","-2.0624666986","-0.4493585098",17,8,9,10,17,93,"2","2.125",14.25,13,1.25,8,9,1.1015042047,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100373864.1.2|m.16543","P12955","PEPD_HUMAN","64.77","474","167","0","31","504","7","480","0","672","1","P12955","PEPD_HUMAN","reviewed","Xaa-Pro dipeptidase (X-Pro dipeptidase) (EC 3.4.13.9) (Imidodipeptidase) (Peptidase D) (Proline dipeptidase) (Prolidase)","PEPD PRD","Homo sapiens (Human)","493","cellular amino acid metabolic process [GO:0006520]; collagen catabolic process [GO:0030574]; proteolysis [GO:0006508]","GO:0004177; GO:0004181; GO:0006508; GO:0006520; GO:0030145; GO:0030574; GO:0070062; GO:0102009","","","","PF05195;PF00557;","extracellular exosome [GO:0070062]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metallocarboxypeptidase activity [GO:0004181]; proline dipeptidase activity [GO:0102009]; cellular amino acid metabolic process [GO:0006520]; collagen catabolic process [GO:0030574]; proteolysis [GO:0006508]"
"CHOYP_LOC100373864.1.2|m.16543",48,"9",14.5,14,12.5,13,13,17,11,8,13.2857142857,3.5742845723,"0.2690321721",12.7755102041,15,"#VALUE!","-2.0624666986","-0.4493585098",17,8,9,10,17,93,"2","2.125",14.25,13,1.25,8,9,1.1015042047,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100373864.1.2|m.16543","P12955","PEPD_HUMAN","64.77","474","167","0","31","504","7","480","0","672","1","P12955","PEPD_HUMAN","reviewed","Xaa-Pro dipeptidase (X-Pro dipeptidase) (EC 3.4.13.9) (Imidodipeptidase) (Peptidase D) (Proline dipeptidase) (Prolidase)","PEPD PRD","Homo sapiens (Human)","493","cellular amino acid metabolic process [GO:0006520]; collagen catabolic process [GO:0030574]; proteolysis [GO:0006508]","GO:0004177; GO:0004181; GO:0006508; GO:0006520; GO:0030145; GO:0030574; GO:0070062; GO:0102009","","","","PF05195;PF00557;","extracellular exosome [GO:0070062]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metallocarboxypeptidase activity [GO:0004181]; proline dipeptidase activity [GO:0102009]; cellular amino acid metabolic process [GO:0006520]; collagen catabolic process [GO:0030574]; proteolysis [GO:0006508]"
"CHOYP_LOC100374422.1.2|m.26376",48,"9",65,12,15.5,12,2.5,6,4.5,3,5.1428571429,1.0594569267,"0.2060055135",1.1224489796,5.5,"#VALUE!","1.4634049587","-1.0724681015",6.5,3,3.5,4.75,6.5,36,"1","2",5.25,4.5,0.75,3.5,2.5,0.4263887244,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100374422.1.2|m.26376","Q9MBF8","DYH1B_CHLRE","32.78","4545","2728","71","307","4700","142","4510","0","2461","1","Q9MBF8","DYH1B_CHLRE","reviewed","Dynein-1-beta heavy chain, flagellar inner arm I1 complex (1-beta DHC) (Dynein-1, subspecies f)","DHC10 IDA2","Chlamydomonas reinhardtii (Chlamydomonas smithii)","4513","cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159]","GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0005930; GO:0008017; GO:0016887; GO:0031514; GO:0036156; GO:0036159; GO:0060294","","","","PF07728;PF12780;PF08385;PF08393;PF03028;PF12777;","axoneme [GO:0005930]; cytoplasm [GO:0005737]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159]"
"CHOYP_LOC100374422.1.2|m.26376",45,"3",65,51,19,17.5,14.5,3,5.5,5.5,5.1428571429,1.0594569267,"0.2060055135",1.1224489796,5.5,"#VALUE!","1.4634049587","-1.0724681015",6.5,3,3.5,4.75,6.5,36,"1","2",5.25,4.5,0.75,3.5,2.5,0.4263887244,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100374422.1.2|m.26376","Q9MBF8","DYH1B_CHLRE","32.78","4545","2728","71","307","4700","142","4510","0","2461","1","Q9MBF8","DYH1B_CHLRE","reviewed","Dynein-1-beta heavy chain, flagellar inner arm I1 complex (1-beta DHC) (Dynein-1, subspecies f)","DHC10 IDA2","Chlamydomonas reinhardtii (Chlamydomonas smithii)","4513","cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159]","GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0005930; GO:0008017; GO:0016887; GO:0031514; GO:0036156; GO:0036159; GO:0060294","","","","PF07728;PF12780;PF08385;PF08393;PF03028;PF12777;","axoneme [GO:0005930]; cytoplasm [GO:0005737]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159]"
"CHOYP_LOC100375022.1.1|m.3033",48,"9",13.5,16.5,14.5,11,10.5,10.5,14,15,12.4285714286,1.916629695,"0.1542115847",3.6734693878,12.5,"#VALUE!","-0.2383888889","-0.6670058686",15,9,6,11.5,15,87,"0.8666666667","0.7",11.5,13.5,-2,4.5,2.5,1.0304394173,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100375022.1.1|m.3033","P14685","PSMD3_MOUSE","64.6","500","174","2","6","503","32","530","0","629","1","P14685","PSMD3_MOUSE","reviewed","26S proteasome non-ATPase regulatory subunit 3 (26S proteasome regulatory subunit RPN3) (26S proteasome regulatory subunit S3) (Proteasome subunit p58) (Transplantation antigen P91A) (Tum-P91A antigen)","Psmd3 P91a Tstap91a","Mus musculus (Mouse)","530","regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000502; GO:0005634; GO:0005838; GO:0006511; GO:0008541; GO:0016020; GO:0022624; GO:0030234; GO:0042176; GO:0070062","","","","PF01399;PF08375;","extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; enzyme regulator activity [GO:0030234]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process [GO:0006511]"
"CHOYP_LOC100375022.1.1|m.3033",37,"3",13.5,15.5,17.5,15.5,18,13,13.5,12.5,12.4285714286,1.916629695,"0.1542115847",3.6734693878,12.5,"#VALUE!","-0.2383888889","-0.6670058686",15,9,6,11.5,15,87,"0.8666666667","0.7",11.5,13.5,-2,4.5,2.5,1.0304394173,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100375022.1.1|m.3033","P14685","PSMD3_MOUSE","64.6","500","174","2","6","503","32","530","0","629","1","P14685","PSMD3_MOUSE","reviewed","26S proteasome non-ATPase regulatory subunit 3 (26S proteasome regulatory subunit RPN3) (26S proteasome regulatory subunit S3) (Proteasome subunit p58) (Transplantation antigen P91A) (Tum-P91A antigen)","Psmd3 P91a Tstap91a","Mus musculus (Mouse)","530","regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000502; GO:0005634; GO:0005838; GO:0006511; GO:0008541; GO:0016020; GO:0022624; GO:0030234; GO:0042176; GO:0070062","","","","PF01399;PF08375;","extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; enzyme regulator activity [GO:0030234]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process [GO:0006511]"
"CHOYP_LOC100375551.1.2|m.27489",37,"3",11,11.5,11.5,11.5,27.5,11,6.5,7,8.0714285714,1.0497813183,"0.1300614023",1.1020408163,8,"#VALUE!","0.6179012346","0.3552166112",10,6.5,3.5,7.5,10,56.5,"1.1","0.85",8.5,8.375,0.125,4.5,3,0.6691934147,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100375551.1.2|m.27489","Q9JJW6","ALRF2_MOUSE","45.29","276","90","5","1","274","1","217","5.00E-57","188","1","Q9JJW6","ALRF2_MOUSE","reviewed","Aly/REF export factor 2 (Alyref) (RNA and export factor-binding protein 2)","Alyref2 Ref2 Refbp2","Mus musculus (Mouse)","218","mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380]","GO:0000166; GO:0003697; GO:0003723; GO:0005681; GO:0005737; GO:0006397; GO:0008380; GO:0051028","","","","PF13865;PF00076;","cytoplasm [GO:0005737]; spliceosomal complex [GO:0005681]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380]"
"CHOYP_LOC100375551.1.2|m.27489",48,"9",11,11.5,10,10.5,11,8.5,8.5,10,8.0714285714,1.0497813183,"0.1300614023",1.1020408163,8,"#VALUE!","0.6179012346","0.3552166112",10,6.5,3.5,7.5,10,56.5,"1.1","0.85",8.5,8.375,0.125,4.5,3,0.6691934147,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100375551.1.2|m.27489","Q9JJW6","ALRF2_MOUSE","45.29","276","90","5","1","274","1","217","5.00E-57","188","1","Q9JJW6","ALRF2_MOUSE","reviewed","Aly/REF export factor 2 (Alyref) (RNA and export factor-binding protein 2)","Alyref2 Ref2 Refbp2","Mus musculus (Mouse)","218","mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380]","GO:0000166; GO:0003697; GO:0003723; GO:0005681; GO:0005737; GO:0006397; GO:0008380; GO:0051028","","","","PF13865;PF00076;","cytoplasm [GO:0005737]; spliceosomal complex [GO:0005681]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380]"
"CHOYP_LOC100376308.1.1|m.60595",48,"3",0,0,6,8.5,11,12,10.5,9,12.2142857143,7.2843135908,"0.5963765513",53.0612244898,10.5,"#VALUE!","-1.3149970118","-0.1763995003",22,0.5,21.5,7.5,22,85.5,"0.6153846154","0.9230769231",10.25,14.125,-3.875,17.5,16,1.0126732204,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100376308.1.1|m.60595","O88281","MEGF6_RAT","29.06","1163","498","59","219","1208","545","1553","4.00E-57","224","1","O88281","MEGF6_RAT","reviewed","Multiple epidermal growth factor-like domains protein 6 (Multiple EGF-like domains protein 6) (Epidermal growth factor-like protein 3) (EGF-like protein 3)","Megf6 Egfl3","Rattus norvegicus (Rat)","1574","","GO:0005509; GO:0005576","","","","PF12662;PF07645;PF12661;PF00053;","extracellular region [GO:0005576]; calcium ion binding [GO:0005509]"
"CHOYP_LOC100376308.1.1|m.60595",37,"9",0,3.5,6,8,14.5,18,22,19.5,12.2142857143,7.2843135908,"0.5963765513",53.0612244898,10.5,"#VALUE!","-1.3149970118","-0.1763995003",22,0.5,21.5,7.5,22,85.5,"0.6153846154","0.9230769231",10.25,14.125,-3.875,17.5,16,1.0126732204,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100376308.1.1|m.60595","O88281","MEGF6_RAT","29.06","1163","498","59","219","1208","545","1553","4.00E-57","224","1","O88281","MEGF6_RAT","reviewed","Multiple epidermal growth factor-like domains protein 6 (Multiple EGF-like domains protein 6) (Epidermal growth factor-like protein 3) (EGF-like protein 3)","Megf6 Egfl3","Rattus norvegicus (Rat)","1574","","GO:0005509; GO:0005576","","","","PF12662;PF07645;PF12661;PF00053;","extracellular region [GO:0005576]; calcium ion binding [GO:0005509]"
"CHOYP_LOC100376610.3.3|m.19687",48,"9",15,18,10.5,9.5,5,8.5,12.5,17,9.9285714286,3.6295274331,"0.3655639141",13.1734693878,8.5,"#VALUE!","1.3669849239","0.7818371991",17,4.5,12.5,8.5,17,69.5,"0.6764705882","0.5",8.25,12,-3.75,7,8.5,0.8231671207,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100376610.3.3|m.19687","Q61656","DDX5_MOUSE","56.77","643","241","10","64","702","2","611","0","705","1","Q61656","DDX5_MOUSE","reviewed","Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box RNA helicase DEAD1) (mDEAD1) (DEAD box protein 5) (RNA helicase p68)","Ddx5 Tnz2","Mus musculus (Mouse)","614","circadian rhythm [GO:0007623]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; mRNA transcription [GO:0009299]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of osteoblast differentiation [GO:0045667]; regulation of protein import into nucleus, translocation [GO:0033158]; regulation of skeletal muscle cell differentiation [GO:2001014]; RNA secondary structure unwinding [GO:0010501]; RNA splicing [GO:0008380]","GO:0000122; GO:0000381; GO:0000956; GO:0001701; GO:0003712; GO:0003713; GO:0003723; GO:0003724; GO:0003730; GO:0004004; GO:0005524; GO:0005634; GO:0005730; GO:0006397; GO:0007623; GO:0008380; GO:0009299; GO:0010501; GO:0016020; GO:0030331; GO:0030529; GO:0031012; GO:0033148; GO:0033158; GO:0036002; GO:0043021; GO:0043517; GO:0045667; GO:0045893; GO:0045944; GO:0050681; GO:0060765; GO:0070062; GO:0071013; GO:0072332; GO:2001014","","","","PF00270;PF00271;PF08061;","catalytic step 2 spliceosome [GO:0071013]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; intracellular ribonucleoprotein complex [GO:0030529]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; estrogen receptor binding [GO:0030331]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA binding [GO:0036002]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transcription coactivator activity [GO:0003713]; transcription cofactor activity [GO:0003712]; circadian rhythm [GO:0007623]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; mRNA processing [GO:0006397]; mRNA transcription [GO:0009299]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of osteoblast differentiation [GO:0045667]; regulation of protein import into nucleus, translocation [GO:0033158]; regulation of skeletal muscle cell differentiation [GO:2001014]; RNA secondary structure unwinding [GO:0010501]; RNA splicing [GO:0008380]"
"CHOYP_LOC100376610.3.3|m.19687",37,"3",15,20,16,19,19,11.5,8.5,8.5,9.9285714286,3.6295274331,"0.3655639141",13.1734693878,8.5,"#VALUE!","1.3669849239","0.7818371991",17,4.5,12.5,8.5,17,69.5,"0.6764705882","0.5",8.25,12,-3.75,7,8.5,0.8231671207,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100376610.3.3|m.19687","Q61656","DDX5_MOUSE","56.77","643","241","10","64","702","2","611","0","705","1","Q61656","DDX5_MOUSE","reviewed","Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box RNA helicase DEAD1) (mDEAD1) (DEAD box protein 5) (RNA helicase p68)","Ddx5 Tnz2","Mus musculus (Mouse)","614","circadian rhythm [GO:0007623]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; mRNA transcription [GO:0009299]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of osteoblast differentiation [GO:0045667]; regulation of protein import into nucleus, translocation [GO:0033158]; regulation of skeletal muscle cell differentiation [GO:2001014]; RNA secondary structure unwinding [GO:0010501]; RNA splicing [GO:0008380]","GO:0000122; GO:0000381; GO:0000956; GO:0001701; GO:0003712; GO:0003713; GO:0003723; GO:0003724; GO:0003730; GO:0004004; GO:0005524; GO:0005634; GO:0005730; GO:0006397; GO:0007623; GO:0008380; GO:0009299; GO:0010501; GO:0016020; GO:0030331; GO:0030529; GO:0031012; GO:0033148; GO:0033158; GO:0036002; GO:0043021; GO:0043517; GO:0045667; GO:0045893; GO:0045944; GO:0050681; GO:0060765; GO:0070062; GO:0071013; GO:0072332; GO:2001014","","","","PF00270;PF00271;PF08061;","catalytic step 2 spliceosome [GO:0071013]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; intracellular ribonucleoprotein complex [GO:0030529]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; estrogen receptor binding [GO:0030331]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA binding [GO:0036002]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transcription coactivator activity [GO:0003713]; transcription cofactor activity [GO:0003712]; circadian rhythm [GO:0007623]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; mRNA processing [GO:0006397]; mRNA transcription [GO:0009299]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of osteoblast differentiation [GO:0045667]; regulation of protein import into nucleus, translocation [GO:0033158]; regulation of skeletal muscle cell differentiation [GO:2001014]; RNA secondary structure unwinding [GO:0010501]; RNA splicing [GO:0008380]"
"CHOYP_LOC100377173.1.2|m.37699",37,"9",0,18.5,10,2.5,3,0.5,24.5,15.5,8.0714285714,8.6867245653,"1.0762313621",75.4591836735,3,"#VALUE!","-0.2165650219","0.9915583789",24.5,0,24.5,1,24.5,56.5,"0.0322580645","0.0322580645",0.625,13.625,-13,1.5,21.5,0.6691934147,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100377173.1.2|m.37699","P04792","HSPB1_HUMAN","38.67","75","43","2","161","233","95","168","0.000000002","59.3","1","P04792","HSPB1_HUMAN","reviewed","Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)","HSPB1 HSP27 HSP28","Homo sapiens (Human)","205","anterograde axonal protein transport [GO:0099641]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chaperone-mediated protein folding [GO:0061077]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of protein phosphorylation [GO:0001932]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]","GO:0000502; GO:0001895; GO:0001932; GO:0003723; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044183; GO:0045766; GO:0048010; GO:0061077; GO:0070062; GO:0070527; GO:0099641; GO:1902176; GO:1904115; GO:2001028","","","","PF00011;","axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; spindle [GO:0005819]; Z disc [GO:0030018]; identical protein binding [GO:0042802]; protein binding involved in protein folding [GO:0044183]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein kinase C inhibitor activity [GO:0008426]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; anterograde axonal protein transport [GO:0099641]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chaperone-mediated protein folding [GO:0061077]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of protein phosphorylation [GO:0001932]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"
"CHOYP_LOC100377173.1.2|m.37699",48,"3",0,5.5,0.5,2.5,1.5,0.5,1.5,11.5,8.0714285714,8.6867245653,"1.0762313621",75.4591836735,3,"#VALUE!","-0.2165650219","0.9915583789",24.5,0,24.5,1,24.5,56.5,"0.0322580645","0.0322580645",0.625,13.625,-13,1.5,21.5,0.6691934147,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100377173.1.2|m.37699","P04792","HSPB1_HUMAN","38.67","75","43","2","161","233","95","168","0.000000002","59.3","1","P04792","HSPB1_HUMAN","reviewed","Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)","HSPB1 HSP27 HSP28","Homo sapiens (Human)","205","anterograde axonal protein transport [GO:0099641]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chaperone-mediated protein folding [GO:0061077]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of protein phosphorylation [GO:0001932]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]","GO:0000502; GO:0001895; GO:0001932; GO:0003723; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044183; GO:0045766; GO:0048010; GO:0061077; GO:0070062; GO:0070527; GO:0099641; GO:1902176; GO:1904115; GO:2001028","","","","PF00011;","axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; spindle [GO:0005819]; Z disc [GO:0030018]; identical protein binding [GO:0042802]; protein binding involved in protein folding [GO:0044183]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein kinase C inhibitor activity [GO:0008426]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; anterograde axonal protein transport [GO:0099641]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chaperone-mediated protein folding [GO:0061077]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of protein phosphorylation [GO:0001932]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]"
"CHOYP_LOC100377364.2.2|m.52803",28,"3",24,28,67,69.5,68.5,63,53,62,65.5,18.8774241584,"0.288204949",356.3571428571,65.5,"#VALUE!","0.5568288479","-0.7284784462",90.5,29.5,61,57.5,90.5,458.5,"0.754491018","0.8922155689",55,75.375,-20.375,45,28.5,5.4305341703,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100377364.2.2|m.52803","Q9NRC6","SPTN5_HUMAN","31.79","2671","1765","20","940","3591","862","3494","0","1273","1","Q9NRC6","SPTN5_HUMAN","reviewed","Spectrin beta chain, non-erythrocytic 5 (Beta-V spectrin)","SPTBN5 BSPECV HUBSPECV HUSPECV","Homo sapiens (Human)","3674","actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; ER to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; lysosomal transport [GO:0007041]; MAPK cascade [GO:0000165]; protein homooligomerization [GO:0051260]","GO:0000165; GO:0003779; GO:0005088; GO:0005737; GO:0005829; GO:0006888; GO:0007030; GO:0007041; GO:0007411; GO:0008091; GO:0016020; GO:0019894; GO:0030036; GO:0030507; GO:0032029; GO:0032391; GO:0034452; GO:0043621; GO:0045505; GO:0051260; GO:0051693; GO:0070062; GO:0097381","","","cd00014;","PF00307;PF00435;","cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; photoreceptor connecting cilium [GO:0032391]; photoreceptor disc membrane [GO:0097381]; spectrin [GO:0008091]; actin binding [GO:0003779]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; kinesin binding [GO:0019894]; myosin tail binding [GO:0032029]; protein self-association [GO:0043621]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; spectrin binding [GO:0030507]; actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; ER to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; lysosomal transport [GO:0007041]; MAPK cascade [GO:0000165]; protein homooligomerization [GO:0051260]"
"CHOYP_LOC100377364.2.2|m.52803",23,"9",24,55,72,59.5,69,74.5,90.5,83.5,65.5,18.8774241584,"0.288204949",356.3571428571,65.5,"#VALUE!","0.5568288479","-0.7284784462",90.5,29.5,61,57.5,90.5,458.5,"0.754491018","0.8922155689",55,75.375,-20.375,45,28.5,5.4305341703,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100377364.2.2|m.52803","Q9NRC6","SPTN5_HUMAN","31.79","2671","1765","20","940","3591","862","3494","0","1273","1","Q9NRC6","SPTN5_HUMAN","reviewed","Spectrin beta chain, non-erythrocytic 5 (Beta-V spectrin)","SPTBN5 BSPECV HUBSPECV HUSPECV","Homo sapiens (Human)","3674","actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; ER to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; lysosomal transport [GO:0007041]; MAPK cascade [GO:0000165]; protein homooligomerization [GO:0051260]","GO:0000165; GO:0003779; GO:0005088; GO:0005737; GO:0005829; GO:0006888; GO:0007030; GO:0007041; GO:0007411; GO:0008091; GO:0016020; GO:0019894; GO:0030036; GO:0030507; GO:0032029; GO:0032391; GO:0034452; GO:0043621; GO:0045505; GO:0051260; GO:0051693; GO:0070062; GO:0097381","","","cd00014;","PF00307;PF00435;","cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; photoreceptor connecting cilium [GO:0032391]; photoreceptor disc membrane [GO:0097381]; spectrin [GO:0008091]; actin binding [GO:0003779]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; kinesin binding [GO:0019894]; myosin tail binding [GO:0032029]; protein self-association [GO:0043621]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; spectrin binding [GO:0030507]; actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; ER to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; lysosomal transport [GO:0007041]; MAPK cascade [GO:0000165]; protein homooligomerization [GO:0051260]"
"CHOYP_LOC100378071.1.1|m.40488",37,"3",34.5,31.5,17,16,15,10,7.5,7.5,7.2857142857,3.0805512361,"0.4228207579",9.4897959184,7.5,"#VALUE!","0.9429677419","-0.5675304828",12,1.5,10.5,6.25,12,51,"1.25","1.5",7.75,7.5,0.25,10.5,4.5,0.6040506929,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100378071.1.1|m.40488","Q16960","DYI3_HELCR","74.18","577","144","2","1","577","1","572","0","912","1","Q16960","DYI3_HELCR","reviewed","Dynein intermediate chain 3, ciliary","","Heliocidaris crassispina (Sea urchin) (Anthocidaris crassispina)","597","","GO:0003774; GO:0005737; GO:0005874; GO:0005929; GO:0030286","","","","","cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motor activity [GO:0003774]"
"CHOYP_LOC100378071.1.1|m.40488",48,"9",34.5,18.5,12.5,14,9.5,12,9.5,8,7.2857142857,3.0805512361,"0.4228207579",9.4897959184,7.5,"#VALUE!","0.9429677419","-0.5675304828",12,1.5,10.5,6.25,12,51,"1.25","1.5",7.75,7.5,0.25,10.5,4.5,0.6040506929,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100378071.1.1|m.40488","Q16960","DYI3_HELCR","74.18","577","144","2","1","577","1","572","0","912","1","Q16960","DYI3_HELCR","reviewed","Dynein intermediate chain 3, ciliary","","Heliocidaris crassispina (Sea urchin) (Anthocidaris crassispina)","597","","GO:0003774; GO:0005737; GO:0005874; GO:0005929; GO:0030286","","","","","cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motor activity [GO:0003774]"
"CHOYP_LOC100378760.1.1|m.37015",37,"9",16,15.5,11.5,9.5,15,12,16,12.5,11.8571428571,3.4714579658,"0.2927735634",12.0510204082,12.5,"#VALUE!","4.3435833093","-1.7862686267",16,4,12,12,16,83,"1.04","0.96",10.75,13.25,-2.5,10,4,0.9830628923,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100378760.1.1|m.37015","P68037","UB2L3_MOUSE","77.27","154","35","0","15","168","1","154","2.00E-84","252","1","P68037","UB2L3_MOUSE","reviewed","Ubiquitin-conjugating enzyme E2 L3 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme L3) (UbcM4) (Ubiquitin carrier protein L3) (Ubiquitin-protein ligase L3)","Ube2l3 Ubce7","Mus musculus (Mouse)","154","cell cycle phase transition [GO:0044770]; cell proliferation [GO:0008283]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to steroid hormone stimulus [GO:0071383]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]","GO:0000209; GO:0003713; GO:0003723; GO:0004842; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006351; GO:0006355; GO:0008283; GO:0016567; GO:0031398; GO:0031625; GO:0042787; GO:0044770; GO:0051443; GO:0061631; GO:0070062; GO:0070979; GO:0071383; GO:0071385; GO:0097027; GO:1903955","PATHWAY: Protein modification; protein ubiquitination. {ECO:0000255|PROSITE-ProRule:PRU00388}.","","","PF00179;","cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activator activity [GO:0097027]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle phase transition [GO:0044770]; cell proliferation [GO:0008283]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to steroid hormone stimulus [GO:0071383]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
"CHOYP_LOC100378760.1.1|m.37015",48,"3",16,14,16,11.5,15.5,13,14,12,11.8571428571,3.4714579658,"0.2927735634",12.0510204082,12.5,"#VALUE!","4.3435833093","-1.7862686267",16,4,12,12,16,83,"1.04","0.96",10.75,13.25,-2.5,10,4,0.9830628923,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100378760.1.1|m.37015","P68037","UB2L3_MOUSE","77.27","154","35","0","15","168","1","154","2.00E-84","252","1","P68037","UB2L3_MOUSE","reviewed","Ubiquitin-conjugating enzyme E2 L3 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme L3) (UbcM4) (Ubiquitin carrier protein L3) (Ubiquitin-protein ligase L3)","Ube2l3 Ubce7","Mus musculus (Mouse)","154","cell cycle phase transition [GO:0044770]; cell proliferation [GO:0008283]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to steroid hormone stimulus [GO:0071383]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]","GO:0000209; GO:0003713; GO:0003723; GO:0004842; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006351; GO:0006355; GO:0008283; GO:0016567; GO:0031398; GO:0031625; GO:0042787; GO:0044770; GO:0051443; GO:0061631; GO:0070062; GO:0070979; GO:0071383; GO:0071385; GO:0097027; GO:1903955","PATHWAY: Protein modification; protein ubiquitination. {ECO:0000255|PROSITE-ProRule:PRU00388}.","","","PF00179;","cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activator activity [GO:0097027]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle phase transition [GO:0044770]; cell proliferation [GO:0008283]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to steroid hormone stimulus [GO:0071383]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; protein ubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0042787]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]"
"CHOYP_LOC100497129.3.8|m.32060",48,"9",33.5,0,10.5,12,20,6,6.5,8.5,7.4285714286,2.8464084065,"0.3831703624",8.1020408163,6.5,"#VALUE!","0.2276291329","-0.0840593923",12,2.5,9.5,6.25,12,52,"1","0.7058823529",6.75,8.375,-1.625,7.5,5.5,0.6158948241,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100497129.3.8|m.32060","Q2PC93","SSPO_CHICK","32.81","1719","955","60","12","1666","7","1589","0","824","1","Q2PC93","SSPO_CHICK","reviewed","SCO-spondin","SSPO","Gallus gallus (Chicken)","5255","cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]","GO:0005615; GO:0007155; GO:0007399; GO:0030154","","","","PF00754;PF00057;PF01826;PF00090;PF00093;PF00094;","extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]"
"CHOYP_LOC100497129.3.8|m.32060",37,"3",33.5,25.5,26.5,8.5,9,8.5,10,12,7.4285714286,2.8464084065,"0.3831703624",8.1020408163,6.5,"#VALUE!","0.2276291329","-0.0840593923",12,2.5,9.5,6.25,12,52,"1","0.7058823529",6.75,8.375,-1.625,7.5,5.5,0.6158948241,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100497129.3.8|m.32060","Q2PC93","SSPO_CHICK","32.81","1719","955","60","12","1666","7","1589","0","824","1","Q2PC93","SSPO_CHICK","reviewed","SCO-spondin","SSPO","Gallus gallus (Chicken)","5255","cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]","GO:0005615; GO:0007155; GO:0007399; GO:0030154","","","","PF00754;PF00057;PF01826;PF00090;PF00093;PF00094;","extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]"
"CHOYP_LOC100497129.6.8|m.41866",48,"9",77,0,0,0,0,0,0,0,0,0,"#DIV/0!",0,0,"#VALUE!","#DIV/0!","Err:502",0,0,0,0,0,0,"#DIV/0!","#DIV/0!",0,0,0,0,0,0,"low_abundance","low_variance","low_abundance-low_variance","CHOYP_LOC100497129.6.8|m.41866","Q9HC84","MUC5B_HUMAN","28.55","1135","667","48","18","1087","205","1260","2.00E-126","454","1","Q9HC84","MUC5B_HUMAN","reviewed","Mucin-5B (MUC-5B) (Cervical mucin) (High molecular weight salivary mucin MG1) (Mucin-5 subtype B, tracheobronchial) (Sublingual gland mucin)","MUC5B MUC5","Homo sapiens (Human)","5762","defense response to bacterium [GO:0042742]; O-glycan processing [GO:0016266]; regulation of macrophage activation [GO:0043030]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]","GO:0002223; GO:0005615; GO:0005796; GO:0005886; GO:0016266; GO:0042742; GO:0043030; GO:0043231; GO:0070062; GO:0070701","","","","PF08742;PF13330;PF01826;PF00093;PF00094;","extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; intracellular membrane-bounded organelle [GO:0043231]; mucus layer [GO:0070701]; plasma membrane [GO:0005886]; defense response to bacterium [GO:0042742]; O-glycan processing [GO:0016266]; regulation of macrophage activation [GO:0043030]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]"
"CHOYP_LOC100497129.6.8|m.41866",45,"3",77,88,0,0,0,0,0,0,0,0,"#DIV/0!",0,0,"#VALUE!","#DIV/0!","Err:502",0,0,0,0,0,0,"#DIV/0!","#DIV/0!",0,0,0,0,0,0,"low_abundance","low_variance","low_abundance-low_variance","CHOYP_LOC100497129.6.8|m.41866","Q9HC84","MUC5B_HUMAN","28.55","1135","667","48","18","1087","205","1260","2.00E-126","454","1","Q9HC84","MUC5B_HUMAN","reviewed","Mucin-5B (MUC-5B) (Cervical mucin) (High molecular weight salivary mucin MG1) (Mucin-5 subtype B, tracheobronchial) (Sublingual gland mucin)","MUC5B MUC5","Homo sapiens (Human)","5762","defense response to bacterium [GO:0042742]; O-glycan processing [GO:0016266]; regulation of macrophage activation [GO:0043030]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]","GO:0002223; GO:0005615; GO:0005796; GO:0005886; GO:0016266; GO:0042742; GO:0043030; GO:0043231; GO:0070062; GO:0070701","","","","PF08742;PF13330;PF01826;PF00093;PF00094;","extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; intracellular membrane-bounded organelle [GO:0043231]; mucus layer [GO:0070701]; plasma membrane [GO:0005886]; defense response to bacterium [GO:0042742]; O-glycan processing [GO:0016266]; regulation of macrophage activation [GO:0043030]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]"
"CHOYP_LOC100497129.7.8|m.41875",48,"3",0,0,11,18,18.5,16,5.5,0,9.2857142857,5.8606261419,"0.6311443537",34.3469387755,7.5,"#VALUE!","-1.3403427162","-0.0636960244",17.5,0,17.5,5.5,17.5,65,"0.9142857143","0.8571428571",11,9.25,1.75,10.5,17.5,0.7698685301,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100497129.7.8|m.41875","Q2PC93","SSPO_CHICK","32.81","1719","955","60","12","1666","7","1589","0","822","1","Q2PC93","SSPO_CHICK","reviewed","SCO-spondin","SSPO","Gallus gallus (Chicken)","5255","cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]","GO:0005615; GO:0007155; GO:0007399; GO:0030154","","","","PF00754;PF00057;PF01826;PF00090;PF00093;PF00094;","extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]"
"CHOYP_LOC100497129.7.8|m.41875",37,"9",0,35.5,4.5,12,10.5,15,14,17.5,9.2857142857,5.8606261419,"0.6311443537",34.3469387755,7.5,"#VALUE!","-1.3403427162","-0.0636960244",17.5,0,17.5,5.5,17.5,65,"0.9142857143","0.8571428571",11,9.25,1.75,10.5,17.5,0.7698685301,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100497129.7.8|m.41875","Q2PC93","SSPO_CHICK","32.81","1719","955","60","12","1666","7","1589","0","822","1","Q2PC93","SSPO_CHICK","reviewed","SCO-spondin","SSPO","Gallus gallus (Chicken)","5255","cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]","GO:0005615; GO:0007155; GO:0007399; GO:0030154","","","","PF00754;PF00057;PF01826;PF00090;PF00093;PF00094;","extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]"
"CHOYP_LOC100533447.2.3|m.44496",17,"3",74.5,76,96,112.5,111,129.5,101,108.5,110.5,21.6432107468,"0.1958661606",468.4285714286,108.5,"#VALUE!","0.6963421055","-0.9073190097",134,68,66,101.75,134,773.5,"0.9664179104","0.9440298507",106.25,119.5,-13.25,61.5,31.5,9.1614355087,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100533447.2.3|m.44496","Q01241","NF70_DORPE","35.94","601","345","8","8","602","29","595","7.00E-95","310","1","Q01241","NF70_DORPE","reviewed","70 kDa neurofilament protein (NF70)","","Doryteuthis pealeii (Longfin inshore squid) (Loligo pealeii)","615","","GO:0005198; GO:0005882","","","","PF00038;","intermediate filament [GO:0005882]; structural molecule activity [GO:0005198]"
"CHOYP_LOC100533447.2.3|m.44496",64,"9",74.5,86,99.5,110,123,126.5,133,134,110.5,21.6432107468,"0.1958661606",468.4285714286,108.5,"#VALUE!","0.6963421055","-0.9073190097",134,68,66,101.75,134,773.5,"0.9664179104","0.9440298507",106.25,119.5,-13.25,61.5,31.5,9.1614355087,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100533447.2.3|m.44496","Q01241","NF70_DORPE","35.94","601","345","8","8","602","29","595","7.00E-95","310","1","Q01241","NF70_DORPE","reviewed","70 kDa neurofilament protein (NF70)","","Doryteuthis pealeii (Longfin inshore squid) (Loligo pealeii)","615","","GO:0005198; GO:0005882","","","","PF00038;","intermediate filament [GO:0005882]; structural molecule activity [GO:0005198]"
"CHOYP_LOC100561262.1.1|m.16846",48,"9",16,15.5,12.5,9.5,10.5,11,12.5,12.5,11.1428571429,2.1665358412,"0.1944327037",4.693877551,12,"#VALUE!","5.6530094518","-2.3279123891",12.5,6,6.5,11.25,12.5,78,"0.96","0.88",10.125,12.375,-2.25,6,0.5,0.9238422362,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100561262.1.1|m.16846","P47791","GSHR_MOUSE","62.93","464","157","4","13","462","38","500","0","581","1","P47791","GSHR_MOUSE","reviewed","Glutathione reductase, mitochondrial (GR) (GRase) (EC 1.8.1.7)","Gsr Gr1","Mus musculus (Mouse)","500","cell redox homeostasis [GO:0045454]; glutathione metabolic process [GO:0006749]","GO:0004362; GO:0005739; GO:0006749; GO:0009897; GO:0045454; GO:0050660; GO:0050661; GO:0070062","","","","PF07992;PF02852;","external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; glutathione-disulfide reductase activity [GO:0004362]; NADP binding [GO:0050661]; cell redox homeostasis [GO:0045454]; glutathione metabolic process [GO:0006749]"
"CHOYP_LOC100561262.1.1|m.16846",37,"3",16,16.5,16,17,15.5,12,11.5,12.5,11.1428571429,2.1665358412,"0.1944327037",4.693877551,12,"#VALUE!","5.6530094518","-2.3279123891",12.5,6,6.5,11.25,12.5,78,"0.96","0.88",10.125,12.375,-2.25,6,0.5,0.9238422362,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100561262.1.1|m.16846","P47791","GSHR_MOUSE","62.93","464","157","4","13","462","38","500","0","581","1","P47791","GSHR_MOUSE","reviewed","Glutathione reductase, mitochondrial (GR) (GRase) (EC 1.8.1.7)","Gsr Gr1","Mus musculus (Mouse)","500","cell redox homeostasis [GO:0045454]; glutathione metabolic process [GO:0006749]","GO:0004362; GO:0005739; GO:0006749; GO:0009897; GO:0045454; GO:0050660; GO:0050661; GO:0070062","","","","PF07992;PF02852;","external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; glutathione-disulfide reductase activity [GO:0004362]; NADP binding [GO:0050661]; cell redox homeostasis [GO:0045454]; glutathione metabolic process [GO:0006749]"
"CHOYP_LOC100636340.1.4|m.5143",48,"9",11,17,14,17,7,6.5,8,17,13.5714285714,4.3950343037,"0.3238446329",19.3163265306,16,"#VALUE!","-1.2268007163","-0.6518175047",19,6.5,12.5,10.25,19,95,"0.9117647059","0.3823529412",13.375,14.25,-0.875,12.5,9,1.1251924671,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100636340.1.4|m.5143","Q9UGM3","DMBT1_HUMAN","41.1","1679","733","37","459","1909","91","1741","0","1106","1","Q9UGM3","DMBT1_HUMAN","reviewed","Deleted in malignant brain tumors 1 protein (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein)","DMBT1 GP340","Homo sapiens (Human)","2413","cellular protein metabolic process [GO:0044267]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; viral process [GO:0016032]","GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0007275; GO:0008329; GO:0015031; GO:0016032; GO:0019898; GO:0030670; GO:0030855; GO:0035375; GO:0042589; GO:0043152; GO:0044267; GO:0045087; GO:0048306; GO:0051607; GO:0070062","","","cd00041;","PF00431;PF00530;PF00100;","cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; cellular protein metabolic process [GO:0044267]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; viral process [GO:0016032]"
"CHOYP_LOC100636340.1.4|m.5143",37,"3",11,17.5,17.5,16.5,16.5,15.5,19,16,13.5714285714,4.3950343037,"0.3238446329",19.3163265306,16,"#VALUE!","-1.2268007163","-0.6518175047",19,6.5,12.5,10.25,19,95,"0.9117647059","0.3823529412",13.375,14.25,-0.875,12.5,9,1.1251924671,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100636340.1.4|m.5143","Q9UGM3","DMBT1_HUMAN","41.1","1679","733","37","459","1909","91","1741","0","1106","1","Q9UGM3","DMBT1_HUMAN","reviewed","Deleted in malignant brain tumors 1 protein (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein)","DMBT1 GP340","Homo sapiens (Human)","2413","cellular protein metabolic process [GO:0044267]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; viral process [GO:0016032]","GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0007275; GO:0008329; GO:0015031; GO:0016032; GO:0019898; GO:0030670; GO:0030855; GO:0035375; GO:0042589; GO:0043152; GO:0044267; GO:0045087; GO:0048306; GO:0051607; GO:0070062","","","cd00041;","PF00431;PF00530;PF00100;","cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; cellular protein metabolic process [GO:0044267]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; viral process [GO:0016032]"
"CHOYP_LOC100636493.1.1|m.65727",6,"3",92.5,133.5,219.5,224.5,208.5,164,173,162.5,164.9285714286,32.3081464422,"0.1958917498",1043.8163265306,171,"#VALUE!","3.5952064167","-1.2206550345",213,95.5,117.5,164.5,213,1154.5,"0.9479768786","0.9884393064",150.875,178.75,-27.875,77.5,50.5,13.6740495085,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100636493.1.1|m.65727","Q2PZL6","FAT4_MOUSE","26.2","3771","2452","142","661","4302","51","3619","0","681","1","Q2PZL6","FAT4_MOUSE","reviewed","Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)","Fat4 Fatj","Mus musculus (Mouse)","4981","branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]","GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005622; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0016021; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0070062; GO:0072006; GO:0072137; GO:0072307","","","","PF00028;PF00008;PF07645;PF12661;PF02210;","apical part of cell [GO:0045177]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]"
"CHOYP_LOC100636493.1.1|m.65727",54,"9",92.5,184,203,198,157.5,171,213,173,164.9285714286,32.3081464422,"0.1958917498",1043.8163265306,171,"#VALUE!","3.5952064167","-1.2206550345",213,95.5,117.5,164.5,213,1154.5,"0.9479768786","0.9884393064",150.875,178.75,-27.875,77.5,50.5,13.6740495085,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100636493.1.1|m.65727","Q2PZL6","FAT4_MOUSE","26.2","3771","2452","142","661","4302","51","3619","0","681","1","Q2PZL6","FAT4_MOUSE","reviewed","Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)","Fat4 Fatj","Mus musculus (Mouse)","4981","branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]","GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005622; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0016021; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0070062; GO:0072006; GO:0072137; GO:0072307","","","","PF00028;PF00008;PF07645;PF12661;PF02210;","apical part of cell [GO:0045177]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]"
"CHOYP_LOC100648516.1.1|m.64902",37,"3",11,21,32,44.5,56,34,40.5,23.5,40.2857142857,23.852009713,"0.5920711631",568.9183673469,40.5,"#VALUE!","-0.540092811","0.6438285403",83,13.5,69.5,19,83,282,"0.5483870968","0.7258064516",33.25,45.75,-12.5,31.5,68.5,3.3400450077,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100648516.1.1|m.64902","Q01705","NOTC1_MOUSE","31.32","645","362","19","1723","2313","243","860","2.00E-63","246","1","Q01705","NOTC1_MOUSE","reviewed","Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]","Notch1 Motch","Mus musculus (Mouse)","2531","animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; humoral immune response [GO:0006959]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; in utero embryonic development [GO:0001701]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of auditory receptor cell differentiation [GO:0045608]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell death [GO:0060548]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; Notch receptor processing [GO:0007220]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral transcription [GO:0050434]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of auditory receptor cell differentiation [GO:0045607]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]","GO:0000122; GO:0000139; GO:0001047; GO:0001190; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003256; GO:0003270; GO:0003273; GO:0003344; GO:0003682; GO:0003700; GO:0004857; GO:0004872; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005887; GO:0005912; GO:0006357; GO:0006959; GO:0007219; GO:0007220; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010468; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031960; GO:0032495; GO:0032496; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0043065; GO:0043086; GO:0043235; GO:0043565; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046982; GO:0048103; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0050434; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060411; GO:0060412; GO:0060528; GO:0060548; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061314; GO:0061344; GO:0061384; GO:0061419; GO:0070986; GO:0071372; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072602; GO:0090051; GO:0090090; GO:0097150; GO:1901189; GO:1901201; GO:1902263; GO:1903849; GO:2000737; GO:2000811; GO:2000974; GO:2001027","","","","PF12796;PF11936;PF00008;PF07645;PF12661;PF06816;PF07684;PF00066;","acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle [GO:0001726]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; core promoter binding [GO:0001047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; Notch binding [GO:0005112]; protein heterodimerization activity [GO:0046982]; receptor activity [GO:0004872]; sequence-specific DNA binding [GO:0043565]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; transcriptional activator activity, RNA polymerase II transcription factor binding [GO:0001190]; animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of auditory receptor cell differentiation [GO:0045608]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell death [GO:0060548]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch receptor processing [GO:0007220]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral transcription [GO:0050434]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of auditory receptor cell differentiation [GO:0045607]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]"
"CHOYP_LOC100648516.1.1|m.64902",71,"9",11,28.5,25,32.5,66,45,83,62,40.2857142857,23.852009713,"0.5920711631",568.9183673469,40.5,"#VALUE!","-0.540092811","0.6438285403",83,13.5,69.5,19,83,282,"0.5483870968","0.7258064516",33.25,45.75,-12.5,31.5,68.5,3.3400450077,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100648516.1.1|m.64902","Q01705","NOTC1_MOUSE","31.32","645","362","19","1723","2313","243","860","2.00E-63","246","1","Q01705","NOTC1_MOUSE","reviewed","Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]","Notch1 Motch","Mus musculus (Mouse)","2531","animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; humoral immune response [GO:0006959]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; in utero embryonic development [GO:0001701]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of auditory receptor cell differentiation [GO:0045608]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell death [GO:0060548]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; Notch receptor processing [GO:0007220]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral transcription [GO:0050434]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of auditory receptor cell differentiation [GO:0045607]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]","GO:0000122; GO:0000139; GO:0001047; GO:0001190; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003256; GO:0003270; GO:0003273; GO:0003344; GO:0003682; GO:0003700; GO:0004857; GO:0004872; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005887; GO:0005912; GO:0006357; GO:0006959; GO:0007219; GO:0007220; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010468; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031960; GO:0032495; GO:0032496; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0043065; GO:0043086; GO:0043235; GO:0043565; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046982; GO:0048103; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0050434; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060411; GO:0060412; GO:0060528; GO:0060548; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061314; GO:0061344; GO:0061384; GO:0061419; GO:0070986; GO:0071372; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072602; GO:0090051; GO:0090090; GO:0097150; GO:1901189; GO:1901201; GO:1902263; GO:1903849; GO:2000737; GO:2000811; GO:2000974; GO:2001027","","","","PF12796;PF11936;PF00008;PF07645;PF12661;PF06816;PF07684;PF00066;","acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle [GO:0001726]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; core promoter binding [GO:0001047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; Notch binding [GO:0005112]; protein heterodimerization activity [GO:0046982]; receptor activity [GO:0004872]; sequence-specific DNA binding [GO:0043565]; transcription factor activity, sequence-specific DNA binding [GO:0003700]; transcriptional activator activity, RNA polymerase II transcription factor binding [GO:0001190]; animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of auditory receptor cell differentiation [GO:0045608]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell death [GO:0060548]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch receptor processing [GO:0007220]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral transcription [GO:0050434]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of auditory receptor cell differentiation [GO:0045607]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]"
"CHOYP_LOC100649130.1.1|m.58207",60,"9",130,141.5,142,128,162,162.5,159.5,163.5,132.5,30.4126383503,"0.229529346",924.9285714286,134,"#VALUE!","-1.4507480635","-0.6250133261",163.5,86.5,77,110.75,163.5,927.5,"0.9143730887","0.993883792",133.375,135.875,-2.5,72,77,10.9854317186,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100649130.1.1|m.58207","Q99323","MYSN_DROME","62.68","1956","691","5","13","1931","56","2009","0","2357","1","Q99323","MYSN_DROME","reviewed","Myosin heavy chain, non-muscle (Myosin II) (Non-muscle MHC) (Zipper protein)","zip CG15792","Drosophila melanogaster (Fruit fly)","2057","anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; establishment of neuroblast polarity [GO:0045200]; establishment of planar polarity [GO:0001736]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; neurogenesis [GO:0022008]; ovarian follicle cell migration [GO:0007297]; protein oligomerization [GO:0051259]; regulation of cell cycle [GO:0051726]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis, open tracheal system [GO:0035277]; wound healing [GO:0042060]","GO:0000281; GO:0001736; GO:0003774; GO:0005524; GO:0005829; GO:0005856; GO:0005938; GO:0006936; GO:0007297; GO:0007298; GO:0007391; GO:0007395; GO:0007435; GO:0007443; GO:0007496; GO:0008258; GO:0016459; GO:0016460; GO:0016461; GO:0022008; GO:0030018; GO:0030239; GO:0031036; GO:0031252; GO:0032027; GO:0032154; GO:0032507; GO:0035017; GO:0035159; GO:0035277; GO:0035317; GO:0042060; GO:0042623; GO:0044291; GO:0045179; GO:0045200; GO:0045214; GO:0046663; GO:0046664; GO:0051259; GO:0051726; GO:0070986; GO:0071260; GO:1901739","","","","PF00612;PF00063;PF02736;PF01576;","apical cortex [GO:0045179]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell-cell contact zone [GO:0044291]; cleavage furrow [GO:0032154]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; myosin complex [GO:0016459]; myosin II complex [GO:0016460]; unconventional myosin complex [GO:0016461]; Z disc [GO:0030018]; ATP binding [GO:0005524]; ATPase activity, coupled [GO:0042623]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; establishment of neuroblast polarity [GO:0045200]; establishment of planar polarity [GO:0001736]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; neurogenesis [GO:0022008]; ovarian follicle cell migration [GO:0007297]; protein oligomerization [GO:0051259]; regulation of cell cycle [GO:0051726]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis, open tracheal system [GO:0035277]; wound healing [GO:0042060]"
"CHOYP_LOC100649130.1.1|m.58207",12,"3",130,143,142.5,140,146,149.5,131,134,132.5,30.4126383503,"0.229529346",924.9285714286,134,"#VALUE!","-1.4507480635","-0.6250133261",163.5,86.5,77,110.75,163.5,927.5,"0.9143730887","0.993883792",133.375,135.875,-2.5,72,77,10.9854317186,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100649130.1.1|m.58207","Q99323","MYSN_DROME","62.68","1956","691","5","13","1931","56","2009","0","2357","1","Q99323","MYSN_DROME","reviewed","Myosin heavy chain, non-muscle (Myosin II) (Non-muscle MHC) (Zipper protein)","zip CG15792","Drosophila melanogaster (Fruit fly)","2057","anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; establishment of neuroblast polarity [GO:0045200]; establishment of planar polarity [GO:0001736]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; neurogenesis [GO:0022008]; ovarian follicle cell migration [GO:0007297]; protein oligomerization [GO:0051259]; regulation of cell cycle [GO:0051726]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis, open tracheal system [GO:0035277]; wound healing [GO:0042060]","GO:0000281; GO:0001736; GO:0003774; GO:0005524; GO:0005829; GO:0005856; GO:0005938; GO:0006936; GO:0007297; GO:0007298; GO:0007391; GO:0007395; GO:0007435; GO:0007443; GO:0007496; GO:0008258; GO:0016459; GO:0016460; GO:0016461; GO:0022008; GO:0030018; GO:0030239; GO:0031036; GO:0031252; GO:0032027; GO:0032154; GO:0032507; GO:0035017; GO:0035159; GO:0035277; GO:0035317; GO:0042060; GO:0042623; GO:0044291; GO:0045179; GO:0045200; GO:0045214; GO:0046663; GO:0046664; GO:0051259; GO:0051726; GO:0070986; GO:0071260; GO:1901739","","","","PF00612;PF00063;PF02736;PF01576;","apical cortex [GO:0045179]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell-cell contact zone [GO:0044291]; cleavage furrow [GO:0032154]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; myosin complex [GO:0016459]; myosin II complex [GO:0016460]; unconventional myosin complex [GO:0016461]; Z disc [GO:0030018]; ATP binding [GO:0005524]; ATPase activity, coupled [GO:0042623]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure, amnioserosa morphology change [GO:0046664]; dorsal closure, leading edge cell differentiation [GO:0046663]; dorsal closure, spreading of leading edge cells [GO:0007395]; establishment of neuroblast polarity [GO:0045200]; establishment of planar polarity [GO:0001736]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; neurogenesis [GO:0022008]; ovarian follicle cell migration [GO:0007297]; protein oligomerization [GO:0051259]; regulation of cell cycle [GO:0051726]; regulation of myoblast fusion [GO:1901739]; regulation of tube length, open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis, open tracheal system [GO:0035277]; wound healing [GO:0042060]"
"CHOYP_LOC100699383.1.1|m.63490",28,"9",24,31,35.5,22.5,69,61,28,43,32.6428571429,13.8530921915,"0.4243835682",191.9081632653,28,"#VALUE!","1.430531119","1.2774372006",61,18.5,42.5,23.5,61,228.5,"1.488372093","1.4186046512",40.625,32.5,8.125,45.5,15,2.7063839867,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100699383.1.1|m.63490","Q95VY2","TCTP_BRABE","51.15","174","80","3","1","174","1","169","5.00E-55","177","1","Q95VY2","TCTP_BRABE","reviewed","Translationally-controlled tumor protein homolog (TCTP)","","Branchiostoma belcheri (Amphioxus)","169","","GO:0005737","","","","PF00838;","cytoplasm [GO:0005737]"
"CHOYP_LOC100699383.1.1|m.63490",37,"3",24,27.5,35,29,38.5,64,19,28,32.6428571429,13.8530921915,"0.4243835682",191.9081632653,28,"#VALUE!","1.430531119","1.2774372006",61,18.5,42.5,23.5,61,228.5,"1.488372093","1.4186046512",40.625,32.5,8.125,45.5,15,2.7063839867,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100699383.1.1|m.63490","Q95VY2","TCTP_BRABE","51.15","174","80","3","1","174","1","169","5.00E-55","177","1","Q95VY2","TCTP_BRABE","reviewed","Translationally-controlled tumor protein homolog (TCTP)","","Branchiostoma belcheri (Amphioxus)","169","","GO:0005737","","","","PF00838;","cytoplasm [GO:0005737]"
"CHOYP_LOC100745429.1.1|m.27818",37,"3",15.5,21,15,10.5,10.5,13.5,7.5,12,10.2142857143,4.5892509726,"0.449297298",21.0612244898,10.5,"#VALUE!","1.348453556","-1.0042555808",16,1,15,8.75,16,71.5,"0.9310344828","0.724137931",8.125,13.125,-5,12.5,6,0.8468553832,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100745429.1.1|m.27818","O95758","PTBP3_HUMAN","54.48","558","215","11","61","593","9","552","0","565","1","O95758","PTBP3_HUMAN","reviewed","Polypyrimidine tract-binding protein 3 (Regulator of differentiation 1) (Rod1)","PTBP3 ROD1","Homo sapiens (Human)","552","anatomical structure morphogenesis [GO:0009653]; erythrocyte maturation [GO:0043249]; mRNA processing [GO:0006397]; negative regulation of RNA splicing [GO:0033119]; regulation of cell differentiation [GO:0045595]; RNA splicing [GO:0008380]","GO:0000166; GO:0003723; GO:0005634; GO:0006397; GO:0008380; GO:0009653; GO:0033119; GO:0043249; GO:0045595","","","cd12779;cd12703;","PF00076;","nucleus [GO:0005634]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; anatomical structure morphogenesis [GO:0009653]; erythrocyte maturation [GO:0043249]; mRNA processing [GO:0006397]; negative regulation of RNA splicing [GO:0033119]; regulation of cell differentiation [GO:0045595]; RNA splicing [GO:0008380]"
"CHOYP_LOC100745429.1.1|m.27818",48,"9",15.5,12,9,5.5,10.5,10.5,16,14.5,10.2142857143,4.5892509726,"0.449297298",21.0612244898,10.5,"#VALUE!","1.348453556","-1.0042555808",16,1,15,8.75,16,71.5,"0.9310344828","0.724137931",8.125,13.125,-5,12.5,6,0.8468553832,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100745429.1.1|m.27818","O95758","PTBP3_HUMAN","54.48","558","215","11","61","593","9","552","0","565","1","O95758","PTBP3_HUMAN","reviewed","Polypyrimidine tract-binding protein 3 (Regulator of differentiation 1) (Rod1)","PTBP3 ROD1","Homo sapiens (Human)","552","anatomical structure morphogenesis [GO:0009653]; erythrocyte maturation [GO:0043249]; mRNA processing [GO:0006397]; negative regulation of RNA splicing [GO:0033119]; regulation of cell differentiation [GO:0045595]; RNA splicing [GO:0008380]","GO:0000166; GO:0003723; GO:0005634; GO:0006397; GO:0008380; GO:0009653; GO:0033119; GO:0043249; GO:0045595","","","cd12779;cd12703;","PF00076;","nucleus [GO:0005634]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; anatomical structure morphogenesis [GO:0009653]; erythrocyte maturation [GO:0043249]; mRNA processing [GO:0006397]; negative regulation of RNA splicing [GO:0033119]; regulation of cell differentiation [GO:0045595]; RNA splicing [GO:0008380]"
"CHOYP_LOC100875390.1.1|m.24780",48,"3",19,15.5,16,12,12.5,11.5,13.5,10,10.7142857143,4.7423407636,"0.4426184713",22.4897959184,10.5,"#VALUE!","0.457270727","0.1073822162",19,3,16,8.25,19,75,"0.92","0.84",9.625,12,-2.375,10.5,12.5,0.8883098425,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100875390.1.1|m.24780","Q641Z6","EHD1_RAT","70.09","535","159","1","1","535","1","534","0","788","1","Q641Z6","EHD1_RAT","reviewed","EH domain-containing protein 1","Ehd1","Rattus norvegicus (Rat)","534","cellular response to nerve growth factor stimulus [GO:1990090]; cholesterol homeostasis [GO:0042632]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; neuron projection development [GO:0031175]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein localization to cilium [GO:0061512]","GO:0005509; GO:0005524; GO:0005525; GO:0005811; GO:0005886; GO:0006886; GO:0006897; GO:0010008; GO:0010886; GO:0020018; GO:0030139; GO:0031095; GO:0031175; GO:0031901; GO:0032456; GO:0034383; GO:0042632; GO:0043209; GO:0048471; GO:0055038; GO:0060271; GO:0061512; GO:1901741; GO:1990090; GO:2001137","","","","PF00350;PF12763;PF16880;","ciliary pocket membrane [GO:0020018]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; lipid particle [GO:0005811]; myelin sheath [GO:0043209]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; cellular response to nerve growth factor stimulus [GO:1990090]; cholesterol homeostasis [GO:0042632]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; neuron projection development [GO:0031175]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein localization to cilium [GO:0061512]"
"CHOYP_LOC100875390.1.1|m.24780",37,"9",19,16,14.5,9.5,10,10.5,19,12.5,10.7142857143,4.7423407636,"0.4426184713",22.4897959184,10.5,"#VALUE!","0.457270727","0.1073822162",19,3,16,8.25,19,75,"0.92","0.84",9.625,12,-2.375,10.5,12.5,0.8883098425,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100875390.1.1|m.24780","Q641Z6","EHD1_RAT","70.09","535","159","1","1","535","1","534","0","788","1","Q641Z6","EHD1_RAT","reviewed","EH domain-containing protein 1","Ehd1","Rattus norvegicus (Rat)","534","cellular response to nerve growth factor stimulus [GO:1990090]; cholesterol homeostasis [GO:0042632]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; neuron projection development [GO:0031175]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein localization to cilium [GO:0061512]","GO:0005509; GO:0005524; GO:0005525; GO:0005811; GO:0005886; GO:0006886; GO:0006897; GO:0010008; GO:0010886; GO:0020018; GO:0030139; GO:0031095; GO:0031175; GO:0031901; GO:0032456; GO:0034383; GO:0042632; GO:0043209; GO:0048471; GO:0055038; GO:0060271; GO:0061512; GO:1901741; GO:1990090; GO:2001137","","","","PF00350;PF12763;PF16880;","ciliary pocket membrane [GO:0020018]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; lipid particle [GO:0005811]; myelin sheath [GO:0043209]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; cellular response to nerve growth factor stimulus [GO:1990090]; cholesterol homeostasis [GO:0042632]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; neuron projection development [GO:0031175]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein localization to cilium [GO:0061512]"
"CHOYP_LOC100890099.1.1|m.11505",78,"9",85,0,21,47,0,98.5,0,0,38.9285714286,39.7361193837,"1.0207443511",1578.9591836735,26.5,"#VALUE!","-1.9248213056","0.4617119756",98.5,0,98.5,0,98.5,272.5,"#DIV/0!","#DIV/0!",31.25,36.875,-5.625,98.5,87.5,3.227525761,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100890099.1.1|m.11505","P53486","ACTB3_TAKRU","82.86","280","10","1","1","280","119","360","2.00E-164","468","1","P53486","ACTB3_TAKRU","reviewed","Actin, cytoplasmic 3 (Beta-actin C) [Cleaved into: Actin, cytoplasmic 3, N-terminally processed]","actbc","Takifugu rubripes (Japanese pufferfish) (Fugu rubripes)","375","","GO:0005524; GO:0005737; GO:0005856","","","","PF00022;","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]"
"CHOYP_LOC100890099.1.1|m.11505",43,"3",85,0,0,0,102,0,0,87.5,38.9285714286,39.7361193837,"1.0207443511",1578.9591836735,26.5,"#VALUE!","-1.9248213056","0.4617119756",98.5,0,98.5,0,98.5,272.5,"#DIV/0!","#DIV/0!",31.25,36.875,-5.625,98.5,87.5,3.227525761,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100890099.1.1|m.11505","P53486","ACTB3_TAKRU","82.86","280","10","1","1","280","119","360","2.00E-164","468","1","P53486","ACTB3_TAKRU","reviewed","Actin, cytoplasmic 3 (Beta-actin C) [Cleaved into: Actin, cytoplasmic 3, N-terminally processed]","actbc","Takifugu rubripes (Japanese pufferfish) (Fugu rubripes)","375","","GO:0005524; GO:0005737; GO:0005856","","","","PF00022;","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]"
"CHOYP_LOC100890512.1.1|m.36422",48,"9",29.5,17.5,15,11.5,10.5,10.5,10,7.5,6.5714285714,2.9450754469,"0.448163655",8.6734693878,7.5,"#VALUE!","-1.6562823529","-0.1042942494",10.5,2.5,8,4,10.5,46,"1.3333333333","1.4",7.625,6.375,1.25,8,7,0.5448300367,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100890512.1.1|m.36422","Q8IYX7","SAXO1_HUMAN","30.79","471","312","8","3","463","4","470","2.00E-63","218","1","Q8IYX7","SAXO1_HUMAN","reviewed","Stabilizer of axonemal microtubules 1","SAXO1 C9orf138 FAM154A","Homo sapiens (Human)","474","cell projection organization [GO:0030030]; cellular response to cold [GO:0070417]; cold acclimation [GO:0009631]; positive regulation of cilium assembly [GO:0045724]","GO:0005814; GO:0005879; GO:0008017; GO:0009631; GO:0030030; GO:0031514; GO:0036064; GO:0036126; GO:0045724; GO:0070417","","","","","axonemal microtubule [GO:0005879]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; microtubule binding [GO:0008017]; cell projection organization [GO:0030030]; cellular response to cold [GO:0070417]; cold acclimation [GO:0009631]; positive regulation of cilium assembly [GO:0045724]"
"CHOYP_LOC100890512.1.1|m.36422",37,"3",29.5,25.5,19,20.5,16.5,10,7.5,5,6.5714285714,2.9450754469,"0.448163655",8.6734693878,7.5,"#VALUE!","-1.6562823529","-0.1042942494",10.5,2.5,8,4,10.5,46,"1.3333333333","1.4",7.625,6.375,1.25,8,7,0.5448300367,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100890512.1.1|m.36422","Q8IYX7","SAXO1_HUMAN","30.79","471","312","8","3","463","4","470","2.00E-63","218","1","Q8IYX7","SAXO1_HUMAN","reviewed","Stabilizer of axonemal microtubules 1","SAXO1 C9orf138 FAM154A","Homo sapiens (Human)","474","cell projection organization [GO:0030030]; cellular response to cold [GO:0070417]; cold acclimation [GO:0009631]; positive regulation of cilium assembly [GO:0045724]","GO:0005814; GO:0005879; GO:0008017; GO:0009631; GO:0030030; GO:0031514; GO:0036064; GO:0036126; GO:0045724; GO:0070417","","","","","axonemal microtubule [GO:0005879]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; microtubule binding [GO:0008017]; cell projection organization [GO:0030030]; cellular response to cold [GO:0070417]; cold acclimation [GO:0009631]; positive regulation of cilium assembly [GO:0045724]"
"CHOYP_LOC100929680.1.2|m.17333",48,"9",4,23.5,11,1.5,8.5,16.5,3,6,7.8571428571,7.467617165,"0.9504240028",55.7653061224,6,"#VALUE!","-0.6893175217","0.8499626395",21,0,21,1.75,21,55,"2.3333333333","2.75",7.75,9.5,-1.75,16.5,18,0.6514272178,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100929680.1.2|m.17333","P15941","MUC1_HUMAN","37.16","915","459","32","2995","3843","78","942","6.00E-48","194","1","P15941","MUC1_HUMAN","reviewed","Mucin-1 (MUC-1) (Breast carcinoma-associated antigen DF3) (Cancer antigen 15-3) (CA 15-3) (Carcinoma-associated mucin) (Episialin) (H23AG) (Krebs von den Lungen-6) (KL-6) (PEMT) (Peanut-reactive urinary mucin) (PUM) (Polymorphic epithelial mucin) (PEM) (Tumor-associated epithelial membrane antigen) (EMA) (Tumor-associated mucin) (CD antigen CD227) [Cleaved into: Mucin-1 subunit alpha (MUC1-NT) (MUC1-alpha); Mucin-1 subunit beta (MUC1-beta) (MUC1-CT)]","MUC1 PUM","Homo sapiens (Human)","1255","DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by competitive promoter binding [GO:0010944]; O-glycan processing [GO:0016266]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]","GO:0000790; GO:0000978; GO:0002039; GO:0002223; GO:0003712; GO:0005615; GO:0005796; GO:0005886; GO:0005887; GO:0006977; GO:0006978; GO:0010944; GO:0016266; GO:0016324; GO:0031982; GO:0033629; GO:0036003; GO:0043618; GO:0070062; GO:0090240; GO:1902166","","","","PF01390;","apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; nuclear chromatin [GO:0000790]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; p53 binding [GO:0002039]; RNA polymerase II core promoter proximal region sequence-specific DNA binding [GO:0000978]; transcription cofactor activity [GO:0003712]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by competitive promoter binding [GO:0010944]; O-glycan processing [GO:0016266]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]"
"CHOYP_LOC100929680.1.2|m.17333",37,"3",4,1.5,8,2,24,14,0.5,8,7.8571428571,7.467617165,"0.9504240028",55.7653061224,6,"#VALUE!","-0.6893175217","0.8499626395",21,0,21,1.75,21,55,"2.3333333333","2.75",7.75,9.5,-1.75,16.5,18,0.6514272178,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC100929680.1.2|m.17333","P15941","MUC1_HUMAN","37.16","915","459","32","2995","3843","78","942","6.00E-48","194","1","P15941","MUC1_HUMAN","reviewed","Mucin-1 (MUC-1) (Breast carcinoma-associated antigen DF3) (Cancer antigen 15-3) (CA 15-3) (Carcinoma-associated mucin) (Episialin) (H23AG) (Krebs von den Lungen-6) (KL-6) (PEMT) (Peanut-reactive urinary mucin) (PUM) (Polymorphic epithelial mucin) (PEM) (Tumor-associated epithelial membrane antigen) (EMA) (Tumor-associated mucin) (CD antigen CD227) [Cleaved into: Mucin-1 subunit alpha (MUC1-NT) (MUC1-alpha); Mucin-1 subunit beta (MUC1-beta) (MUC1-CT)]","MUC1 PUM","Homo sapiens (Human)","1255","DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by competitive promoter binding [GO:0010944]; O-glycan processing [GO:0016266]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]","GO:0000790; GO:0000978; GO:0002039; GO:0002223; GO:0003712; GO:0005615; GO:0005796; GO:0005886; GO:0005887; GO:0006977; GO:0006978; GO:0010944; GO:0016266; GO:0016324; GO:0031982; GO:0033629; GO:0036003; GO:0043618; GO:0070062; GO:0090240; GO:1902166","","","","PF01390;","apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; nuclear chromatin [GO:0000790]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; p53 binding [GO:0002039]; RNA polymerase II core promoter proximal region sequence-specific DNA binding [GO:0000978]; transcription cofactor activity [GO:0003712]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by competitive promoter binding [GO:0010944]; O-glycan processing [GO:0016266]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]"
"CHOYP_LOC101078542.1.1|m.44610",48,"3",14,11.5,12.5,10.5,13.5,13,8.5,11,11.5,2.7645717829,"0.2403975463",7.6428571429,11,"#VALUE!","-1.4080006988","0.019717666",15.5,7.5,8,9.5,15.5,80.5,"1","1.1923076923",11.125,12.25,-1.125,8,4,0.9534525643,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC101078542.1.1|m.44610","Q01518","CAP1_HUMAN","46.46","226","116","2","116","340","2","223","2.00E-60","207","1","Q01518","CAP1_HUMAN","reviewed","Adenylyl cyclase-associated protein 1 (CAP 1)","CAP1 CAP","Homo sapiens (Human)","475","actin polymerization or depolymerization [GO:0008154]; activation of adenylate cyclase activity [GO:0007190]; ameboidal-type cell migration [GO:0001667]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]; neutrophil degranulation [GO:0043312]; receptor-mediated endocytosis [GO:0006898]; signal transduction [GO:0007165]","GO:0000902; GO:0001667; GO:0003779; GO:0005576; GO:0005615; GO:0005886; GO:0005925; GO:0006898; GO:0007163; GO:0007165; GO:0007190; GO:0008154; GO:0008179; GO:0030864; GO:0035578; GO:0043312; GO:0070062","","","","PF08603;PF01213;","azurophil granule lumen [GO:0035578]; cortical actin cytoskeleton [GO:0030864]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; actin polymerization or depolymerization [GO:0008154]; activation of adenylate cyclase activity [GO:0007190]; ameboidal-type cell migration [GO:0001667]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]; neutrophil degranulation [GO:0043312]; receptor-mediated endocytosis [GO:0006898]; signal transduction [GO:0007165]"
"CHOYP_LOC101078542.1.1|m.44610",37,"9",14,12,12.5,13,15,15.5,14.5,13,11.5,2.7645717829,"0.2403975463",7.6428571429,11,"#VALUE!","-1.4080006988","0.019717666",15.5,7.5,8,9.5,15.5,80.5,"1","1.1923076923",11.125,12.25,-1.125,8,4,0.9534525643,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC101078542.1.1|m.44610","Q01518","CAP1_HUMAN","46.46","226","116","2","116","340","2","223","2.00E-60","207","1","Q01518","CAP1_HUMAN","reviewed","Adenylyl cyclase-associated protein 1 (CAP 1)","CAP1 CAP","Homo sapiens (Human)","475","actin polymerization or depolymerization [GO:0008154]; activation of adenylate cyclase activity [GO:0007190]; ameboidal-type cell migration [GO:0001667]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]; neutrophil degranulation [GO:0043312]; receptor-mediated endocytosis [GO:0006898]; signal transduction [GO:0007165]","GO:0000902; GO:0001667; GO:0003779; GO:0005576; GO:0005615; GO:0005886; GO:0005925; GO:0006898; GO:0007163; GO:0007165; GO:0007190; GO:0008154; GO:0008179; GO:0030864; GO:0035578; GO:0043312; GO:0070062","","","","PF08603;PF01213;","azurophil granule lumen [GO:0035578]; cortical actin cytoskeleton [GO:0030864]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; actin polymerization or depolymerization [GO:0008154]; activation of adenylate cyclase activity [GO:0007190]; ameboidal-type cell migration [GO:0001667]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]; neutrophil degranulation [GO:0043312]; receptor-mediated endocytosis [GO:0006898]; signal transduction [GO:0007165]"
"CHOYP_LOC101164482.1.1|m.44586",37,"3",14,15,14.5,14.5,14.5,13,12,16.5,13.5714285714,3.5998866195,"0.2652548035",12.9591836735,13,"#VALUE!","1.0263321967","0.2448275928",20,7.5,12.5,12.25,20,95,"1","1.0384615385",11.5,15.5,-4,6,7.5,1.1251924671,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC101164482.1.1|m.44586","Q5SRX1","TM1L2_MOUSE","43.27","520","224","15","1","495","34","507","1.00E-124","380","1","Q5SRX1","TM1L2_MOUSE","reviewed","TOM1-like protein 2 (Target of Myb-like protein 2)","Tom1l2","Mus musculus (Mouse)","507","intracellular protein transport [GO:0006886]; negative regulation of mitotic nuclear division [GO:0045839]; signal transduction [GO:0007165]","GO:0005622; GO:0006886; GO:0007165; GO:0019901; GO:0030276; GO:0045839; GO:0070062","","","","PF03127;PF00790;","extracellular exosome [GO:0070062]; intracellular [GO:0005622]; clathrin binding [GO:0030276]; protein kinase binding [GO:0019901]; intracellular protein transport [GO:0006886]; negative regulation of mitotic nuclear division [GO:0045839]; signal transduction [GO:0007165]"
"CHOYP_LOC101164482.1.1|m.44586",48,"9",14,15,13.5,13.5,14.5,13.5,12.5,13,13.5714285714,3.5998866195,"0.2652548035",12.9591836735,13,"#VALUE!","1.0263321967","0.2448275928",20,7.5,12.5,12.25,20,95,"1","1.0384615385",11.5,15.5,-4,6,7.5,1.1251924671,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC101164482.1.1|m.44586","Q5SRX1","TM1L2_MOUSE","43.27","520","224","15","1","495","34","507","1.00E-124","380","1","Q5SRX1","TM1L2_MOUSE","reviewed","TOM1-like protein 2 (Target of Myb-like protein 2)","Tom1l2","Mus musculus (Mouse)","507","intracellular protein transport [GO:0006886]; negative regulation of mitotic nuclear division [GO:0045839]; signal transduction [GO:0007165]","GO:0005622; GO:0006886; GO:0007165; GO:0019901; GO:0030276; GO:0045839; GO:0070062","","","","PF03127;PF00790;","extracellular exosome [GO:0070062]; intracellular [GO:0005622]; clathrin binding [GO:0030276]; protein kinase binding [GO:0019901]; intracellular protein transport [GO:0006886]; negative regulation of mitotic nuclear division [GO:0045839]; signal transduction [GO:0007165]"
"CHOYP_LOC101169658.2.3|m.20752",27,"3",1,2.5,17.5,54,60.5,100,76,131,112.0714285714,36.2525157466,"0.3234768773",1314.2448979592,127,"#VALUE!","0.4654627285","-1.0651752661",157,42.5,114.5,97.25,157,784.5,"0.7874015748","0.9330708661",84.25,136.875,-52.625,76,30,9.2917209523,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_LOC101169658.2.3|m.20752",68,"9",1,10.5,38,76.5,105.5,118.5,157,127,112.0714285714,36.2525157466,"0.3234768773",1314.2448979592,127,"#VALUE!","0.4654627285","-1.0651752661",157,42.5,114.5,97.25,157,784.5,"0.7874015748","0.9330708661",84.25,136.875,-52.625,76,30,9.2917209523,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_LOC101171340.1.1|m.29474",48,"3",7.5,10,13,24.5,23.5,8.5,8,5.5,7.7857142857,2.7105237087,"0.3481406598",7.3469387755,7,"#VALUE!","2.3048472222","1.3017897036",13.5,4.5,9,6.25,13.5,54.5,"1.8888888889","3",9.25,6.5,2.75,6.5,4.5,0.6455051522,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC101171340.1.1|m.29474","A3KPQ7","TMEM2_DANRE","27.76","1059","621","34","53","1022","143","1146","4.00E-99","347","1","A3KPQ7","TMEM2_DANRE","reviewed","Transmembrane protein 2","tmem2 si:dkey-24k20.1","Danio rerio (Zebrafish) (Brachydanio rerio)","1378","atrioventricular valve formation [GO:0003190]; cell migration to the midline involved in heart development [GO:0003318]; heart looping [GO:0001947]","GO:0001947; GO:0003190; GO:0003318; GO:0016021","","","","PF10162;","integral component of membrane [GO:0016021]; atrioventricular valve formation [GO:0003190]; cell migration to the midline involved in heart development [GO:0003318]; heart looping [GO:0001947]"
"CHOYP_LOC101171340.1.1|m.29474",37,"9",7.5,6,16,22.5,16.5,13.5,9,4.5,7.7857142857,2.7105237087,"0.3481406598",7.3469387755,7,"#VALUE!","2.3048472222","1.3017897036",13.5,4.5,9,6.25,13.5,54.5,"1.8888888889","3",9.25,6.5,2.75,6.5,4.5,0.6455051522,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC101171340.1.1|m.29474","A3KPQ7","TMEM2_DANRE","27.76","1059","621","34","53","1022","143","1146","4.00E-99","347","1","A3KPQ7","TMEM2_DANRE","reviewed","Transmembrane protein 2","tmem2 si:dkey-24k20.1","Danio rerio (Zebrafish) (Brachydanio rerio)","1378","atrioventricular valve formation [GO:0003190]; cell migration to the midline involved in heart development [GO:0003318]; heart looping [GO:0001947]","GO:0001947; GO:0003190; GO:0003318; GO:0016021","","","","PF10162;","integral component of membrane [GO:0016021]; atrioventricular valve formation [GO:0003190]; cell migration to the midline involved in heart development [GO:0003318]; heart looping [GO:0001947]"
"CHOYP_LOC101173335.2.4|m.33982",40,"3",0,1,27,81.5,87,43,53.5,19.5,32.0714285714,24.1075396793,"0.7516827517",581.1734693878,20.5,"#VALUE!","1.496837104","1.5191931619",82,9,73,19.5,82,224.5,"2.0975609756","1",31.5,35.375,-3.875,44.5,62.5,2.6590074618,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC101173335.2.4|m.33982","P15989","CO6A3_CHICK","23.35","1884","1260","64","1","1826","53","1810","1.00E-117","424","1","P15989","CO6A3_CHICK","reviewed","Collagen alpha-3(VI) chain","COL6A3","Gallus gallus (Chicken)","3137","cell adhesion [GO:0007155]","GO:0004867; GO:0005578; GO:0005581; GO:0007155","","","cd00063;","PF01391;PF00014;PF00092;","collagen trimer [GO:0005581]; proteinaceous extracellular matrix [GO:0005578]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]"
"CHOYP_LOC101173335.2.4|m.33982",76,"9",0,34.5,34,54,87,20.5,82,20.5,32.0714285714,24.1075396793,"0.7516827517",581.1734693878,20.5,"#VALUE!","1.496837104","1.5191931619",82,9,73,19.5,82,224.5,"2.0975609756","1",31.5,35.375,-3.875,44.5,62.5,2.6590074618,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC101173335.2.4|m.33982","P15989","CO6A3_CHICK","23.35","1884","1260","64","1","1826","53","1810","1.00E-117","424","1","P15989","CO6A3_CHICK","reviewed","Collagen alpha-3(VI) chain","COL6A3","Gallus gallus (Chicken)","3137","cell adhesion [GO:0007155]","GO:0004867; GO:0005578; GO:0005581; GO:0007155","","","cd00063;","PF01391;PF00014;PF00092;","collagen trimer [GO:0005581]; proteinaceous extracellular matrix [GO:0005578]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]"
"CHOYP_LOC583472.1.1|m.25642",48,"3",16,16.5,14.5,14.5,11.5,13,7.5,11,11.7857142857,3.4626284696,"0.2937987792",11.9897959184,12,"#VALUE!","-1.2958770122","-0.3661785217",16.5,6.5,10,9.25,16.5,82.5,"0.7878787879","0.8787878788",10.375,13.5,-3.125,8,5.5,0.9771408267,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC583472.1.1|m.25642","P13010","XRCC5_HUMAN","41.1","747","407","16","5","734","2","732","5.00E-176","529","1","P13010","XRCC5_HUMAN","reviewed","X-ray repair cross-complementing protein 5 (EC 3.6.4.-) (86 kDa subunit of Ku antigen) (ATP-dependent DNA helicase 2 subunit 2) (ATP-dependent DNA helicase II 80 kDa subunit) (CTC box-binding factor 85 kDa subunit) (CTC85) (CTCBF) (DNA repair protein XRCC5) (Ku80) (Ku86) (Lupus Ku autoantigen protein p86) (Nuclear factor IV) (Thyroid-lupus autoantigen) (TLAA) (X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining))","XRCC5 G22P2","Homo sapiens (Human)","732","brain development [GO:0007420]; cell proliferation [GO:0008283]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to fatty acid [GO:0071398]; cellular response to gamma radiation [GO:0071480]; cellular response to X-ray [GO:0071481]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of integrated proviral latency [GO:0075713]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of t-circle formation [GO:1904430]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil degranulation [GO:0043312]; positive regulation of neurogenesis [GO:0050769]; positive regulation of type I interferon production [GO:0032481]; regulation of smooth muscle cell proliferation [GO:0048660]; response to drug [GO:0042493]; telomere maintenance [GO:0000723]; transcription, DNA-templated [GO:0006351]","GO:0000723; GO:0000783; GO:0000784; GO:0003677; GO:0003684; GO:0003690; GO:0003723; GO:0004003; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0006302; GO:0006303; GO:0006310; GO:0006351; GO:0007420; GO:0008022; GO:0008283; GO:0016020; GO:0031625; GO:0032481; GO:0034774; GO:0042162; GO:0042493; GO:0043312; GO:0043564; GO:0044212; GO:0044877; GO:0045892; GO:0048660; GO:0050769; GO:0060218; GO:0070419; GO:0071398; GO:0071475; GO:0071480; GO:0071481; GO:0075713; GO:1904430","","","","PF02735;PF03730;PF03731;PF08785;","cytosol [GO:0005829]; extracellular region [GO:0005576]; Ku70:Ku80 complex [GO:0043564]; membrane [GO:0016020]; nonhomologous end joining complex [GO:0070419]; nuclear chromosome, telomeric region [GO:0000784]; nuclear telomere cap complex [GO:0000783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; macromolecular complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; transcription regulatory region DNA binding [GO:0044212]; ubiquitin protein ligase binding [GO:0031625]; brain development [GO:0007420]; cell proliferation [GO:0008283]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to fatty acid [GO:0071398]; cellular response to gamma radiation [GO:0071480]; cellular response to X-ray [GO:0071481]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of integrated proviral latency [GO:0075713]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of t-circle formation [GO:1904430]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil degranulation [GO:0043312]; positive regulation of neurogenesis [GO:0050769]; positive regulation of type I interferon production [GO:0032481]; regulation of smooth muscle cell proliferation [GO:0048660]; response to drug [GO:0042493]; telomere maintenance [GO:0000723]; transcription, DNA-templated [GO:0006351]"
"CHOYP_LOC583472.1.1|m.25642",37,"9",16,14.5,17,11,14.5,14.5,14.5,16.5,11.7857142857,3.4626284696,"0.2937987792",11.9897959184,12,"#VALUE!","-1.2958770122","-0.3661785217",16.5,6.5,10,9.25,16.5,82.5,"0.7878787879","0.8787878788",10.375,13.5,-3.125,8,5.5,0.9771408267,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC583472.1.1|m.25642","P13010","XRCC5_HUMAN","41.1","747","407","16","5","734","2","732","5.00E-176","529","1","P13010","XRCC5_HUMAN","reviewed","X-ray repair cross-complementing protein 5 (EC 3.6.4.-) (86 kDa subunit of Ku antigen) (ATP-dependent DNA helicase 2 subunit 2) (ATP-dependent DNA helicase II 80 kDa subunit) (CTC box-binding factor 85 kDa subunit) (CTC85) (CTCBF) (DNA repair protein XRCC5) (Ku80) (Ku86) (Lupus Ku autoantigen protein p86) (Nuclear factor IV) (Thyroid-lupus autoantigen) (TLAA) (X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining))","XRCC5 G22P2","Homo sapiens (Human)","732","brain development [GO:0007420]; cell proliferation [GO:0008283]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to fatty acid [GO:0071398]; cellular response to gamma radiation [GO:0071480]; cellular response to X-ray [GO:0071481]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of integrated proviral latency [GO:0075713]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of t-circle formation [GO:1904430]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil degranulation [GO:0043312]; positive regulation of neurogenesis [GO:0050769]; positive regulation of type I interferon production [GO:0032481]; regulation of smooth muscle cell proliferation [GO:0048660]; response to drug [GO:0042493]; telomere maintenance [GO:0000723]; transcription, DNA-templated [GO:0006351]","GO:0000723; GO:0000783; GO:0000784; GO:0003677; GO:0003684; GO:0003690; GO:0003723; GO:0004003; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0006302; GO:0006303; GO:0006310; GO:0006351; GO:0007420; GO:0008022; GO:0008283; GO:0016020; GO:0031625; GO:0032481; GO:0034774; GO:0042162; GO:0042493; GO:0043312; GO:0043564; GO:0044212; GO:0044877; GO:0045892; GO:0048660; GO:0050769; GO:0060218; GO:0070419; GO:0071398; GO:0071475; GO:0071480; GO:0071481; GO:0075713; GO:1904430","","","","PF02735;PF03730;PF03731;PF08785;","cytosol [GO:0005829]; extracellular region [GO:0005576]; Ku70:Ku80 complex [GO:0043564]; membrane [GO:0016020]; nonhomologous end joining complex [GO:0070419]; nuclear chromosome, telomeric region [GO:0000784]; nuclear telomere cap complex [GO:0000783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; macromolecular complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; transcription regulatory region DNA binding [GO:0044212]; ubiquitin protein ligase binding [GO:0031625]; brain development [GO:0007420]; cell proliferation [GO:0008283]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to fatty acid [GO:0071398]; cellular response to gamma radiation [GO:0071480]; cellular response to X-ray [GO:0071481]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of integrated proviral latency [GO:0075713]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of t-circle formation [GO:1904430]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil degranulation [GO:0043312]; positive regulation of neurogenesis [GO:0050769]; positive regulation of type I interferon production [GO:0032481]; regulation of smooth muscle cell proliferation [GO:0048660]; response to drug [GO:0042493]; telomere maintenance [GO:0000723]; transcription, DNA-templated [GO:0006351]"
"CHOYP_LOC587133.1.1|m.61281",28,"3",42,53.5,59.5,42,46,49,30.5,37.5,40.5,23.4017703848,"0.577821491",547.6428571429,37.5,"#VALUE!","-1.0783559583","-0.0091998218",74,4,70,25,74,283.5,"0.7259259259","0.7481481481",33.5,49.625,-16.125,46.5,54.5,3.3578112045,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC587133.1.1|m.61281","P72745","Y1101_SYNY3","38.83","103","61","1","51","151","6","108","4.00E-14","68.9","1","P72745","Y1101_SYNY3","reviewed","Universal stress protein Slr1101 (USP Slr1101)","slr1101","Synechocystis sp. (strain PCC 6803 / Kazusa)","108","response to stress [GO:0006950]","GO:0006950","","","","PF00582;","response to stress [GO:0006950]"
"CHOYP_LOC587133.1.1|m.61281",71,"9",42,32,49.5,40,51.5,50.5,74,67.5,40.5,23.4017703848,"0.577821491",547.6428571429,37.5,"#VALUE!","-1.0783559583","-0.0091998218",74,4,70,25,74,283.5,"0.7259259259","0.7481481481",33.5,49.625,-16.125,46.5,54.5,3.3578112045,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC587133.1.1|m.61281","P72745","Y1101_SYNY3","38.83","103","61","1","51","151","6","108","4.00E-14","68.9","1","P72745","Y1101_SYNY3","reviewed","Universal stress protein Slr1101 (USP Slr1101)","slr1101","Synechocystis sp. (strain PCC 6803 / Kazusa)","108","response to stress [GO:0006950]","GO:0006950","","","","PF00582;","response to stress [GO:0006950]"
"CHOYP_LOC654860.3.3|m.63750",48,"3",17,15.5,14,13.5,15.5,11,9,10.5,11.7142857143,3.9266228934,"0.3351995153",15.4183673469,13,"#VALUE!","0.6151340205","-1.0209861877",16,4,12,9.75,16,82,"0.8461538462","1.2307692308",10,13.25,-3.25,12,5,0.9712187611,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC654860.3.3|m.63750","Q13492","PICAL_HUMAN","46.92","682","258","18","46","668","1","637","0","552","1","Q13492","PICAL_HUMAN","reviewed","Phosphatidylinositol-binding clathrin assembly protein (Clathrin assembly lymphoid myeloid leukemia protein)","PICALM CALM","Homo sapiens (Human)","652","axonogenesis [GO:0007409]; cargo loading into vesicle [GO:0035459]; cell proliferation [GO:0008283]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; dendrite morphogenesis [GO:0048813]; endosomal transport [GO:0016197]; hemopoiesis [GO:0030097]; iron ion homeostasis [GO:0055072]; iron ion import into cell [GO:0097459]; membrane organization [GO:0061024]; negative regulation of gene expression [GO:0010629]; negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902963]; negative regulation of receptor-mediated endocytosis [GO:0048261]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of beta-amyloid formation [GO:1902004]; positive regulation of neuron death [GO:1901216]; positive regulation of transcription, DNA-templated [GO:0045893]; protein complex assembly [GO:0006461]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902959]; regulation of endocytosis [GO:0030100]; regulation of protein localization [GO:0032880]; synaptic vesicle maturation [GO:0016188]; vesicle-mediated transport [GO:0016192]","GO:0005545; GO:0005634; GO:0005794; GO:0005829; GO:0005905; GO:0006461; GO:0006898; GO:0007409; GO:0008283; GO:0010629; GO:0016020; GO:0016188; GO:0016192; GO:0016197; GO:0030097; GO:0030100; GO:0030136; GO:0030276; GO:0031623; GO:0031982; GO:0032050; GO:0032880; GO:0035459; GO:0035615; GO:0042734; GO:0043025; GO:0043231; GO:0045211; GO:0045296; GO:0045893; GO:0048261; GO:0048268; GO:0048471; GO:0048813; GO:0055072; GO:0061024; GO:0072583; GO:0097418; GO:0097459; GO:1901216; GO:1902004; GO:1902959; GO:1902961; GO:1902963","","","","PF07651;","clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neurofibrillary tangle [GO:0097418]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; vesicle [GO:0031982]; 1-phosphatidylinositol binding [GO:0005545]; cadherin binding [GO:0045296]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; axonogenesis [GO:0007409]; cargo loading into vesicle [GO:0035459]; cell proliferation [GO:0008283]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; dendrite morphogenesis [GO:0048813]; endosomal transport [GO:0016197]; hemopoiesis [GO:0030097]; iron ion homeostasis [GO:0055072]; iron ion import into cell [GO:0097459]; membrane organization [GO:0061024]; negative regulation of gene expression [GO:0010629]; negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902963]; negative regulation of receptor-mediated endocytosis [GO:0048261]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of beta-amyloid formation [GO:1902004]; positive regulation of neuron death [GO:1901216]; positive regulation of transcription, DNA-templated [GO:0045893]; protein complex assembly [GO:0006461]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902959]; regulation of endocytosis [GO:0030100]; regulation of protein localization [GO:0032880]; synaptic vesicle maturation [GO:0016188]; vesicle-mediated transport [GO:0016192]"
"CHOYP_LOC654860.3.3|m.63750",37,"9",17,16,13.5,11,12.5,16,15.5,13,11.7142857143,3.9266228934,"0.3351995153",15.4183673469,13,"#VALUE!","0.6151340205","-1.0209861877",16,4,12,9.75,16,82,"0.8461538462","1.2307692308",10,13.25,-3.25,12,5,0.9712187611,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC654860.3.3|m.63750","Q13492","PICAL_HUMAN","46.92","682","258","18","46","668","1","637","0","552","1","Q13492","PICAL_HUMAN","reviewed","Phosphatidylinositol-binding clathrin assembly protein (Clathrin assembly lymphoid myeloid leukemia protein)","PICALM CALM","Homo sapiens (Human)","652","axonogenesis [GO:0007409]; cargo loading into vesicle [GO:0035459]; cell proliferation [GO:0008283]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; dendrite morphogenesis [GO:0048813]; endosomal transport [GO:0016197]; hemopoiesis [GO:0030097]; iron ion homeostasis [GO:0055072]; iron ion import into cell [GO:0097459]; membrane organization [GO:0061024]; negative regulation of gene expression [GO:0010629]; negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902963]; negative regulation of receptor-mediated endocytosis [GO:0048261]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of beta-amyloid formation [GO:1902004]; positive regulation of neuron death [GO:1901216]; positive regulation of transcription, DNA-templated [GO:0045893]; protein complex assembly [GO:0006461]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902959]; regulation of endocytosis [GO:0030100]; regulation of protein localization [GO:0032880]; synaptic vesicle maturation [GO:0016188]; vesicle-mediated transport [GO:0016192]","GO:0005545; GO:0005634; GO:0005794; GO:0005829; GO:0005905; GO:0006461; GO:0006898; GO:0007409; GO:0008283; GO:0010629; GO:0016020; GO:0016188; GO:0016192; GO:0016197; GO:0030097; GO:0030100; GO:0030136; GO:0030276; GO:0031623; GO:0031982; GO:0032050; GO:0032880; GO:0035459; GO:0035615; GO:0042734; GO:0043025; GO:0043231; GO:0045211; GO:0045296; GO:0045893; GO:0048261; GO:0048268; GO:0048471; GO:0048813; GO:0055072; GO:0061024; GO:0072583; GO:0097418; GO:0097459; GO:1901216; GO:1902004; GO:1902959; GO:1902961; GO:1902963","","","","PF07651;","clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neurofibrillary tangle [GO:0097418]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; vesicle [GO:0031982]; 1-phosphatidylinositol binding [GO:0005545]; cadherin binding [GO:0045296]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; axonogenesis [GO:0007409]; cargo loading into vesicle [GO:0035459]; cell proliferation [GO:0008283]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; dendrite morphogenesis [GO:0048813]; endosomal transport [GO:0016197]; hemopoiesis [GO:0030097]; iron ion homeostasis [GO:0055072]; iron ion import into cell [GO:0097459]; membrane organization [GO:0061024]; negative regulation of gene expression [GO:0010629]; negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902963]; negative regulation of receptor-mediated endocytosis [GO:0048261]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of beta-amyloid formation [GO:1902004]; positive regulation of neuron death [GO:1901216]; positive regulation of transcription, DNA-templated [GO:0045893]; protein complex assembly [GO:0006461]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902959]; regulation of endocytosis [GO:0030100]; regulation of protein localization [GO:0032880]; synaptic vesicle maturation [GO:0016188]; vesicle-mediated transport [GO:0016192]"
"CHOYP_LOC752782.1.1|m.53937",39,"3",0,104,177,0,0,0,0,0,15.5714285714,35.946814454,"2.30851102",1292.1734693878,0,"#VALUE!","6.9366293238","2.6306492786",103.5,0,103.5,0,103.5,109,"#DIV/0!","#DIV/0!",0,27.25,-27.25,0,103.5,1.2910103044,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC752782.1.1|m.53937","O17320","ACT_CRAGI","99.2","376","3","0","58","433","1","376","0","783","1","O17320","ACT_CRAGI","reviewed","Actin","","Crassostrea gigas (Pacific oyster) (Crassostrea angulata)","376","","GO:0005524; GO:0005737; GO:0005856","","","","PF00022;","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]"
"CHOYP_LOC752782.1.1|m.53937",75,"9",0,219,117.5,0,73.5,0,103.5,0,15.5714285714,35.946814454,"2.30851102",1292.1734693878,0,"#VALUE!","6.9366293238","2.6306492786",103.5,0,103.5,0,103.5,109,"#DIV/0!","#DIV/0!",0,27.25,-27.25,0,103.5,1.2910103044,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC752782.1.1|m.53937","O17320","ACT_CRAGI","99.2","376","3","0","58","433","1","376","0","783","1","O17320","ACT_CRAGI","reviewed","Actin","","Crassostrea gigas (Pacific oyster) (Crassostrea angulata)","376","","GO:0005524; GO:0005737; GO:0005856","","","","PF00022;","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]"
"CHOYP_LOC754102.1.1|m.57578",37,"3",92,25.5,25.5,51,20.5,25,9.5,0,23.5714285714,21.8246724267,"0.9258951939",476.3163265306,12.5,"#VALUE!","-1.8721621069","0.4286446657",58,0,58,4.75,58,165,"0.5813953488","1.3488372093",23.125,24.375,-1.25,58,43,1.9542816534,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC754102.1.1|m.57578","P02553","TBA_LYTPI","97.84","139","3","0","1","139","23","161","6.00E-97","283","1","P02553","TBA_LYTPI","reviewed","Tubulin alpha chain (Fragment)","","Lytechinus pictus (Painted sea urchin)","161","microtubule-based process [GO:0007017]","GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017","","","","PF03953;","cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]"
"CHOYP_LOC754102.1.1|m.57578",28,"9",92,69.5,42.5,28,33.5,58,42,43,23.5714285714,21.8246724267,"0.9258951939",476.3163265306,12.5,"#VALUE!","-1.8721621069","0.4286446657",58,0,58,4.75,58,165,"0.5813953488","1.3488372093",23.125,24.375,-1.25,58,43,1.9542816534,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LOC754102.1.1|m.57578","P02553","TBA_LYTPI","97.84","139","3","0","1","139","23","161","6.00E-97","283","1","P02553","TBA_LYTPI","reviewed","Tubulin alpha chain (Fragment)","","Lytechinus pictus (Painted sea urchin)","161","microtubule-based process [GO:0007017]","GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017","","","","PF03953;","cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]"
"CHOYP_LRP5.1.3|m.18025",37,"3",44,46.5,53,41,35,35,36.5,38.5,43.0714285714,15.9652045118,"0.3706680981",254.887755102,38.5,"#VALUE!","0.6954929265","0.7247621461",73.5,20.5,53,33.75,73.5,301.5,"0.6481481481","0.8796296296",34.875,49.25,-14.375,27,42.5,3.5710055667,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LRP5.1.3|m.18025","Q24JV9","L3BPA_DANRE","48.21","112","54","3","146","257","34","141","1.00E-23","110","1","Q24JV9","L3BPA_DANRE","reviewed","Galectin-3-binding protein A (Lectin galactoside-binding soluble 3-binding protein A)","lgals3bpa lgals3bp zgc:136780","Danio rerio (Zebrafish) (Brachydanio rerio)","567","cell adhesion [GO:0007155]","GO:0005044; GO:0005578; GO:0007155; GO:0016020","","","","PF07707;PF00651;PF00530;","membrane [GO:0016020]; proteinaceous extracellular matrix [GO:0005578]; scavenger receptor activity [GO:0005044]; cell adhesion [GO:0007155]"
"CHOYP_LRP5.1.3|m.18025",28,"9",44,60,51,52,47,47.5,73.5,54,43.0714285714,15.9652045118,"0.3706680981",254.887755102,38.5,"#VALUE!","0.6954929265","0.7247621461",73.5,20.5,53,33.75,73.5,301.5,"0.6481481481","0.8796296296",34.875,49.25,-14.375,27,42.5,3.5710055667,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LRP5.1.3|m.18025","Q24JV9","L3BPA_DANRE","48.21","112","54","3","146","257","34","141","1.00E-23","110","1","Q24JV9","L3BPA_DANRE","reviewed","Galectin-3-binding protein A (Lectin galactoside-binding soluble 3-binding protein A)","lgals3bpa lgals3bp zgc:136780","Danio rerio (Zebrafish) (Brachydanio rerio)","567","cell adhesion [GO:0007155]","GO:0005044; GO:0005578; GO:0007155; GO:0016020","","","","PF07707;PF00651;PF00530;","membrane [GO:0016020]; proteinaceous extracellular matrix [GO:0005578]; scavenger receptor activity [GO:0005044]; cell adhesion [GO:0007155]"
"CHOYP_LYS3.1.1|m.31221",48,"3",11.5,11.5,12,9.5,13,15.5,10,11.5,13.7142857143,6.4246019491,"0.4684605588",41.2755102041,11.5,"#VALUE!","-1.2029049094","-0.2352677193",21.5,3,18.5,10,21.5,96,"0.7209302326","0.976744186",12.375,15.5,-3.125,18,11.5,1.1370365984,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LYS3.1.1|m.31221","B3A003","LYS3_CRAVI","88.24","187","22","0","18","204","1","187","2.00E-119","343","1","B3A003","LYS3_CRAVI","reviewed","Lysozyme 3 (EC 3.2.1.17) (1,4-beta-N-acetylmuramidase 3) (cv-lysozyme 3)","lysoz3","Crassostrea virginica (Eastern oyster)","187","cytolysis [GO:0019835]; defense response to bacterium [GO:0042742]; metabolic process [GO:0008152]","GO:0003796; GO:0005576; GO:0008152; GO:0019835; GO:0042742","","","","PF05497;","extracellular region [GO:0005576]; lysozyme activity [GO:0003796]; cytolysis [GO:0019835]; defense response to bacterium [GO:0042742]; metabolic process [GO:0008152]"
"CHOYP_LYS3.1.1|m.31221",37,"9",11.5,10.5,11,12,17.5,21,19,21.5,13.7142857143,6.4246019491,"0.4684605588",41.2755102041,11.5,"#VALUE!","-1.2029049094","-0.2352677193",21.5,3,18.5,10,21.5,96,"0.7209302326","0.976744186",12.375,15.5,-3.125,18,11.5,1.1370365984,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_LYS3.1.1|m.31221","B3A003","LYS3_CRAVI","88.24","187","22","0","18","204","1","187","2.00E-119","343","1","B3A003","LYS3_CRAVI","reviewed","Lysozyme 3 (EC 3.2.1.17) (1,4-beta-N-acetylmuramidase 3) (cv-lysozyme 3)","lysoz3","Crassostrea virginica (Eastern oyster)","187","cytolysis [GO:0019835]; defense response to bacterium [GO:0042742]; metabolic process [GO:0008152]","GO:0003796; GO:0005576; GO:0008152; GO:0019835; GO:0042742","","","","PF05497;","extracellular region [GO:0005576]; lysozyme activity [GO:0003796]; cytolysis [GO:0019835]; defense response to bacterium [GO:0042742]; metabolic process [GO:0008152]"
"CHOYP_MATN1.2.5|m.45361",52,"9",186,211,188,160.5,236.5,206.5,199.5,229.5,188.0714285714,31.3942994956,"0.1669275324",985.6020408163,195.5,"#VALUE!","2.8389880679","-1.343122595",229.5,121,108.5,182.25,229.5,1316.5,"0.9847494553","0.8997821351",182.25,203.375,-21.125,105,40.5,15.5927987682,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_MATN1.2.5|m.45361","A2AX52","CO6A4_MOUSE","31.44","369","240","8","18","379","53","415","5.00E-45","186","1","A2AX52","CO6A4_MOUSE","reviewed","Collagen alpha-4(VI) chain","Col6a4 Dvwa","Mus musculus (Mouse)","2309","cell adhesion [GO:0007155]; protein heterotrimerization [GO:0070208]","GO:0005576; GO:0005578; GO:0005581; GO:0007155; GO:0043234; GO:0070208","","","","PF01391;PF00092;","collagen trimer [GO:0005581]; extracellular region [GO:0005576]; protein complex [GO:0043234]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]; protein heterotrimerization [GO:0070208]"
"CHOYP_MATN1.2.5|m.45361",4,"3",186,156,202.5,179,203,226,175.5,189,188.0714285714,31.3942994956,"0.1669275324",985.6020408163,195.5,"#VALUE!","2.8389880679","-1.343122595",229.5,121,108.5,182.25,229.5,1316.5,"0.9847494553","0.8997821351",182.25,203.375,-21.125,105,40.5,15.5927987682,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_MATN1.2.5|m.45361","A2AX52","CO6A4_MOUSE","31.44","369","240","8","18","379","53","415","5.00E-45","186","1","A2AX52","CO6A4_MOUSE","reviewed","Collagen alpha-4(VI) chain","Col6a4 Dvwa","Mus musculus (Mouse)","2309","cell adhesion [GO:0007155]; protein heterotrimerization [GO:0070208]","GO:0005576; GO:0005578; GO:0005581; GO:0007155; GO:0043234; GO:0070208","","","","PF01391;PF00092;","collagen trimer [GO:0005581]; extracellular region [GO:0005576]; protein complex [GO:0043234]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]; protein heterotrimerization [GO:0070208]"
"CHOYP_MATN1.3.5|m.46206",58,"9",71.5,120,155.5,154.5,182.5,176.5,180.5,175.5,160.7142857143,25.3530177731,"0.1577521106",642.7755102041,175.5,"#VALUE!","1.9405942741","-1.6380276549",180.5,107,73.5,154.25,180.5,1125,"0.9373219373","1.0056980057",147,175.375,-28.375,69.5,12,13.3246476371,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_MATN1.3.5|m.46206","A6NMZ7","CO6A6_HUMAN","29.61","385","248","11","27","409","436","799","1.00E-40","171","1","A6NMZ7","CO6A6_HUMAN","reviewed","Collagen alpha-6(VI) chain","COL6A6","Homo sapiens (Human)","2263","cell adhesion [GO:0007155]; collagen catabolic process [GO:0030574]","GO:0005576; GO:0005578; GO:0005581; GO:0007155; GO:0030574","","","","PF01391;PF00092;","collagen trimer [GO:0005581]; extracellular region [GO:0005576]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]; collagen catabolic process [GO:0030574]"
"CHOYP_MATN1.3.5|m.46206",10,"3",71.5,84,139,154,176.5,164.5,140,168.5,160.7142857143,25.3530177731,"0.1577521106",642.7755102041,175.5,"#VALUE!","1.9405942741","-1.6380276549",180.5,107,73.5,154.25,180.5,1125,"0.9373219373","1.0056980057",147,175.375,-28.375,69.5,12,13.3246476371,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_MATN1.3.5|m.46206","A6NMZ7","CO6A6_HUMAN","29.61","385","248","11","27","409","436","799","1.00E-40","171","1","A6NMZ7","CO6A6_HUMAN","reviewed","Collagen alpha-6(VI) chain","COL6A6","Homo sapiens (Human)","2263","cell adhesion [GO:0007155]; collagen catabolic process [GO:0030574]","GO:0005576; GO:0005578; GO:0005581; GO:0007155; GO:0030574","","","","PF01391;PF00092;","collagen trimer [GO:0005581]; extracellular region [GO:0005576]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]; collagen catabolic process [GO:0030574]"
"CHOYP_MBCDH18.1.1|m.34344",11,"3",273.5,247.5,202.5,203,157.5,74,124,88,75.6428571429,32.1044214642,"0.4244210581",1030.693877551,88,"#VALUE!","-0.9571961976","-0.2019291516",124,24,100,51,124,529.5,"3.0833333333","2.2291666667",75,75.875,-0.875,75.5,75,6.2714674879,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_MBCDH18.1.1|m.34344","Q2PZL6","FAT4_MOUSE","27.01","3717","2418","143","796","4407","81","3607","0","733","1","Q2PZL6","FAT4_MOUSE","reviewed","Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)","Fat4 Fatj","Mus musculus (Mouse)","4981","branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]","GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005622; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0016021; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0070062; GO:0072006; GO:0072137; GO:0072307","","","","PF00028;PF00008;PF07645;PF12661;PF02210;","apical part of cell [GO:0045177]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]"
"CHOYP_MBCDH18.1.1|m.34344",59,"9",273.5,189,170.5,143,58.5,53.5,92.5,24,75.6428571429,32.1044214642,"0.4244210581",1030.693877551,88,"#VALUE!","-0.9571961976","-0.2019291516",124,24,100,51,124,529.5,"3.0833333333","2.2291666667",75,75.875,-0.875,75.5,75,6.2714674879,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_MBCDH18.1.1|m.34344","Q2PZL6","FAT4_MOUSE","27.01","3717","2418","143","796","4407","81","3607","0","733","1","Q2PZL6","FAT4_MOUSE","reviewed","Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)","Fat4 Fatj","Mus musculus (Mouse)","4981","branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]","GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005622; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0016021; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0070062; GO:0072006; GO:0072137; GO:0072307","","","","PF00028;PF00008;PF07645;PF12661;PF02210;","apical part of cell [GO:0045177]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]"
"CHOYP_MCM2.1.1|m.14569",37,"3",21,18.5,27,22.5,21,18,11,9.5,8.8571428571,3.3135467156,"0.3741101131",10.9795918367,9.5,"#VALUE!","-1.2697191857","-0.352657387",13.5,4,9.5,6.25,13.5,62,"4","2.5555555556",11.125,8.875,2.25,14,9,0.7343361364,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_MCM2.1.1|m.14569","P55861","MCM2_XENLA","76.02","884","204","6","6","884","4","884","0","1381","1","P55861","MCM2_XENLA","reviewed","DNA replication licensing factor mcm2 (EC 3.6.4.12) (BM28-homolog) (Minichromosome maintenance protein 2) (xMCM2) (p112)","mcm2","Xenopus laevis (African clawed frog)","886","cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; regulation of DNA-dependent DNA replication initiation [GO:0030174]","GO:0000785; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006268; GO:0006270; GO:0007049; GO:0030174; GO:0042555; GO:0046872","","","","PF00493;PF12619;PF14551;PF17207;","chromatin [GO:0000785]; MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; regulation of DNA-dependent DNA replication initiation [GO:0030174]"
"CHOYP_MCM2.1.1|m.14569",48,"9",21,19.5,22.5,10.5,14.5,11.5,8,4.5,8.8571428571,3.3135467156,"0.3741101131",10.9795918367,9.5,"#VALUE!","-1.2697191857","-0.352657387",13.5,4,9.5,6.25,13.5,62,"4","2.5555555556",11.125,8.875,2.25,14,9,0.7343361364,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_MCM2.1.1|m.14569","P55861","MCM2_XENLA","76.02","884","204","6","6","884","4","884","0","1381","1","P55861","MCM2_XENLA","reviewed","DNA replication licensing factor mcm2 (EC 3.6.4.12) (BM28-homolog) (Minichromosome maintenance protein 2) (xMCM2) (p112)","mcm2","Xenopus laevis (African clawed frog)","886","cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; regulation of DNA-dependent DNA replication initiation [GO:0030174]","GO:0000785; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0006268; GO:0006270; GO:0007049; GO:0030174; GO:0042555; GO:0046872","","","","PF00493;PF12619;PF14551;PF17207;","chromatin [GO:0000785]; MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; regulation of DNA-dependent DNA replication initiation [GO:0030174]"
"CHOYP_MDN1.3.8|m.3846",37,"3",16.5,18.5,7,3,4,0,24,17.5,10.3571428571,8.3139911583,"0.8027301808",69.1224489796,11,"#VALUE!","-1.2457973657","0.2719021309",24,0,24,2.75,24,72.5,"0","0",9.625,8.5,1.125,24,16.5,0.8586995144,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_MDN1.3.8|m.3846",48,"9",16.5,12.5,10,7,0.5,0,4.5,1,10.3571428571,8.3139911583,"0.8027301808",69.1224489796,11,"#VALUE!","-1.2457973657","0.2719021309",24,0,24,2.75,24,72.5,"0","0",9.625,8.5,1.125,24,16.5,0.8586995144,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_MPP2.1.1|m.62101",37,"9",16,15,15,8.5,14.5,17.5,16,17.5,13,3.5355339059,"0.2719641466",12.5,11,"#VALUE!","-2.4703542857","0.3487994758",17.5,9,8.5,10,17.5,91,"0.7714285714","1",12.5,13.625,-1.125,8.5,7.5,1.0778159422,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_MPP2.1.1|m.62101","Q9WV34","MPP2_MOUSE","44.73","579","284","13","1","570","1","552","1.00E-161","479","1","Q9WV34","MPP2_MOUSE","reviewed","MAGUK p55 subfamily member 2 (Discs large homolog 2) (Protein MPP2)","Mpp2 Dlgh2","Mus musculus (Mouse)","552","excitatory postsynaptic potential [GO:0060079]; long-term synaptic potentiation [GO:0060291]; protein homooligomerization [GO:0051260]","GO:0005856; GO:0014069; GO:0032590; GO:0043197; GO:0043198; GO:0044325; GO:0051260; GO:0060079; GO:0060291","","","","PF00625;PF02828;PF00595;PF07653;","cytoskeleton [GO:0005856]; dendrite membrane [GO:0032590]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]; ion channel binding [GO:0044325]; excitatory postsynaptic potential [GO:0060079]; long-term synaptic potentiation [GO:0060291]; protein homooligomerization [GO:0051260]"
"CHOYP_MPP2.1.1|m.62101",48,"3",16,17.5,14.5,14,14.5,13.5,10,10,13,3.5355339059,"0.2719641466",12.5,11,"#VALUE!","-2.4703542857","0.3487994758",17.5,9,8.5,10,17.5,91,"0.7714285714","1",12.5,13.625,-1.125,8.5,7.5,1.0778159422,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_MPP2.1.1|m.62101","Q9WV34","MPP2_MOUSE","44.73","579","284","13","1","570","1","552","1.00E-161","479","1","Q9WV34","MPP2_MOUSE","reviewed","MAGUK p55 subfamily member 2 (Discs large homolog 2) (Protein MPP2)","Mpp2 Dlgh2","Mus musculus (Mouse)","552","excitatory postsynaptic potential [GO:0060079]; long-term synaptic potentiation [GO:0060291]; protein homooligomerization [GO:0051260]","GO:0005856; GO:0014069; GO:0032590; GO:0043197; GO:0043198; GO:0044325; GO:0051260; GO:0060079; GO:0060291","","","","PF00625;PF02828;PF00595;PF07653;","cytoskeleton [GO:0005856]; dendrite membrane [GO:0032590]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]; ion channel binding [GO:0044325]; excitatory postsynaptic potential [GO:0060079]; long-term synaptic potentiation [GO:0060291]; protein homooligomerization [GO:0051260]"
"CHOYP_MTND.2.3|m.41824",37,"3",8,9.5,18,18,13.5,11.5,6,11.5,8.5,2.7516228978,"0.3237203409",7.5714285714,8.5,"#VALUE!","-0.4763260947","-0.733236043",11.5,3.5,8,7,11.5,59.5,"1.0454545455","0.7272727273",7.25,10.5,-3.25,8,3,0.7047258084,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_MTND.2.3|m.41824","C3ZAH2","MTND_BRAFL","64.8","179","61","1","24","202","1","177","5.00E-84","253","1","C3ZAH2","MTND_BRAFL","reviewed","1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase (EC 1.13.11.54) (Acireductone dioxygenase (Fe(2+)-requiring)) (ARD) (Fe-ARD)","BRAFLDRAFT_119977","Branchiostoma floridae (Florida lancelet) (Amphioxus)","177","L-methionine salvage from methylthioadenosine [GO:0019509]; methionine metabolic process [GO:0006555]","GO:0005634; GO:0005737; GO:0006555; GO:0010309; GO:0019509; GO:0046872","PATHWAY: Amino-acid biosynthesis; L-methionine biosynthesis via salvage pathway; L-methionine from S-methyl-5-thio-alpha-D-ribose 1-phosphate: step 5/6. {ECO:0000255|HAMAP-Rule:MF_03154}.","","","PF03079;","cytoplasm [GO:0005737]; nucleus [GO:0005634]; acireductone dioxygenase [iron(II)-requiring] activity [GO:0010309]; metal ion binding [GO:0046872]; L-methionine salvage from methylthioadenosine [GO:0019509]; methionine metabolic process [GO:0006555]"
"CHOYP_MTND.2.3|m.41824",48,"9",8,15,11.5,14,14,8,11,11,8.5,2.7516228978,"0.3237203409",7.5714285714,8.5,"#VALUE!","-0.4763260947","-0.733236043",11.5,3.5,8,7,11.5,59.5,"1.0454545455","0.7272727273",7.25,10.5,-3.25,8,3,0.7047258084,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_MTND.2.3|m.41824","C3ZAH2","MTND_BRAFL","64.8","179","61","1","24","202","1","177","5.00E-84","253","1","C3ZAH2","MTND_BRAFL","reviewed","1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase (EC 1.13.11.54) (Acireductone dioxygenase (Fe(2+)-requiring)) (ARD) (Fe-ARD)","BRAFLDRAFT_119977","Branchiostoma floridae (Florida lancelet) (Amphioxus)","177","L-methionine salvage from methylthioadenosine [GO:0019509]; methionine metabolic process [GO:0006555]","GO:0005634; GO:0005737; GO:0006555; GO:0010309; GO:0019509; GO:0046872","PATHWAY: Amino-acid biosynthesis; L-methionine biosynthesis via salvage pathway; L-methionine from S-methyl-5-thio-alpha-D-ribose 1-phosphate: step 5/6. {ECO:0000255|HAMAP-Rule:MF_03154}.","","","PF03079;","cytoplasm [GO:0005737]; nucleus [GO:0005634]; acireductone dioxygenase [iron(II)-requiring] activity [GO:0010309]; metal ion binding [GO:0046872]; L-methionine salvage from methylthioadenosine [GO:0019509]; methionine metabolic process [GO:0006555]"
"CHOYP_MVP.1.1|m.56230",28,"3",73,73,69.5,67,67,65.5,54.5,59,59.4285714286,14.3487893253,"0.2414459742",205.887755102,61,"#VALUE!","2.5013928939","-1.3017647008",76.5,29,47.5,56.75,76.5,416,"0.8562091503","0.8235294118",53,67.375,-14.375,36.5,17.5,4.9271585929,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_MVP.1.1|m.56230","Q5EAJ7","MVP_STRPU","75.59","852","205","3","4","854","8","857","0","1347","1","Q5EAJ7","MVP_STRPU","reviewed","Major vault protein (MVP)","MVP","Strongylocentrotus purpuratus (Purple sea urchin)","857","regulation of signaling [GO:0023051]","GO:0005634; GO:0005737; GO:0023051; GO:0030529","","","cd08825;","PF11978;PF01505;","cytoplasm [GO:0005737]; intracellular ribonucleoprotein complex [GO:0030529]; nucleus [GO:0005634]; regulation of signaling [GO:0023051]"
"CHOYP_MVP.1.1|m.56230",23,"9",73,67,52.5,52,61.5,63,73,76.5,59.4285714286,14.3487893253,"0.2414459742",205.887755102,61,"#VALUE!","2.5013928939","-1.3017647008",76.5,29,47.5,56.75,76.5,416,"0.8562091503","0.8235294118",53,67.375,-14.375,36.5,17.5,4.9271585929,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_MVP.1.1|m.56230","Q5EAJ7","MVP_STRPU","75.59","852","205","3","4","854","8","857","0","1347","1","Q5EAJ7","MVP_STRPU","reviewed","Major vault protein (MVP)","MVP","Strongylocentrotus purpuratus (Purple sea urchin)","857","regulation of signaling [GO:0023051]","GO:0005634; GO:0005737; GO:0023051; GO:0030529","","","cd08825;","PF11978;PF01505;","cytoplasm [GO:0005737]; intracellular ribonucleoprotein complex [GO:0030529]; nucleus [GO:0005634]; regulation of signaling [GO:0023051]"
"CHOYP_MYS.4.7|m.18188",2,"3",254,302.5,310,288,275.5,293.5,243.5,223.5,260.7142857143,95.3178356653,"0.3656026573",9085.4897959184,243.5,"#VALUE!","-1.7088840478","-0.2017672773",379,115.5,263.5,191.75,379,1825,"0.8164116829","0.9568845619",260.25,269.375,-9.125,184,263.5,21.6155395002,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_MYS.4.7|m.18188","P24733","MYS_ARGIR","76.84","1926","438","2","7","1932","3","1920","0","2991","1","P24733","MYS_ARGIR","reviewed","Myosin heavy chain, striated muscle","","Argopecten irradians (Bay scallop) (Aequipecten irradians)","1938","","GO:0003774; GO:0005524; GO:0030016; GO:0032982","","","","PF00063;PF02736;PF01576;","myofibril [GO:0030016]; myosin filament [GO:0032982]; ATP binding [GO:0005524]; motor activity [GO:0003774]"
"CHOYP_MYS.4.7|m.18188",50,"9",254,318,298.5,259.5,325,344,379,359.5,260.7142857143,95.3178356653,"0.3656026573",9085.4897959184,243.5,"#VALUE!","-1.7088840478","-0.2017672773",379,115.5,263.5,191.75,379,1825,"0.8164116829","0.9568845619",260.25,269.375,-9.125,184,263.5,21.6155395002,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_MYS.4.7|m.18188","P24733","MYS_ARGIR","76.84","1926","438","2","7","1932","3","1920","0","2991","1","P24733","MYS_ARGIR","reviewed","Myosin heavy chain, striated muscle","","Argopecten irradians (Bay scallop) (Aequipecten irradians)","1938","","GO:0003774; GO:0005524; GO:0030016; GO:0032982","","","","PF00063;PF02736;PF01576;","myofibril [GO:0030016]; myosin filament [GO:0032982]; ATP binding [GO:0005524]; motor activity [GO:0003774]"
"CHOYP_MYS.7.7|m.44341",61,"9",168.5,155,121,107.5,130,136,177.5,143,109.1428571429,46.3709532587,"0.424864755",2150.2653061225,123.5,"#VALUE!","-1.1259115821","-0.262043998",177.5,38.5,139,72.75,177.5,764,"0.8356643357","0.951048951",108.375,112.5,-4.125,81.5,139,9.048916262,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_MYS.7.7|m.44341","P24733","MYS_ARGIR","79.13","939","189","4","4","938","3","938","0","1541","1","P24733","MYS_ARGIR","reviewed","Myosin heavy chain, striated muscle","","Argopecten irradians (Bay scallop) (Aequipecten irradians)","1938","","GO:0003774; GO:0005524; GO:0030016; GO:0032982","","","","PF00063;PF02736;PF01576;","myofibril [GO:0030016]; myosin filament [GO:0032982]; ATP binding [GO:0005524]; motor activity [GO:0003774]"
"CHOYP_MYS.7.7|m.44341",15,"3",168.5,202,143.5,135.5,122,119.5,123.5,91,109.1428571429,46.3709532587,"0.424864755",2150.2653061225,123.5,"#VALUE!","-1.1259115821","-0.262043998",177.5,38.5,139,72.75,177.5,764,"0.8356643357","0.951048951",108.375,112.5,-4.125,81.5,139,9.048916262,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_MYS.7.7|m.44341","P24733","MYS_ARGIR","79.13","939","189","4","4","938","3","938","0","1541","1","P24733","MYS_ARGIR","reviewed","Myosin heavy chain, striated muscle","","Argopecten irradians (Bay scallop) (Aequipecten irradians)","1938","","GO:0003774; GO:0005524; GO:0030016; GO:0032982","","","","PF00063;PF02736;PF01576;","myofibril [GO:0030016]; myosin filament [GO:0032982]; ATP binding [GO:0005524]; motor activity [GO:0003774]"
"CHOYP_MYS.7.7|m.44342",9,"3",195.5,216,145,137,143.5,168.5,144.5,114,139.0714285714,50.757426319,"0.3649737897",2576.3163265306,144.5,"#VALUE!","-1.5302474214","-0.4379117841",193.5,56.5,137,100.75,193.5,973.5,"0.8938992042","1.0026525199",147.375,138.125,9.25,101.5,137,11.5302617553,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_MYS.7.7|m.44342","Q8T305","MYSP_TAESA","37.25","851","529","2","150","995","4","854","2.00E-153","483","1","Q8T305","MYSP_TAESA","reviewed","Paramyosin","PMY","Taenia saginata (Beef tapeworm) (Cysticercus bovis)","863","","GO:0003774; GO:0030016; GO:0032982","","","","PF01576;","myofibril [GO:0030016]; myosin filament [GO:0032982]; motor activity [GO:0003774]"
"CHOYP_MYS.7.7|m.44342",57,"9",195.5,172.5,147,146.5,199.5,189,193.5,188.5,139.0714285714,50.757426319,"0.3649737897",2576.3163265306,144.5,"#VALUE!","-1.5302474214","-0.4379117841",193.5,56.5,137,100.75,193.5,973.5,"0.8938992042","1.0026525199",147.375,138.125,9.25,101.5,137,11.5302617553,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_MYS.7.7|m.44342","Q8T305","MYSP_TAESA","37.25","851","529","2","150","995","4","854","2.00E-153","483","1","Q8T305","MYSP_TAESA","reviewed","Paramyosin","PMY","Taenia saginata (Beef tapeworm) (Cysticercus bovis)","863","","GO:0003774; GO:0030016; GO:0032982","","","","PF01576;","myofibril [GO:0030016]; myosin filament [GO:0032982]; motor activity [GO:0003774]"
"CHOYP_MYSP.1.9|m.1097",37,"3",86,19.5,11.5,43.5,23,54.5,23.5,18.5,48.6428571429,38.6095050156,"0.7937343175",1490.693877551,32,"#VALUE!","2.4170707471","1.7292691233",132,18.5,113.5,24.25,132,340.5,"2.18","3.1",46.875,51.875,-5,54,113.5,4.0329266848,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_MYSP.1.9|m.1097",77,"9",86,21.5,52,9,80.5,77.5,132,25,48.6428571429,38.6095050156,"0.7937343175",1490.693877551,32,"#VALUE!","2.4170707471","1.7292691233",132,18.5,113.5,24.25,132,340.5,"2.18","3.1",46.875,51.875,-5,54,113.5,4.0329266848,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_MYSP.4.9|m.2302",16,"3",45.5,156,180,135.5,145.5,76,134.5,123,100.8571428571,41.8190953357,"0.4146369226",1748.8367346939,109.5,"#VALUE!","-0.6185966052","-0.3826552884",161.5,30.5,131,73.5,161.5,706,"0.4705882353","0.5448916409",82.25,113.25,-31,104,102.5,8.3619566505,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_MYSP.4.9|m.2302",62,"9",45.5,198.5,90,175.5,72.5,88,109.5,161.5,100.8571428571,41.8190953357,"0.4146369226",1748.8367346939,109.5,"#VALUE!","-0.6185966052","-0.3826552884",161.5,30.5,131,73.5,161.5,706,"0.4705882353","0.5448916409",82.25,113.25,-31,104,102.5,8.3619566505,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_MYSP.5.9|m.28124",37,"9",0,6,30,14,5,21,0,7.5,5.1428571429,6.9832160301,"1.3578475614",48.7653061224,3,"#VALUE!","4.0258099524","1.9477715533",21,0,21,0,21,36,"1.5333333333","2.8",8.125,3.75,4.375,21,7.5,0.4263887244,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_MYSP.5.9|m.28124","O96064","MYSP_MYTGA","77","839","190","2","3","840","7","843","0","1213","1","O96064","MYSP_MYTGA","reviewed","Paramyosin","","Mytilus galloprovincialis (Mediterranean mussel)","864","","GO:0003774; GO:0030016; GO:0032982","","","","PF01576;","myofibril [GO:0030016]; myosin filament [GO:0032982]; motor activity [GO:0003774]"
"CHOYP_MYSP.5.9|m.28124",48,"3",0,15,20.5,0,2,11.5,0,4.5,5.1428571429,6.9832160301,"1.3578475614",48.7653061224,3,"#VALUE!","4.0258099524","1.9477715533",21,0,21,0,21,36,"1.5333333333","2.8",8.125,3.75,4.375,21,7.5,0.4263887244,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_MYSP.5.9|m.28124","O96064","MYSP_MYTGA","77","839","190","2","3","840","7","843","0","1213","1","O96064","MYSP_MYTGA","reviewed","Paramyosin","","Mytilus galloprovincialis (Mediterranean mussel)","864","","GO:0003774; GO:0030016; GO:0032982","","","","PF01576;","myofibril [GO:0030016]; myosin filament [GO:0032982]; motor activity [GO:0003774]"
"CHOYP_MYSP.8.9|m.44813",63,"9",102,69.5,139,125.5,117,101,0,131.5,95.5,40.9912882731,"0.4292281495",1680.2857142857,113.5,"#VALUE!","4.9760019405","-2.1443020688",131.5,0,131.5,94.75,131.5,668.5,"0.7604562738","0.7680608365",108.75,83.375,25.375,20,131.5,7.9178017292,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_MYSP.8.9|m.44813","O96064","MYSP_MYTGA","79.36","688","142","0","12","699","177","864","0","998","1","O96064","MYSP_MYTGA","reviewed","Paramyosin","","Mytilus galloprovincialis (Mediterranean mussel)","864","","GO:0003774; GO:0030016; GO:0032982","","","","PF01576;","myofibril [GO:0030016]; myosin filament [GO:0032982]; motor activity [GO:0003774]"
"CHOYP_MYSP.8.9|m.44813",12,"3",102,133.5,125.5,130.5,127.5,100,114,113.5,95.5,40.9912882731,"0.4292281495",1680.2857142857,113.5,"#VALUE!","4.9760019405","-2.1443020688",131.5,0,131.5,94.75,131.5,668.5,"0.7604562738","0.7680608365",108.75,83.375,25.375,20,131.5,7.9178017292,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_MYSP.8.9|m.44813","O96064","MYSP_MYTGA","79.36","688","142","0","12","699","177","864","0","998","1","O96064","MYSP_MYTGA","reviewed","Paramyosin","","Mytilus galloprovincialis (Mediterranean mussel)","864","","GO:0003774; GO:0030016; GO:0032982","","","","PF01576;","myofibril [GO:0030016]; myosin filament [GO:0032982]; motor activity [GO:0003774]"
"CHOYP_NEMVEDRAFT_V1G120119.1.2|m.6082",28,"3",43.5,45,69.5,70,55,48,46.5,42.5,54.4285714286,20.1944627691,"0.371026875",407.8163265306,46.5,"#VALUE!","0.1708615181","0.5343287087",91,24.5,66.5,43.5,91,381,"0.676056338","0.8591549296",45,62.25,-17.25,36.5,48.5,4.5126139998,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_NEMVEDRAFT_V1G120119.1.2|m.6082","Q7Z304","MAMC2_HUMAN","32.48","157","100","4","241","392","509","664","1.00E-14","79.3","1","Q7Z304","MAMC2_HUMAN","reviewed","MAM domain-containing protein 2 (MAM domain-containing proteoglycan) (Mamcan)","MAMDC2","Homo sapiens (Human)","686","","GO:0005578; GO:0005783; GO:0016020","","","cd06263;","PF00629;","endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; proteinaceous extracellular matrix [GO:0005578]"
"CHOYP_NEMVEDRAFT_V1G120119.1.2|m.6082",71,"9",43.5,55,47.5,40.5,58,61,91,71,54.4285714286,20.1944627691,"0.371026875",407.8163265306,46.5,"#VALUE!","0.1708615181","0.5343287087",91,24.5,66.5,43.5,91,381,"0.676056338","0.8591549296",45,62.25,-17.25,36.5,48.5,4.5126139998,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_NEMVEDRAFT_V1G120119.1.2|m.6082","Q7Z304","MAMC2_HUMAN","32.48","157","100","4","241","392","509","664","1.00E-14","79.3","1","Q7Z304","MAMC2_HUMAN","reviewed","MAM domain-containing protein 2 (MAM domain-containing proteoglycan) (Mamcan)","MAMDC2","Homo sapiens (Human)","686","","GO:0005578; GO:0005783; GO:0016020","","","cd06263;","PF00629;","endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; proteinaceous extracellular matrix [GO:0005578]"
"CHOYP_NEMVEDRAFT_V1G180651.1.2|m.2808",37,"3",10,18,24,14.5,15,18,12.5,15.5,13.0714285714,4.4435231471,"0.3399416615",19.7448979592,13.5,"#VALUE!","0.5635771889","-0.4437105203",20,5,15,11,20,91.5,"1.1612903226","0.8709677419",12.25,15.125,-2.875,13,10.5,1.0837380078,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_NEMVEDRAFT_V1G180651.1.2|m.2808","P06797","CATL1_MOUSE","56.52","322","130","6","67","381","15","333","2.00E-122","363","1","P06797","CATL1_MOUSE","reviewed","Cathepsin L1 (EC 3.4.22.15) (Cathepsin L) (Major excreted protein) (MEP) (p39 cysteine proteinase) [Cleaved into: Cathepsin L1 heavy chain; Cathepsin L1 light chain]","Ctsl Ctsl1","Mus musculus (Mouse)","334","autophagic cell death [GO:0048102]; cell communication [GO:0007154]; cellular response to starvation [GO:0009267]; decidualization [GO:0046697]; hair follicle morphogenesis [GO:0031069]; male gonad development [GO:0008584]; multicellular organism aging [GO:0010259]; negative regulation of keratinocyte proliferation [GO:0010839]; nerve development [GO:0021675]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of actin cytoskeleton reorganization [GO:2000249]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to gonadotropin [GO:0034698]; response to odorant [GO:1990834]; response to organic cyclic compound [GO:0014070]; Sertoli cell differentiation [GO:0060008]; spermatogenesis [GO:0007283]","GO:0004177; GO:0004197; GO:0005615; GO:0005634; GO:0005730; GO:0005737; GO:0005764; GO:0005773; GO:0005902; GO:0006508; GO:0007154; GO:0007283; GO:0008584; GO:0009267; GO:0009749; GO:0009897; GO:0010259; GO:0010839; GO:0014070; GO:0016485; GO:0016540; GO:0016807; GO:0021675; GO:0030141; GO:0031069; GO:0031410; GO:0034698; GO:0042277; GO:0042393; GO:0043005; GO:0043204; GO:0045177; GO:0046697; GO:0048102; GO:0051384; GO:0051603; GO:0060008; GO:0070062; GO:1990834; GO:2000249","","","","PF08246;PF00112;","apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764]; microvillus [GO:0005902]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; secretory granule [GO:0030141]; vacuole [GO:0005773]; aminopeptidase activity [GO:0004177]; cysteine-type carboxypeptidase activity [GO:0016807]; cysteine-type endopeptidase activity [GO:0004197]; histone binding [GO:0042393]; peptide binding [GO:0042277]; autophagic cell death [GO:0048102]; cell communication [GO:0007154]; cellular response to starvation [GO:0009267]; decidualization [GO:0046697]; hair follicle morphogenesis [GO:0031069]; male gonad development [GO:0008584]; multicellular organism aging [GO:0010259]; negative regulation of keratinocyte proliferation [GO:0010839]; nerve development [GO:0021675]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of actin cytoskeleton reorganization [GO:2000249]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to gonadotropin [GO:0034698]; response to odorant [GO:1990834]; response to organic cyclic compound [GO:0014070]; Sertoli cell differentiation [GO:0060008]; spermatogenesis [GO:0007283]"
"CHOYP_NEMVEDRAFT_V1G180651.1.2|m.2808",48,"9",10,16,14,8.5,10.5,13.5,9.5,15.5,13.0714285714,4.4435231471,"0.3399416615",19.7448979592,13.5,"#VALUE!","0.5635771889","-0.4437105203",20,5,15,11,20,91.5,"1.1612903226","0.8709677419",12.25,15.125,-2.875,13,10.5,1.0837380078,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_NEMVEDRAFT_V1G180651.1.2|m.2808","P06797","CATL1_MOUSE","56.52","322","130","6","67","381","15","333","2.00E-122","363","1","P06797","CATL1_MOUSE","reviewed","Cathepsin L1 (EC 3.4.22.15) (Cathepsin L) (Major excreted protein) (MEP) (p39 cysteine proteinase) [Cleaved into: Cathepsin L1 heavy chain; Cathepsin L1 light chain]","Ctsl Ctsl1","Mus musculus (Mouse)","334","autophagic cell death [GO:0048102]; cell communication [GO:0007154]; cellular response to starvation [GO:0009267]; decidualization [GO:0046697]; hair follicle morphogenesis [GO:0031069]; male gonad development [GO:0008584]; multicellular organism aging [GO:0010259]; negative regulation of keratinocyte proliferation [GO:0010839]; nerve development [GO:0021675]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of actin cytoskeleton reorganization [GO:2000249]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to gonadotropin [GO:0034698]; response to odorant [GO:1990834]; response to organic cyclic compound [GO:0014070]; Sertoli cell differentiation [GO:0060008]; spermatogenesis [GO:0007283]","GO:0004177; GO:0004197; GO:0005615; GO:0005634; GO:0005730; GO:0005737; GO:0005764; GO:0005773; GO:0005902; GO:0006508; GO:0007154; GO:0007283; GO:0008584; GO:0009267; GO:0009749; GO:0009897; GO:0010259; GO:0010839; GO:0014070; GO:0016485; GO:0016540; GO:0016807; GO:0021675; GO:0030141; GO:0031069; GO:0031410; GO:0034698; GO:0042277; GO:0042393; GO:0043005; GO:0043204; GO:0045177; GO:0046697; GO:0048102; GO:0051384; GO:0051603; GO:0060008; GO:0070062; GO:1990834; GO:2000249","","","","PF08246;PF00112;","apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764]; microvillus [GO:0005902]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; secretory granule [GO:0030141]; vacuole [GO:0005773]; aminopeptidase activity [GO:0004177]; cysteine-type carboxypeptidase activity [GO:0016807]; cysteine-type endopeptidase activity [GO:0004197]; histone binding [GO:0042393]; peptide binding [GO:0042277]; autophagic cell death [GO:0048102]; cell communication [GO:0007154]; cellular response to starvation [GO:0009267]; decidualization [GO:0046697]; hair follicle morphogenesis [GO:0031069]; male gonad development [GO:0008584]; multicellular organism aging [GO:0010259]; negative regulation of keratinocyte proliferation [GO:0010839]; nerve development [GO:0021675]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of actin cytoskeleton reorganization [GO:2000249]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to gonadotropin [GO:0034698]; response to odorant [GO:1990834]; response to organic cyclic compound [GO:0014070]; Sertoli cell differentiation [GO:0060008]; spermatogenesis [GO:0007283]"
"CHOYP_NEMVEDRAFT_V1G204928.2.2|m.27972",48,"3",8,13,9,10,11.5,11.5,13.5,11.5,11.7142857143,3.6337420977,"0.3101974961",13.2040816327,13,"#VALUE!","-0.1958686985","-0.9169868702",15.5,5,10.5,9.75,15.5,82,"0.7419354839","0.5161290323",9.5,13.875,-4.375,8.5,4,0.9712187611,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_NEMVEDRAFT_V1G204928.2.2|m.27972","Q9R013","CATF_MOUSE","54.82","301","132","3","467","765","164","462","1.00E-106","340","1","Q9R013","CATF_MOUSE","reviewed","Cathepsin F (EC 3.4.22.41)","Ctsf","Mus musculus (Mouse)","462","proteolysis involved in cellular protein catabolic process [GO:0051603]","GO:0004197; GO:0005615; GO:0005764; GO:0008234; GO:0051603; GO:0070062; GO:1903561","","","","PF08246;PF00112;","extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; proteolysis involved in cellular protein catabolic process [GO:0051603]"
"CHOYP_NEMVEDRAFT_V1G204928.2.2|m.27972",37,"9",8,8.5,13,12.5,19,8,15.5,15.5,11.7142857143,3.6337420977,"0.3101974961",13.2040816327,13,"#VALUE!","-0.1958686985","-0.9169868702",15.5,5,10.5,9.75,15.5,82,"0.7419354839","0.5161290323",9.5,13.875,-4.375,8.5,4,0.9712187611,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_NEMVEDRAFT_V1G204928.2.2|m.27972","Q9R013","CATF_MOUSE","54.82","301","132","3","467","765","164","462","1.00E-106","340","1","Q9R013","CATF_MOUSE","reviewed","Cathepsin F (EC 3.4.22.41)","Ctsf","Mus musculus (Mouse)","462","proteolysis involved in cellular protein catabolic process [GO:0051603]","GO:0004197; GO:0005615; GO:0005764; GO:0008234; GO:0051603; GO:0070062; GO:1903561","","","","PF08246;PF00112;","extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; proteolysis involved in cellular protein catabolic process [GO:0051603]"
"CHOYP_NEMVEDRAFT_V1G206950.1.1|m.37574",48,"9",11,11.5,11,11,13.5,10,8.5,10,10,1.4880476183,"0.1488047618",2.2142857143,10,"#VALUE!","1.7413111342","0.8850884465",13,8,5,9.25,13,70,"1.75","1",12.125,9.75,2.375,9.5,2,0.8290891863,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_NEMVEDRAFT_V1G206950.1.1|m.37574",37,"3",11,13,16,14,21,17.5,13,10.5,10,1.4880476183,"0.1488047618",2.2142857143,10,"#VALUE!","1.7413111342","0.8850884465",13,8,5,9.25,13,70,"1.75","1",12.125,9.75,2.375,9.5,2,0.8290891863,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_NEMVEDRAFT_V1G236658.3.6|m.24704",48,"3",12,15.5,14,12,10.5,12,8.5,8.5,10.9285714286,3.1671141825,"0.2898012977",10.0306122449,10,"#VALUE!","-1.7442998937","0.1962697195",15.5,6.5,9,8.5,15.5,76.5,"0.7741935484","0.935483871",10.375,11.75,-1.375,8,7,0.9060760393,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_NEMVEDRAFT_V1G236658.3.6|m.24704","P74148","Y1388_SYNY3","33.98","103","66","1","52","154","54","154","2.00E-14","70.9","1","P74148","Y1388_SYNY3","reviewed","Universal stress protein Sll1388 (USP Sll1388)","sll1388","Synechocystis sp. (strain PCC 6803 / Kazusa)","154","response to stress [GO:0006950]","GO:0006950","","","","PF00582;","response to stress [GO:0006950]"
"CHOYP_NEMVEDRAFT_V1G236658.3.6|m.24704",37,"9",12,13.5,9.5,9.5,14,14.5,13,15.5,10.9285714286,3.1671141825,"0.2898012977",10.0306122449,10,"#VALUE!","-1.7442998937","0.1962697195",15.5,6.5,9,8.5,15.5,76.5,"0.7741935484","0.935483871",10.375,11.75,-1.375,8,7,0.9060760393,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_NEMVEDRAFT_V1G236658.3.6|m.24704","P74148","Y1388_SYNY3","33.98","103","66","1","52","154","54","154","2.00E-14","70.9","1","P74148","Y1388_SYNY3","reviewed","Universal stress protein Sll1388 (USP Sll1388)","sll1388","Synechocystis sp. (strain PCC 6803 / Kazusa)","154","response to stress [GO:0006950]","GO:0006950","","","","PF00582;","response to stress [GO:0006950]"
"CHOYP_NEMVEDRAFT_V1G242065.1.1|m.21817",17,"3",104.5,93.5,109,134,110,114.5,93,96,109.9285714286,32.0862994477,"0.2918831659",1029.5306122449,97,"#VALUE!","-0.6582876378","-0.1684490544",154.5,55.5,99,94.5,154.5,769.5,"0.7842465753","0.8732876712",97.625,123.375,-25.75,72,58.5,9.1140589838,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_NEMVEDRAFT_V1G242065.1.1|m.21817","O17320","ACT_CRAGI","94.68","301","16","0","1","301","1","301","0","600","1","O17320","ACT_CRAGI","reviewed","Actin","","Crassostrea gigas (Pacific oyster) (Crassostrea angulata)","376","","GO:0005524; GO:0005737; GO:0005856","","","","PF00022;","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]"
"CHOYP_NEMVEDRAFT_V1G242065.1.1|m.21817",64,"9",104.5,102,102.5,92.5,142.5,127.5,154.5,146,109.9285714286,32.0862994477,"0.2918831659",1029.5306122449,97,"#VALUE!","-0.6582876378","-0.1684490544",154.5,55.5,99,94.5,154.5,769.5,"0.7842465753","0.8732876712",97.625,123.375,-25.75,72,58.5,9.1140589838,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_NEMVEDRAFT_V1G242065.1.1|m.21817","O17320","ACT_CRAGI","94.68","301","16","0","1","301","1","301","0","600","1","O17320","ACT_CRAGI","reviewed","Actin","","Crassostrea gigas (Pacific oyster) (Crassostrea angulata)","376","","GO:0005524; GO:0005737; GO:0005856","","","","PF00022;","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]"
"CHOYP_NF70.1.4|m.31159",48,"3",0,0,0,0,3.5,0,0,2,9.7142857143,10.2742992213,"1.0576484493",105.5612244898,5,"#VALUE!","2.6548990126","1.6380796715",32,0,32,3,32,68,"0","0.2580645161",3.375,13.625,-10.25,9.5,30,0.8054009238,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_NF70.1.4|m.31159","P48675","DESM_RAT","31.58","399","218","5","66","464","71","414","1.00E-37","152","1","P48675","DESM_RAT","reviewed","Desmin","Des","Rattus norvegicus (Rat)","469","intermediate filament organization [GO:0045109]","GO:0005198; GO:0005921; GO:0014704; GO:0030018; GO:0042383; GO:0045098; GO:0045109","","","","PF00038;PF04732;","gap junction [GO:0005921]; intercalated disc [GO:0014704]; sarcolemma [GO:0042383]; type III intermediate filament [GO:0045098]; Z disc [GO:0030018]; structural molecule activity [GO:0005198]; intermediate filament organization [GO:0045109]"
"CHOYP_NF70.1.4|m.31159",37,"9",0,0,0,0,7,4,32,15.5,9.7142857143,10.2742992213,"1.0576484493",105.5612244898,5,"#VALUE!","2.6548990126","1.6380796715",32,0,32,3,32,68,"0","0.2580645161",3.375,13.625,-10.25,9.5,30,0.8054009238,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_NF70.1.4|m.31159","P48675","DESM_RAT","31.58","399","218","5","66","464","71","414","1.00E-37","152","1","P48675","DESM_RAT","reviewed","Desmin","Des","Rattus norvegicus (Rat)","469","intermediate filament organization [GO:0045109]","GO:0005198; GO:0005921; GO:0014704; GO:0030018; GO:0042383; GO:0045098; GO:0045109","","","","PF00038;PF04732;","gap junction [GO:0005921]; intercalated disc [GO:0014704]; sarcolemma [GO:0042383]; type III intermediate filament [GO:0045098]; Z disc [GO:0030018]; structural molecule activity [GO:0005198]; intermediate filament organization [GO:0045109]"
"CHOYP_NRG.1.1|m.10622",48,"9",11,17.5,10,12.5,14,2.5,11,5,4.5,4.0620192023,"0.9026709338",16.5,2.5,"#VALUE!","-1.2247933884","0.7832199618",11,0,11,1.5,11,31.5,"3","0.5",7.125,4.5,2.625,14,11,0.3730901338,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_NRG.1.1|m.10622","P20241","NRG_DROME","33.94","1158","692","23","68","1197","26","1138","0","592","1","P20241","NRG_DROME","reviewed","Neuroglian","Nrg CG1634","Drosophila melanogaster (Fruit fly)","1302","axon ensheathment [GO:0008366]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell adhesion involved in heart morphogenesis [GO:0061343]; central complex development [GO:0048036]; dendrite morphogenesis [GO:0048813]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of glial blood-brain barrier [GO:0060857]; female courtship behavior [GO:0008050]; imaginal disc morphogenesis [GO:0007560]; male courtship behavior [GO:0008049]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; nerve maturation [GO:0021682]; neuron cell-cell adhesion [GO:0007158]; neuron projection morphogenesis [GO:0048812]; photoreceptor cell axon guidance [GO:0072499]; regulation of female receptivity [GO:0045924]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synapse organization [GO:0050808]","GO:0005509; GO:0005886; GO:0005918; GO:0005919; GO:0005923; GO:0007158; GO:0007173; GO:0007409; GO:0007560; GO:0008045; GO:0008049; GO:0008050; GO:0008366; GO:0016021; GO:0016319; GO:0016328; GO:0019991; GO:0021682; GO:0030175; GO:0035011; GO:0035151; GO:0045924; GO:0048036; GO:0048675; GO:0048812; GO:0048813; GO:0050808; GO:0060857; GO:0061343; GO:0072499","","","cd00063;","PF13882;PF00041;PF07679;PF00047;","bicellular tight junction [GO:0005923]; filopodium [GO:0030175]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; septate junction [GO:0005918]; calcium ion binding [GO:0005509]; axon ensheathment [GO:0008366]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell adhesion involved in heart morphogenesis [GO:0061343]; central complex development [GO:0048036]; dendrite morphogenesis [GO:0048813]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of glial blood-brain barrier [GO:0060857]; female courtship behavior [GO:0008050]; imaginal disc morphogenesis [GO:0007560]; male courtship behavior [GO:0008049]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; nerve maturation [GO:0021682]; neuron cell-cell adhesion [GO:0007158]; neuron projection morphogenesis [GO:0048812]; photoreceptor cell axon guidance [GO:0072499]; regulation of female receptivity [GO:0045924]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synapse organization [GO:0050808]"
"CHOYP_NRG.1.1|m.10622",37,"3",11,17,14,21,15,15,10,2,4.5,4.0620192023,"0.9026709338",16.5,2.5,"#VALUE!","-1.2247933884","0.7832199618",11,0,11,1.5,11,31.5,"3","0.5",7.125,4.5,2.625,14,11,0.3730901338,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_NRG.1.1|m.10622","P20241","NRG_DROME","33.94","1158","692","23","68","1197","26","1138","0","592","1","P20241","NRG_DROME","reviewed","Neuroglian","Nrg CG1634","Drosophila melanogaster (Fruit fly)","1302","axon ensheathment [GO:0008366]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell adhesion involved in heart morphogenesis [GO:0061343]; central complex development [GO:0048036]; dendrite morphogenesis [GO:0048813]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of glial blood-brain barrier [GO:0060857]; female courtship behavior [GO:0008050]; imaginal disc morphogenesis [GO:0007560]; male courtship behavior [GO:0008049]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; nerve maturation [GO:0021682]; neuron cell-cell adhesion [GO:0007158]; neuron projection morphogenesis [GO:0048812]; photoreceptor cell axon guidance [GO:0072499]; regulation of female receptivity [GO:0045924]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synapse organization [GO:0050808]","GO:0005509; GO:0005886; GO:0005918; GO:0005919; GO:0005923; GO:0007158; GO:0007173; GO:0007409; GO:0007560; GO:0008045; GO:0008049; GO:0008050; GO:0008366; GO:0016021; GO:0016319; GO:0016328; GO:0019991; GO:0021682; GO:0030175; GO:0035011; GO:0035151; GO:0045924; GO:0048036; GO:0048675; GO:0048812; GO:0048813; GO:0050808; GO:0060857; GO:0061343; GO:0072499","","","cd00063;","PF13882;PF00041;PF07679;PF00047;","bicellular tight junction [GO:0005923]; filopodium [GO:0030175]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; septate junction [GO:0005918]; calcium ion binding [GO:0005509]; axon ensheathment [GO:0008366]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell adhesion involved in heart morphogenesis [GO:0061343]; central complex development [GO:0048036]; dendrite morphogenesis [GO:0048813]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of glial blood-brain barrier [GO:0060857]; female courtship behavior [GO:0008050]; imaginal disc morphogenesis [GO:0007560]; male courtship behavior [GO:0008049]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; nerve maturation [GO:0021682]; neuron cell-cell adhesion [GO:0007158]; neuron projection morphogenesis [GO:0048812]; photoreceptor cell axon guidance [GO:0072499]; regulation of female receptivity [GO:0045924]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synapse organization [GO:0050808]"
"CHOYP_NRP.2.4|m.39720",48,"3",0,5,17,14,15,11,10.5,8.5,11.2142857143,3.8345901518,"0.3419379753",14.7040816327,10.5,"#VALUE!","0.3021094823","1.0004225435",18.5,6.5,12,8.75,18.5,78.5,"1.2222222222","1.6666666667",10.75,11.625,-0.875,8.5,10,0.9297643018,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_NRP.2.4|m.39720","H2A0M0","NRP_PINMG","29.27","246","155","7","327","565","450","683","2.00E-28","124","1","H2A0M0","NRP_PINMG","reviewed","Asparagine-rich protein (Prism uncharacterized shell protein 1) (PUSP1)","","Pinctada margaritifera (Black-lipped pearl oyster)","686","","GO:0005576","","","","","extracellular region [GO:0005576]"
"CHOYP_NRP.2.4|m.39720",37,"9",0,16.5,19.5,15,14.5,15,18.5,9,11.2142857143,3.8345901518,"0.3419379753",14.7040816327,10.5,"#VALUE!","0.3021094823","1.0004225435",18.5,6.5,12,8.75,18.5,78.5,"1.2222222222","1.6666666667",10.75,11.625,-0.875,8.5,10,0.9297643018,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_NRP.2.4|m.39720","H2A0M0","NRP_PINMG","29.27","246","155","7","327","565","450","683","2.00E-28","124","1","H2A0M0","NRP_PINMG","reviewed","Asparagine-rich protein (Prism uncharacterized shell protein 1) (PUSP1)","","Pinctada margaritifera (Black-lipped pearl oyster)","686","","GO:0005576","","","","","extracellular region [GO:0005576]"
"CHOYP_NUCL.1.2|m.19135",37,"3",13,19,17.5,18.5,18,16,16.5,12.5,13.6428571429,1.8070158058,"0.1324514203",3.2653061224,13.5,"#VALUE!","-1.446375","0.2881954903",16.5,11.5,5,12,16.5,95.5,"1.3913043478","1",14.625,13.25,1.375,5,4,1.1311145327,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_NUCL.1.2|m.19135","P20397","NUCL_XENLA","33.33","312","152","7","96","372","196","486","4.00E-27","117","1","P20397","NUCL_XENLA","reviewed","Nucleolin (Protein C23)","ncl","Xenopus laevis (African clawed frog)","651","","GO:0000166; GO:0003677; GO:0003723; GO:0005730","","","cd12403;cd12404;cd12405;cd12406;","PF00076;","nucleolus [GO:0005730]; DNA binding [GO:0003677]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]"
"CHOYP_NUCL.1.2|m.19135",48,"9",13,14.5,15,14,14,11.5,13.5,11.5,13.6428571429,1.8070158058,"0.1324514203",3.2653061224,13.5,"#VALUE!","-1.446375","0.2881954903",16.5,11.5,5,12,16.5,95.5,"1.3913043478","1",14.625,13.25,1.375,5,4,1.1311145327,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_NUCL.1.2|m.19135","P20397","NUCL_XENLA","33.33","312","152","7","96","372","196","486","4.00E-27","117","1","P20397","NUCL_XENLA","reviewed","Nucleolin (Protein C23)","ncl","Xenopus laevis (African clawed frog)","651","","GO:0000166; GO:0003677; GO:0003723; GO:0005730","","","cd12403;cd12404;cd12405;cd12406;","PF00076;","nucleolus [GO:0005730]; DNA binding [GO:0003677]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]"
"CHOYP_ODO1.2.2|m.23540",28,"3",46,44,52.5,48,45,40,33.5,34,32.8571428571,7.42925821,"0.2261078586",55.193877551,34,"#VALUE!","5.1541274187","-2.1385656096",39.5,15.5,24,33.5,39.5,230,"1.038961039","0.8701298701",30.625,36.875,-6.25,24.5,5.5,2.7241501836,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ODO1.2.2|m.23540","Q60HE2","ODO1_MACFA","59.24","1023","368","12","4","1000","20","1019","0","1216","1","Q60HE2","ODO1_MACFA","reviewed","2-oxoglutarate dehydrogenase, mitochondrial (EC 1.2.4.2) (2-oxoglutarate dehydrogenase complex component E1) (OGDC-E1) (Alpha-ketoglutarate dehydrogenase)","OGDH QccE-15394","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","1023","generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]","GO:0004591; GO:0005759; GO:0006091; GO:0006096; GO:0006099; GO:0030976; GO:0031966; GO:0046872","","","","PF16078;PF00676;PF16870;PF02779;","mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]"
"CHOYP_ODO1.2.2|m.23540",37,"9",46,45.5,46,42.5,44.5,33.5,39.5,38.5,32.8571428571,7.42925821,"0.2261078586",55.193877551,34,"#VALUE!","5.1541274187","-2.1385656096",39.5,15.5,24,33.5,39.5,230,"1.038961039","0.8701298701",30.625,36.875,-6.25,24.5,5.5,2.7241501836,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_ODO1.2.2|m.23540","Q60HE2","ODO1_MACFA","59.24","1023","368","12","4","1000","20","1019","0","1216","1","Q60HE2","ODO1_MACFA","reviewed","2-oxoglutarate dehydrogenase, mitochondrial (EC 1.2.4.2) (2-oxoglutarate dehydrogenase complex component E1) (OGDC-E1) (Alpha-ketoglutarate dehydrogenase)","OGDH QccE-15394","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","1023","generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]","GO:0004591; GO:0005759; GO:0006091; GO:0006096; GO:0006099; GO:0030976; GO:0031966; GO:0046872","","","","PF16078;PF00676;PF16870;PF02779;","mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]"
"CHOYP_PAN2.1.1|m.44691",72,"9",80,93,0,0,60,188,0,146.5,47.7857142857,76.3655948817,"1.5980841978",5831.7040816327,0,"#VALUE!","-0.2832277982","1.3192503216",188,0,188,0,188,334.5,"0.409556314","1.2832764505",62,36.625,25.375,188,146.5,3.9618618974,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_PAN2.1.1|m.44691","Q25381","ACTM_LYTPI","71.3","108","30","1","13","120","27","133","1.00E-46","159","1","Q25381","ACTM_LYTPI","reviewed","Actin, muscle (LPM) (Fragment)","","Lytechinus pictus (Painted sea urchin)","172","","GO:0005524; GO:0005737; GO:0005856","","","","PF00022;","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]"
"CHOYP_PAN2.1.1|m.44691",33,"3",80,113.5,0,103,0,60,0,0,47.7857142857,76.3655948817,"1.5980841978",5831.7040816327,0,"#VALUE!","-0.2832277982","1.3192503216",188,0,188,0,188,334.5,"0.409556314","1.2832764505",62,36.625,25.375,188,146.5,3.9618618974,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_PAN2.1.1|m.44691","Q25381","ACTM_LYTPI","71.3","108","30","1","13","120","27","133","1.00E-46","159","1","Q25381","ACTM_LYTPI","reviewed","Actin, muscle (LPM) (Fragment)","","Lytechinus pictus (Painted sea urchin)","172","","GO:0005524; GO:0005737; GO:0005856","","","","PF00022;","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]"
"CHOYP_PCKG.1.2|m.43785",23,"9",66.5,57,61.5,51.5,63,66,80.5,80.5,65.5714285714,12.2165829085,"0.1863095433",149.2448979592,65.5,"#VALUE!","1.3002021673","-0.7470738582",80.5,41.5,39,62.5,80.5,459,"0.6708074534","0.8198757764",55.875,72.375,-16.5,24.5,17.5,5.4364562359,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_PCKG.1.2|m.43785","P29190","PCKG_HAECO","66.4","619","206","2","16","633","1","618","0","889","1","P29190","PCKG_HAECO","reviewed","Phosphoenolpyruvate carboxykinase [GTP] (PEPCK) (EC 4.1.1.32)","PEPCK","Haemonchus contortus (Barber pole worm)","619","gluconeogenesis [GO:0006094]","GO:0004613; GO:0005525; GO:0006094; GO:0046872","","","","PF00821;","GTP binding [GO:0005525]; metal ion binding [GO:0046872]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; gluconeogenesis [GO:0006094]"
"CHOYP_PCKG.1.2|m.43785",28,"3",66.5,58,57,53.5,48.5,54,62,65.5,65.5714285714,12.2165829085,"0.1863095433",149.2448979592,65.5,"#VALUE!","1.3002021673","-0.7470738582",80.5,41.5,39,62.5,80.5,459,"0.6708074534","0.8198757764",55.875,72.375,-16.5,24.5,17.5,5.4364562359,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_PCKG.1.2|m.43785","P29190","PCKG_HAECO","66.4","619","206","2","16","633","1","618","0","889","1","P29190","PCKG_HAECO","reviewed","Phosphoenolpyruvate carboxykinase [GTP] (PEPCK) (EC 4.1.1.32)","PEPCK","Haemonchus contortus (Barber pole worm)","619","gluconeogenesis [GO:0006094]","GO:0004613; GO:0005525; GO:0006094; GO:0046872","","","","PF00821;","GTP binding [GO:0005525]; metal ion binding [GO:0046872]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; gluconeogenesis [GO:0006094]"
"CHOYP_PHUM_PHUM009400.1.1|m.35298",37,"3",22.5,26.5,20,23,21.5,9,4,6,6.5714285714,1.7408653724,"0.2649142958",3.0306122449,6,"#VALUE!","-1.0671768187","0.3185524262",9,4,5,5.5,9,46,"1","0.6111111111",6,7.75,-1.75,5,3,0.5448300367,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_PHUM_PHUM009400.1.1|m.35298","Q9U943","APLP_LOCMI","28.85","1168","731","32","5","1104","9","1144","7.00E-120","433","1","Q9U943","APLP_LOCMI","reviewed","Apolipophorins [Cleaved into: Apolipophorin-2 (Apolipophorin II) (apoLp-2); Apolipophorin-1 (Apolipophorin I) (apoLp-1)]","","Locusta migratoria (Migratory locust)","3380","Wnt signaling pathway [GO:0016055]","GO:0005319; GO:0005576; GO:0008289; GO:0016055","","","","PF08742;PF06448;PF09172;PF01347;PF00094;","extracellular region [GO:0005576]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; Wnt signaling pathway [GO:0016055]"
"CHOYP_PHUM_PHUM009400.1.1|m.35298",48,"9",22.5,24,17.5,15,11.5,5.5,9,9,6.5714285714,1.7408653724,"0.2649142958",3.0306122449,6,"#VALUE!","-1.0671768187","0.3185524262",9,4,5,5.5,9,46,"1","0.6111111111",6,7.75,-1.75,5,3,0.5448300367,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_PHUM_PHUM009400.1.1|m.35298","Q9U943","APLP_LOCMI","28.85","1168","731","32","5","1104","9","1144","7.00E-120","433","1","Q9U943","APLP_LOCMI","reviewed","Apolipophorins [Cleaved into: Apolipophorin-2 (Apolipophorin II) (apoLp-2); Apolipophorin-1 (Apolipophorin I) (apoLp-1)]","","Locusta migratoria (Migratory locust)","3380","Wnt signaling pathway [GO:0016055]","GO:0005319; GO:0005576; GO:0008289; GO:0016055","","","","PF08742;PF06448;PF09172;PF01347;PF00094;","extracellular region [GO:0005576]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; Wnt signaling pathway [GO:0016055]"
"CHOYP_PHUM_PHUM066670.2.3|m.42178",37,"3",11,22,10,18.5,17.5,10,19.5,10,7,5.8614966397,"0.8373566628",34.3571428571,4.5,"#VALUE!","2.3750130748","1.4557290091",19.5,0.5,19,3.5,19.5,49,"20","5",9.125,5.625,3.5,17,9.5,0.5803624304,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_PHUM_PHUM066670.2.3|m.42178","P98160","PGBM_HUMAN","35.99","2751","1520","64","1007","3650","194","2810","0","1591","1","P98160","PGBM_HUMAN","reviewed","Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide]","HSPG2","Homo sapiens (Human)","4391","angiogenesis [GO:0001525]; cellular protein metabolic process [GO:0044267]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; glycosaminoglycan metabolic process [GO:0030203]; retinoid metabolic process [GO:0001523]","GO:0001523; GO:0001525; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006024; GO:0006027; GO:0008022; GO:0022617; GO:0030198; GO:0030203; GO:0031012; GO:0043202; GO:0044267; GO:0070062","","","","PF00008;PF07679;PF13895;PF00052;PF00053;PF00054;PF00057;","basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; protein C-terminus binding [GO:0008022]; angiogenesis [GO:0001525]; cellular protein metabolic process [GO:0044267]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; glycosaminoglycan metabolic process [GO:0030203]; retinoid metabolic process [GO:0001523]"
"CHOYP_PHUM_PHUM066670.2.3|m.42178",48,"9",11,14,9.5,16.5,10.5,2.5,7.5,0.5,7,5.8614966397,"0.8373566628",34.3571428571,4.5,"#VALUE!","2.3750130748","1.4557290091",19.5,0.5,19,3.5,19.5,49,"20","5",9.125,5.625,3.5,17,9.5,0.5803624304,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_PHUM_PHUM066670.2.3|m.42178","P98160","PGBM_HUMAN","35.99","2751","1520","64","1007","3650","194","2810","0","1591","1","P98160","PGBM_HUMAN","reviewed","Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide]","HSPG2","Homo sapiens (Human)","4391","angiogenesis [GO:0001525]; cellular protein metabolic process [GO:0044267]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; glycosaminoglycan metabolic process [GO:0030203]; retinoid metabolic process [GO:0001523]","GO:0001523; GO:0001525; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006024; GO:0006027; GO:0008022; GO:0022617; GO:0030198; GO:0030203; GO:0031012; GO:0043202; GO:0044267; GO:0070062","","","","PF00008;PF07679;PF13895;PF00052;PF00053;PF00054;PF00057;","basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; protein C-terminus binding [GO:0008022]; angiogenesis [GO:0001525]; cellular protein metabolic process [GO:0044267]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; glycosaminoglycan metabolic process [GO:0030203]; retinoid metabolic process [GO:0001523]"
"CHOYP_PHUM_PHUM226120.2.7|m.2274",36,"3",23,13.5,20,35,19.5,21.5,200.5,104.5,73.9285714286,57.8331519925,"0.7822841815",3344.6734693878,52,"#VALUE!","2.9304625829","1.6851505326",200.5,22,178.5,35.25,200.5,517.5,"0.8958333333","2.1666666667",85.5,49.25,36.25,179,82.5,6.1293379131,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_PHUM_PHUM226120.2.7|m.2274","Q8WZ42","TITIN_HUMAN","31.58","2486","1574","57","1398","3814","18470","20897","0","1040","1","Q8WZ42","TITIN_HUMAN","reviewed","Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14)","TTN","Homo sapiens (Human)","34350","cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]","GO:0000794; GO:0002020; GO:0002576; GO:0003300; GO:0004674; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005859; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0019899; GO:0019901; GO:0030018; GO:0030049; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0060048; GO:0070062; GO:0097493","","","cd00063;","PF00041;PF07679;PF00069;PF02818;PF09042;","condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]"
"CHOYP_PHUM_PHUM226120.2.7|m.2274",37,"9",23,22.5,25.5,34,24.5,52,22,24,73.9285714286,57.8331519925,"0.7822841815",3344.6734693878,52,"#VALUE!","2.9304625829","1.6851505326",200.5,22,178.5,35.25,200.5,517.5,"0.8958333333","2.1666666667",85.5,49.25,36.25,179,82.5,6.1293379131,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_PHUM_PHUM226120.2.7|m.2274","Q8WZ42","TITIN_HUMAN","31.58","2486","1574","57","1398","3814","18470","20897","0","1040","1","Q8WZ42","TITIN_HUMAN","reviewed","Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14)","TTN","Homo sapiens (Human)","34350","cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]","GO:0000794; GO:0002020; GO:0002576; GO:0003300; GO:0004674; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005859; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0019899; GO:0019901; GO:0030018; GO:0030049; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0060048; GO:0070062; GO:0097493","","","cd00063;","PF00041;PF07679;PF00069;PF02818;PF09042;","condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]"
"CHOYP_PHUM_PHUM226120.5.7|m.43551",28,"3",33,64.5,43.5,22.5,26,49.5,39.5,45,37.8571428571,18.9033524723,"0.4993338389",357.3367346939,44,"#VALUE!","1.8685246044","-0.8974393495",66,0,66,32.75,66,265,"1.1123595506","1.4831460674",45.25,33.375,11.875,40,45,3.1386947767,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_PHUM_PHUM226120.5.7|m.43551","A2ASS6","TITIN_MOUSE","29.61","4701","2877","132","10714","15246","25708","30144","0","1600","1","A2ASS6","TITIN_MOUSE","reviewed","Titin (EC 2.7.11.1) (Connectin)","Ttn","Mus musculus (Mouse)","35213","actin filament organization [GO:0007015]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591]","GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0006941; GO:0007015; GO:0007507; GO:0007512; GO:0008307; GO:0019899; GO:0019901; GO:0021591; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043056; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0060048; GO:0060419; GO:0070062; GO:0071688; GO:0097493; GO:1901897","","","cd00063;","PF00041;PF07679;PF00069;PF02818;PF09042;","A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; extracellular exosome [GO:0070062]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; actin filament organization [GO:0007015]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591]"
"CHOYP_PHUM_PHUM226120.5.7|m.43551",44,"9",33,53.5,40.5,28.5,41,66,0,44.5,37.8571428571,18.9033524723,"0.4993338389",357.3367346939,44,"#VALUE!","1.8685246044","-0.8974393495",66,0,66,32.75,66,265,"1.1123595506","1.4831460674",45.25,33.375,11.875,40,45,3.1386947767,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_PHUM_PHUM226120.5.7|m.43551","A2ASS6","TITIN_MOUSE","29.61","4701","2877","132","10714","15246","25708","30144","0","1600","1","A2ASS6","TITIN_MOUSE","reviewed","Titin (EC 2.7.11.1) (Connectin)","Ttn","Mus musculus (Mouse)","35213","actin filament organization [GO:0007015]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591]","GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0006941; GO:0007015; GO:0007507; GO:0007512; GO:0008307; GO:0019899; GO:0019901; GO:0021591; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043056; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0060048; GO:0060419; GO:0070062; GO:0071688; GO:0097493; GO:1901897","","","cd00063;","PF00041;PF07679;PF00069;PF02818;PF09042;","A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; extracellular exosome [GO:0070062]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; actin filament organization [GO:0007015]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591]"
"CHOYP_PHUM_PHUM226120.7.7|m.54053",3,"3",179,250,251,239.5,215,245.5,42.5,130.5,196.2142857143,94.3378643656,"0.4807899895",8899.6326530612,188,"#VALUE!","-1.4704064806","-0.2701887653",307,42.5,264.5,129.25,307,1373.5,"0.8196994992","0.9282136895",173.5,231.25,-57.75,235.5,176.5,16.2679142485,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_PHUM_PHUM226120.7.7|m.54053","Q23551","UNC22_CAEEL","42.4","3344","1854","37","1383","4699","3842","7140","0","2639","1","Q23551","UNC22_CAEEL","reviewed","Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)","unc-22 ZK617.1","Caenorhabditis elegans","7158","adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of sarcomere organization [GO:0060298]","GO:0004674; GO:0005524; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0031672; GO:0035095; GO:0046872; GO:0051782; GO:0060298","","","cd00063;","PF00041;PF07679;PF00069;","A band [GO:0031672]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of sarcomere organization [GO:0060298]"
"CHOYP_PHUM_PHUM226120.7.7|m.54053",51,"9",179,258,244.5,201.5,276,278,307,299.5,196.2142857143,94.3378643656,"0.4807899895",8899.6326530612,188,"#VALUE!","-1.4704064806","-0.2701887653",307,42.5,264.5,129.25,307,1373.5,"0.8196994992","0.9282136895",173.5,231.25,-57.75,235.5,176.5,16.2679142485,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_PHUM_PHUM226120.7.7|m.54053","Q23551","UNC22_CAEEL","42.4","3344","1854","37","1383","4699","3842","7140","0","2639","1","Q23551","UNC22_CAEEL","reviewed","Twitchin (EC 2.7.11.1) (Uncoordinated protein 22)","unc-22 ZK617.1","Caenorhabditis elegans","7158","adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of sarcomere organization [GO:0060298]","GO:0004674; GO:0005524; GO:0008344; GO:0018105; GO:0018107; GO:0019901; GO:0031672; GO:0035095; GO:0046872; GO:0051782; GO:0060298","","","cd00063;","PF00041;PF07679;PF00069;","A band [GO:0031672]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of sarcomere organization [GO:0060298]"
"CHOYP_PHUM_PHUM289860.1.1|m.44779",23,"3",67.5,69,72.5,74.5,71,64.5,72,71.5,76,20.521765449,"0.2700232296",421.1428571429,72,"#VALUE!","0.7458396236","-0.3252734235",108.5,38.5,70,68.25,108.5,532,"0.7010869565","0.9184782609",64.875,84.25,-19.375,46,43.5,6.3010778159,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_PHUM_PHUM289860.1.1|m.44779","P37397","CNN3_RAT","35.81","296","172","8","9","301","11","291","2.00E-37","143","1","P37397","CNN3_RAT","reviewed","Calponin-3 (Calponin, acidic isoform) (Calponin, non-muscle isoform)","Cnn3","Rattus norvegicus (Rat)","330","actomyosin structure organization [GO:0031032]; cell-cell adhesion [GO:0098609]; epithelial cell differentiation [GO:0030855]; negative regulation of ATPase activity [GO:0032780]","GO:0005829; GO:0005874; GO:0005884; GO:0005913; GO:0005925; GO:0008017; GO:0014069; GO:0030425; GO:0030674; GO:0030855; GO:0031032; GO:0032780; GO:0043025; GO:0043197; GO:0098609","","","cd00014;","PF00402;PF00307;","actin filament [GO:0005884]; cell-cell adherens junction [GO:0005913]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; focal adhesion [GO:0005925]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; microtubule binding [GO:0008017]; protein binding, bridging [GO:0030674]; actomyosin structure organization [GO:0031032]; cell-cell adhesion [GO:0098609]; epithelial cell differentiation [GO:0030855]; negative regulation of ATPase activity [GO:0032780]"
"CHOYP_PHUM_PHUM289860.1.1|m.44779",21,"9",67.5,76,80,74.5,79,84.5,108.5,92,76,20.521765449,"0.2700232296",421.1428571429,72,"#VALUE!","0.7458396236","-0.3252734235",108.5,38.5,70,68.25,108.5,532,"0.7010869565","0.9184782609",64.875,84.25,-19.375,46,43.5,6.3010778159,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_PHUM_PHUM289860.1.1|m.44779","P37397","CNN3_RAT","35.81","296","172","8","9","301","11","291","2.00E-37","143","1","P37397","CNN3_RAT","reviewed","Calponin-3 (Calponin, acidic isoform) (Calponin, non-muscle isoform)","Cnn3","Rattus norvegicus (Rat)","330","actomyosin structure organization [GO:0031032]; cell-cell adhesion [GO:0098609]; epithelial cell differentiation [GO:0030855]; negative regulation of ATPase activity [GO:0032780]","GO:0005829; GO:0005874; GO:0005884; GO:0005913; GO:0005925; GO:0008017; GO:0014069; GO:0030425; GO:0030674; GO:0030855; GO:0031032; GO:0032780; GO:0043025; GO:0043197; GO:0098609","","","cd00014;","PF00402;PF00307;","actin filament [GO:0005884]; cell-cell adherens junction [GO:0005913]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; focal adhesion [GO:0005925]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; microtubule binding [GO:0008017]; protein binding, bridging [GO:0030674]; actomyosin structure organization [GO:0031032]; cell-cell adhesion [GO:0098609]; epithelial cell differentiation [GO:0030855]; negative regulation of ATPase activity [GO:0032780]"
"CHOYP_PHUM_PHUM549040.1.1|m.10284",48,"3",11,15,13.5,13,9.5,14,14,14,12.6428571429,4.0152769493,"0.3175925271",16.1224489796,14,"#VALUE!","6.1980519148","-2.4201994499",16,3,13,13.5,16,88.5,"0.9655172414","0.9310344828",11.125,14.5,-3.375,11,2.5,1.0482056141,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_PHUM_PHUM549040.1.1|m.10284","O46036","CTBP_DROME","80.72","363","63","3","1","363","1","356","0","614","1","O46036","CTBP_DROME","reviewed","C-terminal-binding protein (CtBP protein) (dCtBP)","CtBP CG7583","Drosophila melanogaster (Fruit fly)","476","ATP-dependent chromatin remodeling [GO:0043044]; chaeta development [GO:0022416]; embryonic development via the syncytial blastoderm [GO:0001700]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of JAK-STAT cascade [GO:0046427]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; regulation of Wnt signaling pathway [GO:0030111]; sensory organ precursor cell fate determination [GO:0016360]; sensory perception of pain [GO:0019233]; transcription, DNA-templated [GO:0006351]; wing disc development [GO:0035220]; Wnt signaling pathway [GO:0016055]","GO:0000122; GO:0001700; GO:0003713; GO:0003714; GO:0005634; GO:0006351; GO:0006355; GO:0006357; GO:0008134; GO:0016055; GO:0016360; GO:0016616; GO:0019233; GO:0022416; GO:0030111; GO:0031010; GO:0035220; GO:0042802; GO:0042803; GO:0043044; GO:0045892; GO:0046427; GO:0051287; GO:0070491","","","","PF00389;PF02826;","ISWI-type complex [GO:0031010]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; ATP-dependent chromatin remodeling [GO:0043044]; chaeta development [GO:0022416]; embryonic development via the syncytial blastoderm [GO:0001700]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of JAK-STAT cascade [GO:0046427]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of Wnt signaling pathway [GO:0030111]; sensory organ precursor cell fate determination [GO:0016360]; sensory perception of pain [GO:0019233]; transcription, DNA-templated [GO:0006351]; wing disc development [GO:0035220]; Wnt signaling pathway [GO:0016055]"
"CHOYP_PHUM_PHUM549040.1.1|m.10284",37,"9",11,15.5,11,9.5,13.5,13.5,16,14.5,12.6428571429,4.0152769493,"0.3175925271",16.1224489796,14,"#VALUE!","6.1980519148","-2.4201994499",16,3,13,13.5,16,88.5,"0.9655172414","0.9310344828",11.125,14.5,-3.375,11,2.5,1.0482056141,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_PHUM_PHUM549040.1.1|m.10284","O46036","CTBP_DROME","80.72","363","63","3","1","363","1","356","0","614","1","O46036","CTBP_DROME","reviewed","C-terminal-binding protein (CtBP protein) (dCtBP)","CtBP CG7583","Drosophila melanogaster (Fruit fly)","476","ATP-dependent chromatin remodeling [GO:0043044]; chaeta development [GO:0022416]; embryonic development via the syncytial blastoderm [GO:0001700]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; positive regulation of JAK-STAT cascade [GO:0046427]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; regulation of Wnt signaling pathway [GO:0030111]; sensory organ precursor cell fate determination [GO:0016360]; sensory perception of pain [GO:0019233]; transcription, DNA-templated [GO:0006351]; wing disc development [GO:0035220]; Wnt signaling pathway [GO:0016055]","GO:0000122; GO:0001700; GO:0003713; GO:0003714; GO:0005634; GO:0006351; GO:0006355; GO:0006357; GO:0008134; GO:0016055; GO:0016360; GO:0016616; GO:0019233; GO:0022416; GO:0030111; GO:0031010; GO:0035220; GO:0042802; GO:0042803; GO:0043044; GO:0045892; GO:0046427; GO:0051287; GO:0070491","","","","PF00389;PF02826;","ISWI-type complex [GO:0031010]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; ATP-dependent chromatin remodeling [GO:0043044]; chaeta development [GO:0022416]; embryonic development via the syncytial blastoderm [GO:0001700]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of JAK-STAT cascade [GO:0046427]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of Wnt signaling pathway [GO:0030111]; sensory organ precursor cell fate determination [GO:0016360]; sensory perception of pain [GO:0019233]; transcription, DNA-templated [GO:0006351]; wing disc development [GO:0035220]; Wnt signaling pathway [GO:0016055]"
"CHOYP_PPN.3.4|m.50209",48,"3",17,10.5,15.5,0,9,21,0,2,7,9.9713876381,"1.4244839483",99.4285714286,2,"#VALUE!","3.7101701843","1.9855193891",29.5,0,29.5,1.5,29.5,49,"14","8.3333333333",8.75,8.75,0,21,28,0.5803624304,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_PPN.3.4|m.50209","Q02445","TFPI1_RAT","38.91","221","92","5","923","1100","52","272","6.00E-36","145","1","Q02445","TFPI1_RAT","reviewed","Tissue factor pathway inhibitor (TFPI) (Extrinsic pathway inhibitor) (EPI) (Lipoprotein-associated coagulation inhibitor) (LACI)","Tfpi","Rattus norvegicus (Rat)","302","blood coagulation [GO:0007596]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]","GO:0004867; GO:0005615; GO:0007596; GO:0009986; GO:0032355; GO:0032496; GO:0071222; GO:0071347","","","","PF00014;","cell surface [GO:0009986]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; blood coagulation [GO:0007596]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]"
"CHOYP_PPN.3.4|m.50209",37,"9",17,33,10,22,1,12.5,29.5,1.5,7,9.9713876381,"1.4244839483",99.4285714286,2,"#VALUE!","3.7101701843","1.9855193891",29.5,0,29.5,1.5,29.5,49,"14","8.3333333333",8.75,8.75,0,21,28,0.5803624304,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_PPN.3.4|m.50209","Q02445","TFPI1_RAT","38.91","221","92","5","923","1100","52","272","6.00E-36","145","1","Q02445","TFPI1_RAT","reviewed","Tissue factor pathway inhibitor (TFPI) (Extrinsic pathway inhibitor) (EPI) (Lipoprotein-associated coagulation inhibitor) (LACI)","Tfpi","Rattus norvegicus (Rat)","302","blood coagulation [GO:0007596]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]","GO:0004867; GO:0005615; GO:0007596; GO:0009986; GO:0032355; GO:0032496; GO:0071222; GO:0071347","","","","PF00014;","cell surface [GO:0009986]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; blood coagulation [GO:0007596]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]"
"CHOYP_PRP6.2.2|m.34365",37,"3",23,27,29.5,29.5,0,0,0,0,1.3571428571,3.3243075081,"2.4494897428",11.0510204082,0,"#VALUE!","7","2.6457513111",9.5,0,9.5,0,9.5,9.5,"#DIV/0!","#DIV/0!",2.375,0,2.375,9.5,0,0.1125192467,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_PRP6.2.2|m.34365","P30568","GSTA_PLEPL","44.5","218","118","3","1","217","1","216","2.00E-59","193","1","P30568","GSTA_PLEPL","reviewed","Glutathione S-transferase A (GST-A) (EC 2.5.1.18) (GST class-theta)","","Pleuronectes platessa (European plaice)","225","","GO:0004364; GO:0005737","","","","PF14497;PF13417;","cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]"
"CHOYP_PRP6.2.2|m.34365",48,"9",23,21,0,10,0,0,0,0,1.3571428571,3.3243075081,"2.4494897428",11.0510204082,0,"#VALUE!","7","2.6457513111",9.5,0,9.5,0,9.5,9.5,"#DIV/0!","#DIV/0!",2.375,0,2.375,9.5,0,0.1125192467,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_PRP6.2.2|m.34365","P30568","GSTA_PLEPL","44.5","218","118","3","1","217","1","216","2.00E-59","193","1","P30568","GSTA_PLEPL","reviewed","Glutathione S-transferase A (GST-A) (EC 2.5.1.18) (GST class-theta)","","Pleuronectes platessa (European plaice)","225","","GO:0004364; GO:0005737","","","","PF14497;PF13417;","cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]"
"CHOYP_PRP8.1.1|m.51584",37,"3",18,20.5,18,18.5,16.5,7,6.5,13.5,9,2.2834810519,"0.2537201169",5.2142857143,9,"#VALUE!","1.2976168137","0.7697852108",13.5,6,7.5,7.75,13.5,63,"0.7777777778","1",7.125,10.375,-3.25,3,4.5,0.7461802677,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_PRP8.1.1|m.51584","Q99PV0","PRP8_MOUSE","92.88","2317","164","1","44","2359","19","2335","0","4554","1","Q99PV0","PRP8_MOUSE","reviewed","Pre-mRNA-processing-splicing factor 8 (Splicing factor Prp8)","Prpf8 Prp8","Mus musculus (Mouse)","2335","cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]","GO:0000244; GO:0000398; GO:0003723; GO:0005634; GO:0005682; GO:0016020; GO:0016607; GO:0017070; GO:0030623; GO:0070530; GO:0071013; GO:0071222; GO:0071356","","","cd13838;","PF01398;PF08082;PF08083;PF08084;PF12134;PF10598;PF10597;PF10596;","catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U5 snRNP [GO:0005682]; K63-linked polyubiquitin binding [GO:0070530]; RNA binding [GO:0003723]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]"
"CHOYP_PRP8.1.1|m.51584",48,"9",18,18,11,6,7,9,10,9,9,2.2834810519,"0.2537201169",5.2142857143,9,"#VALUE!","1.2976168137","0.7697852108",13.5,6,7.5,7.75,13.5,63,"0.7777777778","1",7.125,10.375,-3.25,3,4.5,0.7461802677,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_PRP8.1.1|m.51584","Q99PV0","PRP8_MOUSE","92.88","2317","164","1","44","2359","19","2335","0","4554","1","Q99PV0","PRP8_MOUSE","reviewed","Pre-mRNA-processing-splicing factor 8 (Splicing factor Prp8)","Prpf8 Prp8","Mus musculus (Mouse)","2335","cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]","GO:0000244; GO:0000398; GO:0003723; GO:0005634; GO:0005682; GO:0016020; GO:0016607; GO:0017070; GO:0030623; GO:0070530; GO:0071013; GO:0071222; GO:0071356","","","cd13838;","PF01398;PF08082;PF08083;PF08084;PF12134;PF10598;PF10597;PF10596;","catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U5 snRNP [GO:0005682]; K63-linked polyubiquitin binding [GO:0070530]; RNA binding [GO:0003723]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]"
"CHOYP_PSMC6.1.1|m.13888",37,"3",11.5,12.5,15.5,13.5,13,15,10.5,14,12.4285714286,1.6567733578,"0.1333036035",2.7448979592,12,"#VALUE!","-1.7917082406","-0.2037887617",14.5,10,4.5,11.25,14.5,87,"1.25","1",11.875,13.625,-1.75,5,2.5,1.0304394173,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_PSMC6.1.1|m.13888","P62334","PRS10_MOUSE","88.16","380","45","0","15","394","5","384","0","694","1","P62334","PRS10_MOUSE","reviewed","26S protease regulatory subunit 10B (26S proteasome AAA-ATPase subunit RPT4) (Proteasome 26S subunit ATPase 6) (Proteasome subunit p42)","Psmc6 Sug2","Mus musculus (Mouse)","389","ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045899]","GO:0000502; GO:0005524; GO:0005634; GO:0008540; GO:0016020; GO:0016234; GO:0017025; GO:0022624; GO:0030433; GO:0031595; GO:0031597; GO:0036402; GO:0042802; GO:0045899; GO:0070062; GO:0090261","","","","PF00004;","cytosolic proteasome complex [GO:0031597]; extracellular exosome [GO:0070062]; inclusion body [GO:0016234]; membrane [GO:0016020]; nuclear proteasome complex [GO:0031595]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; proteasome-activating ATPase activity [GO:0036402]; TBP-class protein binding [GO:0017025]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045899]"
"CHOYP_PSMC6.1.1|m.13888",48,"9",11.5,11.5,13.5,12,13.5,12,14,12,12.4285714286,1.6567733578,"0.1333036035",2.7448979592,12,"#VALUE!","-1.7917082406","-0.2037887617",14.5,10,4.5,11.25,14.5,87,"1.25","1",11.875,13.625,-1.75,5,2.5,1.0304394173,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_PSMC6.1.1|m.13888","P62334","PRS10_MOUSE","88.16","380","45","0","15","394","5","384","0","694","1","P62334","PRS10_MOUSE","reviewed","26S protease regulatory subunit 10B (26S proteasome AAA-ATPase subunit RPT4) (Proteasome 26S subunit ATPase 6) (Proteasome subunit p42)","Psmc6 Sug2","Mus musculus (Mouse)","389","ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045899]","GO:0000502; GO:0005524; GO:0005634; GO:0008540; GO:0016020; GO:0016234; GO:0017025; GO:0022624; GO:0030433; GO:0031595; GO:0031597; GO:0036402; GO:0042802; GO:0045899; GO:0070062; GO:0090261","","","","PF00004;","cytosolic proteasome complex [GO:0031597]; extracellular exosome [GO:0070062]; inclusion body [GO:0016234]; membrane [GO:0016020]; nuclear proteasome complex [GO:0031595]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; proteasome-activating ATPase activity [GO:0036402]; TBP-class protein binding [GO:0017025]; ER-associated ubiquitin-dependent protein catabolic process [GO:0030433]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045899]"
"CHOYP_PSMD6.1.1|m.60839",37,"3",12,14.5,15,15.5,16,6.5,13,13,10.1428571429,3.1134992454,"0.3069647143",9.693877551,11.5,"#VALUE!","-2.2085903601","-0.3840597526",13.5,5.5,8,7.25,13.5,71,"0.9285714286","1.0714285714",8.125,11.25,-3.125,7.5,6.5,0.8409333175,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_PSMD6.1.1|m.60839","Q15008","PSMD6_HUMAN","71.47","389","111","0","16","404","1","389","0","587","1","Q15008","PSMD6_HUMAN","reviewed","26S proteasome non-ATPase regulatory subunit 6 (26S proteasome regulatory subunit RPN7) (26S proteasome regulatory subunit S10) (Breast cancer-associated protein SGA-113M) (Phosphonoformate immuno-associated protein 4) (Proteasome regulatory particle subunit p44S10) (p42A)","PSMD6 KIAA0107 PFAAP4","Homo sapiens (Human)","389","anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle [GO:0051436]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition [GO:0051437]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0005576; GO:0005654; GO:0005829; GO:0005838; GO:0006508; GO:0006521; GO:0010972; GO:0016579; GO:0016887; GO:0022624; GO:0031145; GO:0031146; GO:0033209; GO:0034774; GO:0038061; GO:0038095; GO:0043161; GO:0043312; GO:0043488; GO:0050852; GO:0051436; GO:0051437; GO:0055085; GO:0060071; GO:0061418; GO:0070062; GO:0090090; GO:0090263; GO:1904813","","","","PF01399;PF10602;","cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; secretory granule lumen [GO:0034774]; ATPase activity [GO:0016887]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle [GO:0051436]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition [GO:0051437]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"
"CHOYP_PSMD6.1.1|m.60839",48,"9",12,17.5,16,10.5,7.5,7.5,11.5,7,10.1428571429,3.1134992454,"0.3069647143",9.693877551,11.5,"#VALUE!","-2.2085903601","-0.3840597526",13.5,5.5,8,7.25,13.5,71,"0.9285714286","1.0714285714",8.125,11.25,-3.125,7.5,6.5,0.8409333175,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_PSMD6.1.1|m.60839","Q15008","PSMD6_HUMAN","71.47","389","111","0","16","404","1","389","0","587","1","Q15008","PSMD6_HUMAN","reviewed","26S proteasome non-ATPase regulatory subunit 6 (26S proteasome regulatory subunit RPN7) (26S proteasome regulatory subunit S10) (Breast cancer-associated protein SGA-113M) (Phosphonoformate immuno-associated protein 4) (Proteasome regulatory particle subunit p44S10) (p42A)","PSMD6 KIAA0107 PFAAP4","Homo sapiens (Human)","389","anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle [GO:0051436]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition [GO:0051437]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]","GO:0000165; GO:0000209; GO:0000502; GO:0002223; GO:0002479; GO:0005576; GO:0005654; GO:0005829; GO:0005838; GO:0006508; GO:0006521; GO:0010972; GO:0016579; GO:0016887; GO:0022624; GO:0031145; GO:0031146; GO:0033209; GO:0034774; GO:0038061; GO:0038095; GO:0043161; GO:0043312; GO:0043488; GO:0050852; GO:0051436; GO:0051437; GO:0055085; GO:0060071; GO:0061418; GO:0070062; GO:0090090; GO:0090263; GO:1904813","","","","PF01399;PF10602;","cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; secretory granule lumen [GO:0034774]; ATPase activity [GO:0016887]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; Fc-epsilon receptor signaling pathway [GO:0038095]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle [GO:0051436]; neutrophil degranulation [GO:0043312]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition [GO:0051437]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of mRNA stability [GO:0043488]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; transmembrane transport [GO:0055085]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]"
"CHOYP_RAB1A.1.3|m.10036",37,"9",13.5,15,14.5,16.5,13,11,15,12.5,12.3571428571,1.6413036133,"0.1328222577",2.693877551,12,"#VALUE!","-1.2155991736","0.7057360891",15,10.5,4.5,11,15,86.5,"1","0.88",11.25,13.5,-2.25,2,3,1.0245173517,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_RAB1A.1.3|m.10036","Q05974","RAB1A_LYMST","92.23","206","14","2","1","205","1","205","3.00E-138","392","1","Q05974","RAB1A_LYMST","reviewed","Ras-related protein Rab-1A","RAB1A","Lymnaea stagnalis (Great pond snail) (Helix stagnalis)","205","protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]","GO:0005525; GO:0005783; GO:0005794; GO:0007264; GO:0015031; GO:0016192","","","","PF00071;","endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]"
"CHOYP_RAB1A.1.3|m.10036",48,"3",13.5,14.5,15,13,11.5,12.5,11,14.5,12.3571428571,1.6413036133,"0.1328222577",2.693877551,12,"#VALUE!","-1.2155991736","0.7057360891",15,10.5,4.5,11,15,86.5,"1","0.88",11.25,13.5,-2.25,2,3,1.0245173517,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_RAB1A.1.3|m.10036","Q05974","RAB1A_LYMST","92.23","206","14","2","1","205","1","205","3.00E-138","392","1","Q05974","RAB1A_LYMST","reviewed","Ras-related protein Rab-1A","RAB1A","Lymnaea stagnalis (Great pond snail) (Helix stagnalis)","205","protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]","GO:0005525; GO:0005783; GO:0005794; GO:0007264; GO:0015031; GO:0016192","","","","PF00071;","endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]"
"CHOYP_RAB35.1.1|m.8278",37,"9",14,11.5,13.5,13.5,15.5,13.5,14.5,15.5,12.2857142857,3.194382825,"0.2600079044",10.2040816327,13,"#VALUE!","4.3187592","-1.9350335369",15.5,5,10.5,12.25,15.5,86,"1","0.8709677419",11.375,14,-2.625,10.5,2.5,1.018595286,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_RAB35.1.1|m.8278","P62282","RS11_RAT","74.21","159","38","3","1","157","1","158","2.00E-81","244","1","P62282","RS11_RAT","reviewed","40S ribosomal protein S11","Rps11","Rattus norvegicus (Rat)","158","osteoblast differentiation [GO:0001649]; translation [GO:0006412]","GO:0001649; GO:0003735; GO:0006412; GO:0016020; GO:0019843; GO:0022627","","","","PF00366;PF16205;","cytosolic small ribosomal subunit [GO:0022627]; membrane [GO:0016020]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; osteoblast differentiation [GO:0001649]; translation [GO:0006412]"
"CHOYP_RAB35.1.1|m.8278",48,"3",14,12.5,12.5,11.5,14.5,15.5,11.5,13,12.2857142857,3.194382825,"0.2600079044",10.2040816327,13,"#VALUE!","4.3187592","-1.9350335369",15.5,5,10.5,12.25,15.5,86,"1","0.8709677419",11.375,14,-2.625,10.5,2.5,1.018595286,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_RAB35.1.1|m.8278","P62282","RS11_RAT","74.21","159","38","3","1","157","1","158","2.00E-81","244","1","P62282","RS11_RAT","reviewed","40S ribosomal protein S11","Rps11","Rattus norvegicus (Rat)","158","osteoblast differentiation [GO:0001649]; translation [GO:0006412]","GO:0001649; GO:0003735; GO:0006412; GO:0016020; GO:0019843; GO:0022627","","","","PF00366;PF16205;","cytosolic small ribosomal subunit [GO:0022627]; membrane [GO:0016020]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; osteoblast differentiation [GO:0001649]; translation [GO:0006412]"
"CHOYP_RAEL1.1.1|m.40419",37,"3",10.5,12,17.5,17,14,11,10,14.5,10.6428571429,3.6714563645,"0.3449690544",13.4795918367,10,"#VALUE!","0.5133723506","-0.8856387202",14.5,3.5,11,9.25,14.5,74.5,"0.8148148148","0.7407407407",8.625,12.75,-4.125,7.5,6,0.8823877769,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_RAEL1.1.1|m.40419","A5GFN6","RAEL1_PIG","74.12","371","84","5","1","362","1","368","0","564","1","A5GFN6","RAEL1_PIG","reviewed","mRNA export factor (Rae1 protein homolog) (mRNA-associated protein mrnp 41)","RAE1 MRNP41","Sus scrofa (Pig)","368","cellular response to organic cyclic compound [GO:0071407]","GO:0001650; GO:0003723; GO:0005643; GO:0005737; GO:0071407","","","","PF00400;","cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nuclear pore [GO:0005643]; RNA binding [GO:0003723]; cellular response to organic cyclic compound [GO:0071407]"
"CHOYP_RAEL1.1.1|m.40419",48,"9",10.5,16,9.5,9.5,11,10,14.5,13.5,10.6428571429,3.6714563645,"0.3449690544",13.4795918367,10,"#VALUE!","0.5133723506","-0.8856387202",14.5,3.5,11,9.25,14.5,74.5,"0.8148148148","0.7407407407",8.625,12.75,-4.125,7.5,6,0.8823877769,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_RAEL1.1.1|m.40419","A5GFN6","RAEL1_PIG","74.12","371","84","5","1","362","1","368","0","564","1","A5GFN6","RAEL1_PIG","reviewed","mRNA export factor (Rae1 protein homolog) (mRNA-associated protein mrnp 41)","RAE1 MRNP41","Sus scrofa (Pig)","368","cellular response to organic cyclic compound [GO:0071407]","GO:0001650; GO:0003723; GO:0005643; GO:0005737; GO:0071407","","","","PF00400;","cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nuclear pore [GO:0005643]; RNA binding [GO:0003723]; cellular response to organic cyclic compound [GO:0071407]"
"CHOYP_RL10A.1.2|m.7633",37,"3",18.5,22,12.5,7,12.5,5,17,19.5,11.8571428571,5.4031358997,"0.4556861602",29.193877551,13.5,"#VALUE!","-1.3071862912","-0.2549028433",19.5,4,15.5,7.5,19.5,83,"0.3703703704","0.3703703704",7.75,14.25,-6.5,13,9.5,0.9830628923,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_RL10A.1.2|m.7633","Q9N4I4","RL10A_CAEEL","64.81","216","76","0","1","216","1","216","2.00E-95","284","1","Q9N4I4","RL10A_CAEEL","reviewed","60S ribosomal protein L10a","rpl-10a rpl-1 Y71F9AL.13","Caenorhabditis elegans","216","maturation of LSU-rRNA [GO:0000470]; translation [GO:0006412]","GO:0000470; GO:0003723; GO:0003735; GO:0006412; GO:0022625","","","cd00403;","PF00687;","cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA [GO:0000470]; translation [GO:0006412]"
"CHOYP_RL10A.1.2|m.7633",48,"9",18.5,21,9,5.5,14.5,5,10,13.5,11.8571428571,5.4031358997,"0.4556861602",29.193877551,13.5,"#VALUE!","-1.3071862912","-0.2549028433",19.5,4,15.5,7.5,19.5,83,"0.3703703704","0.3703703704",7.75,14.25,-6.5,13,9.5,0.9830628923,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_RL10A.1.2|m.7633","Q9N4I4","RL10A_CAEEL","64.81","216","76","0","1","216","1","216","2.00E-95","284","1","Q9N4I4","RL10A_CAEEL","reviewed","60S ribosomal protein L10a","rpl-10a rpl-1 Y71F9AL.13","Caenorhabditis elegans","216","maturation of LSU-rRNA [GO:0000470]; translation [GO:0006412]","GO:0000470; GO:0003723; GO:0003735; GO:0006412; GO:0022625","","","cd00403;","PF00687;","cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA [GO:0000470]; translation [GO:0006412]"
"CHOYP_RL18A.1.8|m.12900",37,"3",8,9,15.5,15.5,14.5,13.5,10,15,11.1428571429,2.6418917156,"0.2370928463",6.9795918367,10,"#VALUE!","-1.8920898738","0.2213294665",15,8,7,9,15,78,"0.9642857143","0.5714285714",9.875,13,-3.125,5.5,5,0.9238422362,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_RL18A.1.8|m.12900","Q02543","RL18A_HUMAN","70.45","176","52","0","1","176","1","176","3.00E-90","268","1","Q02543","RL18A_HUMAN","reviewed","60S ribosomal protein L18a (Large ribosomal subunit protein eL20)","RPL18A","Homo sapiens (Human)","176","nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; response to antineoplastic agent [GO:0097327]; rRNA processing [GO:0006364]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]","GO:0000184; GO:0003723; GO:0003735; GO:0005829; GO:0006364; GO:0006412; GO:0006413; GO:0006614; GO:0016020; GO:0019083; GO:0022625; GO:0097327","","","","PF01775;","cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; response to antineoplastic agent [GO:0097327]; rRNA processing [GO:0006364]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"
"CHOYP_RL18A.1.8|m.12900",48,"9",8,10.5,11.5,8.5,14,8,10,14,11.1428571429,2.6418917156,"0.2370928463",6.9795918367,10,"#VALUE!","-1.8920898738","0.2213294665",15,8,7,9,15,78,"0.9642857143","0.5714285714",9.875,13,-3.125,5.5,5,0.9238422362,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_RL18A.1.8|m.12900","Q02543","RL18A_HUMAN","70.45","176","52","0","1","176","1","176","3.00E-90","268","1","Q02543","RL18A_HUMAN","reviewed","60S ribosomal protein L18a (Large ribosomal subunit protein eL20)","RPL18A","Homo sapiens (Human)","176","nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; response to antineoplastic agent [GO:0097327]; rRNA processing [GO:0006364]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]","GO:0000184; GO:0003723; GO:0003735; GO:0005829; GO:0006364; GO:0006412; GO:0006413; GO:0006614; GO:0016020; GO:0019083; GO:0022625; GO:0097327","","","","PF01775;","cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; response to antineoplastic agent [GO:0097327]; rRNA processing [GO:0006364]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]; viral transcription [GO:0019083]"
"CHOYP_RL8.10.10|m.65636",37,"9",0,0,12,8,0,0,24,31,11.1428571429,13.0759164817,"1.1734796843",170.9795918367,0,"#VALUE!","-2.3010403801","0.5042172997",31,0,31,0,31,78,"0","0",0,19.5,-19.5,0,31,0.9238422362,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_RL8.10.10|m.65636","P13023","RL8_DICDI","69.05","252","77","1","1","251","1","252","5.00E-126","365","1","P13023","RL8_DICDI","reviewed","60S ribosomal protein L8 (60S ribosomal protein L2)","rpl8 rpgA rpl2 V1 DDB_G0274113","Dictyostelium discoideum (Slime mold)","255","cytoplasmic translation [GO:0002181]","GO:0002181; GO:0003735; GO:0022625","","","","PF00181;PF03947;","cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]"
"CHOYP_RL8.10.10|m.65636",48,"3",0,8.5,16,17.5,15,0,0,23,11.1428571429,13.0759164817,"1.1734796843",170.9795918367,0,"#VALUE!","-2.3010403801","0.5042172997",31,0,31,0,31,78,"0","0",0,19.5,-19.5,0,31,0.9238422362,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_RL8.10.10|m.65636","P13023","RL8_DICDI","69.05","252","77","1","1","251","1","252","5.00E-126","365","1","P13023","RL8_DICDI","reviewed","60S ribosomal protein L8 (60S ribosomal protein L2)","rpl8 rpgA rpl2 V1 DDB_G0274113","Dictyostelium discoideum (Slime mold)","255","cytoplasmic translation [GO:0002181]","GO:0002181; GO:0003735; GO:0022625","","","","PF00181;PF03947;","cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]"
"CHOYP_RN45S.2.5|m.14111",48,"3",5,0,5.5,10.5,5.5,21.5,10,6,8.7857142857,4.2245637379,"0.4808446531",17.8469387755,8.5,"#VALUE!","1.610200389","1.2021764688",17.5,4.5,13,5.25,17.5,61.5,"2.5294117647","2.0588235294",13.375,7.375,6,17,6,0.7284140708,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_RN45S.2.5|m.14111","Q04832","HEXP_LEIMA","41.1","146","65","4","76","203","71","213","2.00E-26","107","1","Q04832","HEXP_LEIMA","reviewed","DNA-binding protein HEXBP (Hexamer-binding protein)","HEXBP","Leishmania major","271","","GO:0003677; GO:0005634; GO:0008270","","","","PF00098;","nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
"CHOYP_RN45S.2.5|m.14111",37,"9",5,10.5,6.5,8,28.5,17.5,10.5,8.5,8.7857142857,4.2245637379,"0.4808446531",17.8469387755,8.5,"#VALUE!","1.610200389","1.2021764688",17.5,4.5,13,5.25,17.5,61.5,"2.5294117647","2.0588235294",13.375,7.375,6,17,6,0.7284140708,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_RN45S.2.5|m.14111","Q04832","HEXP_LEIMA","41.1","146","65","4","76","203","71","213","2.00E-26","107","1","Q04832","HEXP_LEIMA","reviewed","DNA-binding protein HEXBP (Hexamer-binding protein)","HEXBP","Leishmania major","271","","GO:0003677; GO:0005634; GO:0008270","","","","PF00098;","nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]"
"CHOYP_RS15A.5.11|m.18785",48,"3",10,11.5,16.5,8.5,6.5,12,13,6,11.7142857143,3.0220279716,"0.2579779976",9.1326530612,13,"#VALUE!","0.0661230299","-1.1039129016",15,6,9,10.25,15,82,"0.8","0.9",11.75,11.75,0,5,9,0.9712187611,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_RS15A.5.11|m.18785","Q6XIM8","RS15A_DROYA","82.01","139","16","1","6","144","1","130","2.00E-79","237","1","Q6XIM8","RS15A_DROYA","reviewed","40S ribosomal protein S15a","RpS15Aa GE16163","Drosophila yakuba (Fruit fly)","130","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412","","","","PF00410;","ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]"
"CHOYP_RS15A.5.11|m.18785",37,"9",10,7,12.5,12,16,13.5,14,15,11.7142857143,3.0220279716,"0.2579779976",9.1326530612,13,"#VALUE!","0.0661230299","-1.1039129016",15,6,9,10.25,15,82,"0.8","0.9",11.75,11.75,0,5,9,0.9712187611,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_RS15A.5.11|m.18785","Q6XIM8","RS15A_DROYA","82.01","139","16","1","6","144","1","130","2.00E-79","237","1","Q6XIM8","RS15A_DROYA","reviewed","40S ribosomal protein S15a","RpS15Aa GE16163","Drosophila yakuba (Fruit fly)","130","translation [GO:0006412]","GO:0003735; GO:0005840; GO:0006412","","","","PF00410;","ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412]"
"CHOYP_SAHH3.2.2|m.51221",37,"3",0,0,16,16.5,21,0,11,0,5.4285714286,6.2015468775,"1.1423902143",38.4591836735,3.5,"#VALUE!","0.3525636694","1.1218745325",17.5,0,17.5,0,17.5,38,"#DIV/0!","#DIV/0!",7.125,2.375,4.75,17.5,6,0.4500769869,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_SAHH3.2.2|m.51221","A3PFB5","SAHH_PROM0","51.52","462","185","5","100","525","14","472","1.00E-161","475","1","A3PFB5","SAHH_PROM0","reviewed","Adenosylhomocysteinase (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase) (AdoHcyase)","ahcY P9301_18171","Prochlorococcus marinus (strain MIT 9301)","472","one-carbon metabolic process [GO:0006730]","GO:0004013; GO:0005737; GO:0006730","PATHWAY: Amino-acid biosynthesis; L-homocysteine biosynthesis; L-homocysteine from S-adenosyl-L-homocysteine: step 1/1. {ECO:0000255|HAMAP-Rule:MF_00563}.","","cd00401;","PF05221;PF00670;","cytoplasm [GO:0005737]; adenosylhomocysteinase activity [GO:0004013]; one-carbon metabolic process [GO:0006730]"
"CHOYP_SAHH3.2.2|m.51221",48,"9",0,25.5,4.5,3,0,17.5,6,0,5.4285714286,6.2015468775,"1.1423902143",38.4591836735,3.5,"#VALUE!","0.3525636694","1.1218745325",17.5,0,17.5,0,17.5,38,"#DIV/0!","#DIV/0!",7.125,2.375,4.75,17.5,6,0.4500769869,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_SAHH3.2.2|m.51221","A3PFB5","SAHH_PROM0","51.52","462","185","5","100","525","14","472","1.00E-161","475","1","A3PFB5","SAHH_PROM0","reviewed","Adenosylhomocysteinase (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase) (AdoHcyase)","ahcY P9301_18171","Prochlorococcus marinus (strain MIT 9301)","472","one-carbon metabolic process [GO:0006730]","GO:0004013; GO:0005737; GO:0006730","PATHWAY: Amino-acid biosynthesis; L-homocysteine biosynthesis; L-homocysteine from S-adenosyl-L-homocysteine: step 1/1. {ECO:0000255|HAMAP-Rule:MF_00563}.","","cd00401;","PF05221;PF00670;","cytoplasm [GO:0005737]; adenosylhomocysteinase activity [GO:0004013]; one-carbon metabolic process [GO:0006730]"
"CHOYP_SC31A.1.2|m.8241",37,"9",14,20,11.5,15.5,11,13,13.5,10,12.3571428571,1.5518257845,"0.1255812774",2.4081632653,13,"#VALUE!","-1.1073111175","-0.9168941338",14,10,4,11.25,14,86.5,"1.1","1.3",11.625,12.75,-1.125,3,4,1.0245173517,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_SC31A.1.2|m.8241","O57521","HS90B_DANRE","76.72","262","56","2","1","258","465","725","4.00E-138","412","1","O57521","HS90B_DANRE","reviewed","Heat shock protein HSP 90-beta","hsp90ab1 hsp90b","Danio rerio (Zebrafish) (Brachydanio rerio)","725","blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]","GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900","","","","PF02518;PF00183;","cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]"
"CHOYP_SC31A.1.2|m.8241",48,"3",14,16,13,13,11,11,10,14,12.3571428571,1.5518257845,"0.1255812774",2.4081632653,13,"#VALUE!","-1.1073111175","-0.9168941338",14,10,4,11.25,14,86.5,"1.1","1.3",11.625,12.75,-1.125,3,4,1.0245173517,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_SC31A.1.2|m.8241","O57521","HS90B_DANRE","76.72","262","56","2","1","258","465","725","4.00E-138","412","1","O57521","HS90B_DANRE","reviewed","Heat shock protein HSP 90-beta","hsp90ab1 hsp90b","Danio rerio (Zebrafish) (Brachydanio rerio)","725","blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]","GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900","","","","PF02518;PF00183;","cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]"
"CHOYP_SMP_012720.1.2|m.31152",48,"3",1.5,0,4.5,0,0,19.5,0,2.5,2.5714285714,2.484646733,"0.9662515073",6.1734693878,2.5,"#VALUE!","-1.7267591012","0.3242686448",6.5,0,6.5,0,6.5,18,"#DIV/0!","#DIV/0!",6.5,2.875,3.625,19.5,5,0.2131943622,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_SMP_012720.1.2|m.31152","Q21624","CORO_CAEEL","39.7","597","293","12","3","535","4","597","2.00E-139","424","1","Q21624","CORO_CAEEL","reviewed","Coronin-like protein cor-1","cor-1 R01H10.3","Caenorhabditis elegans","607","actin cytoskeleton organization [GO:0030036]","GO:0015629; GO:0030036; GO:0051015","","","","PF08953;PF00400;","actin cytoskeleton [GO:0015629]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]"
"CHOYP_SMP_012720.1.2|m.31152",37,"9",1.5,3,26.5,0,21,6.5,4,0,2.5714285714,2.484646733,"0.9662515073",6.1734693878,2.5,"#VALUE!","-1.7267591012","0.3242686448",6.5,0,6.5,0,6.5,18,"#DIV/0!","#DIV/0!",6.5,2.875,3.625,19.5,5,0.2131943622,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_SMP_012720.1.2|m.31152","Q21624","CORO_CAEEL","39.7","597","293","12","3","535","4","597","2.00E-139","424","1","Q21624","CORO_CAEEL","reviewed","Coronin-like protein cor-1","cor-1 R01H10.3","Caenorhabditis elegans","607","actin cytoskeleton organization [GO:0030036]","GO:0015629; GO:0030036; GO:0051015","","","","PF08953;PF00400;","actin cytoskeleton [GO:0015629]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]"
"CHOYP_SMP_012720.2.2|m.34968",37,"3",34,37.5,37,39,41.5,43,41.5,47,42.7142857143,8.472042859,"0.1983421405",71.7755102041,43,"#VALUE!","0.6332015041","-0.5358296889",55.5,27,28.5,39,55.5,299,"0.7747747748","0.8738738739",40,45.5,-5.5,21.5,19,3.5413952387,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_SMP_012720.2.2|m.34968","Q9WUM3","COR1B_MOUSE","50.3","501","225","9","1","495","1","483","1.00E-175","510","1","Q9WUM3","COR1B_MOUSE","reviewed","Coronin-1B (Coronin-2)","Coro1b","Mus musculus (Mouse)","484","actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; endothelial cell chemotaxis [GO:0035767]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; positive regulation of lamellipodium morphogenesis [GO:2000394]; protein localization to cell leading edge [GO:1902463]; ruffle organization [GO:0031529]; wound healing [GO:0042060]","GO:0001725; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005913; GO:0005925; GO:0015629; GO:0016477; GO:0030027; GO:0030036; GO:0031252; GO:0031529; GO:0034316; GO:0035767; GO:0036120; GO:0042060; GO:0042802; GO:0048471; GO:0051015; GO:0051017; GO:0070062; GO:0071672; GO:0071933; GO:0071944; GO:0090135; GO:0098641; GO:1902463; GO:2000394","","","","PF08953;PF00400;","actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; cadherin binding involved in cell-cell adhesion [GO:0098641]; identical protein binding [GO:0042802]; actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; endothelial cell chemotaxis [GO:0035767]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; positive regulation of lamellipodium morphogenesis [GO:2000394]; protein localization to cell leading edge [GO:1902463]; ruffle organization [GO:0031529]; wound healing [GO:0042060]"
"CHOYP_SMP_012720.2.2|m.34968",28,"9",34,37,18,38.5,42,48.5,43,55.5,42.7142857143,8.472042859,"0.1983421405",71.7755102041,43,"#VALUE!","0.6332015041","-0.5358296889",55.5,27,28.5,39,55.5,299,"0.7747747748","0.8738738739",40,45.5,-5.5,21.5,19,3.5413952387,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_SMP_012720.2.2|m.34968","Q9WUM3","COR1B_MOUSE","50.3","501","225","9","1","495","1","483","1.00E-175","510","1","Q9WUM3","COR1B_MOUSE","reviewed","Coronin-1B (Coronin-2)","Coro1b","Mus musculus (Mouse)","484","actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; endothelial cell chemotaxis [GO:0035767]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; positive regulation of lamellipodium morphogenesis [GO:2000394]; protein localization to cell leading edge [GO:1902463]; ruffle organization [GO:0031529]; wound healing [GO:0042060]","GO:0001725; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005913; GO:0005925; GO:0015629; GO:0016477; GO:0030027; GO:0030036; GO:0031252; GO:0031529; GO:0034316; GO:0035767; GO:0036120; GO:0042060; GO:0042802; GO:0048471; GO:0051015; GO:0051017; GO:0070062; GO:0071672; GO:0071933; GO:0071944; GO:0090135; GO:0098641; GO:1902463; GO:2000394","","","","PF08953;PF00400;","actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; cadherin binding involved in cell-cell adhesion [GO:0098641]; identical protein binding [GO:0042802]; actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; endothelial cell chemotaxis [GO:0035767]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; positive regulation of lamellipodium morphogenesis [GO:2000394]; protein localization to cell leading edge [GO:1902463]; ruffle organization [GO:0031529]; wound healing [GO:0042060]"
"CHOYP_SMRC2.2.2|m.49912",48,"3",14,15.5,16.5,11.5,15,13,7,11.5,10.7142857143,3.8345901518,"0.3578950808",14.7040816327,11.5,"#VALUE!","-0.0551961708","-0.9724249875",14.5,3.5,11,8.75,14.5,75,"1.2380952381","1.380952381",9.5,12.5,-3,11,4,0.8883098425,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_SMRC2.2.2|m.49912","Q8TAQ2","SMRC2_HUMAN","60.68","964","343","15","18","964","3","947","0","1086","1","Q8TAQ2","SMRC2_HUMAN","reviewed","SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2)","SMARCC2 BAF170","Homo sapiens (Human)","1214","ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; covalent chromatin modification [GO:0016569]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment [GO:0021882]; transcription, DNA-templated [GO:0006351]","GO:0000122; GO:0000790; GO:0003677; GO:0003682; GO:0003713; GO:0005654; GO:0006337; GO:0006338; GO:0006351; GO:0006357; GO:0016514; GO:0016569; GO:0021882; GO:0043044; GO:0043234; GO:0045892; GO:0045893; GO:0071564; GO:0071565","","","","PF00249;PF04433;PF16495;PF16496;PF16498;","nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; protein complex [GO:0043234]; SWI/SNF complex [GO:0016514]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; covalent chromatin modification [GO:0016569]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment [GO:0021882]; transcription, DNA-templated [GO:0006351]"
"CHOYP_SMRC2.2.2|m.49912",37,"9",14,16.5,13,9.5,14,14.5,13.5,10.5,10.7142857143,3.8345901518,"0.3578950808",14.7040816327,11.5,"#VALUE!","-0.0551961708","-0.9724249875",14.5,3.5,11,8.75,14.5,75,"1.2380952381","1.380952381",9.5,12.5,-3,11,4,0.8883098425,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_SMRC2.2.2|m.49912","Q8TAQ2","SMRC2_HUMAN","60.68","964","343","15","18","964","3","947","0","1086","1","Q8TAQ2","SMRC2_HUMAN","reviewed","SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2)","SMARCC2 BAF170","Homo sapiens (Human)","1214","ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; covalent chromatin modification [GO:0016569]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment [GO:0021882]; transcription, DNA-templated [GO:0006351]","GO:0000122; GO:0000790; GO:0003677; GO:0003682; GO:0003713; GO:0005654; GO:0006337; GO:0006338; GO:0006351; GO:0006357; GO:0016514; GO:0016569; GO:0021882; GO:0043044; GO:0043234; GO:0045892; GO:0045893; GO:0071564; GO:0071565","","","","PF00249;PF04433;PF16495;PF16496;PF16498;","nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; protein complex [GO:0043234]; SWI/SNF complex [GO:0016514]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; covalent chromatin modification [GO:0016569]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment [GO:0021882]; transcription, DNA-templated [GO:0006351]"
"CHOYP_SPTCA.1.2|m.1905",60,"9",56.5,125.5,128.5,125,164.5,157.5,174,164.5,100.7857142857,71.472700654,"0.7091550738",5108.3469387755,142,"#VALUE!","-1.9046886253","-0.5988734731",174,0,174,33.75,174,705.5,"0.9118541033","0.9574468085",76.875,137,-60.125,157.5,106.5,8.3560345849,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_SPTCA.1.2|m.1905","P02549","SPTA1_HUMAN","46.96","2453","1249","13","2","2443","8","2419","0","2138","1","P02549","SPTA1_HUMAN","reviewed","Spectrin alpha chain, erythrocytic 1 (Erythroid alpha-spectrin)","SPTA1 SPTA","Homo sapiens (Human)","2419","actin filament capping [GO:0051693]; actin filament organization [GO:0007015]; axon guidance [GO:0007411]; ER to Golgi vesicle-mediated transport [GO:0006888]; hemopoiesis [GO:0030097]; lymphocyte homeostasis [GO:0002260]; MAPK cascade [GO:0000165]; plasma membrane organization [GO:0007009]; porphyrin-containing compound biosynthetic process [GO:0006779]; positive regulation of protein binding [GO:0032092]; positive regulation of T cell proliferation [GO:0042102]; regulation of cell shape [GO:0008360]","GO:0000165; GO:0002260; GO:0005088; GO:0005200; GO:0005509; GO:0005829; GO:0006779; GO:0006888; GO:0007009; GO:0007015; GO:0007411; GO:0008091; GO:0008360; GO:0014731; GO:0015629; GO:0030097; GO:0030424; GO:0031235; GO:0032092; GO:0032437; GO:0042102; GO:0051015; GO:0051693","","","","PF08726;PF00018;PF00435;","actin cytoskeleton [GO:0015629]; axon [GO:0030424]; cuticular plate [GO:0032437]; cytosol [GO:0005829]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; actin filament organization [GO:0007015]; axon guidance [GO:0007411]; ER to Golgi vesicle-mediated transport [GO:0006888]; hemopoiesis [GO:0030097]; lymphocyte homeostasis [GO:0002260]; MAPK cascade [GO:0000165]; plasma membrane organization [GO:0007009]; porphyrin-containing compound biosynthetic process [GO:0006779]; positive regulation of protein binding [GO:0032092]; positive regulation of T cell proliferation [GO:0042102]; regulation of cell shape [GO:0008360]"
"CHOYP_SPTCA.1.2|m.1905",19,"3",56.5,59.5,146.5,148,138.5,150,0,142,100.7857142857,71.472700654,"0.7091550738",5108.3469387755,142,"#VALUE!","-1.9046886253","-0.5988734731",174,0,174,33.75,174,705.5,"0.9118541033","0.9574468085",76.875,137,-60.125,157.5,106.5,8.3560345849,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_SPTCA.1.2|m.1905","P02549","SPTA1_HUMAN","46.96","2453","1249","13","2","2443","8","2419","0","2138","1","P02549","SPTA1_HUMAN","reviewed","Spectrin alpha chain, erythrocytic 1 (Erythroid alpha-spectrin)","SPTA1 SPTA","Homo sapiens (Human)","2419","actin filament capping [GO:0051693]; actin filament organization [GO:0007015]; axon guidance [GO:0007411]; ER to Golgi vesicle-mediated transport [GO:0006888]; hemopoiesis [GO:0030097]; lymphocyte homeostasis [GO:0002260]; MAPK cascade [GO:0000165]; plasma membrane organization [GO:0007009]; porphyrin-containing compound biosynthetic process [GO:0006779]; positive regulation of protein binding [GO:0032092]; positive regulation of T cell proliferation [GO:0042102]; regulation of cell shape [GO:0008360]","GO:0000165; GO:0002260; GO:0005088; GO:0005200; GO:0005509; GO:0005829; GO:0006779; GO:0006888; GO:0007009; GO:0007015; GO:0007411; GO:0008091; GO:0008360; GO:0014731; GO:0015629; GO:0030097; GO:0030424; GO:0031235; GO:0032092; GO:0032437; GO:0042102; GO:0051015; GO:0051693","","","","PF08726;PF00018;PF00435;","actin cytoskeleton [GO:0015629]; axon [GO:0030424]; cuticular plate [GO:0032437]; cytosol [GO:0005829]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; actin filament organization [GO:0007015]; axon guidance [GO:0007411]; ER to Golgi vesicle-mediated transport [GO:0006888]; hemopoiesis [GO:0030097]; lymphocyte homeostasis [GO:0002260]; MAPK cascade [GO:0000165]; plasma membrane organization [GO:0007009]; porphyrin-containing compound biosynthetic process [GO:0006779]; positive regulation of protein binding [GO:0032092]; positive regulation of T cell proliferation [GO:0042102]; regulation of cell shape [GO:0008360]"
"CHOYP_SPTCA.2.2|m.25615",69,"9",50.5,67.5,11,10,77,7.5,9,10,57.0714285714,45.2985560882,"0.7937168776",2051.9591836735,75,"#VALUE!","-1.2907646454","0.2772764034",133,7.5,125.5,9.5,133,399.5,"1.05","0.75",58.375,44.125,14.25,125.5,73.5,4.7317304276,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_SPTCA.2.2|m.25615","P13395","SPTCA_DROME","68.87","2432","736","5","1","2428","1","2415","0","3439","1","P13395","SPTCA_DROME","reviewed","Spectrin alpha chain","alpha-Spec SPEC-A CG1977","Drosophila melanogaster (Fruit fly)","2415","actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; epithelium development [GO:0060429]; fusome organization [GO:0045478]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; germ-line cyst formation [GO:0048134]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; ovarian follicle cell development [GO:0030707]; plasma membrane organization [GO:0007009]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]","GO:0003779; GO:0005509; GO:0005794; GO:0005811; GO:0005886; GO:0005938; GO:0007009; GO:0007026; GO:0007274; GO:0007293; GO:0007294; GO:0007308; GO:0007417; GO:0008017; GO:0008091; GO:0008092; GO:0008360; GO:0016199; GO:0016323; GO:0030707; GO:0030727; GO:0031594; GO:0042062; GO:0045169; GO:0045170; GO:0045478; GO:0048134; GO:0048790; GO:0050807; GO:0051693; GO:0060429","","","cd00051;","PF13499;PF08726;PF00018;PF00435;","basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; lipid particle [GO:0005811]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; cytoskeletal protein binding [GO:0008092]; microtubule binding [GO:0008017]; actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; epithelium development [GO:0060429]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; ovarian follicle cell development [GO:0030707]; plasma membrane organization [GO:0007009]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]"
"CHOYP_SPTCA.2.2|m.25615",29,"3",50.5,74.5,6.5,5,11,10.5,133,75,57.0714285714,45.2985560882,"0.7937168776",2051.9591836735,75,"#VALUE!","-1.2907646454","0.2772764034",133,7.5,125.5,9.5,133,399.5,"1.05","0.75",58.375,44.125,14.25,125.5,73.5,4.7317304276,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_SPTCA.2.2|m.25615","P13395","SPTCA_DROME","68.87","2432","736","5","1","2428","1","2415","0","3439","1","P13395","SPTCA_DROME","reviewed","Spectrin alpha chain","alpha-Spec SPEC-A CG1977","Drosophila melanogaster (Fruit fly)","2415","actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; epithelium development [GO:0060429]; fusome organization [GO:0045478]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; germ-line cyst formation [GO:0048134]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; ovarian follicle cell development [GO:0030707]; plasma membrane organization [GO:0007009]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]","GO:0003779; GO:0005509; GO:0005794; GO:0005811; GO:0005886; GO:0005938; GO:0007009; GO:0007026; GO:0007274; GO:0007293; GO:0007294; GO:0007308; GO:0007417; GO:0008017; GO:0008091; GO:0008092; GO:0008360; GO:0016199; GO:0016323; GO:0030707; GO:0030727; GO:0031594; GO:0042062; GO:0045169; GO:0045170; GO:0045478; GO:0048134; GO:0048790; GO:0050807; GO:0051693; GO:0060429","","","cd00051;","PF13499;PF08726;PF00018;PF00435;","basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; lipid particle [GO:0005811]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; cytoskeletal protein binding [GO:0008092]; microtubule binding [GO:0008017]; actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; epithelium development [GO:0060429]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; ovarian follicle cell development [GO:0030707]; plasma membrane organization [GO:0007009]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]"
"CHOYP_STIP1.2.2|m.54723",37,"3",9,11.5,21.5,11.5,12,10.5,16.5,2,10,8.6106246662,"0.8610624666",74.1428571429,9.5,"#VALUE!","-1.0031608139","0.5194553337",25,0.5,24.5,1.75,25,70,"0.42","0.38",9.25,10.875,-1.625,16,23.5,0.8290891863,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_STIP1.2.2|m.54723","Q9USI5","STI1_SCHPO","37.52","597","323","8","21","575","2","590","2.00E-119","372","1","Q9USI5","STI1_SCHPO","reviewed","Heat shock protein sti1 homolog","sti1 stil SPCC645.14c","Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)","591","protein folding [GO:0006457]","GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0031072; GO:0042030; GO:0043234","","","","PF13181;","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein complex [GO:0043234]; ATPase inhibitor activity [GO:0042030]; heat shock protein binding [GO:0031072]; protein folding [GO:0006457]"
"CHOYP_STIP1.2.2|m.54723",48,"9",9,12.5,2.5,10.5,10.5,9.5,15,25,10,8.6106246662,"0.8610624666",74.1428571429,9.5,"#VALUE!","-1.0031608139","0.5194553337",25,0.5,24.5,1.75,25,70,"0.42","0.38",9.25,10.875,-1.625,16,23.5,0.8290891863,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_STIP1.2.2|m.54723","Q9USI5","STI1_SCHPO","37.52","597","323","8","21","575","2","590","2.00E-119","372","1","Q9USI5","STI1_SCHPO","reviewed","Heat shock protein sti1 homolog","sti1 stil SPCC645.14c","Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)","591","protein folding [GO:0006457]","GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0031072; GO:0042030; GO:0043234","","","","PF13181;","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein complex [GO:0043234]; ATPase inhibitor activity [GO:0042030]; heat shock protein binding [GO:0031072]; protein folding [GO:0006457]"
"CHOYP_SYYC.1.2|m.23460",48,"3",10.5,13.5,16.5,14.5,13.5,4.5,8,8,10.3571428571,4.6268956402,"0.4467347515",21.4081632653,8.5,"#VALUE!","-0.9038388733","-0.2378826085",16,2.5,13.5,8,16,72.5,"0.28125","0.84375",7.125,12.125,-5,11,8,0.8586995144,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_SYYC.1.2|m.23460","P31230","AIMP1_MOUSE","56.77","155","64","2","396","550","137","288","2.00E-49","179","1","P31230","AIMP1_MOUSE","reviewed","Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 (Multisynthase complex auxiliary component p43) [Cleaved into: Endothelial monocyte-activating polypeptide 2 (EMAP-2) (Endothelial monocyte-activating polypeptide II) (EMAP-II) (Small inducible cytokine subfamily E member 1)]","Aimp1 Emap2 Scye1","Mus musculus (Mouse)","310","angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; glucose metabolic process [GO:0006006]; inflammatory response [GO:0006954]; leukocyte migration [GO:0050900]; negative regulation of endothelial cell proliferation [GO:0001937]; tRNA aminoacylation for protein translation [GO:0006418]","GO:0000049; GO:0001525; GO:0001937; GO:0005125; GO:0005615; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0006006; GO:0006418; GO:0006915; GO:0006954; GO:0007155; GO:0007267; GO:0009986; GO:0016020; GO:0017101; GO:0017102; GO:0030133; GO:0042803; GO:0050900; GO:0051020","","","","PF01588;","aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; methionyl glutamyl tRNA synthetase complex [GO:0017102]; nucleus [GO:0005634]; transport vesicle [GO:0030133]; cytokine activity [GO:0005125]; GTPase binding [GO:0051020]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; glucose metabolic process [GO:0006006]; inflammatory response [GO:0006954]; leukocyte migration [GO:0050900]; negative regulation of endothelial cell proliferation [GO:0001937]; tRNA aminoacylation for protein translation [GO:0006418]"
"CHOYP_SYYC.1.2|m.23460",37,"9",10.5,16,12.5,8.5,13.5,13.5,16,16,10.3571428571,4.6268956402,"0.4467347515",21.4081632653,8.5,"#VALUE!","-0.9038388733","-0.2378826085",16,2.5,13.5,8,16,72.5,"0.28125","0.84375",7.125,12.125,-5,11,8,0.8586995144,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_SYYC.1.2|m.23460","P31230","AIMP1_MOUSE","56.77","155","64","2","396","550","137","288","2.00E-49","179","1","P31230","AIMP1_MOUSE","reviewed","Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 (Multisynthase complex auxiliary component p43) [Cleaved into: Endothelial monocyte-activating polypeptide 2 (EMAP-2) (Endothelial monocyte-activating polypeptide II) (EMAP-II) (Small inducible cytokine subfamily E member 1)]","Aimp1 Emap2 Scye1","Mus musculus (Mouse)","310","angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; glucose metabolic process [GO:0006006]; inflammatory response [GO:0006954]; leukocyte migration [GO:0050900]; negative regulation of endothelial cell proliferation [GO:0001937]; tRNA aminoacylation for protein translation [GO:0006418]","GO:0000049; GO:0001525; GO:0001937; GO:0005125; GO:0005615; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0006006; GO:0006418; GO:0006915; GO:0006954; GO:0007155; GO:0007267; GO:0009986; GO:0016020; GO:0017101; GO:0017102; GO:0030133; GO:0042803; GO:0050900; GO:0051020","","","","PF01588;","aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; methionyl glutamyl tRNA synthetase complex [GO:0017102]; nucleus [GO:0005634]; transport vesicle [GO:0030133]; cytokine activity [GO:0005125]; GTPase binding [GO:0051020]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; glucose metabolic process [GO:0006006]; inflammatory response [GO:0006954]; leukocyte migration [GO:0050900]; negative regulation of endothelial cell proliferation [GO:0001937]; tRNA aminoacylation for protein translation [GO:0006418]"
"CHOYP_TAGL3.1.1|m.31031",37,"3",41,44.5,42.5,35,39.5,47,30,35,44.4285714286,16.2841477943,"0.3665242269",265.1734693878,36.5,"#VALUE!","-2.2146762365","0.1198037602",64,22,42,32.5,64,311,"0.7899159664","1.0756302521",40.75,48.75,-8,42,29,3.6835248135,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_TAGL3.1.1|m.31031","P37805","TAGL3_RAT","32.7","159","94","6","6","162","4","151","6.00E-11","61.6","1","P37805","TAGL3_RAT","reviewed","Transgelin-3 (Neuronal protein 22) (NP22) (Neuronal protein NP25)","Tagln3 Np25","Rattus norvegicus (Rat)","199","","","","","cd00014;","PF00402;PF00307;",""
"CHOYP_TAGL3.1.1|m.31031",28,"9",41,47,38.5,32,51.5,64,64,59.5,44.4285714286,16.2841477943,"0.3665242269",265.1734693878,36.5,"#VALUE!","-2.2146762365","0.1198037602",64,22,42,32.5,64,311,"0.7899159664","1.0756302521",40.75,48.75,-8,42,29,3.6835248135,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_TAGL3.1.1|m.31031","P37805","TAGL3_RAT","32.7","159","94","6","6","162","4","151","6.00E-11","61.6","1","P37805","TAGL3_RAT","reviewed","Transgelin-3 (Neuronal protein 22) (NP22) (Neuronal protein NP25)","Tagln3 Np25","Rattus norvegicus (Rat)","199","","","","","cd00014;","PF00402;PF00307;",""
"CHOYP_TBA.1.6|m.12217",48,"9",58.5,4.5,17,20,10.5,6,0,12.5,12.4285714286,8.6455131692,"0.6956160021",74.7448979592,12,"#VALUE!","0.0611796396","0.5813868785",28,0,28,7,28,87,"0.16","0.48",12,10.25,1.75,26,20.5,1.0304394173,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_TBA.1.6|m.12217",45,"3",58.5,75,27,19,14.5,2,28,20.5,12.4285714286,8.6455131692,"0.6956160021",74.7448979592,12,"#VALUE!","0.0611796396","0.5813868785",28,0,28,7,28,87,"0.16","0.48",12,10.25,1.75,26,20.5,1.0304394173,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_TBA1.7.9|m.44107",48,"3",0,0,0,0,0,0,0,0,0,0,"#DIV/0!",0,0,"#VALUE!","#DIV/0!","Err:502",0,0,0,0,0,0,"#DIV/0!","#DIV/0!",0,0,0,0,0,0,"low_abundance","low_variance","low_abundance-low_variance","CHOYP_TBA1.7.9|m.44107","P33628","TBA_PICAB","86.73","113","15","0","20","132","1","113","4.00E-67","216","1","P33628","TBA_PICAB","reviewed","Tubulin alpha chain (Fragment)","TUBA","Picea abies (Norway spruce) (Picea excelsa)","113","microtubule-based process [GO:0007017]","GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017","","","","PF00091;","cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]"
"CHOYP_TBA1.7.9|m.44107",84,"9",0,0,58,0,0,0,0,0,0,0,"#DIV/0!",0,0,"#VALUE!","#DIV/0!","Err:502",0,0,0,0,0,0,"#DIV/0!","#DIV/0!",0,0,0,0,0,0,"low_abundance","low_variance","low_abundance-low_variance","CHOYP_TBA1.7.9|m.44107","P33628","TBA_PICAB","86.73","113","15","0","20","132","1","113","4.00E-67","216","1","P33628","TBA_PICAB","reviewed","Tubulin alpha chain (Fragment)","TUBA","Picea abies (Norway spruce) (Picea excelsa)","113","microtubule-based process [GO:0007017]","GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017","","","","PF00091;","cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]"
"CHOYP_TBA2.1.1|m.955",24,"3",122,99,84,72,82.5,65,21.5,80,59.7142857143,20.9418534158,"0.3507008945",438.5612244898,56,"#VALUE!","0.44973887","-0.3686728175",91,21.5,69.5,51.5,91,418,"1.1607142857","0.9821428571",47.375,73.375,-26,43.5,35,4.9508468554,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_TBA2.1.1|m.955","P09643","TBA4_CHICK","92.24","322","25","0","84","405","1","322","0","602","1","P09643","TBA4_CHICK","reviewed","Tubulin alpha-4 chain (Fragment)","","Gallus gallus (Chicken)","322","microtubule-based process [GO:0007017]","GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017","","","","PF00091;PF03953;","cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]"
"CHOYP_TBA2.1.1|m.955",67,"9",122,95.5,65.5,70.5,55,55,91,56,59.7142857143,20.9418534158,"0.3507008945",438.5612244898,56,"#VALUE!","0.44973887","-0.3686728175",91,21.5,69.5,51.5,91,418,"1.1607142857","0.9821428571",47.375,73.375,-26,43.5,35,4.9508468554,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_TBA2.1.1|m.955","P09643","TBA4_CHICK","92.24","322","25","0","84","405","1","322","0","602","1","P09643","TBA4_CHICK","reviewed","Tubulin alpha-4 chain (Fragment)","","Gallus gallus (Chicken)","322","microtubule-based process [GO:0007017]","GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017","","","","PF00091;PF03953;","cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]"
"CHOYP_TBB4B.1.7|m.12262",8,"3",114.5,136.5,222.5,227.5,171,114,129.5,62.5,141,74.3072770903,"0.5270019652",5521.5714285714,129.5,"#VALUE!","-2.5217133606","0.0783226146",227.5,52,175.5,68.75,227.5,987,"0.5277777778","1.0532407407",136.5,138.75,-2.25,152.5,172.5,11.6901575269,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_TBB4B.1.7|m.12262","Q07972","TBAA_PNECA","39.15","212","121","1","202","405","1","212","9.00E-53","182","1","Q07972","TBAA_PNECA","reviewed","Tubulin alpha chain (Fragment)","TUB-A","Pneumocystis carinii","212","microtubule-based process [GO:0007017]","GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017","","","","PF03953;","cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]"
"CHOYP_TBB4B.1.7|m.12262",56,"9",114.5,223,95,119.5,150,227.5,224.5,216,141,74.3072770903,"0.5270019652",5521.5714285714,129.5,"#VALUE!","-2.5217133606","0.0783226146",227.5,52,175.5,68.75,227.5,987,"0.5277777778","1.0532407407",136.5,138.75,-2.25,152.5,172.5,11.6901575269,"high_abundance","high_variance","high_abundance-high_variance","CHOYP_TBB4B.1.7|m.12262","Q07972","TBAA_PNECA","39.15","212","121","1","202","405","1","212","9.00E-53","182","1","Q07972","TBAA_PNECA","reviewed","Tubulin alpha chain (Fragment)","TUB-A","Pneumocystis carinii","212","microtubule-based process [GO:0007017]","GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017","","","","PF03953;","cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]"
"CHOYP_TBB4B.7.7|m.63980",55,"9",372.5,174,221.5,146,183,108.5,130.5,117.5,137.5,55.8358563751,"0.4060789555",3117.6428571429,130.5,"#VALUE!","0.1890949114","-0.4573167201",211,35,176,113,211,962.5,"2.0340425532","0.9234042553",135,165.375,-30.375,204,93.5,11.3999763117,"high_abundance","high_variance","high_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_TBB4B.7.7|m.63980",7,"3",372.5,301.5,169.5,165,146,239,157.5,211,137.5,55.8358563751,"0.4060789555",3117.6428571429,130.5,"#VALUE!","0.1890949114","-0.4573167201",211,35,176,113,211,962.5,"2.0340425532","0.9234042553",135,165.375,-30.375,204,93.5,11.3999763117,"high_abundance","high_variance","high_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_TCPD.1.1|m.13556",28,"3",38,41.5,39.5,37.5,66.5,39.5,31,35,31.3571428571,6.7066826253,"0.2138805393",44.9795918367,32.5,"#VALUE!","4.4159141851","-1.9668229204",37.5,16,21.5,31,37.5,219.5,"1.0821917808","1.0273972603",31,33.75,-2.75,23.5,5.5,2.5997868056,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_TCPD.1.1|m.13556","Q2T9X2","TCPD_BOVIN","77.03","518","117","2","16","532","24","540","0","827","1","Q2T9X2","TCPD_BOVIN","reviewed","T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta)","CCT4","Bos taurus (Bovine)","542","'de novo' protein folding [GO:0006458]; chaperone-mediated protein folding [GO:0061077]","GO:0005524; GO:0005815; GO:0005832; GO:0005929; GO:0006458; GO:0042470; GO:0044183; GO:0051082; GO:0061077","","","cd03338;","PF00118;","chaperonin-containing T-complex [GO:0005832]; cilium [GO:0005929]; melanosome [GO:0042470]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082]; 'de novo' protein folding [GO:0006458]; chaperone-mediated protein folding [GO:0061077]"
"CHOYP_TCPD.1.1|m.13556",37,"9",38,38,38.5,33,36.5,37.5,32.5,36.5,31.3571428571,6.7066826253,"0.2138805393",44.9795918367,32.5,"#VALUE!","4.4159141851","-1.9668229204",37.5,16,21.5,31,37.5,219.5,"1.0821917808","1.0273972603",31,33.75,-2.75,23.5,5.5,2.5997868056,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_TCPD.1.1|m.13556","Q2T9X2","TCPD_BOVIN","77.03","518","117","2","16","532","24","540","0","827","1","Q2T9X2","TCPD_BOVIN","reviewed","T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta)","CCT4","Bos taurus (Bovine)","542","'de novo' protein folding [GO:0006458]; chaperone-mediated protein folding [GO:0061077]","GO:0005524; GO:0005815; GO:0005832; GO:0005929; GO:0006458; GO:0042470; GO:0044183; GO:0051082; GO:0061077","","","cd03338;","PF00118;","chaperonin-containing T-complex [GO:0005832]; cilium [GO:0005929]; melanosome [GO:0042470]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082]; 'de novo' protein folding [GO:0006458]; chaperone-mediated protein folding [GO:0061077]"
"CHOYP_TEKT3.1.1|m.37281",45,"3",57,52.5,16.5,20,20,16.5,11,7,7.8571428571,3.2372197696,"0.4120097889",10.4795918367,8.5,"#VALUE!","-1.6211984311","-0.5705923386",11,3,8,5.25,11,55,"1.9411764706","1.2941176471",10.5,7.375,3.125,13,8,0.6514272178,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_TEKT3.1.1|m.37281","A6H782","TEKT3_BOVIN","51.14","395","193","0","60","454","87","481","4.00E-138","413","1","A6H782","TEKT3_BOVIN","reviewed","Tektin-3","TEKT3","Bos taurus (Bovine)","490","cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of fertilization [GO:0080154]","GO:0002080; GO:0005634; GO:0005874; GO:0030317; GO:0036126; GO:0060271; GO:0060294; GO:0080154","","","","","acrosomal membrane [GO:0002080]; microtubule [GO:0005874]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of fertilization [GO:0080154]"
"CHOYP_TEKT3.1.1|m.37281",37,"9",57,20.5,14,17.5,18,11,11,8.5,7.8571428571,3.2372197696,"0.4120097889",10.4795918367,8.5,"#VALUE!","-1.6211984311","-0.5705923386",11,3,8,5.25,11,55,"1.9411764706","1.2941176471",10.5,7.375,3.125,13,8,0.6514272178,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_TEKT3.1.1|m.37281","A6H782","TEKT3_BOVIN","51.14","395","193","0","60","454","87","481","4.00E-138","413","1","A6H782","TEKT3_BOVIN","reviewed","Tektin-3","TEKT3","Bos taurus (Bovine)","490","cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of fertilization [GO:0080154]","GO:0002080; GO:0005634; GO:0005874; GO:0030317; GO:0036126; GO:0060271; GO:0060294; GO:0080154","","","","","acrosomal membrane [GO:0002080]; microtubule [GO:0005874]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of fertilization [GO:0080154]"
"CHOYP_TITIN.19.19|m.66288",37,"3",0.5,1,17.5,19,20.5,5.5,0,2,14.9285714286,22.3948791523,"1.5001354456",501.5306122449,1.5,"#VALUE!","0.6829076654","1.4748321437",59.5,0,59.5,1.25,59.5,104.5,"0.141025641","0.0384615385",2.125,25.375,-23.25,5.5,58.5,1.2377117138,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_TITIN.19.19|m.66288","A2ASS6","TITIN_MOUSE","29.61","4701","2877","132","6562","11094","25708","30144","0","1602","1","A2ASS6","TITIN_MOUSE","reviewed","Titin (EC 2.7.11.1) (Connectin)","Ttn","Mus musculus (Mouse)","35213","actin filament organization [GO:0007015]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591]","GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0006941; GO:0007015; GO:0007507; GO:0007512; GO:0008307; GO:0019899; GO:0019901; GO:0021591; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043056; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0060048; GO:0060419; GO:0070062; GO:0071688; GO:0097493; GO:1901897","","","cd00063;","PF00041;PF07679;PF00069;PF02818;PF09042;","A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; extracellular exosome [GO:0070062]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; actin filament organization [GO:0007015]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591]"
"CHOYP_TITIN.19.19|m.66288",82,"9",0.5,0,1,0.5,18.5,1.5,59.5,39,14.9285714286,22.3948791523,"1.5001354456",501.5306122449,1.5,"#VALUE!","0.6829076654","1.4748321437",59.5,0,59.5,1.25,59.5,104.5,"0.141025641","0.0384615385",2.125,25.375,-23.25,5.5,58.5,1.2377117138,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_TITIN.19.19|m.66288","A2ASS6","TITIN_MOUSE","29.61","4701","2877","132","6562","11094","25708","30144","0","1602","1","A2ASS6","TITIN_MOUSE","reviewed","Titin (EC 2.7.11.1) (Connectin)","Ttn","Mus musculus (Mouse)","35213","actin filament organization [GO:0007015]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591]","GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0006941; GO:0007015; GO:0007507; GO:0007512; GO:0008307; GO:0019899; GO:0019901; GO:0021591; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043056; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0060048; GO:0060419; GO:0070062; GO:0071688; GO:0097493; GO:1901897","","","cd00063;","PF00041;PF07679;PF00069;PF02818;PF09042;","A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; extracellular exosome [GO:0070062]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; actin filament organization [GO:0007015]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591]"
"CHOYP_TITIN.6.19|m.31591",83,"9",0,0,18.5,15,0,22.5,64.5,0,12.4285714286,22.6312498415,"1.8209051597",512.1734693878,0,"#VALUE!","4.3783530162","2.1184067285",64.5,0,64.5,0,64.5,87,"#DIV/0!","#DIV/0!",8.75,16.125,-7.375,22.5,64.5,1.0304394173,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_TITIN.6.19|m.31591","Q8WZ42","TITIN_HUMAN","29.19","1881","1049","52","2884","4674","942","2629","3.00E-178","628","1","Q8WZ42","TITIN_HUMAN","reviewed","Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14)","TTN","Homo sapiens (Human)","34350","cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]","GO:0000794; GO:0002020; GO:0002576; GO:0003300; GO:0004674; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005859; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0019899; GO:0019901; GO:0030018; GO:0030049; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0060048; GO:0070062; GO:0097493","","","cd00063;","PF00041;PF07679;PF00069;PF02818;PF09042;","condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]"
"CHOYP_TITIN.6.19|m.31591",48,"3",0,0,0,0,15,12.5,0,0,12.4285714286,22.6312498415,"1.8209051597",512.1734693878,0,"#VALUE!","4.3783530162","2.1184067285",64.5,0,64.5,0,64.5,87,"#DIV/0!","#DIV/0!",8.75,16.125,-7.375,22.5,64.5,1.0304394173,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_TITIN.6.19|m.31591","Q8WZ42","TITIN_HUMAN","29.19","1881","1049","52","2884","4674","942","2629","3.00E-178","628","1","Q8WZ42","TITIN_HUMAN","reviewed","Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14)","TTN","Homo sapiens (Human)","34350","cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]","GO:0000794; GO:0002020; GO:0002576; GO:0003300; GO:0004674; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005859; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0019899; GO:0019901; GO:0030018; GO:0030049; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0060048; GO:0070062; GO:0097493","","","cd00063;","PF00041;PF07679;PF00069;PF02818;PF09042;","condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]"
"CHOYP_TLN1.4.4|m.33719",64,"9",93,115.5,114.5,94.5,114.5,127.5,139,124,106.9285714286,31.7506226839,"0.2969330111",1008.1020408163,122.5,"#VALUE!","3.3683552119","-1.7338978534",139,36.5,102.5,99.5,139,748.5,"0.9959677419","1.0282258065",96.625,121.375,-24.75,91,39,8.8653322279,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_TLN1.4.4|m.33719","Q9Y490","TLN1_HUMAN","57.8","2559","1041","15","1","2548","1","2531","0","2836","1","Q9Y490","TLN1_HUMAN","reviewed","Talin-1","TLN1 KIAA1027 TLN","Homo sapiens (Human)","2541","cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeletal anchoring at plasma membrane [GO:0007016]; IRE1-mediated unfolded protein response [GO:0036498]; movement of cell or subcellular component [GO:0006928]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032]","GO:0001726; GO:0002576; GO:0005178; GO:0005200; GO:0005576; GO:0005829; GO:0005856; GO:0005911; GO:0005925; GO:0006928; GO:0006936; GO:0007016; GO:0007043; GO:0007044; GO:0009986; GO:0016032; GO:0017166; GO:0030274; GO:0030866; GO:0032587; GO:0036498; GO:0045296; GO:0070062; GO:0070527","","","","PF16511;PF00373;PF09379;PF01608;PF09141;PF08913;","cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeletal anchoring at plasma membrane [GO:0007016]; IRE1-mediated unfolded protein response [GO:0036498]; movement of cell or subcellular component [GO:0006928]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032]"
"CHOYP_TLN1.4.4|m.33719",17,"3",93,108,108,106.5,109.5,123.5,99,122.5,106.9285714286,31.7506226839,"0.2969330111",1008.1020408163,122.5,"#VALUE!","3.3683552119","-1.7338978534",139,36.5,102.5,99.5,139,748.5,"0.9959677419","1.0282258065",96.625,121.375,-24.75,91,39,8.8653322279,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_TLN1.4.4|m.33719","Q9Y490","TLN1_HUMAN","57.8","2559","1041","15","1","2548","1","2531","0","2836","1","Q9Y490","TLN1_HUMAN","reviewed","Talin-1","TLN1 KIAA1027 TLN","Homo sapiens (Human)","2541","cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeletal anchoring at plasma membrane [GO:0007016]; IRE1-mediated unfolded protein response [GO:0036498]; movement of cell or subcellular component [GO:0006928]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032]","GO:0001726; GO:0002576; GO:0005178; GO:0005200; GO:0005576; GO:0005829; GO:0005856; GO:0005911; GO:0005925; GO:0006928; GO:0006936; GO:0007016; GO:0007043; GO:0007044; GO:0009986; GO:0016032; GO:0017166; GO:0030274; GO:0030866; GO:0032587; GO:0036498; GO:0045296; GO:0070062; GO:0070527","","","","PF16511;PF00373;PF09379;PF01608;PF09141;PF08913;","cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeletal anchoring at plasma membrane [GO:0007016]; IRE1-mediated unfolded protein response [GO:0036498]; movement of cell or subcellular component [GO:0006928]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032]"
"CHOYP_TPM.17.19|m.63919",37,"3",0,0,23,21.5,19,19,14.5,0,13.1428571429,16.9257080158,"1.2878256099",286.4795918367,0,"#VALUE!","-1.2903716634","0.939040119",39.5,0,39.5,0,39.5,92,"0.4810126582","0.9620253165",17.875,9.875,8,38,39.5,1.0896600734,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_TPM.17.19|m.63919",81,"9",0,0,0,10.5,37,38,0,39.5,13.1428571429,16.9257080158,"1.2878256099",286.4795918367,0,"#VALUE!","-1.2903716634","0.939040119",39.5,0,39.5,0,39.5,92,"0.4810126582","0.9620253165",17.875,9.875,8,38,39.5,1.0896600734,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_TRIADDRAFT_26208.1.1|m.10460",48,"3",14.5,15,14.5,14,11,11.5,10,10,10.5,4.1231056256,"0.3926767262",17,10,"#VALUE!","-0.3268413248","-0.6577828798",15.5,3,12.5,8.5,15.5,73.5,"0.7931034483","0.9310344828",9.5,11.75,-2.25,10.5,8.5,0.8705436456,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_TRIADDRAFT_26208.1.1|m.10460","P31029","SPYA_CALJA","55.41","379","169","0","43","421","29","407","4.00E-153","447","1","P31029","SPYA_CALJA","reviewed","Serine--pyruvate aminotransferase, mitochondrial (SPT) (EC 2.6.1.51) (Alanine--glyoxylate aminotransferase) (AGT) (EC 2.6.1.44)","AGXT AGT1","Callithrix jacchus (White-tufted-ear marmoset)","414","glycine biosynthetic process, by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; L-alanine catabolic process [GO:0042853]; L-cysteine catabolic process [GO:0019448]; Notch signaling pathway [GO:0007219]; oxalic acid secretion [GO:0046724]; proteasomal protein catabolic process [GO:0010498]","GO:0004760; GO:0005759; GO:0005782; GO:0007219; GO:0008453; GO:0009436; GO:0010498; GO:0016597; GO:0019265; GO:0019448; GO:0030170; GO:0042803; GO:0042853; GO:0043621; GO:0046724","","","","PF00266;","mitochondrial matrix [GO:0005759]; peroxisomal matrix [GO:0005782]; alanine-glyoxylate transaminase activity [GO:0008453]; amino acid binding [GO:0016597]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; pyridoxal phosphate binding [GO:0030170]; serine-pyruvate transaminase activity [GO:0004760]; glycine biosynthetic process, by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; L-alanine catabolic process [GO:0042853]; L-cysteine catabolic process [GO:0019448]; Notch signaling pathway [GO:0007219]; oxalic acid secretion [GO:0046724]; proteasomal protein catabolic process [GO:0010498]"
"CHOYP_TRIADDRAFT_26208.1.1|m.10460",37,"9",14.5,14,11.5,11.5,12,13.5,15.5,14.5,10.5,4.1231056256,"0.3926767262",17,10,"#VALUE!","-0.3268413248","-0.6577828798",15.5,3,12.5,8.5,15.5,73.5,"0.7931034483","0.9310344828",9.5,11.75,-2.25,10.5,8.5,0.8705436456,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_TRIADDRAFT_26208.1.1|m.10460","P31029","SPYA_CALJA","55.41","379","169","0","43","421","29","407","4.00E-153","447","1","P31029","SPYA_CALJA","reviewed","Serine--pyruvate aminotransferase, mitochondrial (SPT) (EC 2.6.1.51) (Alanine--glyoxylate aminotransferase) (AGT) (EC 2.6.1.44)","AGXT AGT1","Callithrix jacchus (White-tufted-ear marmoset)","414","glycine biosynthetic process, by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; L-alanine catabolic process [GO:0042853]; L-cysteine catabolic process [GO:0019448]; Notch signaling pathway [GO:0007219]; oxalic acid secretion [GO:0046724]; proteasomal protein catabolic process [GO:0010498]","GO:0004760; GO:0005759; GO:0005782; GO:0007219; GO:0008453; GO:0009436; GO:0010498; GO:0016597; GO:0019265; GO:0019448; GO:0030170; GO:0042803; GO:0042853; GO:0043621; GO:0046724","","","","PF00266;","mitochondrial matrix [GO:0005759]; peroxisomal matrix [GO:0005782]; alanine-glyoxylate transaminase activity [GO:0008453]; amino acid binding [GO:0016597]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; pyridoxal phosphate binding [GO:0030170]; serine-pyruvate transaminase activity [GO:0004760]; glycine biosynthetic process, by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; L-alanine catabolic process [GO:0042853]; L-cysteine catabolic process [GO:0019448]; Notch signaling pathway [GO:0007219]; oxalic acid secretion [GO:0046724]; proteasomal protein catabolic process [GO:0010498]"
"CHOYP_TRIADDRAFT_63204.1.2|m.30701",17,"3",97.5,103.5,102.5,111.5,99.5,111.5,85.5,94.5,94.6428571429,21.9312469285,"0.2317263826",480.9795918367,94.5,"#VALUE!","1.3188493086","-1.122908573",117.5,50,67.5,86.75,117.5,662.5,"0.9489361702","0.9872340426",90.75,102.75,-12,66,29.5,7.8467369418,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_TRIADDRAFT_63204.1.2|m.30701","Q9BYV1","AGT2_HUMAN","56.32","451","193","3","21","470","44","491","0","563","1","Q9BYV1","AGT2_HUMAN","reviewed","Alanine--glyoxylate aminotransferase 2, mitochondrial (AGT 2) (EC 2.6.1.44) ((R)-3-amino-2-methylpropionate--pyruvate transaminase) (EC 2.6.1.40) (Beta-ALAAT II) (Beta-alanine-pyruvate aminotransferase) (D-AIBAT)","AGXT2 AGT2","Homo sapiens (Human)","514","glycine biosynthetic process, by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; glyoxylate metabolic process [GO:0046487]; L-alanine catabolic process, by transamination [GO:0019481]; positive regulation of nitric oxide biosynthetic process [GO:0045429]","GO:0005739; GO:0005759; GO:0008453; GO:0009436; GO:0019265; GO:0019481; GO:0030170; GO:0042802; GO:0045429; GO:0046487; GO:0047305","","","cd00610;","PF00202;","mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; (R)-3-amino-2-methylpropionate-pyruvate transaminase activity [GO:0047305]; alanine-glyoxylate transaminase activity [GO:0008453]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170]; glycine biosynthetic process, by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; glyoxylate metabolic process [GO:0046487]; L-alanine catabolic process, by transamination [GO:0019481]; positive regulation of nitric oxide biosynthetic process [GO:0045429]"
"CHOYP_TRIADDRAFT_63204.1.2|m.30701",64,"9",97.5,106,96.5,87.5,111,116,111,117.5,94.6428571429,21.9312469285,"0.2317263826",480.9795918367,94.5,"#VALUE!","1.3188493086","-1.122908573",117.5,50,67.5,86.75,117.5,662.5,"0.9489361702","0.9872340426",90.75,102.75,-12,66,29.5,7.8467369418,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_TRIADDRAFT_63204.1.2|m.30701","Q9BYV1","AGT2_HUMAN","56.32","451","193","3","21","470","44","491","0","563","1","Q9BYV1","AGT2_HUMAN","reviewed","Alanine--glyoxylate aminotransferase 2, mitochondrial (AGT 2) (EC 2.6.1.44) ((R)-3-amino-2-methylpropionate--pyruvate transaminase) (EC 2.6.1.40) (Beta-ALAAT II) (Beta-alanine-pyruvate aminotransferase) (D-AIBAT)","AGXT2 AGT2","Homo sapiens (Human)","514","glycine biosynthetic process, by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; glyoxylate metabolic process [GO:0046487]; L-alanine catabolic process, by transamination [GO:0019481]; positive regulation of nitric oxide biosynthetic process [GO:0045429]","GO:0005739; GO:0005759; GO:0008453; GO:0009436; GO:0019265; GO:0019481; GO:0030170; GO:0042802; GO:0045429; GO:0046487; GO:0047305","","","cd00610;","PF00202;","mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; (R)-3-amino-2-methylpropionate-pyruvate transaminase activity [GO:0047305]; alanine-glyoxylate transaminase activity [GO:0008453]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170]; glycine biosynthetic process, by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; glyoxylate metabolic process [GO:0046487]; L-alanine catabolic process, by transamination [GO:0019481]; positive regulation of nitric oxide biosynthetic process [GO:0045429]"
"CHOYP_TVAG_355490.15.22|m.47579",37,"3",30.5,23,18.5,6,4,0,22.5,22,10.5714285714,8.5290619624,"0.8068031586",72.7448979592,9,"#VALUE!","-1.3604526888","0.2427800929",22.5,0,22.5,4,22.5,74,"0","0",5.625,12.875,-7.25,22.5,14,0.8764657112,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_TVAG_355490.15.22|m.47579",48,"9",30.5,10,7,7,1,0,8,9,10.5714285714,8.5290619624,"0.8068031586",72.7448979592,9,"#VALUE!","-1.3604526888","0.2427800929",22.5,0,22.5,4,22.5,74,"0","0",5.625,12.875,-7.25,22.5,14,0.8764657112,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_TYRO.1.1|m.38876",48,"3",0,2.5,11.5,16,17,12.5,4,5,7.7857142857,5.0203666831,"0.6448177391",25.2040816327,6.5,"#VALUE!","-1.2052194266","0.0469916778",15,0,15,4.5,15,54.5,"1.1904761905","1.4285714286",7.875,8.875,-1,15,8.5,0.6455051522,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_TYRO.1.1|m.38876",37,"9",0,13,19,13,13.5,15,13.5,10.5,7.7857142857,5.0203666831,"0.6448177391",25.2040816327,6.5,"#VALUE!","-1.2052194266","0.0469916778",15,0,15,4.5,15,54.5,"1.1904761905","1.4285714286",7.875,8.875,-1,15,8.5,0.6455051522,"low_abundance","high_variance","low_abundance-high_variance","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None","None"
"CHOYP_U2AF2.1.1|m.30416",37,"3",14,13.5,16.5,15.5,17,17.5,10.5,12.5,10.5714285714,3.0169588688,"0.2853880011",9.1020408163,12,"#VALUE!","5.1838695731","-2.2000862225",13,3.5,9.5,10.5,13,74,"1.4583333333","0.875",10.5,12.375,-1.875,14,1,0.8764657112,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_U2AF2.1.1|m.30416","Q24562","U2AF2_DROME","75.46","383","81","4","97","469","37","416","0","610","1","Q24562","U2AF2_DROME","reviewed","Splicing factor U2AF 50 kDa subunit (U2 auxiliary factor 50 kDa subunit) (U2 snRNP auxiliary factor large subunit)","U2af50 CG9998","Drosophila melanogaster (Fruit fly)","416","mRNA splicing, via spliceosome [GO:0000398]; neurogenesis [GO:0022008]; nuclear export [GO:0051168]; positive regulation of RNA export from nucleus [GO:0046833]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]","GO:0000166; GO:0000243; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0008187; GO:0008380; GO:0016607; GO:0022008; GO:0030628; GO:0046833; GO:0051168; GO:0071004; GO:0071011; GO:0089701","","","","PF00076;","commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2-type prespliceosome [GO:0071004]; U2AF [GO:0089701]; mRNA binding [GO:0003729]; nucleotide binding [GO:0000166]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; neurogenesis [GO:0022008]; nuclear export [GO:0051168]; positive regulation of RNA export from nucleus [GO:0046833]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"
"CHOYP_U2AF2.1.1|m.30416",48,"9",14,14.5,13,10,15.5,10.5,12,12,10.5714285714,3.0169588688,"0.2853880011",9.1020408163,12,"#VALUE!","5.1838695731","-2.2000862225",13,3.5,9.5,10.5,13,74,"1.4583333333","0.875",10.5,12.375,-1.875,14,1,0.8764657112,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_U2AF2.1.1|m.30416","Q24562","U2AF2_DROME","75.46","383","81","4","97","469","37","416","0","610","1","Q24562","U2AF2_DROME","reviewed","Splicing factor U2AF 50 kDa subunit (U2 auxiliary factor 50 kDa subunit) (U2 snRNP auxiliary factor large subunit)","U2af50 CG9998","Drosophila melanogaster (Fruit fly)","416","mRNA splicing, via spliceosome [GO:0000398]; neurogenesis [GO:0022008]; nuclear export [GO:0051168]; positive regulation of RNA export from nucleus [GO:0046833]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]","GO:0000166; GO:0000243; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0008187; GO:0008380; GO:0016607; GO:0022008; GO:0030628; GO:0046833; GO:0051168; GO:0071004; GO:0071011; GO:0089701","","","","PF00076;","commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2-type prespliceosome [GO:0071004]; U2AF [GO:0089701]; mRNA binding [GO:0003729]; nucleotide binding [GO:0000166]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; neurogenesis [GO:0022008]; nuclear export [GO:0051168]; positive regulation of RNA export from nucleus [GO:0046833]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]"
"CHOYP_UAFA.3.8|m.34702",48,"3",12,11,0,7,0,17.5,7.5,10.5,7.4285714286,7.4662505958,"1.0050721956",55.7448979592,7.5,"#VALUE!","-0.5330332767","0.6547589635",21,0,21,0,21,52,"1.3461538462","1.6153846154",11.5,5.875,5.625,21,13,0.6158948241,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_UAFA.3.8|m.34702","P11137","MTAP2_HUMAN","53.08","130","48","3","1606","1727","1649","1773","2.00E-27","125","1","P11137","MTAP2_HUMAN","reviewed","Microtubule-associated protein 2 (MAP-2)","MAP2","Homo sapiens (Human)","1827","central nervous system neuron development [GO:0021954]; dendrite morphogenesis [GO:0048813]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; neuron projection development [GO:0031175]","GO:0000226; GO:0001578; GO:0002162; GO:0005198; GO:0005730; GO:0005829; GO:0005874; GO:0005875; GO:0008017; GO:0021954; GO:0031175; GO:0043005; GO:0048813","","","","PF08377;PF00418;","cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; dystroglycan binding [GO:0002162]; microtubule binding [GO:0008017]; structural molecule activity [GO:0005198]; central nervous system neuron development [GO:0021954]; dendrite morphogenesis [GO:0048813]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; neuron projection development [GO:0031175]"
"CHOYP_UAFA.3.8|m.34702",37,"9",12,17,12.5,10.5,23,21,0,13,7.4285714286,7.4662505958,"1.0050721956",55.7448979592,7.5,"#VALUE!","-0.5330332767","0.6547589635",21,0,21,0,21,52,"1.3461538462","1.6153846154",11.5,5.875,5.625,21,13,0.6158948241,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_UAFA.3.8|m.34702","P11137","MTAP2_HUMAN","53.08","130","48","3","1606","1727","1649","1773","2.00E-27","125","1","P11137","MTAP2_HUMAN","reviewed","Microtubule-associated protein 2 (MAP-2)","MAP2","Homo sapiens (Human)","1827","central nervous system neuron development [GO:0021954]; dendrite morphogenesis [GO:0048813]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; neuron projection development [GO:0031175]","GO:0000226; GO:0001578; GO:0002162; GO:0005198; GO:0005730; GO:0005829; GO:0005874; GO:0005875; GO:0008017; GO:0021954; GO:0031175; GO:0043005; GO:0048813","","","","PF08377;PF00418;","cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; dystroglycan binding [GO:0002162]; microtubule binding [GO:0008017]; structural molecule activity [GO:0005198]; central nervous system neuron development [GO:0021954]; dendrite morphogenesis [GO:0048813]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; neuron projection development [GO:0031175]"
"CHOYP_UBP15.4.4|m.56615",48,"3",10.5,9,13.5,10.5,11,10.5,11.5,14.5,12.4285714286,3.0169588688,"0.242743817",9.1020408163,13,"#VALUE!","2.2999748638","-1.4309797568",15.5,6,9.5,11.5,15.5,87,"0.7","0.8666666667",10.25,14.125,-3.875,7,4,1.0304394173,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_UBP15.4.4|m.56615","Q9R085","UBP15_RAT","54.85","928","374","12","1","907","1","904","0","1025","1","Q9R085","UBP15_RAT","reviewed","Ubiquitin carboxyl-terminal hydrolase 15 (EC 3.4.19.12) (Deubiquitinating enzyme 15) (Ubiquitin carboxyl-terminal hydrolase of 109 kDa) (Ubiquitin thioesterase 15) (Ubiquitin-specific-processing protease 15)","Usp15 ubp109","Rattus norvegicus (Rat)","952","BMP signaling pathway [GO:0030509]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; monoubiquitinated protein deubiquitination [GO:0035520]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; protein deubiquitination [GO:0016579]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0006511; GO:0007179; GO:0016579; GO:0030509; GO:0035520; GO:0035616; GO:0060389","","","","PF06337;PF14836;PF00443;PF14533;","cytoplasm [GO:0005737]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; BMP signaling pathway [GO:0030509]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; monoubiquitinated protein deubiquitination [GO:0035520]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; protein deubiquitination [GO:0016579]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511]"
"CHOYP_UBP15.4.4|m.56615",37,"9",10.5,16.5,13,11.5,15.5,13,15.5,15,12.4285714286,3.0169588688,"0.242743817",9.1020408163,13,"#VALUE!","2.2999748638","-1.4309797568",15.5,6,9.5,11.5,15.5,87,"0.7","0.8666666667",10.25,14.125,-3.875,7,4,1.0304394173,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_UBP15.4.4|m.56615","Q9R085","UBP15_RAT","54.85","928","374","12","1","907","1","904","0","1025","1","Q9R085","UBP15_RAT","reviewed","Ubiquitin carboxyl-terminal hydrolase 15 (EC 3.4.19.12) (Deubiquitinating enzyme 15) (Ubiquitin carboxyl-terminal hydrolase of 109 kDa) (Ubiquitin thioesterase 15) (Ubiquitin-specific-processing protease 15)","Usp15 ubp109","Rattus norvegicus (Rat)","952","BMP signaling pathway [GO:0030509]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; monoubiquitinated protein deubiquitination [GO:0035520]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; protein deubiquitination [GO:0016579]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0006511; GO:0007179; GO:0016579; GO:0030509; GO:0035520; GO:0035616; GO:0060389","","","","PF06337;PF14836;PF00443;PF14533;","cytoplasm [GO:0005737]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; BMP signaling pathway [GO:0030509]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; monoubiquitinated protein deubiquitination [GO:0035520]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; protein deubiquitination [GO:0016579]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511]"
"CHOYP_VATE.1.1|m.21420",37,"3",13.5,16.5,14,9.5,13,15,10,10.5,10.2142857143,2.8767186522,"0.2816367911",8.2755102041,11,"#VALUE!","5.0636640764","-2.1481392718",12.5,3.5,9,10.25,12.5,71.5,"1.2","0.88",9.875,11.75,-1.875,11.5,2,0.8468553832,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_VATE.1.1|m.21420","P54611","VATE_DROME","65.04","226","79","0","57","282","1","226","2.00E-102","305","1","P54611","VATE_DROME","reviewed","V-type proton ATPase subunit E (V-ATPase subunit E) (V-ATPase 26 kDa subunit) (Vacuolar proton pump subunit E)","Vha26 CG1088","Drosophila melanogaster (Fruit fly)","226","apical protein localization [GO:0045176]; ATP hydrolysis coupled proton transport [GO:0015991]; terminal branching, open tracheal system [GO:0007430]; trachea morphogenesis [GO:0060439]","GO:0000221; GO:0005886; GO:0007430; GO:0015991; GO:0033181; GO:0045176; GO:0046961; GO:0060439","","","","PF01991;","plasma membrane [GO:0005886]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; apical protein localization [GO:0045176]; ATP hydrolysis coupled proton transport [GO:0015991]; terminal branching, open tracheal system [GO:0007430]; trachea morphogenesis [GO:0060439]"
"CHOYP_VATE.1.1|m.21420",48,"9",13.5,13,14.5,11.5,13.5,11,12.5,12.5,10.2142857143,2.8767186522,"0.2816367911",8.2755102041,11,"#VALUE!","5.0636640764","-2.1481392718",12.5,3.5,9,10.25,12.5,71.5,"1.2","0.88",9.875,11.75,-1.875,11.5,2,0.8468553832,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_VATE.1.1|m.21420","P54611","VATE_DROME","65.04","226","79","0","57","282","1","226","2.00E-102","305","1","P54611","VATE_DROME","reviewed","V-type proton ATPase subunit E (V-ATPase subunit E) (V-ATPase 26 kDa subunit) (Vacuolar proton pump subunit E)","Vha26 CG1088","Drosophila melanogaster (Fruit fly)","226","apical protein localization [GO:0045176]; ATP hydrolysis coupled proton transport [GO:0015991]; terminal branching, open tracheal system [GO:0007430]; trachea morphogenesis [GO:0060439]","GO:0000221; GO:0005886; GO:0007430; GO:0015991; GO:0033181; GO:0045176; GO:0046961; GO:0060439","","","","PF01991;","plasma membrane [GO:0005886]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; apical protein localization [GO:0045176]; ATP hydrolysis coupled proton transport [GO:0015991]; terminal branching, open tracheal system [GO:0007430]; trachea morphogenesis [GO:0060439]"
"CHOYP_VOLCADRAFT_93060.2.2|m.26741",35,"3",110.5,102,50,40,43.5,44.5,27,28.5,29.2142857143,5.6748640189,"0.1942496241",32.2040816327,28.5,"#VALUE!","0.8466458963","-0.1776749979",38.5,19,19.5,27,38.5,204.5,"1.6481481481","1.2592592593",31.125,31.125,0,25.5,11.5,2.4221248371,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_VOLCADRAFT_93060.2.2|m.26741","P81262","IPSG_UNCUN","36.27","102","46","4","55","138","22","122","7.00E-10","58.2","1","P81262","IPSG_PANUN","reviewed","Double-headed protease inhibitor, submandibular gland","","Panthera uncia (Snow leopard) (Uncia uncia)","122","","GO:0004867; GO:0005576","","","","PF00050;","extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]"
"CHOYP_VOLCADRAFT_93060.2.2|m.26741",37,"9",110.5,54,32,26.5,33.5,34,30.5,27,29.2142857143,5.6748640189,"0.1942496241",32.2040816327,28.5,"#VALUE!","0.8466458963","-0.1776749979",38.5,19,19.5,27,38.5,204.5,"1.6481481481","1.2592592593",31.125,31.125,0,25.5,11.5,2.4221248371,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_VOLCADRAFT_93060.2.2|m.26741","P81262","IPSG_UNCUN","36.27","102","46","4","55","138","22","122","7.00E-10","58.2","1","P81262","IPSG_PANUN","reviewed","Double-headed protease inhibitor, submandibular gland","","Panthera uncia (Snow leopard) (Uncia uncia)","122","","GO:0004867; GO:0005576","","","","PF00050;","extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]"
"CHOYP_Y0417.2.2|m.29395",37,"3",13,16,16,15.5,15,16.5,13.5,14,11.6428571429,2.6687916703,"0.2292213705",7.1224489796,12.5,"#VALUE!","-0.9166131641","-0.5492845522",15,7,8,9.75,15,81.5,"1.7368421053","0.7368421053",12.375,12.125,0.25,9.5,5.5,0.9652966955,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_Y0417.2.2|m.29395","F1LNI5","PPM1G_RAT","60.19","206","71","3","500","702","320","517","1.00E-71","248","1","F1LNI5","PPM1G_RAT","reviewed","Protein phosphatase 1G (EC 3.1.3.16) (Protein phosphatase magnesium-dependent 1 gamma)","Ppm1g","Rattus norvegicus (Rat)","542","cell cycle [GO:0007049]","GO:0004722; GO:0005737; GO:0007049; GO:0016020; GO:0046872","","","","PF00481;","cytoplasm [GO:0005737]; membrane [GO:0016020]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle [GO:0007049]"
"CHOYP_Y0417.2.2|m.29395",48,"9",13,13.5,16,11.5,15.5,7,10,9.5,11.6428571429,2.6687916703,"0.2292213705",7.1224489796,12.5,"#VALUE!","-0.9166131641","-0.5492845522",15,7,8,9.75,15,81.5,"1.7368421053","0.7368421053",12.375,12.125,0.25,9.5,5.5,0.9652966955,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_Y0417.2.2|m.29395","F1LNI5","PPM1G_RAT","60.19","206","71","3","500","702","320","517","1.00E-71","248","1","F1LNI5","PPM1G_RAT","reviewed","Protein phosphatase 1G (EC 3.1.3.16) (Protein phosphatase magnesium-dependent 1 gamma)","Ppm1g","Rattus norvegicus (Rat)","542","cell cycle [GO:0007049]","GO:0004722; GO:0005737; GO:0007049; GO:0016020; GO:0046872","","","","PF00481;","cytoplasm [GO:0005737]; membrane [GO:0016020]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle [GO:0007049]"
"CHOYP_Y1004.1.1|m.18927",48,"3",13,15.5,12.5,10.5,8.5,6.5,11,12,13.5714285714,5.088001091,"0.3749053435",25.887755102,12.5,"#VALUE!","0.3662919575","-0.6174281499",20.5,4,16.5,11.5,20.5,95,"0.3170731707","0.8292682927",9.625,15.75,-6.125,13,8.5,1.1251924671,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_Y1004.1.1|m.18927","P34501","YMS5_CAEEL","26.45","1017","615","32","148","1062","311","1296","9.00E-85","304","1","P34501","YMS5_CAEEL","reviewed","Uncharacterized protein K03H1.5","K03H1.5","Caenorhabditis elegans","1385","cell-matrix adhesion [GO:0007160]","GO:0007160","","","cd00033;","PF03782;PF06119;PF00084;PF00094;","cell-matrix adhesion [GO:0007160]"
"CHOYP_Y1004.1.1|m.18927",37,"9",13,11,10.5,9,9,17,18,20.5,13.5714285714,5.088001091,"0.3749053435",25.887755102,12.5,"#VALUE!","0.3662919575","-0.6174281499",20.5,4,16.5,11.5,20.5,95,"0.3170731707","0.8292682927",9.625,15.75,-6.125,13,8.5,1.1251924671,"low_abundance","high_variance","low_abundance-high_variance","CHOYP_Y1004.1.1|m.18927","P34501","YMS5_CAEEL","26.45","1017","615","32","148","1062","311","1296","9.00E-85","304","1","P34501","YMS5_CAEEL","reviewed","Uncharacterized protein K03H1.5","K03H1.5","Caenorhabditis elegans","1385","cell-matrix adhesion [GO:0007160]","GO:0007160","","","cd00033;","PF03782;PF06119;PF00084;PF00094;","cell-matrix adhesion [GO:0007160]"
